

  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzaldehyde
C7H5BrO
3132-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[Bis(ethylthio)methyl]-3-bromobenzene
C11H15BrS2
1073536-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8500 0.0 0
M  V30 2 S 6.6684 4.6201 0.0 0
M  V30 3 S 5.3348 2.3100 0.0 0
M  V30 4 C 8.0022 3.8500 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 C 6.6684 0.0000 0.0 0
M  V30 8 Br 0.0000 3.8500 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 2.6675 3.8500 0.0 0
M  V30 11 C 4.0011 6.1601 0.0 0
M  V30 12 C 1.3337 4.6201 0.0 0
M  V30 13 C 2.6675 6.9301 0.0 0
M  V30 14 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3132-99-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1073536-42-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-18890777
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-63-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chlorotrimethylsilane and Sodium Iodide: A Remarkable Metal-Free
Association for the Desulfurization of Benzylic Dithioketals under Mild
Conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Guangkuan; Yuan, Ling-Zhi; Alami, Mouad; Provot, Olivier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2018), 360(13), 2522-2536

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tributyltin chloride
C12H27ClSn
1461-22-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Sn 4.6201 5.3348 0.0 0
M  V30 2 C 3.8501 6.6687 0.0 0
M  V30 3 C 5.3901 4.0012 0.0 0
M  V30 4 C 5.9539 6.1048 0.0 0
M  V30 5 Cl 3.2864 4.5648 0.0 0
M  V30 6 C 2.3101 6.6687 0.0 0
M  V30 7 C 4.6201 2.6675 0.0 0
M  V30 8 C 7.2876 5.3348 0.0 0
M  V30 9 C 1.5400 8.0023 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 11 C 8.6213 6.1048 0.0 0
M  V30 12 C 0.0000 8.0023 0.0 0
M  V30 13 C 4.6201 0.0000 0.0 0
M  V30 14 C 9.9551 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(tert-Butylsulphanyl)tributyltin
C16H36SSn
23728-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Sn 5.3348 5.3348 0.0 0
M  V30 2 S 6.1048 6.6685 0.0 0
M  V30 3 C 4.5648 4.0012 0.0 0
M  V30 4 C 4.0012 6.1048 0.0 0
M  V30 5 C 6.6685 4.5648 0.0 0
M  V30 6 C 5.3348 8.0023 0.0 0
M  V30 7 C 5.3348 2.6675 0.0 0
M  V30 8 C 2.6673 5.3348 0.0 0
M  V30 9 C 8.0023 5.3348 0.0 0
M  V30 10 C 6.6685 8.7723 0.0 0
M  V30 11 C 4.5648 9.3360 0.0 0
M  V30 12 C 4.0012 7.2323 0.0 0
M  V30 13 C 4.5648 1.3337 0.0 0
M  V30 14 C 1.3337 6.1048 0.0 0
M  V30 15 C 9.3360 4.5648 0.0 0
M  V30 16 C 5.3348 0.0000 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 18 C 10.6697 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1461-22-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23728-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-3119422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 56-23-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM McMurry intermolecular cross-coupling between an ester and a ketone:
scope and limitations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sabelle, Stephane; Hydrio, Jerome; Leclerc, Eric; Mioskowski, Charles;
Renard, Pierre-Yves
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(20), 3645-3648

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Galactose pentaacetate
C16H22O11
4163-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 3.8500 0.0 0
M  V30 2 C 1.3336 4.6200 0.0 0
M  V30 3 C 0.0000 3.8500 0.0 0
M  V30 4 O 1.3336 6.1600 0.0 0
M  V30 5 O 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6673 2.3100 0.0 0
M  V30 8 O 4.0011 0.0000 0.0 0
M  V30 9 O 2.6673 6.9300 0.0 0
M  V30 10 C 2.6673 8.4700 0.0 0
M  V30 11 C 4.0011 9.2400 0.0 0
M  V30 12 O 1.3336 9.2400 0.0 0
M  V30 13 C 8.0020 3.8500 0.0 0
M  V30 14 O 9.3358 4.6200 0.0 0
M  V30 15 C 10.6694 3.8500 0.0 0
M  V30 16 C 10.6694 2.3100 0.0 0
M  V30 17 O 12.0031 4.6200 0.0 0
M  V30 18 O 5.3347 8.4700 0.0 0
M  V30 19 C 6.6684 9.2400 0.0 0
M  V30 20 C 6.6684 10.7800 0.0 0
M  V30 21 O 8.0020 8.4700 0.0 0
M  V30 22 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 23 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 24 C 4.0011 6.1600 0.0 0 CFG=1
M  V30 25 C 6.6684 4.6200 0.0 0 CFG=1
M  V30 26 C 5.3347 6.9300 0.0 0 CFG=2
M  V30 27 O 6.6684 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 23 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 24 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 25 13 CFG=3
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 26 18 CFG=3
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 22 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethyl 1-thio-β-D-galactopyranoside tetraacetate
C16H24O9S
55722-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 6.9300 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 C 0.0000 6.9300 0.0 0
M  V30 4 O 1.3336 4.6200 0.0 0
M  V30 5 O 5.3347 8.4700 0.0 0
M  V30 6 C 4.0011 9.2400 0.0 0
M  V30 7 C 2.6673 8.4700 0.0 0
M  V30 8 O 4.0011 10.7800 0.0 0
M  V30 9 O 2.6673 3.8500 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 O 1.3336 1.5400 0.0 0
M  V30 13 C 8.0020 6.9300 0.0 0
M  V30 14 O 9.3358 6.1600 0.0 0
M  V30 15 C 10.6694 6.9300 0.0 0
M  V30 16 C 10.6694 8.4700 0.0 0
M  V30 17 O 12.0031 6.1600 0.0 0
M  V30 18 S 5.3347 2.3100 0.0 0
M  V30 19 C 6.6684 1.5400 0.0 0
M  V30 20 C 6.6684 0.0000 0.0 0
M  V30 21 C 4.0011 6.1600 0.0 0 CFG=2
M  V30 22 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 23 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 24 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 25 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 26 O 6.6684 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 24 13 CFG=1
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 25 18 CFG=1
M  V30 20 1 19 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 21 22 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4163-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55722-49-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-231542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-63-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Studies Related to Norway Spruce Galactoglucomannans: Chemical Synthesis,
Conformation Analysis, NMR Spectroscopic Characterization, and Molecular
Recognition of Model Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ekholm, Filip S.; Arda, Ana; Eklund, Patrik; Andre, Sabine; Gabius,
Hans-Joachim; Jimenez-Barbero, Jesus; Leino, Reko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2012), 18(45), 14392-14405

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
β-D-Galactose pentaacetate
C16H22O11
4163-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 3.8500 0.0 0
M  V30 2 C 1.3336 4.6200 0.0 0
M  V30 3 C 0.0000 3.8500 0.0 0
M  V30 4 O 1.3336 6.1600 0.0 0
M  V30 5 O 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6673 2.3100 0.0 0
M  V30 8 O 4.0011 0.0000 0.0 0
M  V30 9 O 2.6673 6.9300 0.0 0
M  V30 10 C 2.6673 8.4700 0.0 0
M  V30 11 C 4.0011 9.2400 0.0 0
M  V30 12 O 1.3336 9.2400 0.0 0
M  V30 13 C 8.0020 3.8500 0.0 0
M  V30 14 O 9.3358 4.6200 0.0 0
M  V30 15 C 10.6694 3.8500 0.0 0
M  V30 16 C 10.6694 2.3100 0.0 0
M  V30 17 O 12.0031 4.6200 0.0 0
M  V30 18 O 5.3347 8.4700 0.0 0
M  V30 19 C 6.6684 9.2400 0.0 0
M  V30 20 C 6.6684 10.7800 0.0 0
M  V30 21 O 8.0020 8.4700 0.0 0
M  V30 22 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 23 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 24 C 4.0011 6.1600 0.0 0 CFG=1
M  V30 25 C 6.6684 4.6200 0.0 0 CFG=1
M  V30 26 C 5.3347 6.9300 0.0 0 CFG=2
M  V30 27 O 6.6684 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 23 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 24 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 25 13 CFG=3
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 26 18 CFG=3
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 22 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-thio-β-D-galactopyranoside tetraacetate
C16H24O9S
55722-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 6.9300 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 C 0.0000 6.9300 0.0 0
M  V30 4 O 1.3336 4.6200 0.0 0
M  V30 5 O 5.3347 8.4700 0.0 0
M  V30 6 C 4.0011 9.2400 0.0 0
M  V30 7 C 2.6673 8.4700 0.0 0
M  V30 8 O 4.0011 10.7800 0.0 0
M  V30 9 O 2.6673 3.8500 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 O 1.3336 1.5400 0.0 0
M  V30 13 C 8.0020 6.9300 0.0 0
M  V30 14 O 9.3358 6.1600 0.0 0
M  V30 15 C 10.6694 6.9300 0.0 0
M  V30 16 C 10.6694 8.4700 0.0 0
M  V30 17 O 12.0031 6.1600 0.0 0
M  V30 18 S 5.3347 2.3100 0.0 0
M  V30 19 C 6.6684 1.5400 0.0 0
M  V30 20 C 6.6684 0.0000 0.0 0
M  V30 21 C 4.0011 6.1600 0.0 0 CFG=2
M  V30 22 C 5.3347 6.9300 0.0 0 CFG=1
M  V30 23 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 24 C 6.6684 6.1600 0.0 0 CFG=1
M  V30 25 C 5.3347 3.8500 0.0 0 CFG=2
M  V30 26 O 6.6684 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 24 13 CFG=1
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 25 18 CFG=1
M  V30 20 1 19 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 21 22 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4163-60-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55722-49-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-9678317
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10026-11-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of B4-2 [0070] A solution of B4-1 (150 g, 385 mmol) in CH2Cl2
(800 mL) was added slowly to a slurry of ZrCl4 (85 g, 366 mmol) in
CH2Cl2(800 mL) at 0° C. After the reaction was stirred at 0° C. for 30
min, EtSH (32 mL, 423 mmol) was added and the reaction was complete
within 2 h. The reaction was quenched by brine (500 mL). The layers were
separated and the organic layer was washed with saturated aqueous NaHCO3
(1×500 mL) and brine (1×500 mL), dried over MgSO4, filtered, and
concentrated to give an oily residue. This was dissolved in MTBE (300 mL)
and the solution was diluted with heptane (1.2 L). After the resulting
slurry had been stirred in an ice bath for 1 h, the mixture was filtered
to provide compound B4-2 (143 g, 95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin
or both the lectins from Pseudomonas aeruginosa
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Magnani, John L.; Patton, John T.; Sarkar, Arun K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070037775 A1 2007-02-15

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) hydrogen N-[(1,1-dimethylethoxy)carbonyl]-L-aspartate
C13H23NO6
34582-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 2 N 6.1600 5.3347 0.0 0
M  V30 3 C 3.8500 4.0011 0.0 0
M  V30 4 C 6.1600 2.6674 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 O 3.0800 5.3347 0.0 0
M  V30 7 O 3.0800 2.6674 0.0 0
M  V30 8 C 5.3900 1.3338 0.0 0
M  V30 9 O 8.4700 6.6685 0.0 0
M  V30 10 O 8.4700 4.0011 0.0 0
M  V30 11 C 1.5400 5.3347 0.0 0
M  V30 12 O 3.8500 1.3338 0.0 0
M  V30 13 O 6.1600 0.0000 0.0 0
M  V30 14 C 10.0100 6.6685 0.0 0
M  V30 15 C 1.5400 6.8747 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 C 1.5400 3.7947 0.0 0
M  V30 18 C 10.0100 8.2085 0.0 0
M  V30 19 C 11.5500 6.6685 0.0 0
M  V30 20 C 10.0100 5.1285 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-S-ethyl-4-oxo-L-homocysteine 1,1-dimethyleth...
C15H27NO5S
147698-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0 CFG=2
M  V30 2 C 3.8500 6.6684 0.0 0
M  V30 3 N 6.1600 8.0021 0.0 0
M  V30 4 C 6.1600 5.3347 0.0 0
M  V30 5 O 3.0800 8.0021 0.0 0
M  V30 6 O 3.0800 5.3347 0.0 0
M  V30 7 C 7.7000 8.0021 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 1.5400 8.0021 0.0 0
M  V30 10 O 8.4700 9.3358 0.0 0
M  V30 11 O 8.4700 6.6684 0.0 0
M  V30 12 S 6.1600 2.6674 0.0 0
M  V30 13 O 3.8500 4.0011 0.0 0
M  V30 14 C 1.5400 6.4621 0.0 0
M  V30 15 C 0.0000 8.0021 0.0 0
M  V30 16 C 1.5400 9.5421 0.0 0
M  V30 17 C 10.0100 9.3358 0.0 0
M  V30 18 C 5.3900 1.3336 0.0 0
M  V30 19 C 10.0100 7.7958 0.0 0
M  V30 20 C 11.5500 9.3358 0.0 0
M  V30 21 C 10.0100 10.8758 0.0 0
M  V30 22 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 10 17
M  V30 17 1 12 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34582-32-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147698-03-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-12780001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 4-mercapto-L-lysine derivatives: Potential building blocks
for sequential native chemical ligation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pasunooti, Kalyan Kumar; Yang, Renliang; Vedachalam, Seenuvasan;
Gorityala, Bala Kishan; Liu, Chuan-Fa; Liu, Xue-Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(22), 6268-6271

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-4-butyrolactone
C4H5BrO2
5061-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.2459 0.0000 0.0 0
M  V30 2 O 3.9563 1.9692 0.0 0
M  V30 3 C 1.2459 1.5400 0.0 0
M  V30 4 C 2.4917 2.4452 0.0 0
M  V30 5 C 0.0000 2.4452 0.0 0
M  V30 6 O 2.0159 3.9098 0.0 0
M  V30 7 C 0.4759 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 4
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(1,1-Dimethylethyl)thio]dihydro-2(3H)-furanone
C8H14O2S
391605-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7709 1.3627 0.0 0
M  V30 2 C 5.1047 2.1327 0.0 0
M  V30 3 C 5.8747 0.7991 0.0 0
M  V30 4 C 6.4383 2.9027 0.0 0
M  V30 5 C 4.3347 3.4665 0.0 0
M  V30 6 O 0.7102 0.0000 0.0 0
M  V30 7 C 2.4373 2.1327 0.0 0
M  V30 8 C 1.0306 1.5064 0.0 0
M  V30 9 C 2.2764 3.6642 0.0 0
M  V30 10 O 0.0000 2.6508 0.0 0
M  V30 11 C 0.7700 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 6 8
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5061-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 391605-59-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-17596011
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM key step
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthetic approaches to 1-thiocyclopropanecarboxylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiansheng; Wu, Jingwei; Liu, Yuqiang; Xie, Yafei; Liu, Changying;
Wang, Jianwu; Zhao, Guilong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2017), 192(7),
799-811

$RFMT $RIREG SCHEME6 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]benzenesulfonamide
C14H13NO3S
664985-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 O 13.0900 2.8736 0.0 0
M  V30 7 C 13.8600 4.2073 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 2.3100 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.7700 2.8736 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 9.2400 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 19 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Methoxyphenyl)-1-(phenylsulfonyl)-4-(2-propen-1-ylthio...
C24H29NO5S2
951635-94-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.2489 0.0 0 VAL=6
M  V30 2 O 4.6200 9.7889 0.0 0
M  V30 3 O 4.6200 6.7089 0.0 0
M  V30 4 C 6.5894 10.9593 0.0 0
M  V30 5 C 7.6198 12.1038 0.0 0
M  V30 6 C 7.1439 13.5683 0.0 0
M  V30 7 C 9.7758 6.5736 0.0 0
M  V30 8 O 9.6147 5.0420 0.0 0
M  V30 9 O 11.1826 7.2000 0.0 0
M  V30 10 S 9.7758 9.9239 0.0 0
M  V30 11 C 11.1826 9.2976 0.0 0
M  V30 12 C 12.4284 10.2028 0.0 0
M  V30 13 C 13.8354 9.5765 0.0 0
M  V30 14 O 5.1616 1.1444 0.0 0
M  V30 15 C 6.1922 0.0000 0.0 0
M  V30 16 N 6.1600 8.2489 0.0 0
M  V30 17 C 7.0652 7.0028 0.0 0 CFG=1
M  V30 18 C 7.0652 9.4947 0.0 0 CFG=2
M  V30 19 C 8.5299 7.4789 0.0 0 CFG=2
M  V30 20 C 8.5299 9.0189 0.0 0 CFG=1
M  V30 21 C 6.5894 5.5383 0.0 0
M  V30 22 C 7.6198 4.3938 0.0 0
M  V30 23 C 5.0829 5.2181 0.0 0
M  V30 24 C 7.1439 2.9292 0.0 0
M  V30 25 C 4.6071 3.7534 0.0 0
M  V30 26 C 5.6375 2.6091 0.0 0
M  V30 27 C 3.0800 8.2489 0.0 0
M  V30 28 C 2.3100 6.9151 0.0 0
M  V30 29 C 2.3100 9.5825 0.0 0
M  V30 30 C 0.7700 6.9151 0.0 0
M  V30 31 C 0.7700 9.5825 0.0 0
M  V30 32 C 0.0000 8.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-99-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-94-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089892
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME7 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]benzenesulfonamide
C13H10ClNO2S
664986-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 Cl 13.0900 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 2.3100 2.8736 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 0.7700 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 14 C 9.2400 1.5400 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-(phenylsulfonyl)-4-(2-propen-1-ylthio)...
C23H26ClNO4S2
951635-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5645 0.0 0
M  V30 3 O 4.6200 8.6445 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 5.1616 0.0000 0.0 0
M  V30 15 N 6.1600 7.1045 0.0 0
M  V30 16 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 17 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 18 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 19 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 20 C 6.5894 4.3939 0.0 0
M  V30 21 C 5.0829 4.0738 0.0 0
M  V30 22 C 7.6198 3.2496 0.0 0
M  V30 23 C 4.6071 2.6091 0.0 0
M  V30 24 C 7.1439 1.7849 0.0 0
M  V30 25 C 5.6376 1.4647 0.0 0
M  V30 26 C 3.0800 7.1045 0.0 0
M  V30 27 C 2.3100 5.7708 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 0.7700 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 17 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 18 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 19 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 20 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664986-03-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-91-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME8 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
738626-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Methylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen...
C25H31NO4S2
951635-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 C 5.6610 11.7835 0.0 0
M  V30 15 C 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088399
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME9 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(1-naphthalenylmethylene)benzenesulfonamide
C18H15NO2S
738626-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 S 8.0022 3.0801 0.0 0 VAL=6
M  V30 4 O 8.7722 1.7464 0.0 0
M  V30 5 O 7.2322 4.4137 0.0 0
M  V30 6 C 13.3370 6.1601 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 4.0010 0.7700 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 18 C 9.3360 5.3901 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 10.6697 6.1601 0.0 0
M  V30 21 C 12.0033 3.8501 0.0 0
M  V30 22 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-4-[(1,1-Dimethylethyl)thio]-1-[(4-methylphenyl)sulfonyl]-2-...
C29H35NO4S2
951333-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.0840 7.0618 0.0 0 VAL=6
M  V30 2 O 7.4042 5.5554 0.0 0
M  V30 3 O 6.7638 8.5681 0.0 0
M  V30 4 C 2.3892 4.3513 0.0 0
M  V30 5 O 0.8829 4.6714 0.0 0
M  V30 6 O 2.8650 2.8866 0.0 0
M  V30 7 C 4.5941 9.3036 0.0 0
M  V30 8 C 6.0009 9.9301 0.0 0
M  V30 9 C 6.1620 11.4616 0.0 0
M  V30 10 S 1.6926 7.6284 0.0 0
M  V30 11 C 1.5317 9.1601 0.0 0
M  V30 12 C 0.0000 8.9990 0.0 0
M  V30 13 C 1.3706 10.6916 0.0 0
M  V30 14 C 3.0632 9.3210 0.0 0
M  V30 15 C 13.1094 8.3425 0.0 0
M  V30 16 C 4.9513 5.3347 0.0 0 CFG=1
M  V30 17 N 5.5776 6.7417 0.0 0
M  V30 18 C 3.4197 5.4958 0.0 0 CFG=2
M  V30 19 C 4.4332 7.7721 0.0 0 CFG=2
M  V30 20 C 3.0994 7.0021 0.0 0 CFG=2
M  V30 21 C 5.7213 4.0011 0.0 0
M  V30 22 C 4.9513 2.6674 0.0 0
M  V30 23 C 7.2613 4.0011 0.0 0
M  V30 24 C 5.7213 1.3336 0.0 0
M  V30 25 C 3.4113 2.6674 0.0 0
M  V30 26 C 8.0313 2.6674 0.0 0
M  V30 27 C 7.2613 1.3336 0.0 0
M  V30 28 C 4.9513 0.0000 0.0 0
M  V30 29 C 2.6413 1.3336 0.0 0
M  V30 30 C 3.4113 0.0000 0.0 0
M  V30 31 C 8.5903 7.3820 0.0 0
M  V30 32 C 9.6207 6.2375 0.0 0
M  V30 33 C 9.0661 8.8465 0.0 0
M  V30 34 C 11.1271 6.5578 0.0 0
M  V30 35 C 10.5726 9.1669 0.0 0
M  V30 36 C 11.6030 8.0223 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 36
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 2 25 29
M  V30 31 2 26 27
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-22-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951333-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16081817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME10 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(1-naphthalenylmethylene)benzenesulfonamide
C18H15NO2S
738626-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 S 8.0022 3.0801 0.0 0 VAL=6
M  V30 4 O 8.7722 1.7464 0.0 0
M  V30 5 O 7.2322 4.4137 0.0 0
M  V30 6 C 13.3370 6.1601 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 4.0010 0.7700 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 18 C 9.3360 5.3901 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 10.6697 6.1601 0.0 0
M  V30 21 C 12.0033 3.8501 0.0 0
M  V30 22 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Methylphenyl)sulfonyl]-2-(1-naphthalenyl)-4-(2-propen...
C28H31NO4S2
951635-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2900 4.6786 0.0 0 VAL=6
M  V30 2 O 9.6102 6.1850 0.0 0
M  V30 3 O 8.9698 3.1723 0.0 0
M  V30 4 C 6.8002 2.4368 0.0 0
M  V30 5 C 5.5542 1.5315 0.0 0
M  V30 6 C 5.7153 0.0000 0.0 0
M  V30 7 C 4.5953 7.3891 0.0 0
M  V30 8 O 3.0888 7.0690 0.0 0
M  V30 9 O 5.0711 8.8539 0.0 0
M  V30 10 S 3.8987 4.1120 0.0 0
M  V30 11 C 2.6527 5.0172 0.0 0
M  V30 12 C 1.2459 4.3907 0.0 0
M  V30 13 C 0.0000 5.2960 0.0 0
M  V30 14 C 15.3154 3.3979 0.0 0
M  V30 15 N 7.7837 4.9989 0.0 0
M  V30 16 C 7.1572 6.4057 0.0 0 CFG=1
M  V30 17 C 6.6392 3.9683 0.0 0 CFG=2
M  V30 18 C 5.6257 6.2448 0.0 0 CFG=2
M  V30 19 C 5.3055 4.7383 0.0 0 CFG=1
M  V30 20 C 7.9272 7.7393 0.0 0
M  V30 21 C 7.1572 9.0732 0.0 0
M  V30 22 C 9.4672 7.7393 0.0 0
M  V30 23 C 7.9272 10.4068 0.0 0
M  V30 24 C 5.6172 9.0732 0.0 0
M  V30 25 C 10.2372 9.0732 0.0 0
M  V30 26 C 9.4672 10.4068 0.0 0
M  V30 27 C 7.1572 11.7405 0.0 0
M  V30 28 C 4.8472 10.4068 0.0 0
M  V30 29 C 5.6172 11.7405 0.0 0
M  V30 30 C 10.7964 4.3584 0.0 0
M  V30 31 C 11.8269 5.5029 0.0 0
M  V30 32 C 11.2723 2.8938 0.0 0
M  V30 33 C 13.3333 5.1828 0.0 0
M  V30 34 C 12.7786 2.5737 0.0 0
M  V30 35 C 13.8092 3.7181 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 17 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 18 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 19 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 35
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 20 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 21 24
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 2 25 26
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-22-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-84-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME11 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethoxyphenyl)-4-[(1-methylethyl)thio]-1-[(4-methylphen...
C26H35NO5S2
951303-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6814 5.3348 0.0 0 VAL=6
M  V30 2 O 8.0152 6.1048 0.0 0
M  V30 3 O 5.3477 4.5648 0.0 0
M  V30 4 C 3.3494 5.6851 0.0 0
M  V30 5 C 3.8253 4.2204 0.0 0
M  V30 6 C 2.7948 3.0760 0.0 0
M  V30 7 C 5.5542 10.6376 0.0 0
M  V30 8 O 6.9612 11.2639 0.0 0
M  V30 9 O 4.3084 11.5428 0.0 0
M  V30 10 S 2.6527 8.9623 0.0 0
M  V30 11 C 1.4068 8.0571 0.0 0
M  V30 12 C 0.0000 8.6834 0.0 0
M  V30 13 C 1.5679 6.5255 0.0 0
M  V30 14 O 12.5634 9.3563 0.0 0
M  V30 15 C 13.0392 10.8208 0.0 0
M  V30 16 C 14.5455 11.1410 0.0 0
M  V30 17 C 9.7614 0.0000 0.0 0
M  V30 18 N 5.9114 6.6686 0.0 0
M  V30 19 C 6.5379 8.0754 0.0 0 CFG=1
M  V30 20 C 4.3798 6.8295 0.0 0 CFG=2
M  V30 21 C 5.3933 9.1058 0.0 0 CFG=2
M  V30 22 C 4.0597 8.3358 0.0 0 CFG=1
M  V30 23 C 8.0442 8.3956 0.0 0
M  V30 24 C 9.0746 7.2512 0.0 0
M  V30 25 C 8.5200 9.8603 0.0 0
M  V30 26 C 10.5810 7.5714 0.0 0
M  V30 27 C 10.0265 10.1805 0.0 0
M  V30 28 C 11.0569 9.0361 0.0 0
M  V30 29 C 7.4514 4.0011 0.0 0
M  V30 30 C 6.6814 2.6675 0.0 0
M  V30 31 C 8.9914 4.0011 0.0 0
M  V30 32 C 7.4514 1.3338 0.0 0
M  V30 33 C 9.7614 2.6675 0.0 0
M  V30 34 C 8.9914 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 21 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 22 10 CFG=1
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 28
M  V30 17 1 15 16
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951303-06-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083273
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME12 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Cyanophenyl)methylene]-4-methylbenzenesulfonamide
C15H12N2O2S
848005-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 N 16.1700 2.8736 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 3 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Cyanophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-...
C25H28N2O4S2
951635-78-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 8.5690 0.0 0 VAL=6
M  V30 2 O 9.2154 7.0290 0.0 0
M  V30 3 O 9.2154 10.1090 0.0 0
M  V30 4 C 7.2460 11.2796 0.0 0
M  V30 5 C 6.2156 12.4240 0.0 0
M  V30 6 C 6.6915 13.8886 0.0 0
M  V30 7 C 4.0596 6.8938 0.0 0
M  V30 8 O 2.6528 7.5203 0.0 0
M  V30 9 O 4.2207 5.3623 0.0 0
M  V30 10 S 4.0596 10.2442 0.0 0
M  V30 11 C 2.6528 9.6179 0.0 0
M  V30 12 C 1.4069 10.5230 0.0 0
M  V30 13 C 0.0000 9.8967 0.0 0
M  V30 14 C 8.6737 1.4647 0.0 0
M  V30 15 N 9.1496 0.0000 0.0 0
M  V30 16 C 15.3754 8.5690 0.0 0
M  V30 17 N 7.6754 8.5690 0.0 0
M  V30 18 C 6.7701 7.3232 0.0 0 CFG=1
M  V30 19 C 6.7701 9.8149 0.0 0 CFG=2
M  V30 20 C 5.3055 7.7990 0.0 0 CFG=2
M  V30 21 C 5.3055 9.3390 0.0 0 CFG=1
M  V30 22 C 7.2460 5.8585 0.0 0
M  V30 23 C 6.2156 4.7141 0.0 0
M  V30 24 C 8.7524 5.5383 0.0 0
M  V30 25 C 6.6915 3.2494 0.0 0
M  V30 26 C 9.2283 4.0738 0.0 0
M  V30 27 C 8.1977 2.9292 0.0 0
M  V30 28 C 10.7554 8.5690 0.0 0
M  V30 29 C 11.5254 9.9027 0.0 0
M  V30 30 C 11.5254 7.2354 0.0 0
M  V30 31 C 13.0654 9.9027 0.0 0
M  V30 32 C 13.0654 7.2354 0.0 0
M  V30 33 C 13.8354 8.5690 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 20 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 3 14 15
M  V30 16 1 14 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848005-24-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-78-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082703
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME13 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
861145-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(4-methylphenyl)-4-(2-propen-...
C24H28BrNO4S2
951689-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 C 8.6737 0.0000 0.0 0
M  V30 15 Br 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 861145-18-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-14-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16065194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME14 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
863401-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen...
C24H28ClNO4S2
951635-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 Cl 5.6610 11.7835 0.0 0
M  V30 15 C 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-19-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-81-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087243
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME15 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
865060-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen...
C24H28ClNO4S2
951635-95-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 C 3.0800 9.7718 0.0 0
M  V30 15 Cl 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865060-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-95-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091415
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME16 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-...
C26H33NO4S2
951635-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 8.2489 0.0 0 VAL=6
M  V30 2 O 9.2154 9.7889 0.0 0
M  V30 3 O 9.2154 6.7089 0.0 0
M  V30 4 C 7.2460 10.9593 0.0 0
M  V30 5 C 6.2156 12.1038 0.0 0
M  V30 6 C 6.6915 13.5683 0.0 0
M  V30 7 C 4.0596 6.5736 0.0 0
M  V30 8 O 2.6528 7.2000 0.0 0
M  V30 9 O 4.2207 5.0420 0.0 0
M  V30 10 S 4.0596 9.9239 0.0 0
M  V30 11 C 2.6528 9.2976 0.0 0
M  V30 12 C 1.4069 10.2028 0.0 0
M  V30 13 C 0.0000 9.5765 0.0 0
M  V30 14 C 8.6737 1.1444 0.0 0
M  V30 15 C 7.6432 0.0000 0.0 0
M  V30 16 C 15.3754 8.2489 0.0 0
M  V30 17 N 7.6754 8.2489 0.0 0
M  V30 18 C 6.7701 7.0028 0.0 0 CFG=1
M  V30 19 C 6.7701 9.4947 0.0 0 CFG=2
M  V30 20 C 5.3055 7.4789 0.0 0 CFG=2
M  V30 21 C 5.3055 9.0189 0.0 0 CFG=1
M  V30 22 C 7.2460 5.5383 0.0 0
M  V30 23 C 6.2156 4.3938 0.0 0
M  V30 24 C 8.7524 5.2181 0.0 0
M  V30 25 C 6.6915 2.9292 0.0 0
M  V30 26 C 9.2283 3.7534 0.0 0
M  V30 27 C 8.1977 2.6091 0.0 0
M  V30 28 C 10.7554 8.2489 0.0 0
M  V30 29 C 11.5254 9.5825 0.0 0
M  V30 30 C 11.5254 6.9151 0.0 0
M  V30 31 C 13.0654 9.5825 0.0 0
M  V30 32 C 13.0654 6.9151 0.0 0
M  V30 33 C 13.8354 8.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 20 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-74-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087663
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME17 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen...
C26H33NO5S2
951635-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 9.7135 0.0 0 VAL=6
M  V30 2 O 9.2154 8.1735 0.0 0
M  V30 3 O 9.2154 11.2535 0.0 0
M  V30 4 C 7.2460 12.4241 0.0 0
M  V30 5 C 6.2156 13.5685 0.0 0
M  V30 6 C 6.6915 15.0332 0.0 0
M  V30 7 C 4.0596 8.0383 0.0 0
M  V30 8 O 4.2207 6.5068 0.0 0
M  V30 9 O 2.6528 8.6647 0.0 0
M  V30 10 S 4.0596 11.3888 0.0 0
M  V30 11 C 2.6528 10.7623 0.0 0
M  V30 12 C 1.4069 11.6675 0.0 0
M  V30 13 C 0.0000 11.0412 0.0 0
M  V30 14 O 8.6737 2.6091 0.0 0
M  V30 15 C 7.6432 1.4647 0.0 0
M  V30 16 C 8.1192 0.0000 0.0 0
M  V30 17 C 15.3754 9.7135 0.0 0
M  V30 18 N 7.6754 9.7135 0.0 0
M  V30 19 C 6.7701 8.4677 0.0 0 CFG=1
M  V30 20 C 6.7701 10.9594 0.0 0 CFG=2
M  V30 21 C 5.3055 8.9435 0.0 0 CFG=2
M  V30 22 C 5.3055 10.4835 0.0 0 CFG=1
M  V30 23 C 7.2460 7.0030 0.0 0
M  V30 24 C 6.2156 5.8586 0.0 0
M  V30 25 C 8.7524 6.6828 0.0 0
M  V30 26 C 6.6915 4.3939 0.0 0
M  V30 27 C 9.2283 5.2181 0.0 0
M  V30 28 C 8.1977 4.0738 0.0 0
M  V30 29 C 10.7554 9.7135 0.0 0
M  V30 30 C 11.5254 8.3799 0.0 0
M  V30 31 C 11.5254 11.0472 0.0 0
M  V30 32 C 13.0654 8.3799 0.0 0
M  V30 33 C 13.0654 11.0472 0.0 0
M  V30 34 C 13.8354 9.7135 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 21 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 22 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 28
M  V30 17 1 15 16
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-76-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME18 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 N 5.3900 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 13.0900 4.0009 0.0 0
M  V30 7 F 3.0800 0.0000 0.0 0
M  V30 8 C 8.4700 4.0009 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 9.2400 2.6673 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 10.7800 2.6673 0.0 0
M  V30 13 C 11.5500 4.0009 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 C 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0009 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(2-Fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen...
C24H28FNO4S2
951635-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 7.2460 2.6091 0.0 0
M  V30 5 C 6.2156 1.4645 0.0 0
M  V30 6 C 6.6915 0.0000 0.0 0
M  V30 7 C 4.0596 6.9947 0.0 0
M  V30 8 O 2.6528 6.3684 0.0 0
M  V30 9 O 4.2207 8.5264 0.0 0
M  V30 10 S 4.0596 3.6444 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 F 4.7092 8.8544 0.0 0
M  V30 15 C 15.3754 5.3195 0.0 0
M  V30 16 N 7.6754 5.3195 0.0 0
M  V30 17 C 6.7701 6.5655 0.0 0 CFG=1
M  V30 18 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 19 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=1
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1745 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 22
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-62-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME19 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 C 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-pr...
C24H27Cl2NO4S2
951635-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 4.2207 3.8977 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Cl 5.6610 0.6405 0.0 0
M  V30 15 Cl 8.6737 0.0000 0.0 0
M  V30 16 C 15.3754 7.1045 0.0 0
M  V30 17 N 7.6754 7.1045 0.0 0
M  V30 18 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 19 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 20 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 21 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 22 C 7.2460 4.3939 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 8.7524 4.0738 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 9.2283 2.6091 0.0 0
M  V30 27 C 8.1977 1.4647 0.0 0
M  V30 28 C 10.7554 7.1045 0.0 0
M  V30 29 C 11.5254 5.7708 0.0 0
M  V30 30 C 11.5254 8.4381 0.0 0
M  V30 31 C 13.0654 5.7708 0.0 0
M  V30 32 C 13.0654 8.4381 0.0 0
M  V30 33 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 20 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-63-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME20 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(2-thienylmethylene)benzenesulfonamide
C12H11NO2S2
951762-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.2198 2.5795 0.0 0 VAL=6
M  V30 2 N 4.6798 2.5795 0.0 0
M  V30 3 O 6.2198 1.0395 0.0 0
M  V30 4 O 6.2198 4.1195 0.0 0
M  V30 5 C 3.9098 1.2459 0.0 0
M  V30 6 C 12.3798 2.5795 0.0 0
M  V30 7 C 7.7598 2.5795 0.0 0
M  V30 8 C 8.5298 1.2459 0.0 0
M  V30 9 C 8.5298 3.9132 0.0 0
M  V30 10 C 10.0698 1.2459 0.0 0
M  V30 11 C 10.0698 3.9132 0.0 0
M  V30 12 C 10.8398 2.5795 0.0 0
M  V30 13 C 2.3698 1.2459 0.0 0
M  V30 14 C 1.4645 2.4917 0.0 0
M  V30 15 S 1.4645 0.0000 0.0 0
M  V30 16 C 0.0000 2.0159 0.0 0
M  V30 17 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Methylphenyl)sulfonyl]-4-(2-propen-1-ylthio)-5-propyl...
C22H27NO4S3
951635-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3196 0.0 0 VAL=6
M  V30 2 O 9.2154 3.7796 0.0 0
M  V30 3 O 9.2154 6.8596 0.0 0
M  V30 4 C 7.2460 2.6091 0.0 0
M  V30 5 C 6.2156 1.4647 0.0 0
M  V30 6 C 6.6915 0.0000 0.0 0
M  V30 7 C 4.0596 6.9948 0.0 0
M  V30 8 O 2.6528 6.3684 0.0 0
M  V30 9 O 4.2207 8.5264 0.0 0
M  V30 10 S 4.0596 3.6444 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9920 0.0 0
M  V30 14 C 15.3754 5.3196 0.0 0
M  V30 15 N 7.6754 5.3196 0.0 0
M  V30 16 C 6.7701 6.5655 0.0 0 CFG=1
M  V30 17 C 6.7701 4.0738 0.0 0 CFG=2
M  V30 18 C 5.3055 6.0896 0.0 0 CFG=2
M  V30 19 C 5.3055 4.5496 0.0 0 CFG=1
M  V30 20 C 7.2460 8.0302 0.0 0
M  V30 21 C 6.3408 9.2760 0.0 0
M  V30 22 S 8.7107 8.5060 0.0 0
M  V30 23 C 7.2460 10.5219 0.0 0
M  V30 24 C 8.7107 10.0460 0.0 0
M  V30 25 C 10.7554 5.3196 0.0 0
M  V30 26 C 11.5254 6.6533 0.0 0
M  V30 27 C 11.5254 3.9860 0.0 0
M  V30 28 C 13.0654 6.6533 0.0 0
M  V30 29 C 13.0654 3.9860 0.0 0
M  V30 30 C 13.8354 5.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 17 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 18 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 19 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 30
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 20 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-64-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-86-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26188517
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME21 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[[4-(1-methylethyl)phenyl]methylene]benzenesulfonamide
C17H19NO2S
951762-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 9.2400 0.0000 0.0 0
M  V30 4 O 9.2400 3.0800 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 15.4000 1.5400 0.0 0
M  V30 7 C 0.7700 2.8736 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 0.0000 4.2073 0.0 0
M  V30 10 C 10.7800 1.5400 0.0 0
M  V30 11 C 11.5500 2.8736 0.0 0
M  V30 12 C 11.5500 0.2062 0.0 0
M  V30 13 C 13.0900 2.8736 0.0 0
M  V30 14 C 13.0900 0.2062 0.0 0
M  V30 15 C 13.8600 1.5400 0.0 0
M  V30 16 C 5.3900 2.8736 0.0 0
M  V30 17 C 4.6200 4.2073 0.0 0
M  V30 18 C 4.6200 1.5400 0.0 0
M  V30 19 C 3.0800 4.2073 0.0 0
M  V30 20 C 3.0800 1.5400 0.0 0
M  V30 21 C 2.3100 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-[4-(1-Methylethyl)phenyl]-1-[(4-methylphenyl)sulfonyl]-4-...
C27H35NO4S2
951635-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 8.2489 0.0 0 VAL=6
M  V30 2 O 9.2154 6.7089 0.0 0
M  V30 3 O 9.2154 9.7889 0.0 0
M  V30 4 C 7.2460 10.9593 0.0 0
M  V30 5 C 6.2156 12.1038 0.0 0
M  V30 6 C 6.6915 13.5683 0.0 0
M  V30 7 C 4.0596 6.5736 0.0 0
M  V30 8 O 2.6528 7.2000 0.0 0
M  V30 9 O 4.2207 5.0420 0.0 0
M  V30 10 S 4.0596 9.9239 0.0 0
M  V30 11 C 2.6528 9.2976 0.0 0
M  V30 12 C 1.4069 10.2028 0.0 0
M  V30 13 C 0.0000 9.5765 0.0 0
M  V30 14 C 8.6737 1.1444 0.0 0
M  V30 15 C 10.1800 0.8242 0.0 0
M  V30 16 C 7.6432 0.0000 0.0 0
M  V30 17 C 15.3754 8.2489 0.0 0
M  V30 18 N 7.6754 8.2489 0.0 0
M  V30 19 C 6.7701 7.0028 0.0 0 CFG=1
M  V30 20 C 6.7701 9.4947 0.0 0 CFG=2
M  V30 21 C 5.3055 7.4789 0.0 0 CFG=2
M  V30 22 C 5.3055 9.0189 0.0 0 CFG=1
M  V30 23 C 7.2460 5.5383 0.0 0
M  V30 24 C 6.2156 4.3938 0.0 0
M  V30 25 C 8.7524 5.2181 0.0 0
M  V30 26 C 6.6915 2.9292 0.0 0
M  V30 27 C 9.2283 3.7534 0.0 0
M  V30 28 C 8.1977 2.6091 0.0 0
M  V30 29 C 10.7554 8.2489 0.0 0
M  V30 30 C 11.5254 9.5825 0.0 0
M  V30 31 C 11.5254 6.9151 0.0 0
M  V30 32 C 13.0654 9.5825 0.0 0
M  V30 33 C 13.0654 6.9151 0.0 0
M  V30 34 C 13.8354 8.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 21 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 22 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-66-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16075788
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME22 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen...
C24H28FNO4S2
951635-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 F 5.6610 11.7835 0.0 0
M  V30 15 C 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-68-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-89-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071114
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME23 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951762-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(4-chlorophenyl)sulfonyl]-4-(2-propen...
C23H25Cl2NO4S2
951635-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Cl 8.6737 0.0000 0.0 0
M  V30 15 Cl 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-69-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-90-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16059196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME24 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(2-propen...
C24H28ClNO4S2
951635-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 C 8.6737 0.0000 0.0 0
M  V30 15 Cl 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-72-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086871
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME25 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Methylphenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen...
C25H31NO4S2
951635-96-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5645 0.0 0
M  V30 3 O 4.6200 8.6445 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 9.6147 3.8977 0.0 0
M  V30 9 O 11.1826 6.0556 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 C 3.0800 9.7718 0.0 0
M  V30 15 C 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 7.6198 3.2496 0.0 0
M  V30 23 C 5.0829 4.0738 0.0 0
M  V30 24 C 7.1439 1.7849 0.0 0
M  V30 25 C 4.6071 2.6091 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-79-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-96-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076537
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME26 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-pr...
C24H27Cl2NO4S2
951687-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5645 0.0 0
M  V30 3 O 4.6200 8.6445 0.0 0
M  V30 4 C 9.7758 5.4293 0.0 0
M  V30 5 O 11.1826 6.0556 0.0 0
M  V30 6 O 9.6147 3.8977 0.0 0
M  V30 7 C 6.5894 9.8150 0.0 0
M  V30 8 C 7.6198 10.9594 0.0 0
M  V30 9 C 7.1439 12.4241 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 8.1743 0.6405 0.0 0
M  V30 15 C 3.0800 9.7718 0.0 0
M  V30 16 Cl 5.1616 0.0000 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 N 6.1600 7.1045 0.0 0
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 21 C 8.5299 7.8745 0.0 0 CFG=2
M  V30 22 C 6.5894 4.3939 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 5.0829 4.0738 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 4.6071 2.6091 0.0 0
M  V30 27 C 5.6376 1.4647 0.0 0
M  V30 28 C 3.0800 7.1045 0.0 0
M  V30 29 C 2.3100 8.4381 0.0 0
M  V30 30 C 2.3100 5.7708 0.0 0
M  V30 31 C 0.7700 8.4381 0.0 0
M  V30 32 C 0.7700 5.7708 0.0 0
M  V30 33 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-84-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME27 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-2-fluorobenzenesulfonamide
C13H8Cl2FNO2S
951762-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 F 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(2-pr...
C23H24Cl2FNO4S2
951687-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5645 0.0 0
M  V30 3 O 4.6200 8.6445 0.0 0
M  V30 4 C 9.7758 5.4293 0.0 0
M  V30 5 O 9.6147 3.8977 0.0 0
M  V30 6 O 11.1826 6.0556 0.0 0
M  V30 7 C 6.5894 9.8150 0.0 0
M  V30 8 C 7.6198 10.9594 0.0 0
M  V30 9 C 7.1439 12.4241 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 8.1743 0.6405 0.0 0
M  V30 15 F 3.0800 9.7718 0.0 0
M  V30 16 Cl 5.1616 0.0000 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 N 6.1600 7.1045 0.0 0
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 21 C 8.5299 7.8745 0.0 0 CFG=2
M  V30 22 C 6.5894 4.3939 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 5.0829 4.0738 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 4.6071 2.6091 0.0 0
M  V30 27 C 5.6376 1.4647 0.0 0
M  V30 28 C 3.0800 7.1045 0.0 0
M  V30 29 C 2.3100 8.4381 0.0 0
M  V30 30 C 2.3100 5.7708 0.0 0
M  V30 31 C 0.7700 8.4381 0.0 0
M  V30 32 C 0.7700 5.7708 0.0 0
M  V30 33 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-85-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME28 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8Cl3NO2S
951762-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 Cl 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-4-(2-pr...
C23H24Cl3NO4S2
951687-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5645 0.0 0
M  V30 3 O 4.6200 8.6445 0.0 0
M  V30 4 C 9.7758 5.4293 0.0 0
M  V30 5 O 11.1826 6.0556 0.0 0
M  V30 6 O 9.6147 3.8977 0.0 0
M  V30 7 C 6.5894 9.8150 0.0 0
M  V30 8 C 7.6198 10.9594 0.0 0
M  V30 9 C 7.1439 12.4241 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 8.1743 0.6405 0.0 0
M  V30 15 Cl 3.0800 9.7718 0.0 0
M  V30 16 Cl 5.1616 0.0000 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 N 6.1600 7.1045 0.0 0
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 21 C 8.5299 7.8745 0.0 0 CFG=2
M  V30 22 C 6.5894 4.3939 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 5.0829 4.0738 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 4.6071 2.6091 0.0 0
M  V30 27 C 5.6376 1.4647 0.0 0
M  V30 28 C 3.0800 7.1045 0.0 0
M  V30 29 C 2.3100 8.4381 0.0 0
M  V30 30 C 2.3100 5.7708 0.0 0
M  V30 31 C 0.7700 8.4381 0.0 0
M  V30 32 C 0.7700 5.7708 0.0 0
M  V30 33 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-86-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16058382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME29 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8BrCl2NO2S
951762-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 Br 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-4-(2-pro...
C23H24BrCl2NO4S2
951687-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5645 0.0 0
M  V30 3 O 4.6200 8.6445 0.0 0
M  V30 4 C 9.7758 5.4293 0.0 0
M  V30 5 O 11.1826 6.0556 0.0 0
M  V30 6 O 9.6147 3.8977 0.0 0
M  V30 7 C 6.5894 9.8150 0.0 0
M  V30 8 C 7.6198 10.9594 0.0 0
M  V30 9 C 7.1439 12.4241 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 8.1743 0.6405 0.0 0
M  V30 15 Br 3.0800 9.7718 0.0 0
M  V30 16 Cl 5.1616 0.0000 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 N 6.1600 7.1045 0.0 0
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 21 C 8.5299 7.8745 0.0 0 CFG=2
M  V30 22 C 6.5894 4.3939 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 5.0829 4.0738 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 4.6071 2.6091 0.0 0
M  V30 27 C 5.6376 1.4647 0.0 0
M  V30 28 C 3.0800 7.1045 0.0 0
M  V30 29 C 2.3100 8.4381 0.0 0
M  V30 30 C 2.3100 5.7708 0.0 0
M  V30 31 C 0.7700 8.4381 0.0 0
M  V30 32 C 0.7700 5.7708 0.0 0
M  V30 33 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-87-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-56-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088648
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME30 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Methylphenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen...
C25H31NO4S2
951687-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 C 8.1743 0.0000 0.0 0
M  V30 15 C 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-88-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME31 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Fluorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12FNO2S
951762-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Fluorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen...
C24H28FNO4S2
951687-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 F 8.1743 0.0000 0.0 0
M  V30 15 C 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-90-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091670
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME32 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
951762-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen...
C24H28ClNO4S2
951687-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Cl 8.1743 0.0000 0.0 0
M  V30 15 C 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-91-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-59-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082069
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME33 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-2-methylbenzenesulfonamide
C14H12BrNO2S
951762-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen-...
C24H28BrNO4S2
951687-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Br 8.1743 0.0000 0.0 0
M  V30 15 C 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-92-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-60-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083671
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME34 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951762-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Fluorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(2-propen...
C24H28FNO4S2
951687-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 C 8.1743 0.0000 0.0 0
M  V30 15 F 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-93-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076283
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME35 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951762-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Fluorophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(2-propen...
C23H25F2NO4S2
951687-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 F 8.1743 0.0000 0.0 0
M  V30 15 F 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-94-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091856
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME36 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9ClFNO2S
951762-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(2-propen...
C23H25ClFNO4S2
951687-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Cl 8.1743 0.0000 0.0 0
M  V30 15 F 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-95-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-63-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME37 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9BrFNO2S
951762-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrFNO4S2
951687-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Br 8.1743 0.0000 0.0 0
M  V30 15 F 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-96-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-64-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME38 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(2-propen...
C24H28ClNO4S2
951687-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 C 8.1743 0.0000 0.0 0
M  V30 15 Cl 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-97-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085365
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME39 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951762-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-2-(3-fluorophenyl)-4-(2-propen...
C23H25ClFNO4S2
951687-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 F 8.1743 0.0000 0.0 0
M  V30 15 Cl 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-98-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-66-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086898
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME40 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951762-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 3.2311 4.4137 0.0 0
M  V30 4 O 4.7712 1.7464 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(2-chlorophenyl)sulfonyl]-4-(2-propen...
C23H25Cl2NO4S2
951687-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Cl 8.1743 0.0000 0.0 0
M  V30 15 Cl 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-99-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-67-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088414
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME41 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-2-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(2-chlorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrClNO4S2
951687-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Br 8.1743 0.0000 0.0 0
M  V30 15 Cl 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-00-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-68-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16070854
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME42 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
951763-01-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(3-methylphenyl)-4-(2-propen-...
C24H28BrNO4S2
951687-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 C 8.1743 0.0000 0.0 0
M  V30 15 Br 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-01-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-69-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME43 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951763-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(3-fluorophenyl)-4-(2-propen-...
C23H25BrFNO4S2
951687-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 F 8.1743 0.0000 0.0 0
M  V30 15 Br 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-02-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME44 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(3-chlorophenyl)-4-(2-propen-...
C23H25BrClNO4S2
951687-71-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Cl 8.1743 0.0000 0.0 0
M  V30 15 Br 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-03-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-71-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME45 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(2-bromophenyl)sulfonyl]-4-(2-propen-1...
C23H25Br2NO4S2
951687-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Br 8.1743 0.0000 0.0 0
M  V30 15 Br 3.0800 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 28
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-04-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-72-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME46 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Fluorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12FNO2S
951763-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Fluorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen...
C24H28FNO4S2
951687-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 C 3.0800 9.7718 0.0 0
M  V30 15 F 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-05-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-73-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091617
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME47 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-2-methylbenzenesulfonamide
C14H12BrNO2S
951763-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen-...
C24H28BrNO4S2
951687-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 C 3.0800 9.7718 0.0 0
M  V30 15 Br 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-06-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-74-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082033
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME48 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951763-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Fluorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(2-propen...
C24H28FNO4S2
951687-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 F 3.0800 9.7718 0.0 0
M  V30 15 C 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-07-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-75-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083633
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME49 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951763-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Fluorophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(2-propen...
C23H25F2NO4S2
951687-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 F 3.0800 9.7718 0.0 0
M  V30 15 F 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-08-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085141
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME50 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9ClFNO2S
951763-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(2-propen...
C23H25ClFNO4S2
951687-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 F 3.0800 9.7718 0.0 0
M  V30 15 Cl 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-09-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-77-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082148
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME51 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9BrFNO2S
951763-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrFNO4S2
951687-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 9.6147 3.8977 0.0 0
M  V30 9 O 11.1826 6.0556 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 F 3.0800 9.7718 0.0 0
M  V30 15 Br 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-10-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088176
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME52 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(2-propen...
C24H28ClNO4S2
951687-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 3.0800 9.7718 0.0 0
M  V30 15 C 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-11-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089676
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME53 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-2-(4-fluorophenyl)-4-(2-propen...
C23H25ClFNO4S2
951687-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 3.0800 9.7718 0.0 0
M  V30 15 F 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-12-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-80-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091206
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME54 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(2-chlorophenyl)sulfonyl]-4-(2-propen...
C23H25Cl2NO4S2
951687-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 3.0800 9.7718 0.0 0
M  V30 15 Cl 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-13-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-81-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086858
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME55 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-2-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(2-chlorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrClNO4S2
951687-82-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 3.0800 9.7718 0.0 0
M  V30 15 Br 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-14-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-82-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME56 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
951763-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(4-methylphenyl)-4-(2-propen-...
C24H28BrNO4S2
951687-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Br 3.0800 9.7718 0.0 0
M  V30 15 C 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-15-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-83-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089872
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME57 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951763-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(4-fluorophenyl)-4-(2-propen-...
C23H25BrFNO4S2
951687-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5645 0.0 0
M  V30 3 O 4.6200 8.6445 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Br 3.0800 9.7718 0.0 0
M  V30 15 F 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-16-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-84-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME58 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(4-chlorophenyl)-4-(2-propen-...
C23H25BrClNO4S2
951687-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Br 3.0800 9.7718 0.0 0
M  V30 15 Cl 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-85-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16056091
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME59 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(2-bromophenyl)sulfonyl]-4-(2-propen-1...
C23H25Br2NO4S2
951687-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Br 3.0800 9.7718 0.0 0
M  V30 15 Br 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-18-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071569
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME60 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-fluorobenzenesulfonamide
C13H8Cl2FNO2S
951763-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 F 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(2-pr...
C23H24Cl2FNO4S2
951688-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 4.2207 3.8977 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Cl 5.6610 0.6405 0.0 0
M  V30 15 Cl 8.6737 0.0000 0.0 0
M  V30 16 F 15.3754 7.1045 0.0 0
M  V30 17 N 7.6754 7.1045 0.0 0
M  V30 18 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 19 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 20 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 21 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 22 C 7.2460 4.3939 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 8.7524 4.0738 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 9.2283 2.6091 0.0 0
M  V30 27 C 8.1977 1.4647 0.0 0
M  V30 28 C 10.7554 7.1045 0.0 0
M  V30 29 C 11.5254 5.7708 0.0 0
M  V30 30 C 11.5254 8.4381 0.0 0
M  V30 31 C 13.0654 5.7708 0.0 0
M  V30 32 C 13.0654 8.4381 0.0 0
M  V30 33 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 20 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-19-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-93-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16064703
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME61 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8Cl3NO2S
951763-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 Cl 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-4-(2-pr...
C23H24Cl3NO4S2
951688-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 4.2207 3.8977 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Cl 5.6610 0.6405 0.0 0
M  V30 15 Cl 8.6737 0.0000 0.0 0
M  V30 16 Cl 15.3754 7.1045 0.0 0
M  V30 17 N 7.6754 7.1045 0.0 0
M  V30 18 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 19 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 20 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 21 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 22 C 7.2460 4.3939 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 8.7524 4.0738 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 9.2283 2.6091 0.0 0
M  V30 27 C 8.1977 1.4647 0.0 0
M  V30 28 C 10.7554 7.1045 0.0 0
M  V30 29 C 11.5254 5.7708 0.0 0
M  V30 30 C 11.5254 8.4381 0.0 0
M  V30 31 C 13.0654 5.7708 0.0 0
M  V30 32 C 13.0654 8.4381 0.0 0
M  V30 33 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 20 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-21-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-94-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME62 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8BrCl2NO2S
951763-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 Br 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-4-(2-pro...
C23H24BrCl2NO4S2
951688-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 4.2207 3.8977 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Cl 5.6610 0.6405 0.0 0
M  V30 15 Cl 8.6737 0.0000 0.0 0
M  V30 16 Br 15.3754 7.1045 0.0 0
M  V30 17 N 7.6754 7.1045 0.0 0
M  V30 18 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 19 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 20 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 21 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 22 C 7.2460 4.3939 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 8.7524 4.0738 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 9.2283 2.6091 0.0 0
M  V30 27 C 8.1977 1.4647 0.0 0
M  V30 28 C 10.7554 7.1045 0.0 0
M  V30 29 C 11.5254 5.7708 0.0 0
M  V30 30 C 11.5254 8.4381 0.0 0
M  V30 31 C 13.0654 5.7708 0.0 0
M  V30 32 C 13.0654 8.4381 0.0 0
M  V30 33 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 20 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-23-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-95-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16081842
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME63 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951763-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Fluorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(2-propen...
C24H28FNO4S2
951688-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 C 5.6610 11.7835 0.0 0
M  V30 15 F 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-24-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME64 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951763-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Fluorophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(2-propen...
C23H25F2NO4S2
951688-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 F 5.6610 11.7835 0.0 0
M  V30 15 F 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 6.6533 0.0 0
M  V30 29 C 11.5254 3.9858 0.0 0
M  V30 30 C 13.0654 6.6533 0.0 0
M  V30 31 C 13.0654 3.9858 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-25-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-97-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME65 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9ClFNO2S
951763-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(2-propen...
C23H25ClFNO4S2
951688-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 Cl 5.6610 11.7835 0.0 0
M  V30 15 F 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-26-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-98-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086638
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME66 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9BrFNO2S
951763-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrFNO4S2
951688-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 3.7795 0.0 0
M  V30 3 O 9.2154 6.8595 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 Br 5.6610 11.7835 0.0 0
M  V30 15 F 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 6.6533 0.0 0
M  V30 29 C 11.5254 3.9858 0.0 0
M  V30 30 C 13.0654 6.6533 0.0 0
M  V30 31 C 13.0654 3.9858 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-27-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-99-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME67 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(2-propen...
C24H28ClNO4S2
951689-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 C 5.6610 11.7835 0.0 0
M  V30 15 Cl 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 6.6533 0.0 0
M  V30 29 C 11.5254 3.9858 0.0 0
M  V30 30 C 13.0654 6.6533 0.0 0
M  V30 31 C 13.0654 3.9858 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-28-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-00-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME68 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-2-(3-fluorophenyl)-4-(2-propen...
C23H25ClFNO4S2
951689-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 F 5.6610 11.7835 0.0 0
M  V30 15 Cl 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-29-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-01-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME69 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(4-chlorophenyl)sulfonyl]-4-(2-propen...
C23H25Cl2NO4S2
951689-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 3.7795 0.0 0
M  V30 3 O 9.2154 6.8595 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 Cl 5.6610 11.7835 0.0 0
M  V30 15 Cl 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 6.6533 0.0 0
M  V30 29 C 11.5254 3.9858 0.0 0
M  V30 30 C 13.0654 6.6533 0.0 0
M  V30 31 C 13.0654 3.9858 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-30-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-02-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092649
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME70 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(4-chlorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrClNO4S2
951689-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 Br 5.6610 11.7835 0.0 0
M  V30 15 Cl 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-31-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-03-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083194
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME71 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
951763-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 4.0010 5.3901 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 2.6673 6.1601 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(3-methylphenyl)-4-(2-propen-...
C24H28BrNO4S2
951689-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 C 5.6610 11.7835 0.0 0
M  V30 15 Br 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-32-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-04-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084674
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME72 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(3-chlorophenyl)-4-(2-propen-...
C23H25BrClNO4S2
951689-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 Cl 5.6610 11.7835 0.0 0
M  V30 15 Br 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-33-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME73 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(4-bromophenyl)sulfonyl]-4-(2-propen-1...
C23H25Br2NO4S2
951689-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 Br 5.6610 11.7835 0.0 0
M  V30 15 Br 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-34-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-07-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME74 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951763-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Fluorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(2-propen...
C24H28FNO4S2
951689-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 C 8.6737 0.0000 0.0 0
M  V30 15 F 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-35-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-08-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084877
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME75 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951763-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Fluorophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(2-propen...
C23H25F2NO4S2
951689-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 F 8.6737 0.0000 0.0 0
M  V30 15 F 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-36-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-09-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16065908
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME76 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9ClFNO2S
951763-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(2-propen...
C23H25ClFNO4S2
951689-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Cl 8.6737 0.0000 0.0 0
M  V30 15 F 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-37-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-10-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087925
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME77 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9BrFNO2S
951763-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrFNO4S2
951689-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Br 8.6737 0.0000 0.0 0
M  V30 15 F 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-38-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-11-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME78 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 0.0000 0.0 0
M  V30 16 C 10.7800 2.6673 0.0 0
M  V30 17 C 12.3200 0.0000 0.0 0
M  V30 18 C 12.3200 2.6673 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-2-(4-fluorophenyl)-4-(2-propen...
C23H25ClFNO4S2
951689-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 4.2207 3.8977 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 F 8.6737 0.0000 0.0 0
M  V30 15 Cl 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-39-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-12-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME79 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(4-chlorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrClNO4S2
951689-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Br 8.6737 0.0000 0.0 0
M  V30 15 Cl 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 6.2156 3.2496 0.0 0
M  V30 23 C 8.7524 4.0738 0.0 0
M  V30 24 C 6.6915 1.7849 0.0 0
M  V30 25 C 9.2283 2.6091 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-40-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092409
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME80 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951763-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(4-fluorophenyl)-4-(2-propen-...
C23H25BrFNO4S2
951689-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 F 8.6737 0.0000 0.0 0
M  V30 15 Br 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-41-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-15-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME81 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(4-chlorophenyl)-4-(2-propen-...
C23H25BrClNO4S2
951689-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5645 0.0 0
M  V30 3 O 9.2154 8.6445 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Cl 8.6737 0.0000 0.0 0
M  V30 15 Br 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 8.7524 4.0738 0.0 0
M  V30 23 C 6.2156 3.2496 0.0 0
M  V30 24 C 9.2283 2.6091 0.0 0
M  V30 25 C 6.6915 1.7849 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-42-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-16-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME82 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(4-bromophenyl)sulfonyl]-4-(2-propen-1...
C23H25Br2NO4S2
951689-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1045 0.0 0 VAL=6
M  V30 2 O 9.2154 8.6445 0.0 0
M  V30 3 O 9.2154 5.5645 0.0 0
M  V30 4 C 7.2460 9.8150 0.0 0
M  V30 5 C 6.2156 10.9594 0.0 0
M  V30 6 C 6.6915 12.4241 0.0 0
M  V30 7 C 4.0596 5.4293 0.0 0
M  V30 8 O 2.6528 6.0556 0.0 0
M  V30 9 O 4.2207 3.8977 0.0 0
M  V30 10 S 4.0596 8.7797 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0584 0.0 0
M  V30 13 C 0.0000 8.4321 0.0 0
M  V30 14 Br 8.6737 0.0000 0.0 0
M  V30 15 Br 15.3754 7.1045 0.0 0
M  V30 16 N 7.6754 7.1045 0.0 0
M  V30 17 C 6.7701 5.8586 0.0 0 CFG=1
M  V30 18 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3345 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8745 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3939 0.0 0
M  V30 22 C 6.2156 3.2496 0.0 0
M  V30 23 C 8.7524 4.0738 0.0 0
M  V30 24 C 6.6915 1.7849 0.0 0
M  V30 25 C 9.2283 2.6091 0.0 0
M  V30 26 C 8.1977 1.4647 0.0 0
M  V30 27 C 10.7554 7.1045 0.0 0
M  V30 28 C 11.5254 5.7708 0.0 0
M  V30 29 C 11.5254 8.4381 0.0 0
M  V30 30 C 13.0654 5.7708 0.0 0
M  V30 31 C 13.0654 8.4381 0.0 0
M  V30 32 C 13.8354 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-43-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-17-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME83 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8Cl3NO2S
951763-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0022 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 7.2322 1.7464 0.0 0
M  V30 4 O 8.7722 4.4137 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 Cl 13.3370 3.0801 0.0 0
M  V30 7 Cl 0.0000 3.0801 0.0 0
M  V30 8 Cl 0.0000 6.1601 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 C 12.0033 2.3101 0.0 0
M  V30 13 C 10.6697 0.0000 0.0 0
M  V30 14 C 12.0033 0.7700 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 4.0010 5.3901 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 2.6673 6.1601 0.0 0
M  V30 20 C 1.3337 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 12
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-4-(2-pr...
C23H24Cl3NO4S2
951689-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5645 0.0 0
M  V30 3 O 4.6200 8.6445 0.0 0
M  V30 4 C 9.7758 5.4293 0.0 0
M  V30 5 O 11.1826 6.0556 0.0 0
M  V30 6 O 9.6147 3.8977 0.0 0
M  V30 7 C 6.5894 9.8150 0.0 0
M  V30 8 C 7.6198 10.9594 0.0 0
M  V30 9 C 7.1439 12.4241 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 8.1743 0.6405 0.0 0
M  V30 15 Cl 5.1616 0.0000 0.0 0
M  V30 16 Cl 0.0000 9.7718 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 N 6.1600 7.1045 0.0 0
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 21 C 8.5299 7.8745 0.0 0 CFG=2
M  V30 22 C 6.5894 4.3939 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 5.0829 4.0738 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 4.6071 2.6091 0.0 0
M  V30 27 C 5.6376 1.4647 0.0 0
M  V30 28 C 3.0800 7.1045 0.0 0
M  V30 29 C 2.3100 8.4381 0.0 0
M  V30 30 C 2.3100 5.7708 0.0 0
M  V30 31 C 0.7700 8.4381 0.0 0
M  V30 32 C 0.7700 5.7708 0.0 0
M  V30 33 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 27
M  V30 17 1 16 31
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-44-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083159
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME84 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(2-propen...
C24H28ClNO4S2
951689-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 C 8.1743 0.0000 0.0 0
M  V30 15 Cl 0.0000 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 30
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-45-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084640
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME85 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-2-(3-fluorophenyl)-4-(2-propen...
C23H25ClFNO4S2
951689-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 F 8.1743 0.0000 0.0 0
M  V30 15 Cl 0.0000 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 30
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-46-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086154
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME86 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]-4-(2-propen...
C23H25Cl2NO4S2
951689-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 11.1826 5.4151 0.0 0
M  V30 6 O 9.6147 3.2573 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Cl 8.1743 0.0000 0.0 0
M  V30 15 Cl 0.0000 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 30
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-47-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-21-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087675
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME87 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-3-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(3-chlorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrClNO4S2
951689-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 9.7758 4.7888 0.0 0
M  V30 5 O 9.6147 3.2573 0.0 0
M  V30 6 O 11.1826 5.4151 0.0 0
M  V30 7 C 6.5894 9.1744 0.0 0
M  V30 8 C 7.6198 10.3189 0.0 0
M  V30 9 C 7.1439 11.7835 0.0 0
M  V30 10 S 9.7758 8.1392 0.0 0
M  V30 11 C 11.1826 7.5127 0.0 0
M  V30 12 C 12.4284 8.4179 0.0 0
M  V30 13 C 13.8354 7.7916 0.0 0
M  V30 14 Br 8.1743 0.0000 0.0 0
M  V30 15 Cl 0.0000 9.1313 0.0 0
M  V30 16 C 7.0652 5.2181 0.0 0 CFG=1
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 19 C 7.0652 7.7099 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 6.5894 3.7534 0.0 0
M  V30 22 C 7.6198 2.6091 0.0 0
M  V30 23 C 5.0829 3.4333 0.0 0
M  V30 24 C 7.1439 1.1444 0.0 0
M  V30 25 C 4.6071 1.9686 0.0 0
M  V30 26 C 5.6376 0.8242 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 7.7976 0.0 0
M  V30 29 C 2.3100 5.1302 0.0 0
M  V30 30 C 0.7700 7.7976 0.0 0
M  V30 31 C 0.7700 5.1302 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 30
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-48-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-22-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089205
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME88 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 C 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(2-propen...
C24H28ClNO4S2
951689-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 0.0000 9.7718 0.0 0
M  V30 15 C 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 30
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-49-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-23-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16070643
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME89 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 F 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-2-(4-fluorophenyl)-4-(2-propen...
C23H25ClFNO4S2
951689-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 9.6147 3.8977 0.0 0
M  V30 9 O 11.1826 6.0556 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 0.0000 9.7718 0.0 0
M  V30 15 F 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 7.6198 3.2496 0.0 0
M  V30 23 C 5.0829 4.0738 0.0 0
M  V30 24 C 7.1439 1.7849 0.0 0
M  V30 25 C 4.6071 2.6091 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 30
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-50-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092189
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME90 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Cl 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]-4-(2-propen...
C23H25Cl2NO4S2
951689-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 0.0000 9.7718 0.0 0
M  V30 15 Cl 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 7.6198 3.2496 0.0 0
M  V30 23 C 5.0829 4.0738 0.0 0
M  V30 24 C 7.1439 1.7849 0.0 0
M  V30 25 C 4.6071 2.6091 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 30
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-51-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-25-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME91 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-3-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Br 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(3-chlorophenyl)sulfonyl]-4-(2-propen-...
C23H25BrClNO4S2
951689-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1045 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6445 0.0 0
M  V30 3 O 4.6200 5.5645 0.0 0
M  V30 4 C 6.5894 9.8150 0.0 0
M  V30 5 C 7.6198 10.9594 0.0 0
M  V30 6 C 7.1439 12.4241 0.0 0
M  V30 7 C 9.7758 5.4293 0.0 0
M  V30 8 O 11.1826 6.0556 0.0 0
M  V30 9 O 9.6147 3.8977 0.0 0
M  V30 10 S 9.7758 8.7797 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0584 0.0 0
M  V30 13 C 13.8354 8.4321 0.0 0
M  V30 14 Cl 0.0000 9.7718 0.0 0
M  V30 15 Br 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1045 0.0 0
M  V30 17 C 7.0652 5.8586 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3503 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3345 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8745 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3939 0.0 0
M  V30 22 C 5.0829 4.0738 0.0 0
M  V30 23 C 7.6198 3.2496 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7849 0.0 0
M  V30 26 C 5.6376 1.4647 0.0 0
M  V30 27 C 3.0800 7.1045 0.0 0
M  V30 28 C 2.3100 8.4381 0.0 0
M  V30 29 C 2.3100 5.7708 0.0 0
M  V30 30 C 0.7700 8.4381 0.0 0
M  V30 31 C 0.7700 5.7708 0.0 0
M  V30 32 C 0.0000 7.1045 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 30
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-52-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-26-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME92 STEP1
$RXN



  3  1
$MOL
2,3-Heptadienoic acid
C7H10O2
145204-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 0.7700 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951764-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(3-fluorophenyl)-4-(2-propen-...
C23H25BrFNO4S2
951689-05-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.3195 0.0 0 VAL=6
M  V30 2 O 9.2154 6.8595 0.0 0
M  V30 3 O 9.2154 3.7795 0.0 0
M  V30 4 C 4.0596 6.9947 0.0 0
M  V30 5 O 2.6528 6.3684 0.0 0
M  V30 6 O 4.2207 8.5262 0.0 0
M  V30 7 C 7.2460 2.6091 0.0 0
M  V30 8 C 6.2156 1.4645 0.0 0
M  V30 9 C 6.6915 0.0000 0.0 0
M  V30 10 S 4.0596 3.6443 0.0 0
M  V30 11 C 2.6528 4.2707 0.0 0
M  V30 12 C 1.4069 3.3655 0.0 0
M  V30 13 C 0.0000 3.9918 0.0 0
M  V30 14 F 5.6610 11.7835 0.0 0
M  V30 15 Br 15.3754 5.3195 0.0 0
M  V30 16 C 6.7701 6.5653 0.0 0 CFG=1
M  V30 17 N 7.6754 5.3195 0.0 0
M  V30 18 C 5.3055 6.0895 0.0 0 CFG=2
M  V30 19 C 6.7701 4.0736 0.0 0 CFG=2
M  V30 20 C 5.3055 4.5495 0.0 0 CFG=2
M  V30 21 C 7.2460 8.0300 0.0 0
M  V30 22 C 6.2156 9.1744 0.0 0
M  V30 23 C 8.7524 8.3502 0.0 0
M  V30 24 C 6.6915 10.6391 0.0 0
M  V30 25 C 9.2283 9.8149 0.0 0
M  V30 26 C 8.1977 10.9593 0.0 0
M  V30 27 C 10.7554 5.3195 0.0 0
M  V30 28 C 11.5254 3.9858 0.0 0
M  V30 29 C 11.5254 6.6533 0.0 0
M  V30 30 C 13.0654 3.9858 0.0 0
M  V30 31 C 13.0654 6.6533 0.0 0
M  V30 32 C 13.8354 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 145204-05-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951764-30-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-05-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16057150
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
1-Nonanethiol
C9H20S
1455-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 C 4.0012 0.0000 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 C 9.3360 0.0000 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 10 S 12.0033 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Ribonic acid, 5-bromo-5-deoxy-, γ-lactone
C5H7BrO4
160456-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0286 0.0 0
M  V30 2 Br 6.6363 3.2586 0.0 0
M  V30 3 O 2.2418 5.3914 0.0 0
M  V30 4 O 0.0000 2.9016 0.0 0
M  V30 5 O 1.6752 0.0000 0.0 0
M  V30 6 C 3.9690 3.2586 0.0 0 CFG=1
M  V30 7 C 2.5620 3.8850 0.0 0 CFG=1
M  V30 8 O 3.8079 1.7270 0.0 0
M  V30 9 C 1.5316 2.7405 0.0 0 CFG=1
M  V30 10 C 2.3016 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=1
M  V30 3 1 7 3 CFG=3
M  V30 4 1 9 4 CFG=3
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Ribonic acid, 5-S-nonyl-5-thio-, γ-lactone
C14H26O4S
1616346-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0286 0.0 0
M  V30 2 S 6.6363 3.2586 0.0 0
M  V30 3 C 7.9700 4.0286 0.0 0
M  V30 4 C 9.3038 3.2586 0.0 0
M  V30 5 C 10.6375 4.0286 0.0 0
M  V30 6 C 11.9711 3.2586 0.0 0
M  V30 7 C 13.3048 4.0286 0.0 0
M  V30 8 C 14.6386 3.2586 0.0 0
M  V30 9 C 15.9723 4.0286 0.0 0
M  V30 10 C 17.3060 3.2586 0.0 0
M  V30 11 C 18.6396 4.0286 0.0 0
M  V30 12 O 2.2418 5.3914 0.0 0
M  V30 13 O 0.0000 2.9016 0.0 0
M  V30 14 O 1.6751 0.0000 0.0 0
M  V30 15 C 3.9690 3.2586 0.0 0 CFG=1
M  V30 16 C 2.5620 3.8850 0.0 0 CFG=1
M  V30 17 O 3.8079 1.7270 0.0 0
M  V30 18 C 1.5316 2.7405 0.0 0 CFG=1
M  V30 19 C 2.3016 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 16 12 CFG=3
M  V30 13 1 18 13 CFG=3
M  V30 14 2 14 19
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 15 16 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1455-21-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160456-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616346-67-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-11405085
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-78-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Influence of alkyl chain length on the mesomorphism of
5-S-alkyl-5-thiopentonolactones and 5-S-alkyl-5-thiopentitols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stasik, Imane; Gottis, Sebastien; Falentin-Daudre, Celine; Meyer, Claire
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Carbohydrate Research (2014), 39231-39

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4R)-4-[(2,3-Dihydro-3-methyl-2-oxo-1H-imidazol-4-yl)methyl]-3,4-dihyd...
C20H22N4O3
1492052-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 2.3101 0.0 0
M  V30 2 O 6.6685 0.7700 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 O 4.0012 5.3901 0.0 0
M  V30 6 C 12.3968 0.9473 0.0 0
M  V30 7 O 14.6386 3.4370 0.0 0
M  V30 8 C 8.0023 3.0801 0.0 0 CFG=2
M  V30 9 N 8.0023 4.6201 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 11 C 6.6685 5.3901 0.0 0
M  V30 12 C 9.1467 5.6505 0.0 0
M  V30 13 N 5.3348 3.0801 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 6.9887 6.8964 0.0 0
M  V30 16 C 8.5204 7.0574 0.0 0
M  V30 17 C 10.6697 3.0801 0.0 0
M  V30 18 N 12.0765 2.4536 0.0 0
M  V30 19 C 10.8306 4.6116 0.0 0
M  V30 20 C 13.1071 3.5981 0.0 0
M  V30 21 N 12.3371 4.9318 0.0 0
M  V30 22 C 2.6673 3.0801 0.0 0
M  V30 23 C 2.6675 4.6201 0.0 0
M  V30 24 C 1.3337 2.3101 0.0 0
M  V30 25 C 1.3337 5.3901 0.0 0
M  V30 26 C 0.0000 3.0801 0.0 0
M  V30 27 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=3
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 10 2 CFG=1
M  V30 5 1 4 13
M  V30 6 1 4 22
M  V30 7 2 5 14
M  V30 8 1 6 18
M  V30 9 2 7 20
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 1 13 14
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3R,4R)-4-[(2,3-Dihydro-3-methyl-2-oxo-1H-imidazol-4-yl)methyl]-3-(ethylt...
C21H24N4O2S
1492052-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.8501 0.0 0
M  V30 2 S 6.6685 2.3101 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 C 4.0012 3.8501 0.0 0
M  V30 6 O 4.0012 6.9302 0.0 0
M  V30 7 C 12.3968 2.4873 0.0 0
M  V30 8 O 14.6386 4.9771 0.0 0
M  V30 9 C 8.0023 4.6201 0.0 0 CFG=2
M  V30 10 N 8.0023 6.1601 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 12 C 6.6685 6.9302 0.0 0
M  V30 13 C 9.1467 7.1906 0.0 0
M  V30 14 N 5.3348 4.6201 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 6.9887 8.4365 0.0 0
M  V30 17 C 8.5204 8.5974 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 N 12.0765 3.9936 0.0 0
M  V30 20 C 10.8306 6.1517 0.0 0
M  V30 21 C 13.1071 5.1382 0.0 0
M  V30 22 N 12.3371 6.4718 0.0 0
M  V30 23 C 2.6673 4.6201 0.0 0
M  V30 24 C 1.3337 3.8501 0.0 0
M  V30 25 C 2.6673 6.1601 0.0 0
M  V30 26 C 0.0000 4.6201 0.0 0
M  V30 27 C 1.3337 6.9302 0.0 0
M  V30 28 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 11 2 CFG=1
M  V30 5 1 3 4
M  V30 6 1 5 14
M  V30 7 1 5 23
M  V30 8 2 6 15
M  V30 9 1 7 19
M  V30 10 2 8 21
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 15
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1492052-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1492052-36-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-013-CAS-5532693
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds, compositions and methods for treatment of blood cancer with
agelastatin alkaloids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Movassaghi, Mohammad; Hergenrother, Paul J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150080405 A1 2015-03-19

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4R)-4-[(2,3-Dihydro-3-methyl-2-oxo-1H-imidazol-4-yl)methyl]-3,4-dihyd...
C20H22N4O3
1492052-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 2.3101 0.0 0
M  V30 2 O 6.6685 0.7700 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 O 4.0012 5.3901 0.0 0
M  V30 6 C 12.3968 0.9473 0.0 0
M  V30 7 O 14.6386 3.4370 0.0 0
M  V30 8 C 8.0023 3.0801 0.0 0 CFG=2
M  V30 9 N 8.0023 4.6201 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 11 C 6.6685 5.3901 0.0 0
M  V30 12 C 9.1467 5.6505 0.0 0
M  V30 13 N 5.3348 3.0801 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 6.9887 6.8964 0.0 0
M  V30 16 C 8.5204 7.0574 0.0 0
M  V30 17 C 10.6697 3.0801 0.0 0
M  V30 18 N 12.0765 2.4536 0.0 0
M  V30 19 C 10.8306 4.6116 0.0 0
M  V30 20 C 13.1071 3.5981 0.0 0
M  V30 21 N 12.3371 4.9318 0.0 0
M  V30 22 C 2.6673 3.0801 0.0 0
M  V30 23 C 2.6675 4.6201 0.0 0
M  V30 24 C 1.3337 2.3101 0.0 0
M  V30 25 C 1.3337 5.3901 0.0 0
M  V30 26 C 0.0000 3.0801 0.0 0
M  V30 27 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=3
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 10 2 CFG=1
M  V30 5 1 4 13
M  V30 6 1 4 22
M  V30 7 2 5 14
M  V30 8 1 6 18
M  V30 9 2 7 20
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 1 13 14
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3R,4R)-4-[(2,3-Dihydro-3-methyl-2-oxo-1H-imidazol-4-yl)methyl]-3-(ethylt...
C21H24N4O2S
1492052-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.8501 0.0 0
M  V30 2 S 6.6685 2.3101 0.0 0
M  V30 3 C 5.3348 1.5400 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 C 4.0012 3.8501 0.0 0
M  V30 6 O 4.0012 6.9302 0.0 0
M  V30 7 C 12.3968 2.4873 0.0 0
M  V30 8 O 14.6386 4.9771 0.0 0
M  V30 9 C 8.0023 4.6201 0.0 0 CFG=2
M  V30 10 N 8.0023 6.1601 0.0 0
M  V30 11 C 6.6685 3.8501 0.0 0 CFG=1
M  V30 12 C 6.6685 6.9302 0.0 0
M  V30 13 C 9.1467 7.1906 0.0 0
M  V30 14 N 5.3348 4.6201 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 6.9887 8.4365 0.0 0
M  V30 17 C 8.5204 8.5974 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 N 12.0765 3.9936 0.0 0
M  V30 20 C 10.8306 6.1517 0.0 0
M  V30 21 C 13.1071 5.1382 0.0 0
M  V30 22 N 12.3371 6.4718 0.0 0
M  V30 23 C 2.6673 4.6201 0.0 0
M  V30 24 C 1.3337 3.8501 0.0 0
M  V30 25 C 2.6673 6.1601 0.0 0
M  V30 26 C 0.0000 4.6201 0.0 0
M  V30 27 C 1.3337 6.9302 0.0 0
M  V30 28 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 11 2 CFG=1
M  V30 5 1 3 4
M  V30 6 1 5 14
M  V30 7 1 5 23
M  V30 8 2 6 15
M  V30 9 1 7 19
M  V30 10 2 8 21
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 1 14 15
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1492052-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1492052-36-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-013-CAS-13612619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Anticancer Activity of All Known (-)-Agelastatin Alkaloids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Sunkyu; Siegel, Dustin S.; Morrison, Karen C.; Hergenrother, Paul
J.; Movassaghi, Mohammad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2013), 78(23), 11970-11984

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1-Methylethyl)thio]-2-nitrobenzene
C9H11NO2S
70415-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0 VAL=5
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 5.3349 0.0 0
M  V30 4 S 2.3100 4.0011 0.0 0
M  V30 5 C 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 C 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70415-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-7368695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: Preparation of isopropyl (2-nitrophenyl)sulfane (2)
1-fluoro-2-nitrobenzene (1, 10 g, 70 mmol) was taken up in DMF (100 mL)
along with 2-propanethiol (5.4g, 70mmol) and K2CO3 (25 g, 177 mmol) to
form a mixture. The mixture was then heated at 100°C for 16 h. Compound 2
was detected in the reaction mixture by liquid chromatography-mass
spectrometry (LC-MS), and TLC of the reaction mixture showed complete
conversion of compound 1 to compound 2. The reaction mixture was then
cooled to room temperature, water was added, and the product was
extracted with ethyl acetate. The organic extract was dried over sodium
sulfate and concentrated to obtain isopropyl(2-nitrophenyl)sulfane (2).
Yield 13.3 g, 95.27%. 1H NMR (CDCl3): 8.14-8.10 (d, 1H), 7.58-7.47 (m,
2H), 7.28-7.21 (m, 1H), 3.60-3.50 (m, 1H), 1.40 (s, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinyl benzamides and similar compounds as
therapeutic modulators of mutant EGFR activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Zhou, Wenjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011140338 A1 2011-11-10

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1-Methylethyl)thio]-2-nitrobenzene
C9H11NO2S
70415-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0 VAL=5
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 5.3349 0.0 0
M  V30 4 S 2.3100 4.0011 0.0 0
M  V30 5 C 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 C 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70415-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-13006872
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM isopropyl(2-nitrophenyl)sulfane To a solution of 1-fluoro-2-nitrobenzene
(3.0 g, 21.2 mmol) in DMF (60 mL) was added 2-propane thiol (2.2 mL, 23.4
mmol) and K2CO3 (6.8g, 42.4 mmol). The reaction was heated to 45 °C for
16 hours. The mixture was then diluted with 300mL of ethyl acetate,
filtrated, washed five times with 60mL of water and brine. The organic
phase was dried over sodium sulfate, filtered, concentrated. The
resulting yellow solid (4.0 g, 95% yield) was used without further
purification.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-(Het)arylamino-6-aminopyridine derivatives and fused
forms thereof as kinase inhibitors for treating hyperproliferative and
angiogenesis disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Michellys, Pierre-Yves; Pei, Wei; Marsilje, Thomas
H.; Lu, Wenshuo; Chen, Bei; Uno, Tetsuo; Jin, Yunho; Jiang, Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009032703 A1 2009-03-12

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1-Methylethyl)thio]-2-nitrobenzene
C9H11NO2S
70415-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0 VAL=5
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 5.3349 0.0 0
M  V30 4 S 2.3100 4.0011 0.0 0
M  V30 5 C 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 C 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 70415-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-10038469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 6-0.
N6-(2-isopropoxy-5-methyl-4-(1-methylpiperidin-4-yl)phenyl)-N4-(2-(isopro
pylsulfonyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine.
isopropyl(2-nitrophenyl)sulfane. To a solution of 1-fluoro-2-nitrobenzene
(3.0 g, 21.2 mmol) in DMF (60 mL) was added 2-propane thiol (2.2 mL, 23.4
mmol) and K2CO3 (6.8g, 42.4 mmol). The reaction was heated to 45 °C for
16 hours. The mixture was then diluted with 300mL of ethyl acetate,
filtrated, washed five times with 60mL of water and brine. The organic
phase was dried over sodium sulfate, filtered, concentrated. The
resulting yellow solid (4.0 g, 95% yield) was used without further
purification.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino substituted pyrimidine, pyrrolopyridine and
pyrazolopyrimidine derivatives useful as kinase inhibitors and in
treating proliferative disorders and diseases associated with
angiogenesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael; Sim, Taebo; Choi, Hwan Guen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009032694 A1 2009-03-12

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-D-Mannopyranosyl isothiocyanate, 2-deoxy-2-iodo-, 3,4,6-triacetate
C13H16INO7S
155114-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 6.1601 0.0 0
M  V30 2 C 1.3337 5.3901 0.0 0
M  V30 3 C 1.3337 3.8501 0.0 0
M  V30 4 O 0.0000 6.1601 0.0 0
M  V30 5 O 5.3348 7.7002 0.0 0
M  V30 6 C 4.0012 8.4702 0.0 0
M  V30 7 C 2.6673 7.7002 0.0 0
M  V30 8 O 4.0012 10.0102 0.0 0
M  V30 9 I 2.6673 3.0801 0.0 0
M  V30 10 C 8.0022 6.1601 0.0 0
M  V30 11 O 9.3360 5.3901 0.0 0
M  V30 12 C 10.6697 6.1601 0.0 0
M  V30 13 C 10.6697 7.7002 0.0 0
M  V30 14 O 12.0033 5.3901 0.0 0
M  V30 15 N 5.3348 1.5400 0.0 0
M  V30 16 C 6.6685 0.7700 0.0 0
M  V30 17 S 8.0022 0.0000 0.0 0
M  V30 18 C 4.0012 5.3901 0.0 0 CFG=2
M  V30 19 C 5.3348 6.1601 0.0 0 CFG=2
M  V30 20 C 4.0012 3.8501 0.0 0 CFG=2
M  V30 21 C 6.6685 5.3901 0.0 0 CFG=1
M  V30 22 C 5.3348 3.0801 0.0 0 CFG=1
M  V30 23 O 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 19 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 20 9 CFG=1
M  V30 10 1 10 11
M  V30 11 1 21 10 CFG=1
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 15 16
M  V30 16 1 22 15 CFG=3
M  V30 17 2 16 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 18 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamodithioic acid, (3,4,6-tri-O-acetyl-2-deoxy-2-iodo-α-D-mannopyranosyl)-...
C15H22INO7S2
653572-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 4.6201 0.0 0
M  V30 2 C 1.3337 5.3901 0.0 0
M  V30 3 C 1.3337 6.9302 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 O 2.6673 7.7002 0.0 0
M  V30 6 C 2.6673 9.2402 0.0 0
M  V30 7 C 4.0010 10.0102 0.0 0
M  V30 8 O 1.3337 10.0102 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 O 6.6685 2.3101 0.0 0
M  V30 11 C 6.6685 0.7700 0.0 0
M  V30 12 C 8.0022 0.0000 0.0 0
M  V30 13 O 5.3348 0.0000 0.0 0
M  V30 14 I 5.3348 9.2402 0.0 0
M  V30 15 N 8.0022 7.7002 0.0 0
M  V30 16 C 9.3360 6.9302 0.0 0
M  V30 17 S 10.6697 7.7002 0.0 0
M  V30 18 S 9.3360 5.3901 0.0 0
M  V30 19 C 12.0033 6.9302 0.0 0
M  V30 20 C 13.3370 7.7002 0.0 0
M  V30 21 C 4.0010 5.3901 0.0 0 CFG=2
M  V30 22 C 4.0010 6.9302 0.0 0 CFG=2
M  V30 23 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 24 C 5.3348 7.7002 0.0 0 CFG=2
M  V30 25 O 6.6685 5.3901 0.0 0
M  V30 26 C 6.6685 6.9302 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 22 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 24 14 CFG=3
M  V30 15 1 15 16
M  V30 16 1 26 15 CFG=1
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 21 22 23 24 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 155114-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 653572-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-304-CAS-441532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of S-ethyl
N-(2,4,6-tri-O-acetyl-2-deoxy-2-iodo-α-D-manopyranosyl)-dithiocarbamate
(6). Triethylamine (0.075 mL) was added to a cold solution (0 °C) of 1
(0.22 g, 0.48 mmol) and ethanethiol (0.035 mL, 0.48 mmol) in
1,2-dichloroetane (6 mL). After 5 min addition of 1,2-dichloroethane was
followed by washing with 5% HCl aqueous solution and water. The organic
phase was dried (Na2SO4) and evaporated to yield a crude product that was
purified by a short column chromatography (ether-hexane 2:1) giving 621
(237 mg, 95%) as a foam solid. mp 54-57 °C;[α]D +51° (c 1, chloroform);
IR (film) 3286, 1746, 1232 cm-1; 1H NMR (300 MHz, Cl3CD): δ 7.82 (br s,
1H, NH), 6.22 (br s, 1 H, H-1), 5.13 (t, 1 H,J= 6.3 Hz, H-4), 4.87 (dd, 1
H,J= 6.5 and 4.0 Hz, H-3),4.65 (dd, 1 H, J = 5.6 and 3.9 Hz, H-2), 4.42
(dd, 1 H; J= 12.1 and 6.4 Hz, H-6), 4.30 (dd, 1 H, J = 12.1 and 4.2 Hz,
H-6'), 4.17 (m, 1 H, H-5), 3.27 (q, 2 H,J= 7.5 Hz, CH2S), 2.17, 2.10,
2.09 (3s, 9 H, 3 MeCO), and 1.34 (t, 3 H,J= 7.5 Hz, CH3CH2S); 13C NMR
(100 MHz, DMSO-d6): δ 200.1 (CS), 169.9, 169.1, 168.8 (CO), 81.9 (C-1),
72.0, 69.1, 67.1 (C-3,4,5), 61.1 (C-6), 28.5 (C-2), 27.4 (SCH2), 20.3,
20.5,20.4 (MeCO), 13.9 (CH3CH2);Anal. Calcd for C12H22INO7S2: C, 34.69;
H, 4.27; N, 2.70; S, 12.35. Found: C, 34.70; H, 4.34, N, 2.74; S, 11.86.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactivity of 2-Deoxy-2-iodoglycosyl Isothiocyanates with O-, S-, and
N-Nucleophiles. Synthesis of Glycopyranoso-Fused Thiazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Isac-Garcia, Joaquin; Hernandez-Mateo, Fernando; Calvo-Flores, Francisco
G.; Santoyo-Gonzalez, Francisco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2004), 69(1), 202-205

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Stereoisomer of pentacarbonyl[μ-[η:η4-1-ethoxy-2-(2,4-cyclohexadien-1-yl)ethy...
C18H14FeO9W
156499-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3408 0.8681 0.0 0
M  V30 2 O 6.2113 0.8681 0.0 0 VAL=3
M  V30 3 C 2.3287 0.8681 0.0 0
M  V30 4 O 1.4581 0.8681 0.0 0 VAL=3
M  V30 5 C 3.8347 0.0000 0.0 0
M  V30 6 O 4.7053 0.0000 0.0 0 VAL=3
M  V30 7 C 3.0049 6.5423 0.0 0
M  V30 8 C 2.2519 6.9764 0.0 0 CHG=-2 VAL=4
M  V30 9 W 2.2519 8.7175 0.0 0 CHG=1 VAL=7
M  V30 10 O 1.4989 6.5423 0.0 0
M  V30 11 C 3.1488 10.2067 0.0 0
M  V30 12 C 1.3550 7.2258 0.0 0
M  V30 13 C 0.7602 9.6120 0.0 0
M  V30 14 C 2.2519 10.4562 0.0 0
M  V30 15 C 3.7436 7.8205 0.0 0
M  V30 16 C 0.7458 6.9764 0.0 0
M  V30 17 O 3.9019 9.7727 0.0 0 VAL=3
M  V30 18 O 0.6019 7.6599 0.0 0 VAL=3
M  V30 19 O 0.0072 9.1779 0.0 0 VAL=3
M  V30 20 O 1.4989 10.8902 0.0 0 VAL=3
M  V30 21 O 4.4966 8.2546 0.0 0 VAL=3
M  V30 22 C 0.0000 6.5279 0.0 0
M  V30 23 Fe 3.8347 1.7387 0.0 0 CHG=1 VAL=7
M  V30 24 C 3.0049 4.1225 0.0 0 VAL=5
M  V30 25 C 4.5542 4.1225 0.0 0 VAL=5
M  V30 26 C 1.6739 4.8971 0.0 0 VAL=5
M  V30 27 C 5.8828 4.8971 0.0 0 VAL=5
M  V30 28 C 3.0049 5.6717 0.0 0
M  V30 29 C 4.5542 5.6717 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 23
M  V30 3 3 3 4
M  V30 4 1 3 23
M  V30 5 3 5 6
M  V30 6 1 5 23
M  V30 7 1 7 8
M  V30 8 1 7 28
M  V30 9 2 8 9 CFG=2
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 3 15 21
M  V30 22 1 16 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 23 27
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Stereoisomer of pentacarbonyl[μ-[2-[(2,3,4,5-η)-2,4-cyclohexadien-1-yl]-1-(et...
C18H14FeO8SW
952595-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3408 0.8681 0.0 0
M  V30 2 O 6.2113 0.8681 0.0 0 VAL=3
M  V30 3 C 2.3287 0.8681 0.0 0
M  V30 4 O 1.4581 0.8681 0.0 0 VAL=3
M  V30 5 C 3.8347 0.0000 0.0 0
M  V30 6 O 4.7053 0.0000 0.0 0 VAL=3
M  V30 7 C 3.0049 6.5423 0.0 0
M  V30 8 C 2.2519 6.9764 0.0 0 CHG=-2 VAL=4
M  V30 9 W 2.2519 8.7175 0.0 0 CHG=2 VAL=7
M  V30 10 S 1.4989 6.5423 0.0 0
M  V30 11 C 3.1488 10.2067 0.0 0
M  V30 12 C 1.3550 7.2258 0.0 0
M  V30 13 C 0.7602 9.6120 0.0 0
M  V30 14 C 2.2519 10.4562 0.0 0
M  V30 15 C 3.7436 7.8205 0.0 0
M  V30 16 C 0.7458 6.9764 0.0 0
M  V30 17 O 3.9019 9.7727 0.0 0 VAL=3
M  V30 18 O 0.6019 7.6599 0.0 0 VAL=3
M  V30 19 O 0.0072 9.1779 0.0 0 VAL=3
M  V30 20 O 1.4989 10.8902 0.0 0 VAL=3
M  V30 21 O 4.4966 8.2546 0.0 0 VAL=3
M  V30 22 C 0.0000 6.5279 0.0 0
M  V30 23 Fe 3.8347 1.7387 0.0 0 VAL=7
M  V30 24 C 3.0049 4.1225 0.0 0 VAL=5
M  V30 25 C 4.5542 4.1225 0.0 0 VAL=5
M  V30 26 C 1.6739 4.8971 0.0 0 VAL=5
M  V30 27 C 5.8828 4.8971 0.0 0 VAL=5
M  V30 28 C 3.0049 5.6717 0.0 0
M  V30 29 C 4.5542 5.6717 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 23
M  V30 3 3 3 4
M  V30 4 1 3 23
M  V30 5 3 5 6
M  V30 6 1 5 23
M  V30 7 1 7 8
M  V30 8 1 7 28
M  V30 9 2 8 9 CFG=2
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 3 15 21
M  V30 22 1 16 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 23 27
M  V30 27 1 24 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 156499-92-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 952595-03-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-013-CAS-14785440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-38-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Pentacarbonyl[1-(ethylthio)-2-{tricarbonyl(2,4-cyclohexadien-1-yl)iron}ethylidene]tungsten
(8d). To
pentacarbonyl[1-ethoxy-2-tricarbonyl(2,4-cyclohexadien-1-yl)ironethylidene]tungsten
(7d) (200 mg, 0.33 mmol) in dichloromethane/ether, 1:3 (2 mL), was added
a mixture of ethanethiol (40 mg, 0.65 mmol) and triethylamine (66 mg,
0.65 mmol) in ether (0.5 mL) at -40 C. Stirring was continued for 2-2.5
h at this temperature. After the consumption of the starting carbene
complex, controlled by IR measurements, the reaction was quenched with
phosphoric acid (2-3 drops). The afforded red solution was diluted with
ether (30 mL) and then extracted with water (3 _ 15 mL). Finally the
organic phase was dried over magnesium sulfate, and the solvent was
removed at reduced pressure to give 8d (195 mg, Rf = 0.7 in
n-pentane/dichloromethane, 4:1, red oil).
Pentacarbonyl[1-(ethylthio)-2-{tricarbonyl(2,4-cyclohexadien-1-l)iron}ethylidene]tungsten
(8d), yield 95% 8d. 1H NMR (400 MHz, C6D6, 25 C): δ 4.76 (m, 1H; H-4),
4.64 (m, 1H; 3-H), 3.12 and 3.01 (m each, 1H each; 2-H2), 2.87 (m, 1H;
1-H), 2.71 (m, 1H; 2-H), 2.57 (m, 1H; 5-H), 2.09 (q, 3J = 7.7 Hz, 2H;
SCH2), 1.84 (ddd, 1H; 6endo-H), 0.89 (m, 1H; 6exo-H), 0.62 (t, 3J = 7.7
Hz, 3H; SCH2CH3). 13C NMR (C6D6, 25 C): δ 333.7 (Cq, C1), 211.6 [Cq, CO
of Fe(CO)3], 206.2 and 198.1 [Cq, 1:4 C; trans- and cis-CO of W(CO)5],
86.1 (CH, C-4), 84.4 (CH, C-3), 67.2 (CH2, C2), 64.6 (CH, C2), 59.2
(CH, C-5), 41.3 (CH, C-1), 38.0 (SCH2), 29.7 (CH2, C-6), 11.2
(SCH2CH3). IR (n-pentane): ν˜ 2066.6 (60), 2052.0 (70), 1992.6 (40),
1957.6 (95), 1952.2 (100), 1941.7 (90), 1933.5 (90) cm-1 (C≡O). MS (70
eV, EI): m/z (%) 630 [M]+, 574 [M - 2CO]+, 490 [M - 5CO]+, 192 (100).
HRMS (ESI-): m/z calcd for C18H13O8SFeW 628.9200, found 628.9202.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Strikingly Different Reactivity Patterns of Fischer Alkoxycarbene and
Thiocarbene Complexes in Experimental and Theoretical Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karatas, Betuel; Hyla-Kryspin, Isabella; Aumann, Rudolf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organometallics (2007), 26(20), 4983-4996

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
2-Butanethiol, (2S)-
C4H10S
20407-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0 CFG=1
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-Methoxy-2-naphthaleneacetic acid
C13H12O3
156942-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 2.3100 0.0 0 CFG=1
M  V30 2 C 8.0021 3.0800 0.0 0
M  V30 3 O 6.6684 0.7700 0.0 0
M  V30 4 O 8.0021 4.6200 0.0 0
M  V30 5 O 9.3358 2.3100 0.0 0
M  V30 6 C 8.0021 0.0000 0.0 0
M  V30 7 C 5.3347 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 5.3347 4.6200 0.0 0
M  V30 10 C 2.6674 3.0800 0.0 0
M  V30 11 C 4.0011 5.3900 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 14 C 1.3336 5.3900 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 12
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-[(1S)-1-Methylpropyl] (αR)-α-methoxy-2-naphthaleneethanethioate
C17H20O2S
1603112-08-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0 CFG=1
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 O 6.6685 0.7700 0.0 0
M  V30 4 S 9.3360 2.3101 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 C 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0 CFG=1
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 10.6697 4.6201 0.0 0
M  V30 10 C 13.3370 3.0801 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 4.0010 5.3901 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 1.3337 5.3901 0.0 0
M  V30 19 C 0.0000 3.0801 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 16
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 20407-74-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 156942-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1603112-08-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-5921161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing chiral derivatizing agents (CDA) for the NMR assignment of the
absolute configuration: a theoretical and experimental approach with
thiols as a case study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Porto, Silvia; Quinoa, Emilio; Riguera, Ricardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(20), 3276-3283

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
2-Butanethiol, (2S)-
C4H10S
20407-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0 CFG=1
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-Methoxy-9-anthraceneacetic acid
C17H14O3
156942-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 5.3900 0.0 0 CFG=1
M  V30 2 C 6.6685 4.6200 0.0 0
M  V30 3 O 5.3347 6.9300 0.0 0
M  V30 4 O 6.6685 3.0800 0.0 0
M  V30 5 O 8.0021 5.3900 0.0 0
M  V30 6 C 6.6685 7.7000 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 2.6674 5.3900 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 2.6674 6.9300 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 1.3336 3.0800 0.0 0
M  V30 15 C 0.0000 5.3900 0.0 0
M  V30 16 C 1.3336 7.7000 0.0 0
M  V30 17 C 2.6674 0.7700 0.0 0
M  V30 18 C 5.3347 0.7700 0.0 0
M  V30 19 C 0.0000 6.9300 0.0 0
M  V30 20 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 2 11 16
M  V30 16 2 12 14
M  V30 17 1 12 17
M  V30 18 2 13 18
M  V30 19 2 15 19
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 1 18 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-[(1S)-1-Methylpropyl] (αR)-α-methoxy-9-anthraceneethanethioate
C21H22O2S
1603112-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3901 0.0 0 CFG=1
M  V30 2 C 6.6684 4.6201 0.0 0
M  V30 3 O 5.3348 6.9301 0.0 0
M  V30 4 S 8.0021 5.3901 0.0 0
M  V30 5 O 6.6684 3.0800 0.0 0
M  V30 6 C 6.6684 7.7001 0.0 0
M  V30 7 C 9.3359 4.6201 0.0 0 CFG=1
M  V30 8 C 10.6695 5.3901 0.0 0
M  V30 9 C 9.3359 3.0800 0.0 0
M  V30 10 C 12.0032 4.6201 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 4.0011 3.0800 0.0 0
M  V30 13 C 2.6673 5.3901 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 15 C 5.3348 2.3100 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 2.6673 6.9301 0.0 0
M  V30 18 C 1.3337 3.0800 0.0 0
M  V30 19 C 2.6673 0.7700 0.0 0
M  V30 20 C 5.3348 0.7700 0.0 0
M  V30 21 C 0.0000 5.3901 0.0 0
M  V30 22 C 1.3337 7.7001 0.0 0
M  V30 23 C 4.0011 0.0000 0.0 0
M  V30 24 C 0.0000 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=3
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 2 15 20
M  V30 20 2 16 18
M  V30 21 1 16 21
M  V30 22 2 17 22
M  V30 23 2 19 23
M  V30 24 1 20 23
M  V30 25 2 21 24
M  V30 26 1 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 20407-74-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 156942-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1603112-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-8055910
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing chiral derivatizing agents (CDA) for the NMR assignment of the
absolute configuration: a theoretical and experimental approach with
thiols as a case study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Porto, Silvia; Quinoa, Emilio; Riguera, Ricardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(20), 3276-3283

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Diethyl 2-(acetylamino)-2-(2-phenylethynyl)propanedioate
C17H19NO5
156979-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 C 6.1600 4.6200 0.0 0
M  V30 3 C 4.6200 3.0800 0.0 0
M  V30 4 C 3.0800 4.6200 0.0 0
M  V30 5 N 4.6200 6.1600 0.0 0
M  V30 6 C 7.7000 4.6200 0.0 0
M  V30 7 O 3.2864 2.3100 0.0 0
M  V30 8 O 5.9536 2.3100 0.0 0
M  V30 9 O 2.3100 5.9536 0.0 0
M  V30 10 O 2.3100 3.2864 0.0 0
M  V30 11 C 5.9536 6.9300 0.0 0
M  V30 12 C 3.2864 0.7700 0.0 0
M  V30 13 C 0.7700 5.9536 0.0 0
M  V30 14 C 5.9536 8.4700 0.0 0
M  V30 15 O 7.2874 6.1600 0.0 0
M  V30 16 C 1.9526 0.0000 0.0 0
M  V30 17 C 0.0000 7.2874 0.0 0
M  V30 18 C 9.2400 4.6200 0.0 0
M  V30 19 C 10.0100 3.2864 0.0 0
M  V30 20 C 10.0100 5.9536 0.0 0
M  V30 21 C 11.5500 3.2864 0.0 0
M  V30 22 C 11.5500 5.9536 0.0 0
M  V30 23 C 12.3200 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 1 5 11
M  V30 11 1 6 18
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (3E)-2-(acetylamino)-3-(ethylthio)-4-phenyl-3-butenoate
C16H21NO3S
156979-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3146 0.0 0
M  V30 2 C 5.9856 3.9189 0.0 0 CFG=3
M  V30 3 C 4.0010 6.0846 0.0 0
M  V30 4 S 6.6685 6.0846 0.0 0
M  V30 5 C 7.5198 3.7846 0.0 0
M  V30 6 N 5.1022 2.6573 0.0 0
M  V30 7 C 6.6685 7.6247 0.0 0
M  V30 8 O 8.4031 5.0460 0.0 0
M  V30 9 O 8.1706 2.3889 0.0 0
M  V30 10 C 5.7531 1.2616 0.0 0
M  V30 11 C 8.0021 8.3947 0.0 0
M  V30 12 C 9.9373 4.9119 0.0 0
M  V30 13 C 4.8699 0.0000 0.0 0
M  V30 14 O 7.2872 1.1273 0.0 0
M  V30 15 C 10.8205 6.1733 0.0 0
M  V30 16 C 2.6673 5.3146 0.0 0
M  V30 17 C 2.6673 3.7746 0.0 0
M  V30 18 C 1.3337 6.0846 0.0 0
M  V30 19 C 1.3337 3.0046 0.0 0
M  V30 20 C 0.0000 5.3146 0.0 0
M  V30 21 C 0.0000 3.7746 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 16
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 156979-38-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 156979-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-238-CAS-10124066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Expeditious syntheses of conjugated allenyl esters and oxazoles through a
cascade reaction of α-alkynyl malonates under alkaline conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sano, Shigeki; Shimizu, Hisashi; Kim, Kweon; Lee, Woo Song; Shiro, Motoo;
Nagao, Yoshimitsu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2006), 54(2), 196-203

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methyl 4-formylbenzoate
C9H8O3
1571-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 O 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-5-heptene-2-thiol
C8H16S
181940-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 2.3100 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 0.0000 0.0 0
M  V30 9 S 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl 4-[(2R,3S,6R)-tetrahydro-6-methyl-3-(1-methylethenyl)-2H-thiopyran...
C17H22O2S
1360830-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 1.3338 0.0 0
M  V30 2 C 4.6201 1.3338 0.0 0
M  V30 3 C 2.3101 0.0000 0.0 0
M  V30 4 C 0.0000 6.6687 0.0 0
M  V30 5 C 9.2402 4.0012 0.0 0
M  V30 6 O 10.0102 5.3348 0.0 0
M  V30 7 O 10.0102 2.6675 0.0 0
M  V30 8 C 11.5503 5.3348 0.0 0
M  V30 9 C 3.0801 4.0012 0.0 0 CFG=2
M  V30 10 C 2.3101 2.6675 0.0 0 CFG=2
M  V30 11 S 2.3101 5.3348 0.0 0
M  V30 12 C 0.7700 2.6675 0.0 0
M  V30 13 C 0.7700 5.3348 0.0 0 CFG=2
M  V30 14 C 0.0000 4.0012 0.0 0
M  V30 15 C 4.6201 4.0012 0.0 0
M  V30 16 C 5.3901 2.6675 0.0 0
M  V30 17 C 5.3901 5.3348 0.0 0
M  V30 18 C 6.9302 2.6675 0.0 0
M  V30 19 C 6.9302 5.3348 0.0 0
M  V30 20 C 7.7002 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=3
M  V30 4 1 13 4 CFG=1
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 20
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 9 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1571-08-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 181940-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1360830-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29529373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-63-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Procedure for the Synthesis of
3-Isopropenyl-6-methyl-2-phenyltetrahydrothiopyran (3a, Table 1).
6-Methyl-hept-5-ene-2-thiol (86 mg, 0.6 mmol) in 2 mL of toluene was
added dropwise to a stirring mixture of benzaldehyde (53 mg, 0.5 mmol),
boron trifluoride etherate (63 μL, 0.5 mmol), and toluene (2 mL) at 0°C.
The stirring was continued at the same temperature for 30 min, and then
the mixture was poured into saturated NaHCO3 (5 mL). The reaction mixture
was extracted with ethyl acetate and then washed with brine and water.
The organic layers were collected, dried over Na2SO4, filtered, and
concentrated. Then the resultant crude residue was purified by column
chromatography over silica gel (petroleum ether/ EtOAc 98:2). Methyl
4-(tetrahydro-6-methyl-3-(prop-1-en-2-yl)-2H-thio-pyran-2-yl)benzoate
(3c): pale yellow crystalline solid; mp 58-60°C (138 mg, 95%). 1H NMR
(400 MHz, CDCl3) δ 1.21 (d, J= 6.4 Hz, 3 H), 1.47 (s, 3 H), 1.53-1.64 (m,
2 H), 1.92-2.00 (m, 1 H), 2.07-2.17 (m, 1 H), 2.63 (dt, J= 14.0 and 2.8
Hz, 1 H), 2.98-3.06 (m, 1 H), 3.89 (s, 3 H), 3.96 (d, J= 10.8 Hz, 1 H),
4.54-4.58 (m, 2 H), 7.34 (d, J= 8.4 Hz, 2 H), 7.94 (d, J= 8.4 Hz, 2 H);
13C NMR (100 MHz, CDCl3) δ 20.3, 21.1, 33.6, 37.1, 39.9, 50.8, 51.5,
52.1, 112.6, 128.4, 129.1, 129.8, 146.1, 147.0, 167.0; IR (KBr, neat)
2954, 2923, 1722, 1610, 1435, 1375, 1279, 1112, 1019, 752 cm-1; HRMS
(APCI) calcd for C17H22O2S (M + H)+ requires 291.1413, found 291.1406.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Prins cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereoselective Synthesis of Substituted Tetrahydrothiopyrans via
(3,5)-Thionium-Ene Cyclization Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bondalapati, Somasekhar; Gogoi, Paramartha; Indukuri, Kiran; Saikia, Anil
K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(5), 2508-2512

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
1-Heptanethiol
C7H16S
1639-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 S 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Ribonic acid, 5-bromo-5-deoxy-, γ-lactone
C5H7BrO4
160456-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0286 0.0 0
M  V30 2 Br 6.6363 3.2586 0.0 0
M  V30 3 O 2.2418 5.3914 0.0 0
M  V30 4 O 0.0000 2.9016 0.0 0
M  V30 5 O 1.6752 0.0000 0.0 0
M  V30 6 C 3.9690 3.2586 0.0 0 CFG=1
M  V30 7 C 2.5620 3.8850 0.0 0 CFG=1
M  V30 8 O 3.8079 1.7270 0.0 0
M  V30 9 C 1.5316 2.7405 0.0 0 CFG=1
M  V30 10 C 2.3016 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=1
M  V30 3 1 7 3 CFG=3
M  V30 4 1 9 4 CFG=3
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Ribonic acid, 5-S-heptyl-5-thio-, γ-lactone
C12H22O4S
1616346-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0286 0.0 0
M  V30 2 S 6.6363 3.2586 0.0 0
M  V30 3 C 7.9701 4.0286 0.0 0
M  V30 4 C 9.3038 3.2586 0.0 0
M  V30 5 C 10.6375 4.0286 0.0 0
M  V30 6 C 11.9711 3.2586 0.0 0
M  V30 7 C 13.3050 4.0286 0.0 0
M  V30 8 C 14.6386 3.2586 0.0 0
M  V30 9 C 15.9723 4.0286 0.0 0
M  V30 10 O 2.2418 5.3914 0.0 0
M  V30 11 O 0.0000 2.9016 0.0 0
M  V30 12 O 1.6752 0.0000 0.0 0
M  V30 13 C 3.9690 3.2586 0.0 0 CFG=1
M  V30 14 C 2.5620 3.8850 0.0 0 CFG=1
M  V30 15 O 3.8080 1.7270 0.0 0
M  V30 16 C 1.5316 2.7405 0.0 0 CFG=1
M  V30 17 C 2.3016 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 14 10 CFG=3
M  V30 11 1 16 11 CFG=3
M  V30 12 2 12 17
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1639-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160456-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616346-66-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-11160305
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-78-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Influence of alkyl chain length on the mesomorphism of
5-S-alkyl-5-thiopentonolactones and 5-S-alkyl-5-thiopentitols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stasik, Imane; Gottis, Sebastien; Falentin-Daudre, Celine; Meyer, Claire
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Carbohydrate Research (2014), 39231-39

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
1-Undecanethiol
C11H24S
5332-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 8.0022 0.7700 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 9.3358 0.0000 0.0 0
M  V30 5 C 4.0010 0.0000 0.0 0
M  V30 6 C 10.6697 0.7700 0.0 0
M  V30 7 C 2.6673 0.7700 0.0 0
M  V30 8 C 12.0033 0.0000 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 13.3370 0.7700 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 12 S 14.6707 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Ribonic acid, 5-bromo-5-deoxy-, γ-lactone
C5H7BrO4
160456-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0286 0.0 0
M  V30 2 Br 6.6363 3.2586 0.0 0
M  V30 3 O 2.2418 5.3914 0.0 0
M  V30 4 O 0.0000 2.9016 0.0 0
M  V30 5 O 1.6752 0.0000 0.0 0
M  V30 6 C 3.9690 3.2586 0.0 0 CFG=1
M  V30 7 C 2.5620 3.8850 0.0 0 CFG=1
M  V30 8 O 3.8079 1.7270 0.0 0
M  V30 9 C 1.5316 2.7405 0.0 0 CFG=1
M  V30 10 C 2.3016 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=1
M  V30 3 1 7 3 CFG=3
M  V30 4 1 9 4 CFG=3
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Ribonic acid, 5-thio-5-S-undecyl-, γ-lactone
C16H30O4S
1616346-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3028 4.0286 0.0 0
M  V30 2 S 6.6365 3.2586 0.0 0
M  V30 3 C 7.9701 4.0286 0.0 0
M  V30 4 C 9.3038 3.2586 0.0 0
M  V30 5 C 10.6376 4.0286 0.0 0
M  V30 6 C 11.9713 3.2586 0.0 0
M  V30 7 C 13.3050 4.0286 0.0 0
M  V30 8 C 14.6386 3.2586 0.0 0
M  V30 9 C 15.9725 4.0286 0.0 0
M  V30 10 C 17.3061 3.2586 0.0 0
M  V30 11 C 18.6398 4.0286 0.0 0
M  V30 12 C 19.9735 3.2586 0.0 0
M  V30 13 C 21.3073 4.0286 0.0 0
M  V30 14 O 2.2420 5.3914 0.0 0
M  V30 15 O 0.0000 2.9016 0.0 0
M  V30 16 O 1.6752 0.0000 0.0 0
M  V30 17 C 3.9690 3.2586 0.0 0 CFG=1
M  V30 18 C 2.5622 3.8850 0.0 0 CFG=1
M  V30 19 O 3.8080 1.7270 0.0 0
M  V30 20 C 1.5317 2.7405 0.0 0 CFG=1
M  V30 21 C 2.3017 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 18 14 CFG=3
M  V30 15 1 20 15 CFG=3
M  V30 16 2 16 21
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 17 18 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5332-52-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160456-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616346-68-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-6576612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-78-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Influence of alkyl chain length on the mesomorphism of
5-S-alkyl-5-thiopentonolactones and 5-S-alkyl-5-thiopentitols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stasik, Imane; Gottis, Sebastien; Falentin-Daudre, Celine; Meyer, Claire
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Carbohydrate Research (2014), 39231-39

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5Z,9α,11α,13E)-(±)-9-(acetyloxy)-15-oxo-11-[(tetrahydro-2H-pyran-2-yl...
C28H44O7
1628900-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4069 8.9716 0.0 0
M  V30 2 C 6.3764 7.8272 0.0 0
M  V30 3 C 6.8524 6.3625 0.0 0
M  V30 4 C 5.8218 5.2181 0.0 0
M  V30 5 O 8.3587 6.0423 0.0 0
M  V30 6 C 6.2978 3.7534 0.0 0
M  V30 7 C 5.2673 2.6091 0.0 0
M  V30 8 C 5.7431 1.1444 0.0 0
M  V30 9 C 4.7127 0.0000 0.0 0
M  V30 10 C 9.3761 11.6821 0.0 0
M  V30 11 C 10.1461 13.0158 0.0 0
M  V30 12 C 11.6861 13.0158 0.0 0
M  V30 13 C 12.4561 11.6821 0.0 0
M  V30 14 C 13.9961 11.6821 0.0 0
M  V30 15 C 14.7661 10.3483 0.0 0
M  V30 16 C 16.3061 10.3483 0.0 0
M  V30 17 O 17.0761 9.0147 0.0 0
M  V30 18 O 17.0761 11.6821 0.0 0
M  V30 19 C 18.6161 9.0147 0.0 0
M  V30 20 O 4.2205 10.0069 0.0 0
M  V30 21 O 7.4069 14.3925 0.0 0
M  V30 22 C 6.3764 15.5371 0.0 0
M  V30 23 C 4.8701 15.2169 0.0 0
M  V30 24 O 6.8524 17.0016 0.0 0
M  V30 25 C 6.9311 10.4363 0.0 0 CFG=1
M  V30 26 C 7.8361 11.6821 0.0 0 CFG=1
M  V30 27 C 5.4664 10.9121 0.0 0 CFG=2
M  V30 28 C 6.9311 12.9280 0.0 0 CFG=1
M  V30 29 C 5.4664 12.4521 0.0 0
M  V30 30 C 2.8136 10.6332 0.0 0 CFG=3
M  V30 31 C 1.5677 9.7280 0.0 0
M  V30 32 O 2.6526 12.1648 0.0 0
M  V30 33 C 0.1609 10.3545 0.0 0
M  V30 34 C 1.2459 12.7912 0.0 0
M  V30 35 C 0.0000 11.8860 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 25 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 26 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 27 20 CFG=3
M  V30 21 1 20 30
M  V30 22 1 21 22
M  V30 23 1 28 21 CFG=3
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 25 26 27 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (5Z,9α,11α)-(±)-9-(acetyloxy)-13-(ethylthio)-15-oxo-11-[(tetrahydro-2H...
C30H50O7S
1628900-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 7.4547 0.0 0 CFG=3
M  V30 2 C 6.9300 7.4547 0.0 0
M  V30 3 S 9.2400 8.7884 0.0 0
M  V30 4 C 6.1600 8.7884 0.0 0
M  V30 5 C 8.4700 10.1220 0.0 0
M  V30 6 C 4.6200 8.7884 0.0 0
M  V30 7 O 6.9300 10.1220 0.0 0
M  V30 8 C 9.2400 11.4557 0.0 0
M  V30 9 C 3.8500 10.1220 0.0 0
M  V30 10 C 2.3100 10.1220 0.0 0
M  V30 11 C 1.5400 11.4557 0.0 0
M  V30 12 C 0.0000 11.4557 0.0 0
M  V30 13 O 7.1073 4.3940 0.0 0
M  V30 14 C 11.8022 7.1045 0.0 0
M  V30 15 C 13.3084 6.7842 0.0 0
M  V30 16 C 14.3389 7.9287 0.0 0
M  V30 17 C 13.8630 9.3933 0.0 0
M  V30 18 C 14.8934 10.5378 0.0 0
M  V30 19 C 16.3999 10.2176 0.0 0
M  V30 20 C 17.4303 11.3620 0.0 0
M  V30 21 O 18.9367 11.0419 0.0 0
M  V30 22 O 16.9544 12.8267 0.0 0
M  V30 23 C 19.9671 12.1864 0.0 0
M  V30 24 O 12.4987 3.8272 0.0 0
M  V30 25 C 12.6596 2.2957 0.0 0
M  V30 26 C 14.0666 1.6694 0.0 0
M  V30 27 O 11.4138 1.3905 0.0 0
M  V30 28 C 9.2400 6.1209 0.0 0 CFG=2
M  V30 29 C 8.6137 4.7141 0.0 0 CFG=2
M  V30 30 C 10.7716 5.9600 0.0 0 CFG=1
M  V30 31 C 9.7581 3.6837 0.0 0
M  V30 32 C 11.0918 4.4537 0.0 0 CFG=1
M  V30 33 C 6.6314 2.9292 0.0 0 CFG=3
M  V30 34 C 7.6618 1.7849 0.0 0
M  V30 35 O 5.1250 2.6091 0.0 0
M  V30 36 C 7.1860 0.3202 0.0 0
M  V30 37 C 4.6491 1.1445 0.0 0
M  V30 38 C 5.6797 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 28 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 29 13 CFG=1
M  V30 14 1 13 33
M  V30 15 1 14 15
M  V30 16 1 30 14 CFG=1
M  V30 17 2 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 24 25
M  V30 26 1 32 24 CFG=1
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 32
M  V30 34 1 33 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 1 36 38
M  V30 39 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 28 29 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1628900-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628900-42-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2558463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl
(±)-(5Z,9α,11α)-9-acetoxy-15-oxo-13-ethylsulfanyl-11-(tetrahydro-2H-pyran-2-yloxy)-prost-5-en-1-oate
(20). Sodium hydride, 0.04 g, was added under stirring in an argon
atmosphere to a solution of 1.44 g (2.92 mmol) of enone 19 and 0.27 g
(4.17 mmol) of ethanethiol in 40 mL of anhydrous THF. The mixture was
stirred for 30 min, 80 mL of a saturated aqueous solution of ammonium
chloride was added, and the mixture was extracted with methylene chloride
(3 × 40 mL). The extract was dried over MgSO4 and evaporated under
reduced pressure, and the residue was purified by silica gel
chromatography. Yield 1.54 g (95%), colorless oily material. R f 0.6
(petroleum ether-ethyl acetate, 7 : 3), a mixture of diastereoisomers. IR
spectrum, ν, cm-1: 2952, 2929, 1735, 1714, 1680, 1373, 1244, 1027. 1H NMR
spectrum (CDCl3), δ, ppm: 0.85 t (3H, CH3, J = 6.4 Hz), 1.20 t (3H, CH3,
J = 6.4 Hz), 1.96 s and 1.98 s (3H, OAc), 3.60 s (3H, OCH3), 4.40 m and
4.55 m (0.5H each, 2″-H), 5.0 m (1H, 9-H), 5.35 br.s (2H, CH=CH). 13C NMR
spectrum (CDCl3), δC, ppm: 13.91 (CH3), 15.03 (CH3), 31.37 and 31.44
(C18), 33.51 (C2), 51.47 (OCH3), 94.64, 97.64, 100.18 (C2″), 170.34,
170.79, 170.88 (MeCO), 173.96 (CO2Me), 208.75, 209.44, 209.76, 210.09
(C15).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, Michael reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (±)-15-deoxy-Δ12,14-prostaglandin J2 and Δ12-prostaglandin
J2 15-acetate methyl esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vostrikov, N. S.; Lobko, I. F.; Ishimova, D. U.; Miftakhov, M. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2015), 51(1), 1-9

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5Z,9α,11α,13E)-(±)-9-(acetyloxy)-15-oxo-11-[(tetrahydro-2H-pyran-2-yl...
C28H44O7
1628900-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4069 8.9716 0.0 0
M  V30 2 C 6.3764 7.8272 0.0 0
M  V30 3 C 6.8524 6.3625 0.0 0
M  V30 4 C 5.8218 5.2181 0.0 0
M  V30 5 O 8.3587 6.0423 0.0 0
M  V30 6 C 6.2978 3.7534 0.0 0
M  V30 7 C 5.2673 2.6091 0.0 0
M  V30 8 C 5.7431 1.1444 0.0 0
M  V30 9 C 4.7127 0.0000 0.0 0
M  V30 10 C 9.3761 11.6821 0.0 0
M  V30 11 C 10.1461 13.0158 0.0 0
M  V30 12 C 11.6861 13.0158 0.0 0
M  V30 13 C 12.4561 11.6821 0.0 0
M  V30 14 C 13.9961 11.6821 0.0 0
M  V30 15 C 14.7661 10.3483 0.0 0
M  V30 16 C 16.3061 10.3483 0.0 0
M  V30 17 O 17.0761 9.0147 0.0 0
M  V30 18 O 17.0761 11.6821 0.0 0
M  V30 19 C 18.6161 9.0147 0.0 0
M  V30 20 O 4.2205 10.0069 0.0 0
M  V30 21 O 7.4069 14.3925 0.0 0
M  V30 22 C 6.3764 15.5371 0.0 0
M  V30 23 C 4.8701 15.2169 0.0 0
M  V30 24 O 6.8524 17.0016 0.0 0
M  V30 25 C 6.9311 10.4363 0.0 0 CFG=1
M  V30 26 C 7.8361 11.6821 0.0 0 CFG=1
M  V30 27 C 5.4664 10.9121 0.0 0 CFG=2
M  V30 28 C 6.9311 12.9280 0.0 0 CFG=1
M  V30 29 C 5.4664 12.4521 0.0 0
M  V30 30 C 2.8136 10.6332 0.0 0 CFG=3
M  V30 31 C 1.5677 9.7280 0.0 0
M  V30 32 O 2.6526 12.1648 0.0 0
M  V30 33 C 0.1609 10.3545 0.0 0
M  V30 34 C 1.2459 12.7912 0.0 0
M  V30 35 C 0.0000 11.8860 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 25 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 26 10 CFG=3
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 27 20 CFG=3
M  V30 21 1 20 30
M  V30 22 1 21 22
M  V30 23 1 28 21 CFG=3
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 25 26 27 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (5Z,9α,11α)-(±)-9-(acetyloxy)-13-(ethylthio)-15-oxo-11-[(tetrahydro-2H...
C30H50O7S
1628900-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 7.4547 0.0 0 CFG=3
M  V30 2 C 6.9300 7.4547 0.0 0
M  V30 3 S 9.2400 8.7884 0.0 0
M  V30 4 C 6.1600 8.7884 0.0 0
M  V30 5 C 8.4700 10.1220 0.0 0
M  V30 6 C 4.6200 8.7884 0.0 0
M  V30 7 O 6.9300 10.1220 0.0 0
M  V30 8 C 9.2400 11.4557 0.0 0
M  V30 9 C 3.8500 10.1220 0.0 0
M  V30 10 C 2.3100 10.1220 0.0 0
M  V30 11 C 1.5400 11.4557 0.0 0
M  V30 12 C 0.0000 11.4557 0.0 0
M  V30 13 O 7.1073 4.3940 0.0 0
M  V30 14 C 11.8022 7.1045 0.0 0
M  V30 15 C 13.3084 6.7842 0.0 0
M  V30 16 C 14.3389 7.9287 0.0 0
M  V30 17 C 13.8630 9.3933 0.0 0
M  V30 18 C 14.8934 10.5378 0.0 0
M  V30 19 C 16.3999 10.2176 0.0 0
M  V30 20 C 17.4303 11.3620 0.0 0
M  V30 21 O 18.9367 11.0419 0.0 0
M  V30 22 O 16.9544 12.8267 0.0 0
M  V30 23 C 19.9671 12.1864 0.0 0
M  V30 24 O 12.4987 3.8272 0.0 0
M  V30 25 C 12.6596 2.2957 0.0 0
M  V30 26 C 14.0666 1.6694 0.0 0
M  V30 27 O 11.4138 1.3905 0.0 0
M  V30 28 C 9.2400 6.1209 0.0 0 CFG=2
M  V30 29 C 8.6137 4.7141 0.0 0 CFG=2
M  V30 30 C 10.7716 5.9600 0.0 0 CFG=1
M  V30 31 C 9.7581 3.6837 0.0 0
M  V30 32 C 11.0918 4.4537 0.0 0 CFG=1
M  V30 33 C 6.6314 2.9292 0.0 0 CFG=3
M  V30 34 C 7.6618 1.7849 0.0 0
M  V30 35 O 5.1250 2.6091 0.0 0
M  V30 36 C 7.1860 0.3202 0.0 0
M  V30 37 C 4.6491 1.1445 0.0 0
M  V30 38 C 5.6797 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 28 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 29 13 CFG=1
M  V30 14 1 13 33
M  V30 15 1 14 15
M  V30 16 1 30 14 CFG=1
M  V30 17 2 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 24 25
M  V30 26 1 32 24 CFG=1
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 32
M  V30 34 1 33 34
M  V30 35 1 33 35
M  V30 36 1 34 36
M  V30 37 1 35 37
M  V30 38 1 36 38
M  V30 39 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 28 29 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1628900-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628900-42-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-4216922
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new approach to the synthesis of cross-conjugated cyclopentenone
prostaglandins. Synthesis of (±)-15-deoxy-Δ12,14-prostaglandin J2 methyl
ester
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vostrikov, N. S.; Lobko, I. F.; Miftakhov, M. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(41), 5622-5624

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,4E)-1-(3,4-Dimethoxyphenyl)-5-phenyl-2,4-pentadien-1-one
C19H18O3
1632032-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 O 5.3348 6.1601 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 C 9.3358 3.8501 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 C 0.0000 6.1601 0.0 0
M  V30 9 O 0.0000 1.5400 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 4.0010 3.8501 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 13.3370 4.6201 0.0 0
M  V30 19 C 12.0033 2.3101 0.0 0
M  V30 20 C 14.6707 3.8501 0.0 0
M  V30 21 C 13.3370 1.5400 0.0 0
M  V30 22 C 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 14
M  V30 10 1 9 10
M  V30 11 1 9 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,5R)-1-(3,4-Dimethoxyphenyl)-5-(ethylthio)-5-phenyl-2-penten-1-one
C21H24O3S
1809159-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 O 5.3348 2.3101 0.0 0
M  V30 4 C 8.0022 3.8501 0.0 0
M  V30 5 C 9.3358 4.6201 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0 CFG=2
M  V30 7 S 10.6697 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 12.0033 0.0000 0.0 0
M  V30 10 O 0.0000 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 O 0.0000 6.9302 0.0 0
M  V30 13 C 0.0000 8.4702 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 4.0010 6.1601 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 20 C 12.0033 4.6201 0.0 0
M  V30 21 C 12.0033 6.1601 0.0 0
M  V30 22 C 13.3370 3.8501 0.0 0
M  V30 23 C 13.3370 6.9302 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 17
M  V30 13 1 12 13
M  V30 14 1 12 19
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1632032-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1809159-17-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-238-CAS-15729453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14104-20-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1628575-38-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, 90% ee, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Catalysis with Iron-Salen Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shaw, Subrata; White, James D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2016), 48(17), 2768-2780

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,4E)-1-(3,4-Dimethoxyphenyl)-5-phenyl-2,4-pentadien-1-one
C19H18O3
1632032-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 O 5.3348 6.1601 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 C 9.3358 3.8501 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 C 0.0000 6.1601 0.0 0
M  V30 9 O 0.0000 1.5400 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 4.0010 3.8501 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 1.3337 2.3101 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 13.3370 4.6201 0.0 0
M  V30 19 C 12.0033 2.3101 0.0 0
M  V30 20 C 14.6707 3.8501 0.0 0
M  V30 21 C 13.3370 1.5400 0.0 0
M  V30 22 C 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 14
M  V30 10 1 9 10
M  V30 11 1 9 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,5R)-1-(3,4-Dimethoxyphenyl)-5-(ethylthio)-5-phenyl-2-penten-1-one
C21H24O3S
1809159-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 O 5.3348 2.3101 0.0 0
M  V30 4 C 8.0022 3.8501 0.0 0
M  V30 5 C 9.3358 4.6201 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0 CFG=2
M  V30 7 S 10.6697 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 12.0033 0.0000 0.0 0
M  V30 10 O 0.0000 3.8501 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 O 0.0000 6.9302 0.0 0
M  V30 13 C 0.0000 8.4702 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 4.0010 6.1601 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 20 C 12.0033 4.6201 0.0 0
M  V30 21 C 12.0033 6.1601 0.0 0
M  V30 22 C 13.3370 3.8501 0.0 0
M  V30 23 C 13.3370 6.9302 0.0 0
M  V30 24 C 14.6707 4.6201 0.0 0
M  V30 25 C 14.6707 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 17
M  V30 13 1 12 13
M  V30 14 1 12 19
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1632032-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1809159-17-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-238-CAS-365981
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14104-20-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1628575-38-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, regioselective, stereoselective, sulfa-Michael
reaction, 90% ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective and Enantioselective Addition of Sulfur Nucleophiles to
Acyclic α,β,γ,δ-Unsaturated Dienones Catalyzed by an Iron(III)-Salen
Complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shaw, Subrata; White, James D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(18), 4564-4567

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
1-Heptanethiol
C7H16S
1639-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 S 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Securinine
C13H15NO2
5610-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.3288 5.4237 0.0 0
M  V30 2 C 4.7196 3.7343 0.0 0 CFG=2
M  V30 3 C 3.8736 2.6673 0.0 0 CFG=1
M  V30 4 C 4.3484 5.2289 0.0 0
M  V30 5 C 3.0545 4.2624 0.0 0
M  V30 6 O 6.2558 3.6252 0.0 0
M  V30 7 N 2.3336 2.6673 0.0 0
M  V30 8 C 4.6437 1.3337 0.0 0
M  V30 9 C 3.0995 5.7862 0.0 0
M  V30 10 C 5.6553 6.0437 0.0 0
M  V30 11 C 1.4948 3.7270 0.0 0 CFG=1
M  V30 12 C 6.8341 5.0527 0.0 0
M  V30 13 C 1.5636 1.3337 0.0 0
M  V30 14 C 3.8736 0.0000 0.0 0
M  V30 15 C 1.7436 5.0687 0.0 0
M  V30 16 C 2.3336 0.0000 0.0 0
M  V30 17 H 5.4095 2.5545 0.0 0
M  V30 18 H 0.0000 3.3563 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 17 CFG=3
M  V30 9 1 4 9
M  V30 10 2 4 10
M  V30 11 1 11 5 CFG=1
M  V30 12 1 6 12
M  V30 13 1 7 11
M  V30 14 1 7 13
M  V30 15 1 8 14
M  V30 16 2 9 15
M  V30 17 1 10 12
M  V30 18 1 11 15
M  V30 19 1 11 18
M  V30 20 1 13 16
M  V30 21 1 14 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 3 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6S,11aR,11bS)-5-(Heptylthio)-5,6,9,10,11,11a-hexahydro-8H-6,11b-methanofuro[...
C20H31NO2S
1693754-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.1768 0.0000 0.0 0
M  V30 2 S 6.8313 6.9429 0.0 0
M  V30 3 C 8.1650 6.1729 0.0 0
M  V30 4 C 9.4986 6.9429 0.0 0
M  V30 5 C 10.8324 6.1729 0.0 0
M  V30 6 C 12.1661 6.9429 0.0 0
M  V30 7 C 13.4998 6.1729 0.0 0
M  V30 8 C 14.8335 6.9429 0.0 0
M  V30 9 C 16.1673 6.1729 0.0 0
M  V30 10 C 3.0798 3.9839 0.0 0 CFG=2
M  V30 11 C 2.4426 5.1871 0.0 0 CFG=1
M  V30 12 C 4.5976 3.7232 0.0 0
M  V30 13 C 4.2323 5.2965 0.0 0
M  V30 14 O 2.3629 2.6210 0.0 0
M  V30 15 N 3.0614 6.5974 0.0 0
M  V30 16 C 0.9120 5.0179 0.0 0
M  V30 17 C 5.6097 4.6430 0.0 0
M  V30 18 C 4.8186 2.1990 0.0 0
M  V30 19 C 4.3689 6.9399 0.0 0 CFG=1
M  V30 20 C 3.4375 1.5179 0.0 0
M  V30 21 C 2.1496 7.8383 0.0 0
M  V30 22 C 0.0000 6.2589 0.0 0
M  V30 23 C 5.4975 6.1729 0.0 0 CFG=3
M  V30 24 C 0.6188 7.6691 0.0 0
M  V30 25 H 1.7222 3.8261 0.0 0
M  V30 26 H 4.6300 8.4576 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13 CFG=1
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 25 CFG=3
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 19 13 CFG=1
M  V30 20 1 14 20
M  V30 21 1 15 19
M  V30 22 1 15 21
M  V30 23 1 16 22
M  V30 24 1 17 23
M  V30 25 1 18 20
M  V30 26 1 19 23
M  V30 27 1 19 26
M  V30 28 1 21 24
M  V30 29 1 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 11 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1639-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5610-40-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693754-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-238-CAS-4286441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Small molecule securinine and norsecurinine analogs and their use in
cancers inflammatory diseases and infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gundluru, Mahesh K.; Agarwal, Mukesh; Xia, Zhiqing; Karan, Goutam; Wald,
David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015051284 A2 2015-04-09

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
1-Heptanethiol
C7H16S
1639-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 S 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Securinine
C13H15NO2
5610-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.3288 5.4237 0.0 0
M  V30 2 C 4.7196 3.7343 0.0 0 CFG=2
M  V30 3 C 3.8736 2.6673 0.0 0 CFG=1
M  V30 4 C 4.3484 5.2289 0.0 0
M  V30 5 C 3.0545 4.2624 0.0 0
M  V30 6 O 6.2558 3.6252 0.0 0
M  V30 7 N 2.3336 2.6673 0.0 0
M  V30 8 C 4.6437 1.3337 0.0 0
M  V30 9 C 3.0995 5.7862 0.0 0
M  V30 10 C 5.6553 6.0437 0.0 0
M  V30 11 C 1.4948 3.7270 0.0 0 CFG=1
M  V30 12 C 6.8341 5.0527 0.0 0
M  V30 13 C 1.5636 1.3337 0.0 0
M  V30 14 C 3.8736 0.0000 0.0 0
M  V30 15 C 1.7436 5.0687 0.0 0
M  V30 16 C 2.3336 0.0000 0.0 0
M  V30 17 H 5.4095 2.5545 0.0 0
M  V30 18 H 0.0000 3.3563 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 17 CFG=3
M  V30 9 1 4 9
M  V30 10 2 4 10
M  V30 11 1 11 5 CFG=1
M  V30 12 1 6 12
M  V30 13 1 7 11
M  V30 14 1 7 13
M  V30 15 1 8 14
M  V30 16 2 9 15
M  V30 17 1 10 12
M  V30 18 1 11 15
M  V30 19 1 11 18
M  V30 20 1 13 16
M  V30 21 1 14 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 3 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6S,11aR,11bS)-5-(Heptylthio)-5,6,9,10,11,11a-hexahydro-8H-6,11b-methanofuro[...
C20H31NO2S
1693754-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.1768 0.0000 0.0 0
M  V30 2 S 6.8313 6.9429 0.0 0
M  V30 3 C 8.1650 6.1729 0.0 0
M  V30 4 C 9.4986 6.9429 0.0 0
M  V30 5 C 10.8324 6.1729 0.0 0
M  V30 6 C 12.1661 6.9429 0.0 0
M  V30 7 C 13.4998 6.1729 0.0 0
M  V30 8 C 14.8335 6.9429 0.0 0
M  V30 9 C 16.1673 6.1729 0.0 0
M  V30 10 C 3.0798 3.9839 0.0 0 CFG=2
M  V30 11 C 2.4426 5.1871 0.0 0 CFG=1
M  V30 12 C 4.5976 3.7232 0.0 0
M  V30 13 C 4.2323 5.2965 0.0 0
M  V30 14 O 2.3629 2.6210 0.0 0
M  V30 15 N 3.0614 6.5974 0.0 0
M  V30 16 C 0.9120 5.0179 0.0 0
M  V30 17 C 5.6097 4.6430 0.0 0
M  V30 18 C 4.8186 2.1990 0.0 0
M  V30 19 C 4.3689 6.9399 0.0 0 CFG=1
M  V30 20 C 3.4375 1.5179 0.0 0
M  V30 21 C 2.1496 7.8383 0.0 0
M  V30 22 C 0.0000 6.2589 0.0 0
M  V30 23 C 5.4975 6.1729 0.0 0 CFG=3
M  V30 24 C 0.6188 7.6691 0.0 0
M  V30 25 H 1.7222 3.8261 0.0 0
M  V30 26 H 4.6300 8.4576 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13 CFG=1
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 11 25 CFG=3
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 19 13 CFG=1
M  V30 20 1 14 20
M  V30 21 1 15 19
M  V30 22 1 15 21
M  V30 23 1 16 22
M  V30 24 1 17 23
M  V30 25 1 18 20
M  V30 26 1 19 23
M  V30 27 1 19 26
M  V30 28 1 21 24
M  V30 29 1 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 11 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1639-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5610-40-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693754-39-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-238-CAS-7146585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Small molecule securinine and norsecurinine analogs and their use in
inhibiting myeloperoxidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gundluru, Mahesh K.; Agarwal, Mukesh; Xia, Zhiqing; Karan, Goutam; Wald,
David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015051276 A1 2015-04-09

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
1-Heptanethiol
C7H16S
1639-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 S 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Arabinonic acid, 5-bromo-5-deoxy-, γ-lactone
C5H7BrO4
82805-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0286 0.0 0
M  V30 2 Br 6.6363 3.2586 0.0 0
M  V30 3 O 2.2418 5.3914 0.0 0
M  V30 4 O 0.0000 2.9016 0.0 0
M  V30 5 O 1.6752 0.0000 0.0 0
M  V30 6 C 3.9690 3.2586 0.0 0 CFG=1
M  V30 7 C 2.5620 3.8850 0.0 0 CFG=1
M  V30 8 O 3.8079 1.7270 0.0 0
M  V30 9 C 1.5316 2.7405 0.0 0 CFG=2
M  V30 10 C 2.3016 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=1
M  V30 3 1 7 3 CFG=3
M  V30 4 1 9 4 CFG=1
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 6 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Arabinonic acid, 5-S-heptyl-5-thio-, γ-lactone
C12H22O4S
1616346-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0286 0.0 0
M  V30 2 S 6.6363 3.2586 0.0 0
M  V30 3 C 7.9701 4.0286 0.0 0
M  V30 4 C 9.3038 3.2586 0.0 0
M  V30 5 C 10.6375 4.0286 0.0 0
M  V30 6 C 11.9711 3.2586 0.0 0
M  V30 7 C 13.3050 4.0286 0.0 0
M  V30 8 C 14.6386 3.2586 0.0 0
M  V30 9 C 15.9723 4.0286 0.0 0
M  V30 10 O 2.2418 5.3914 0.0 0
M  V30 11 O 0.0000 2.9016 0.0 0
M  V30 12 O 1.6752 0.0000 0.0 0
M  V30 13 C 3.9690 3.2586 0.0 0 CFG=1
M  V30 14 C 2.5620 3.8850 0.0 0 CFG=1
M  V30 15 O 3.8080 1.7270 0.0 0
M  V30 16 C 1.5316 2.7405 0.0 0 CFG=2
M  V30 17 C 2.3016 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 14 10 CFG=3
M  V30 11 1 16 11 CFG=1
M  V30 12 2 12 17
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1639-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82805-13-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616346-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-2265618
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-78-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Influence of alkyl chain length on the mesomorphism of
5-S-alkyl-5-thiopentonolactones and 5-S-alkyl-5-thiopentitols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stasik, Imane; Gottis, Sebastien; Falentin-Daudre, Celine; Meyer, Claire
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Carbohydrate Research (2014), 39231-39

$RFMT $RIREG SCHEME108 STEP1
$RXN



  3  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloromethylbenzyl alcohol
C8H9ClO
16473-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl [4-(hydroxymethyl)phenyl]methyl carbonotrithioate
C11H14OS3
1310353-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 S 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 S 10.6697 2.3101 0.0 0
M  V30 5 S 9.3360 0.0000 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 C 13.3370 2.3101 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 4.0010 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 16473-35-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1310353-08-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25384562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile method for the stain-free visualization of hierarchical
structures with electron microscopy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Williams, Paul E.; Appel, Eric A.; Jones, Samuel T.; Del Barrio, Jesus;
Lan, Yang; Scherman, Oren A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Polymer Science, Part A: Polymer Chemistry (2015), 53(7),
842-845

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-O-(1-Methoxyethylidene)-3,4,6-tris-O-(phenylmethyl)-β-D-mannopyranose
C30H34O7
16697-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 6.9300 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 O 8.0022 5.3900 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0
M  V30 5 O 6.4707 13.1837 0.0 0
M  V30 6 C 5.3261 14.2143 0.0 0
M  V30 7 C 4.6858 12.1533 0.0 0
M  V30 8 C 10.6695 6.9300 0.0 0
M  V30 9 O 12.0033 7.7000 0.0 0
M  V30 10 C 13.3369 6.9300 0.0 0
M  V30 11 C 6.6685 9.2400 0.0 0 CFG=2
M  V30 12 C 6.6685 7.7000 0.0 0 CFG=1
M  V30 13 C 8.0022 10.0101 0.0 0 CFG=2
M  V30 14 O 5.5240 10.2706 0.0 0
M  V30 15 C 8.0022 6.9300 0.0 0 CFG=2
M  V30 16 O 9.3358 9.2400 0.0 0
M  V30 17 O 7.6820 11.5165 0.0 0
M  V30 18 C 6.1505 11.6774 0.0 0 CFG=3
M  V30 19 C 9.3358 7.7000 0.0 0 CFG=1
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 1.3338 7.7000 0.0 0
M  V30 22 C 2.6674 5.3900 0.0 0
M  V30 23 C 0.0000 6.9300 0.0 0
M  V30 24 C 1.3338 4.6200 0.0 0
M  V30 25 C 0.0000 5.3900 0.0 0
M  V30 26 C 9.3358 3.0800 0.0 0
M  V30 27 C 8.0022 2.3100 0.0 0
M  V30 28 C 10.6695 2.3100 0.0 0
M  V30 29 C 8.0022 0.7700 0.0 0
M  V30 30 C 10.6695 0.7700 0.0 0
M  V30 31 C 9.3358 0.0000 0.0 0
M  V30 32 C 14.6706 7.7000 0.0 0
M  V30 33 C 16.0042 6.9300 0.0 0
M  V30 34 C 14.6706 9.2400 0.0 0
M  V30 35 C 17.3380 7.7000 0.0 0
M  V30 36 C 16.0042 10.0101 0.0 0
M  V30 37 C 17.3380 9.2400 0.0 0
M  V30 38 H 5.2616 8.6137 0.0 0
M  V30 39 H 9.2481 10.9153 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 15 3 CFG=1
M  V30 6 1 4 26
M  V30 7 1 5 6
M  V30 8 1 5 18
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 19 8 CFG=3
M  V30 12 1 9 10
M  V30 13 1 10 32
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 11 38 CFG=1
M  V30 18 1 12 15
M  V30 19 1 13 16
M  V30 20 1 13 17
M  V30 21 1 13 39 CFG=1
M  V30 22 1 14 18
M  V30 23 1 15 19
M  V30 24 1 16 19
M  V30 25 1 17 18
M  V30 26 2 20 21
M  V30 27 1 20 22
M  V30 28 1 21 23
M  V30 29 2 22 24
M  V30 30 2 23 25
M  V30 31 1 24 25
M  V30 32 2 26 27
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 2 28 30
M  V30 36 2 29 31
M  V30 37 1 30 31
M  V30 38 2 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 2 34 36
M  V30 42 2 35 37
M  V30 43 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 15 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
α-D-Mannopyranoside, ethyl 3,4,6-tris-O-(phenylmethyl)-1-thio-, 2-acetate
C31H36O6S
130525-72-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 6.9300 0.0 0
M  V30 2 C 4.0011 7.7000 0.0 0
M  V30 3 O 8.0021 5.3900 0.0 0
M  V30 4 C 9.3358 4.6200 0.0 0
M  V30 5 O 5.3347 10.0100 0.0 0
M  V30 6 C 5.3347 11.5500 0.0 0
M  V30 7 C 6.6685 12.3200 0.0 0
M  V30 8 O 4.0011 12.3200 0.0 0
M  V30 9 C 10.6694 6.9300 0.0 0
M  V30 10 O 12.0032 7.7000 0.0 0
M  V30 11 C 13.3369 6.9300 0.0 0
M  V30 12 S 8.0021 11.5500 0.0 0
M  V30 13 C 9.3358 12.3200 0.0 0
M  V30 14 C 9.3358 13.8600 0.0 0
M  V30 15 C 6.6685 7.7000 0.0 0 CFG=2
M  V30 16 C 8.0021 6.9300 0.0 0 CFG=2
M  V30 17 C 6.6685 9.2400 0.0 0 CFG=2
M  V30 18 C 9.3358 7.7000 0.0 0 CFG=1
M  V30 19 C 8.0021 10.0100 0.0 0 CFG=1
M  V30 20 O 9.3358 9.2400 0.0 0
M  V30 21 C 2.6674 6.9300 0.0 0
M  V30 22 C 2.6674 5.3900 0.0 0
M  V30 23 C 1.3338 7.7000 0.0 0
M  V30 24 C 1.3338 4.6200 0.0 0
M  V30 25 C 0.0000 6.9300 0.0 0
M  V30 26 C 0.0000 5.3900 0.0 0
M  V30 27 C 9.3358 3.0800 0.0 0
M  V30 28 C 10.6694 2.3100 0.0 0
M  V30 29 C 8.0021 2.3100 0.0 0
M  V30 30 C 10.6694 0.7700 0.0 0
M  V30 31 C 8.0021 0.7700 0.0 0
M  V30 32 C 9.3358 0.0000 0.0 0
M  V30 33 C 14.6705 7.7000 0.0 0
M  V30 34 C 16.0041 6.9300 0.0 0
M  V30 35 C 14.6705 9.2400 0.0 0
M  V30 36 C 17.3379 7.7000 0.0 0
M  V30 37 C 16.0041 10.0100 0.0 0
M  V30 38 C 17.3379 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 16 3 CFG=1
M  V30 6 1 4 27
M  V30 7 1 5 6
M  V30 8 1 17 5 CFG=3
M  V30 9 1 6 7
M  V30 10 2 6 8
M  V30 11 1 9 10
M  V30 12 1 18 9 CFG=3
M  V30 13 1 10 11
M  V30 14 1 11 33
M  V30 15 1 12 13
M  V30 16 1 19 12 CFG=1
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 15 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16697-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 130525-72-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-006-CAS-4882405
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7789-47-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A highly convergent synthesis of an N-linked glycopeptide presenting the
H-type 2 human blood group determinant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Zhi-Guang; Warren, J. David; Dudkin, Vadim Y.; Zhang, Xufang;
Iserloh, Ulrich; Visser, Michael; Eckhardt, Matthias; Seeberger, Peter
H.; Danishefsky, Samuel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(20), 4954-4978

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-D-Glucofuranose, 1,2-O-(1-methylethylidene)-, 5,6-diacetate 3-(4-methylbenz...
C20H26O10S
16848-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.7611 7.9583 0.0 0
M  V30 2 S 7.5311 9.2919 0.0 0 VAL=6
M  V30 3 O 8.3011 10.6256 0.0 0
M  V30 4 O 6.1975 10.0619 0.0 0
M  V30 5 C 3.6896 5.3055 0.0 0 CFG=2
M  V30 6 C 4.5948 4.0596 0.0 0
M  V30 7 O 2.1580 5.1446 0.0 0
M  V30 8 O 3.9683 2.6527 0.0 0
M  V30 9 C 1.5315 3.7376 0.0 0
M  V30 10 C 4.8735 1.4068 0.0 0
M  V30 11 C 0.0000 3.5767 0.0 0
M  V30 12 O 2.4368 2.4917 0.0 0
M  V30 13 C 4.2472 0.0000 0.0 0
M  V30 14 O 6.4050 1.5677 0.0 0
M  V30 15 C 3.4776 12.6268 0.0 0
M  V30 16 C 1.5175 11.9900 0.0 0
M  V30 17 C 12.8658 6.2119 0.0 0
M  V30 18 C 5.2211 7.9583 0.0 0 CFG=1
M  V30 19 C 4.3159 9.2042 0.0 0 CFG=1
M  V30 20 C 4.3159 6.7123 0.0 0 CFG=1
M  V30 21 C 2.8513 8.7283 0.0 0 CFG=1
M  V30 22 O 4.3159 10.7442 0.0 0
M  V30 23 O 2.8513 7.1883 0.0 0
M  V30 24 O 1.9461 9.9742 0.0 0
M  V30 25 C 2.8513 11.2200 0.0 0
M  V30 26 C 8.8647 8.5219 0.0 0
M  V30 27 C 10.1985 9.2919 0.0 0
M  V30 28 C 8.8647 6.9819 0.0 0
M  V30 29 C 11.5322 8.5219 0.0 0
M  V30 30 C 10.1985 6.2119 0.0 0
M  V30 31 C 11.5322 6.9819 0.0 0
M  V30 32 H 5.7806 9.6800 0.0 0
M  V30 33 H 5.6495 5.9423 0.0 0
M  V30 34 H 1.3866 8.2523 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=1
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 26
M  V30 6 1 5 6
M  V30 7 1 5 7 CFG=1
M  V30 8 1 5 20
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 15 25
M  V30 17 1 16 25
M  V30 18 1 17 31
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 19 32 CFG=1
M  V30 24 1 20 23
M  V30 25 1 20 33 CFG=3
M  V30 26 1 21 23
M  V30 27 1 21 24
M  V30 28 1 21 34 CFG=1
M  V30 29 1 22 25
M  V30 30 1 24 25
M  V30 31 2 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 30
M  V30 35 2 29 31
M  V30 36 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 5 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
D-Glucose, diethyl dithioacetal, 5,6-diacetate 3-(4-methylbenzenesulfonate)
C21H32O9S3
1214721-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 6.1600 0.0 0 CFG=2
M  V30 2 C 5.3347 6.9300 0.0 0 CFG=2
M  V30 3 C 6.6685 4.6200 0.0 0 CFG=1
M  V30 4 O 8.0021 6.9300 0.0 0
M  V30 5 C 4.0011 6.1600 0.0 0 CFG=2
M  V30 6 O 5.3347 8.4700 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 O 5.3347 3.8500 0.0 0
M  V30 9 S 8.0021 8.4700 0.0 0 VAL=6
M  V30 10 C 2.6674 6.9300 0.0 0
M  V30 11 O 4.0011 4.6200 0.0 0
M  V30 12 S 8.0021 2.3100 0.0 0
M  V30 13 S 9.3358 4.6200 0.0 0
M  V30 14 O 8.0021 10.0100 0.0 0
M  V30 15 O 6.4621 8.4700 0.0 0
M  V30 16 O 2.6674 8.4700 0.0 0
M  V30 17 C 2.6674 3.8500 0.0 0
M  V30 18 C 9.3358 1.5400 0.0 0
M  V30 19 C 10.6694 3.8500 0.0 0
M  V30 20 C 1.3336 9.2400 0.0 0
M  V30 21 C 2.6674 2.3100 0.0 0
M  V30 22 O 1.3338 4.6200 0.0 0
M  V30 23 C 9.3358 0.0000 0.0 0
M  V30 24 C 12.0032 4.6200 0.0 0
M  V30 25 C 1.3336 10.7800 0.0 0
M  V30 26 O 0.0000 8.4700 0.0 0
M  V30 27 C 14.1621 8.4700 0.0 0
M  V30 28 C 9.5421 8.4700 0.0 0
M  V30 29 C 10.3121 7.1364 0.0 0
M  V30 30 C 10.3121 9.8036 0.0 0
M  V30 31 C 11.8521 7.1364 0.0 0
M  V30 32 C 11.8521 9.8036 0.0 0
M  V30 33 C 12.6221 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11 CFG=3
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 2 9 14
M  V30 14 2 9 15
M  V30 15 1 9 28
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 1 12 18
M  V30 19 1 13 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 17 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 2 20 26
M  V30 27 1 27 33
M  V30 28 2 28 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 2 30 32
M  V30 32 2 31 33
M  V30 33 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16848-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1214721-03-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-013-CAS-4400511
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7699-45-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A vicinal acyloxy group participation SN2 reaction of thiol nucleophiles
in the formation of thioacetals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Qinpei; Xi, Xiaodong; Chen, Xi; Li, Hui; Zhang, Qingshan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Chemistry (2009), 27(10), 1962-1966

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[1-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl)-1H-1,2,3-triazol-4-yl]metho...
C24H27N3O11
1705620-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9301 9.3359 0.0 0
M  V30 2 C 6.1601 10.6695 0.0 0
M  V30 3 C 4.6200 10.6695 0.0 0
M  V30 4 O 6.9301 12.0032 0.0 0
M  V30 5 O 3.8500 9.3359 0.0 0
M  V30 6 C 2.3100 9.3359 0.0 0
M  V30 7 C 1.5400 10.6695 0.0 0
M  V30 8 O 1.5400 8.0021 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 O 4.6200 2.6673 0.0 0
M  V30 11 C 3.8500 1.3337 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 O 2.3100 1.3337 0.0 0
M  V30 14 O 2.3100 6.6684 0.0 0
M  V30 15 C 1.5400 5.3348 0.0 0
M  V30 16 C 0.0000 5.3348 0.0 0
M  V30 17 O 2.3100 4.0011 0.0 0
M  V30 18 C 12.0857 4.9932 0.0 0
M  V30 19 O 13.4927 5.6197 0.0 0
M  V30 20 C 16.3064 6.8723 0.0 0
M  V30 21 O 17.7133 7.4988 0.0 0
M  V30 22 C 6.9301 6.6684 0.0 0 CFG=2
M  V30 23 C 6.1601 8.0021 0.0 0 CFG=2
M  V30 24 O 6.1601 5.3348 0.0 0
M  V30 25 C 4.6200 8.0021 0.0 0 CFG=1
M  V30 26 C 4.6200 5.3348 0.0 0 CFG=2
M  V30 27 C 3.8500 6.6684 0.0 0 CFG=2
M  V30 28 N 8.4701 6.6684 0.0 0
M  V30 29 C 9.3753 5.4225 0.0 0
M  V30 30 N 9.3753 7.9143 0.0 0
M  V30 31 C 10.8399 5.8984 0.0 0
M  V30 32 N 10.8399 7.4384 0.0 0
M  V30 33 C 14.7386 4.7144 0.0 0
M  V30 34 C 16.1454 5.3408 0.0 0
M  V30 35 C 14.5776 3.1829 0.0 0
M  V30 36 C 17.3914 4.4356 0.0 0
M  V30 37 C 15.8235 2.2777 0.0 0
M  V30 38 C 17.2303 2.9040 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 25 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 26 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 27 14 CFG=1
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 18 31
M  V30 20 1 19 33
M  V30 21 2 20 21
M  V30 22 1 20 34
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 28 CFG=3
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 22 23 25 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C28H37N3O10S2
2365105-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 9.3358 0.0 0
M  V30 2 C 6.1600 10.6695 0.0 0
M  V30 3 C 6.9300 12.0031 0.0 0
M  V30 4 O 4.6200 10.6695 0.0 0
M  V30 5 O 3.8500 9.3358 0.0 0
M  V30 6 C 2.3100 9.3358 0.0 0
M  V30 7 C 1.5400 10.6695 0.0 0
M  V30 8 O 1.5400 8.0020 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 O 4.6200 2.6673 0.0 0
M  V30 11 C 3.8500 1.3336 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 O 4.6200 0.0000 0.0 0
M  V30 14 O 2.3100 6.6684 0.0 0
M  V30 15 C 1.5400 5.3347 0.0 0
M  V30 16 C 0.0000 5.3347 0.0 0
M  V30 17 O 2.3100 4.0011 0.0 0
M  V30 18 C 12.0858 4.9932 0.0 0
M  V30 19 O 13.4926 5.6196 0.0 0
M  V30 20 C 16.3064 6.8723 0.0 0
M  V30 21 S 17.7133 7.4988 0.0 0
M  V30 22 S 15.0605 7.7775 0.0 0
M  V30 23 C 17.8743 9.0303 0.0 0
M  V30 24 C 15.2214 9.3090 0.0 0
M  V30 25 C 19.2812 9.6566 0.0 0
M  V30 26 C 13.9756 10.2143 0.0 0
M  V30 27 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 28 C 6.1600 8.0020 0.0 0 CFG=2
M  V30 29 O 6.1600 5.3347 0.0 0
M  V30 30 C 4.6200 8.0020 0.0 0 CFG=1
M  V30 31 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 32 C 3.8500 6.6684 0.0 0 CFG=2
M  V30 33 N 8.4700 6.6684 0.0 0
M  V30 34 C 9.3753 5.4225 0.0 0
M  V30 35 N 9.3753 7.9143 0.0 0
M  V30 36 C 10.8400 5.8984 0.0 0
M  V30 37 N 10.8400 7.4384 0.0 0
M  V30 38 C 14.7386 4.7144 0.0 0
M  V30 39 C 16.1454 5.3407 0.0 0
M  V30 40 C 14.5776 3.1829 0.0 0
M  V30 41 C 17.3913 4.4355 0.0 0
M  V30 42 C 15.8236 2.2777 0.0 0
M  V30 43 C 17.2304 2.9040 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 28 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 30 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 31 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 32 14 CFG=1
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 18 36
M  V30 20 1 19 38
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 39
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 27 33 CFG=3
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 32
M  V30 35 1 33 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 42
M  V30 44 2 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 27 28 30 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1705620-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2365105-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-20462327
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-38-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst (silica supported sodium hydrogen sulfate
catalyst used)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First Anti-ToCV Activity Evaluation of Glucopyranoside Derivatives
Containing a Dithioacetal Moiety through a Novel ToCVCP-Oriented
Screening Method
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xie, Dandan; Zhang, Jian; Yang, Huanyu; Liu, Yuewen; Hu, Deyu; Song,
Baoan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2019), 67(26), 7243-7248

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-[[1-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-1H-1,2,3-triazol-...
C25H29N3O12
1705620-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.2401 0.0 0
M  V30 2 C 4.0011 10.0101 0.0 0
M  V30 3 C 2.6675 9.2401 0.0 0
M  V30 4 O 4.0011 11.5501 0.0 0
M  V30 5 O 2.6675 7.7001 0.0 0
M  V30 6 C 1.3337 6.9301 0.0 0
M  V30 7 C 0.0000 7.7001 0.0 0
M  V30 8 O 1.3337 5.3901 0.0 0
M  V30 9 C 5.3348 3.0800 0.0 0
M  V30 10 O 6.6684 2.3100 0.0 0
M  V30 11 C 6.6684 0.7700 0.0 0
M  V30 12 C 8.0022 0.0000 0.0 0
M  V30 13 O 5.3348 0.0000 0.0 0
M  V30 14 O 2.6675 4.6200 0.0 0
M  V30 15 C 2.6675 3.0800 0.0 0
M  V30 16 C 1.3337 2.3100 0.0 0
M  V30 17 O 4.0011 2.3100 0.0 0
M  V30 18 C 11.9712 8.0572 0.0 0
M  V30 19 O 12.8764 9.3031 0.0 0
M  V30 20 O 14.6867 11.7950 0.0 0
M  V30 21 C 15.5919 13.0409 0.0 0
M  V30 22 C 19.0026 8.6592 0.0 0
M  V30 23 O 19.6290 7.2524 0.0 0
M  V30 24 C 6.6684 6.9301 0.0 0 CFG=2
M  V30 25 C 5.3348 7.7001 0.0 0 CFG=2
M  V30 26 O 6.6684 5.3901 0.0 0
M  V30 27 C 4.0011 6.9301 0.0 0 CFG=1
M  V30 28 C 5.3348 4.6200 0.0 0 CFG=2
M  V30 29 C 4.0011 5.3901 0.0 0 CFG=2
M  V30 30 N 8.0022 7.7001 0.0 0
M  V30 31 C 9.4090 7.0738 0.0 0
M  V30 32 N 8.1632 9.2316 0.0 0
M  V30 33 C 10.4395 8.2181 0.0 0
M  V30 34 N 9.6695 9.5519 0.0 0
M  V30 35 C 14.4079 9.1422 0.0 0
M  V30 36 C 15.3131 10.3880 0.0 0
M  V30 37 C 15.0343 7.7352 0.0 0
M  V30 38 C 16.8447 10.2271 0.0 0
M  V30 39 C 16.5658 7.5743 0.0 0
M  V30 40 C 17.4710 8.8201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 25 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 27 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 28 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 29 14 CFG=1
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 18 33
M  V30 20 1 19 35
M  V30 21 1 20 21
M  V30 22 1 20 36
M  V30 23 2 22 23
M  V30 24 1 22 40
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 24 30 CFG=3
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 37 2 35 36
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 2 37 39
M  V30 41 2 38 40
M  V30 42 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 24 25 27 28 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C29H39N3O11S2
2365105-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 11.3054 0.0 0
M  V30 2 C 6.1600 12.6390 0.0 0
M  V30 3 C 4.6200 12.6390 0.0 0
M  V30 4 O 6.9300 13.9728 0.0 0
M  V30 5 O 3.8500 11.3054 0.0 0
M  V30 6 C 2.3100 11.3054 0.0 0
M  V30 7 C 1.5400 9.9717 0.0 0
M  V30 8 O 1.5400 12.6390 0.0 0
M  V30 9 C 3.8500 5.9706 0.0 0
M  V30 10 O 4.6200 4.6370 0.0 0
M  V30 11 C 3.8500 3.3033 0.0 0
M  V30 12 C 4.6200 1.9695 0.0 0
M  V30 13 O 2.3100 3.3033 0.0 0
M  V30 14 O 2.3100 8.6381 0.0 0
M  V30 15 C 1.5400 7.3043 0.0 0
M  V30 16 C 0.0000 7.3043 0.0 0
M  V30 17 O 2.3100 5.9706 0.0 0
M  V30 18 C 12.0858 6.9628 0.0 0
M  V30 19 O 13.4926 7.5892 0.0 0
M  V30 20 O 16.3064 8.8420 0.0 0
M  V30 21 C 17.7132 9.4683 0.0 0
M  V30 22 C 18.4762 3.9684 0.0 0
M  V30 23 S 18.3153 2.4368 0.0 0
M  V30 24 S 19.8830 4.5948 0.0 0
M  V30 25 C 19.5612 1.5317 0.0 0
M  V30 26 C 21.1289 3.6896 0.0 0
M  V30 27 C 19.4001 0.0000 0.0 0
M  V30 28 C 22.5359 4.3160 0.0 0
M  V30 29 C 6.9300 8.6381 0.0 0 CFG=2
M  V30 30 C 6.1600 9.9717 0.0 0 CFG=2
M  V30 31 O 6.1600 7.3043 0.0 0
M  V30 32 C 4.6200 9.9717 0.0 0 CFG=1
M  V30 33 C 4.6200 7.3043 0.0 0 CFG=2
M  V30 34 C 3.8500 8.6381 0.0 0 CFG=2
M  V30 35 N 8.4700 8.6381 0.0 0
M  V30 36 C 9.3753 7.3920 0.0 0
M  V30 37 N 9.3753 9.8839 0.0 0
M  V30 38 C 10.8400 7.8681 0.0 0
M  V30 39 N 10.8400 9.4081 0.0 0
M  V30 40 C 14.7385 6.6839 0.0 0
M  V30 41 C 16.1454 7.3104 0.0 0
M  V30 42 C 14.5776 5.1524 0.0 0
M  V30 43 C 17.3913 6.4052 0.0 0
M  V30 44 C 15.8234 4.2472 0.0 0
M  V30 45 C 17.2304 4.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 30 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 32 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 33 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 34 14 CFG=1
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 18 38
M  V30 20 1 19 40
M  V30 21 1 20 21
M  V30 22 1 20 41
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 45
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 29 35 CFG=3
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 34
M  V30 37 1 35 36
M  V30 38 1 35 37
M  V30 39 2 36 38
M  V30 40 2 37 39
M  V30 41 1 38 39
M  V30 42 2 40 41
M  V30 43 1 40 42
M  V30 44 1 41 43
M  V30 45 2 42 44
M  V30 46 2 43 45
M  V30 47 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 29 30 32 33 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1705620-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2365105-29-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-20462323
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-38-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst (silica supported sodium hydrogen sulfate
catalyst used)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First Anti-ToCV Activity Evaluation of Glucopyranoside Derivatives
Containing a Dithioacetal Moiety through a Novel ToCVCP-Oriented
Screening Method
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xie, Dandan; Zhang, Jian; Yang, Huanyu; Liu, Yuewen; Hu, Deyu; Song,
Baoan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2019), 67(26), 7243-7248

$RFMT $RIREG SCHEME113 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-[(2-methylpr...
C24H31NO4S2
942287-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 O 9.2400 8.2084 0.0 0
M  V30 3 O 9.2400 5.1284 0.0 0
M  V30 4 S 3.0800 6.6684 0.0 0
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 C 0.7700 5.3347 0.0 0
M  V30 7 C 0.0000 6.6684 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 O 3.0800 9.3358 0.0 0
M  V30 11 O 5.3900 10.6694 0.0 0
M  V30 12 C 10.0100 0.0000 0.0 0
M  V30 13 C 15.4000 6.6684 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 N 7.7000 6.6684 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 19 C 5.3900 8.0021 0.0 0 CFG=1
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 7.7000 1.3336 0.0 0
M  V30 24 C 10.0100 2.6673 0.0 0
M  V30 25 C 9.2400 1.3336 0.0 0
M  V30 26 C 10.7800 6.6684 0.0 0
M  V30 27 C 11.5500 5.3347 0.0 0
M  V30 28 C 11.5500 8.0021 0.0 0
M  V30 29 C 13.0900 5.3347 0.0 0
M  V30 30 C 13.0900 8.0020 0.0 0
M  V30 31 C 13.8600 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 19 9 CFG=3
M  V30 13 1 12 25
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=3
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942287-25-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16092522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C02E21, yield 95%. MW: 461.64
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME114 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-[(3-Methylbutyl)thio]-6-(4-methylphenyl)-1-[(4-methylphenyl)...
C25H33NO4S2
942287-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 C 10.7800 9.3358 0.0 0
M  V30 5 O 12.3200 9.3358 0.0 0
M  V30 6 O 10.0100 10.6694 0.0 0
M  V30 7 S 12.3200 6.6684 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 C 14.6300 5.3347 0.0 0
M  V30 10 C 15.4000 4.0011 0.0 0
M  V30 11 C 16.9400 4.0011 0.0 0
M  V30 12 C 14.6300 2.6673 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 N 7.7000 6.6684 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 20 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 6.1600 4.0011 0.0 0
M  V30 23 C 8.4700 2.6673 0.0 0
M  V30 24 C 5.3900 2.6673 0.0 0
M  V30 25 C 7.7000 1.3336 0.0 0
M  V30 26 C 6.1600 1.3336 0.0 0
M  V30 27 C 4.6200 6.6684 0.0 0
M  V30 28 C 3.8500 8.0021 0.0 0
M  V30 29 C 3.8500 5.3347 0.0 0
M  V30 30 C 2.3100 8.0021 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 26
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942287-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16087479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C02E23, yield 95%. MW: 475.66
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME115 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-6-(4-methylphenyl)-1-[(4-methylphenyl)sulfonyl]-...
C22H27NO4S2
942287-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 6.6684 0.0 0 VAL=6
M  V30 2 O 8.4700 5.1284 0.0 0
M  V30 3 O 8.4700 8.2084 0.0 0
M  V30 4 C 3.8500 9.3358 0.0 0
M  V30 5 O 4.6200 10.6694 0.0 0
M  V30 6 O 2.3100 9.3358 0.0 0
M  V30 7 S 2.3100 6.6684 0.0 0
M  V30 8 C 1.5400 5.3347 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 C 9.2400 0.0000 0.0 0
M  V30 11 C 14.6300 6.6684 0.0 0
M  V30 12 N 6.9300 6.6684 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 14 C 6.1600 8.0021 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 4.6200 8.0021 0.0 0 CFG=1
M  V30 17 C 3.8500 6.6684 0.0 0 CFG=1
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 6.1600 2.6673 0.0 0
M  V30 21 C 9.2400 2.6673 0.0 0
M  V30 22 C 6.9300 1.3336 0.0 0
M  V30 23 C 8.4700 1.3336 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 25 C 10.7800 8.0021 0.0 0
M  V30 26 C 10.7800 5.3347 0.0 0
M  V30 27 C 12.3200 8.0021 0.0 0
M  V30 28 C 12.3200 5.3347 0.0 0
M  V30 29 C 13.0900 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 17 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 10 23
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 18 CFG=3
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942287-21-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16085485
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C02E16, yield 95%. MW: 433.58
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME116 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1-...
C23H27NO4S2
942287-34-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 C 10.7800 9.3358 0.0 0
M  V30 5 O 12.3200 9.3358 0.0 0
M  V30 6 O 10.0100 10.6694 0.0 0
M  V30 7 S 12.3200 6.6684 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 C 14.6300 5.3347 0.0 0
M  V30 10 C 15.4000 4.0011 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 0.0000 6.6684 0.0 0
M  V30 13 N 7.7000 6.6684 0.0 0
M  V30 14 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 15 C 8.4700 8.0021 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 18 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 6.1600 4.0011 0.0 0
M  V30 21 C 8.4700 2.6673 0.0 0
M  V30 22 C 5.3900 2.6673 0.0 0
M  V30 23 C 7.7000 1.3336 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 4.6200 6.6684 0.0 0
M  V30 26 C 3.8500 5.3347 0.0 0
M  V30 27 C 3.8500 8.0021 0.0 0
M  V30 28 C 2.3100 5.3347 0.0 0
M  V30 29 C 2.3100 8.0021 0.0 0
M  V30 30 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 18 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 24
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942287-34-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16076267
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C02E30, yield 95%. MW: 445.59
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME117 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(1-Methylethyl)-2-(4-methylphenyl)-1-[(4-methylphenyl)sul...
C25H31NO4S2
951635-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 8.6443 0.0 0
M  V30 3 O 9.2154 5.5643 0.0 0
M  V30 4 C 7.2460 9.8149 0.0 0
M  V30 5 C 8.7525 10.1351 0.0 0
M  V30 6 C 6.2156 10.9593 0.0 0
M  V30 7 C 4.0596 5.4291 0.0 0
M  V30 8 O 4.2207 3.8976 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7796 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0583 0.0 0
M  V30 13 C 0.0000 8.4320 0.0 0
M  V30 14 C 8.6738 0.0000 0.0 0
M  V30 15 C 15.3754 7.1043 0.0 0
M  V30 16 N 7.6754 7.1043 0.0 0
M  V30 17 C 6.7702 5.8585 0.0 0 CFG=1
M  V30 18 C 6.7702 8.3502 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8743 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3938 0.0 0
M  V30 22 C 6.2156 3.2494 0.0 0
M  V30 23 C 8.7525 4.0736 0.0 0
M  V30 24 C 6.6915 1.7847 0.0 0
M  V30 25 C 9.2283 2.6091 0.0 0
M  V30 26 C 8.1977 1.4645 0.0 0
M  V30 27 C 10.7554 7.1043 0.0 0
M  V30 28 C 11.5254 8.4380 0.0 0
M  V30 29 C 11.5254 5.7707 0.0 0
M  V30 30 C 13.0654 8.4380 0.0 0
M  V30 31 C 13.0654 5.7707 0.0 0
M  V30 32 C 13.8354 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-46-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087944
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME118 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-2-(4-methylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C28H37NO4S2
951636-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 C 0.0000 6.7017 0.0 0
M  V30 18 C 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-48-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087235
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME119 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-methylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C26H33NO4S2
951635-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 4.2207 9.6708 0.0 0
M  V30 10 O 2.6528 7.5128 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 C 8.6738 13.5684 0.0 0
M  V30 16 C 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 7.7977 0.0 0
M  V30 30 C 11.5254 5.1304 0.0 0
M  V30 31 C 13.0654 7.7977 0.0 0
M  V30 32 C 13.0654 5.1304 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-98-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084928
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME120 STEP1
$RXN



  3  1
$MOL
5-Cyclopentyl-2,3-pentadienoic acid
C10H14O2
942283-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4384 2.6218 0.0 0
M  V30 4 C 7.7722 3.3918 0.0 0
M  V30 5 C 9.1059 2.6218 0.0 0
M  V30 6 O 10.4396 3.3918 0.0 0
M  V30 7 O 9.1059 1.0817 0.0 0
M  V30 8 C 2.4374 1.8517 0.0 0
M  V30 9 C 2.2763 0.3202 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3 CFG=2
M  V30 4 2 3 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(Cyclopentylmethyl)-4-[(3-methylbutyl)thio]-2-(4-methylph...
C30H41NO4S2
951341-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 10.4612 7.1043 0.0 0 VAL=6
M  V30 2 O 10.4612 8.6443 0.0 0
M  V30 3 O 10.4612 5.5643 0.0 0
M  V30 4 C 8.4919 9.8149 0.0 0
M  V30 5 C 5.3055 5.4293 0.0 0
M  V30 6 O 5.4665 3.8976 0.0 0
M  V30 7 O 3.8987 6.0556 0.0 0
M  V30 8 S 5.3055 8.7795 0.0 0
M  V30 9 C 3.8987 8.1532 0.0 0
M  V30 10 C 2.6528 9.0584 0.0 0
M  V30 11 C 1.2459 8.4320 0.0 0
M  V30 12 C 0.0000 9.3372 0.0 0
M  V30 13 C 1.0849 6.9004 0.0 0
M  V30 14 C 9.9196 0.0000 0.0 0
M  V30 15 C 16.6212 7.1043 0.0 0
M  V30 16 N 8.9212 7.1043 0.0 0
M  V30 17 C 8.0160 5.8585 0.0 0 CFG=1
M  V30 18 C 8.0160 8.3503 0.0 0 CFG=2
M  V30 19 C 6.5515 6.3343 0.0 0 CFG=2
M  V30 20 C 6.5515 7.8743 0.0 0 CFG=1
M  V30 21 C 8.4919 4.3939 0.0 0
M  V30 22 C 9.9983 4.0738 0.0 0
M  V30 23 C 7.4615 3.2494 0.0 0
M  V30 24 C 10.4742 2.6091 0.0 0
M  V30 25 C 7.9373 1.7849 0.0 0
M  V30 26 C 9.4437 1.4647 0.0 0
M  V30 27 C 12.0012 7.1043 0.0 0
M  V30 28 C 12.7712 5.7707 0.0 0
M  V30 29 C 12.7712 8.4381 0.0 0
M  V30 30 C 14.3112 5.7707 0.0 0
M  V30 31 C 14.3112 8.4381 0.0 0
M  V30 32 C 15.0812 7.1043 0.0 0
M  V30 33 C 7.4615 10.9594 0.0 0
M  V30 34 C 5.9299 10.7983 0.0 0
M  V30 35 C 7.7816 12.4657 0.0 0
M  V30 36 C 5.3035 12.2053 0.0 0
M  V30 37 C 6.4480 13.2357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 18 4 CFG=1
M  V30 6 1 4 33
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 19 5 CFG=3
M  V30 10 1 8 9
M  V30 11 1 20 8 CFG=3
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 14 26
M  V30 17 1 15 32
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 21 CFG=1
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 942283-78-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951341-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME121 STEP1
$RXN



  3  1
$MOL
2,3-Nonadienoic acid
C9H14O2
80472-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Methylphenyl)-1-[(4-methylphenyl)sulfonyl]-5-pentyl-4-...
C27H35NO4S2
951636-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.9287 0.0 0 VAL=6
M  V30 2 O 9.2154 9.4687 0.0 0
M  V30 3 O 9.2154 6.3887 0.0 0
M  V30 4 C 7.2460 5.2181 0.0 0
M  V30 5 C 6.2156 4.0738 0.0 0
M  V30 6 C 6.6915 2.6091 0.0 0
M  V30 7 C 5.6610 1.4647 0.0 0
M  V30 8 C 6.1369 0.0000 0.0 0
M  V30 9 C 4.0596 9.6039 0.0 0
M  V30 10 O 2.6528 8.9776 0.0 0
M  V30 11 O 4.2207 11.1354 0.0 0
M  V30 12 S 4.0596 6.2535 0.0 0
M  V30 13 C 2.6528 6.8799 0.0 0
M  V30 14 C 1.4069 5.9747 0.0 0
M  V30 15 C 0.0000 6.6011 0.0 0
M  V30 16 C 8.6737 15.0332 0.0 0
M  V30 17 C 15.3754 7.9287 0.0 0
M  V30 18 N 7.6754 7.9287 0.0 0
M  V30 19 C 6.7701 9.1745 0.0 0 CFG=1
M  V30 20 C 6.7701 6.6828 0.0 0 CFG=2
M  V30 21 C 5.3055 8.6987 0.0 0 CFG=2
M  V30 22 C 5.3055 7.1587 0.0 0 CFG=1
M  V30 23 C 7.2460 10.6392 0.0 0
M  V30 24 C 6.2156 11.7836 0.0 0
M  V30 25 C 8.7524 10.9594 0.0 0
M  V30 26 C 6.6915 13.2483 0.0 0
M  V30 27 C 9.2283 12.4241 0.0 0
M  V30 28 C 8.1977 13.5685 0.0 0
M  V30 29 C 10.7554 7.9287 0.0 0
M  V30 30 C 11.5254 9.2623 0.0 0
M  V30 31 C 11.5254 6.5950 0.0 0
M  V30 32 C 13.0654 9.2623 0.0 0
M  V30 33 C 13.0654 6.5950 0.0 0
M  V30 34 C 13.8354 7.9287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 21 9 CFG=1
M  V30 13 1 12 13
M  V30 14 1 22 12 CFG=1
M  V30 15 1 13 14
M  V30 16 2 14 15
M  V30 17 1 16 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 80472-30-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-23-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083165
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME122 STEP1
$RXN



  3  1
$MOL
5-Cyclopentyl-2,3-pentadienoic acid
C10H14O2
942283-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4384 2.6218 0.0 0
M  V30 4 C 7.7722 3.3918 0.0 0
M  V30 5 C 9.1059 2.6218 0.0 0
M  V30 6 O 10.4396 3.3918 0.0 0
M  V30 7 O 9.1059 1.0817 0.0 0
M  V30 8 C 2.4374 1.8517 0.0 0
M  V30 9 C 2.2763 0.3202 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3 CFG=2
M  V30 4 2 3 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
172656-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(Cyclopentylmethyl)-2-(4-methylphenyl)-1-[(4-methylphenyl...
C28H35NO4S2
951636-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5643 0.0 0
M  V30 3 O 9.2154 8.6443 0.0 0
M  V30 4 C 4.0596 5.4293 0.0 0
M  V30 5 O 4.2207 3.8976 0.0 0
M  V30 6 O 2.6528 6.0556 0.0 0
M  V30 7 C 7.2460 9.8149 0.0 0
M  V30 8 S 4.0596 8.7795 0.0 0
M  V30 9 C 2.6528 8.1532 0.0 0
M  V30 10 C 1.4069 9.0584 0.0 0
M  V30 11 C 0.0000 8.4320 0.0 0
M  V30 12 C 8.6737 0.0000 0.0 0
M  V30 13 C 15.3754 7.1043 0.0 0
M  V30 14 C 6.7701 5.8585 0.0 0 CFG=1
M  V30 15 N 7.6754 7.1043 0.0 0
M  V30 16 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 17 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 18 C 5.3055 7.8743 0.0 0 CFG=2
M  V30 19 C 7.2460 4.3939 0.0 0
M  V30 20 C 6.2156 3.2494 0.0 0
M  V30 21 C 8.7524 4.0738 0.0 0
M  V30 22 C 6.6915 1.7849 0.0 0
M  V30 23 C 9.2283 2.6091 0.0 0
M  V30 24 C 8.1977 1.4647 0.0 0
M  V30 25 C 10.7554 7.1043 0.0 0
M  V30 26 C 11.5254 5.7707 0.0 0
M  V30 27 C 11.5254 8.4381 0.0 0
M  V30 28 C 13.0654 5.7707 0.0 0
M  V30 29 C 13.0654 8.4381 0.0 0
M  V30 30 C 13.8354 7.1043 0.0 0
M  V30 31 C 6.2156 10.9594 0.0 0
M  V30 32 C 4.6841 10.7983 0.0 0
M  V30 33 C 6.5358 12.4657 0.0 0
M  V30 34 C 4.0576 12.2053 0.0 0
M  V30 35 C 5.2021 13.2357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=3
M  V30 8 1 17 7 CFG=1
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 1 18 8 CFG=3
M  V30 12 1 9 10
M  V30 13 2 10 11
M  V30 14 1 12 24
M  V30 15 1 13 30
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19 CFG=1
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 14 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 942283-78-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 172656-81-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-84-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085415
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-32)-Tetracarbonyl(1,2-dioxopropyl)(methoxycarbonyl)iron
C9H6FeO8
177174-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Fe 3.9964 4.2042 0.0 0 CHG=2 VAL=6
M  V30 2 C 6.6606 2.6642 0.0 0 CHG=-1 VAL=4
M  V30 3 C 3.9964 7.2800 0.0 0 CHG=-1 VAL=4
M  V30 4 C 5.5364 1.5400 0.0 0
M  V30 5 C 2.4564 6.8685 0.0 0
M  V30 6 C 1.3321 2.6642 0.0 0
M  V30 7 C 6.6606 5.7400 0.0 0
M  V30 8 C 8.7903 3.8945 0.0 0
M  V30 9 O 6.6606 1.1285 0.0 0
M  V30 10 O 5.3327 8.0479 0.0 0
M  V30 11 O 2.6642 8.0479 0.0 0
M  V30 12 O 5.5364 0.0000 0.0 0 VAL=3
M  V30 13 O 1.1242 6.0964 0.0 0 VAL=3
M  V30 14 O 0.0000 3.4321 0.0 0 VAL=3
M  V30 15 O 7.9927 4.9721 0.0 0 VAL=3
M  V30 16 C 8.7903 5.4345 0.0 0
M  V30 17 O 10.1224 3.1267 0.0 0
M  V30 18 C 6.6648 7.2800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 2 2 9
M  V30 9 1 3 10
M  V30 10 2 3 11
M  V30 11 3 4 12
M  V30 12 3 5 13
M  V30 13 3 6 14
M  V30 14 3 7 15
M  V30 15 1 8 16
M  V30 16 2 8 17
M  V30 17 1 10 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iron, tetracarbonyl[carbonyloxy[1-(ethylthio)-1-methyl-2-oxo-1,2-ethanediyl]]...
C10H8FeO7S
439216-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0243 4.0341 0.0 0
M  V30 2 O 10.5423 4.0341 0.0 0 VAL=3
M  V30 3 C 8.7979 1.4719 0.0 0
M  V30 4 O 10.3201 1.4719 0.0 0 VAL=3
M  V30 5 C 4.2102 0.6626 0.0 0
M  V30 6 O 2.6880 0.6626 0.0 0 VAL=3
M  V30 7 C 6.6927 0.0000 0.0 0
M  V30 8 O 8.2150 0.0000 0.0 0 VAL=3
M  V30 9 O 2.5119 1.7487 0.0 0
M  V30 10 O 8.5253 5.9673 0.0 0
M  V30 11 S 2.6335 7.0660 0.0 0
M  V30 12 C 1.3167 7.8250 0.0 0
M  V30 13 C 0.0000 7.0660 0.0 0
M  V30 14 C 1.3167 6.3027 0.0 0
M  V30 15 Fe 6.1644 2.9941 0.0 0 CHG=2 VAL=6
M  V30 16 C 3.4177 2.9941 0.0 0 CHG=-1 VAL=4
M  V30 17 C 7.0450 5.5437 0.0 0 CHG=-1 VAL=4
M  V30 18 C 2.6335 5.5437 0.0 0
M  V30 19 O 4.8938 7.2127 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 15
M  V30 3 3 3 4
M  V30 4 1 3 15
M  V30 5 3 5 6
M  V30 6 1 5 15
M  V30 7 3 7 8
M  V30 8 1 7 15
M  V30 9 2 9 16
M  V30 10 2 10 17
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 1 12 13
M  V30 14 1 14 18
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 177174-06-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 439216-12-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-574-CAS-7138706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Thermal Evolution of 1a in the Presence of EtSH: Formation of 2c. The
reaction was performed at 0 °C by reacting 100 mg of 1a (0.33 mmol) in
the presence of 80 equiv (27 mmol, 2 mL, 1.7 g) of ethanethiol. The
reaction was complete after 48 h at 0 °C. After evaporation of the
solvent, the usual workup of the reaction mixture failed to afford a
solid product. As determined by 13C NMR, the oily residue thus obtained
was found to be composed of 95% of 2c and 5% of 2a. The oily residue
failed to afford correct analyses corresponding to 2c. The possible
formation of Fe[C(O)SEt][C(O)C(O)CH3](CO)4 was not evidenced by a
monitoring of the reaction by 13C NMR. 2c, Yield 95% IR (hexane, cm-1):
ν(C≡O) 2120 (w), 2075 (w, sh), 2067 (w, sh), 2050 (s); ν(C=O) 1728 (br),
1705 (w, sh). 1H NMR (CD2Cl2, 273 K; δ, ppm): 2.54 (q, J = 6 Hz, 2H,
SCH2), 1.64 (t, J = 6 Hz, 3H, CH3), 1.20 (s, 3H, CH3). 13C{1H} NMR
(CD2Cl2, 273 K; δ, ppm): 199.8, 199.7, 198.2, 196.4 (C≡O); 245.2 (C=O);
196.9 (C=O); 98.2 (C(CH3)(SC2H5)); 23.9 (SCH2); 23.1 (CH3), 14.3 (CH3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclization of the Pyruvyl(methoxycarbonyl)tetracarbonyliron Complex
cis-(CO)4Fe[C(O)C(O)CH3](CO2CH3) Induced by Pronucleophile Reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cabon, Patrice; Sellin, Murielle; Salauen, Jean-Yves; Patinec, Veronique;
des Abbayes, Herve; Kubicki, Marek M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organometallics (2002), 21(11), 2196-2202

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2-Pyridinyldithio)methyl]-3-furanmethanol
C11H11NO2S2
1773531-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7710 0.0 0
M  V30 2 S 5.3900 3.7710 0.0 0
M  V30 3 S 4.6200 5.1048 0.0 0
M  V30 4 C 10.2621 3.4208 0.0 0
M  V30 5 O 11.7684 3.1006 0.0 0
M  V30 6 C 7.7000 2.4374 0.0 0
M  V30 7 C 9.2315 2.2764 0.0 0
M  V30 8 C 7.0737 1.0306 0.0 0
M  V30 9 C 9.5517 0.7700 0.0 0
M  V30 10 O 8.2181 0.0000 0.0 0
M  V30 11 C 3.0800 5.1048 0.0 0
M  V30 12 C 2.3100 6.4384 0.0 0
M  V30 13 N 2.3100 3.7710 0.0 0
M  V30 14 C 0.7700 6.4384 0.0 0
M  V30 15 C 0.7700 3.7710 0.0 0
M  V30 16 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 1 4 7
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[(1,1-Dimethylethyl)dithio]methyl]-3-furanmethanol
C10H16O2S2
1773531-91-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.8738 0.0 0
M  V30 2 S 3.8500 2.8738 0.0 0
M  V30 3 S 3.0800 1.5400 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 8.7221 3.2240 0.0 0
M  V30 9 O 10.2284 3.5442 0.0 0
M  V30 10 C 6.1600 4.2074 0.0 0
M  V30 11 C 7.6915 4.3684 0.0 0
M  V30 12 C 5.5337 5.6142 0.0 0
M  V30 13 C 8.0117 5.8748 0.0 0
M  V30 14 O 6.6781 6.6448 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 11
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1773531-90-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1773531-91-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-511-CAS-21397837
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nucleic acids containing base analogs and backbone modifications that
improve cellular uptake and nuclease resistance and their uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bradshaw, Curt W.; Sakamuri, Sukumar; Eltepu, Laxman; Lam, Son; Liu,
Dingguo; Meade, Bryan; Dello Iacono, Giuseppe; Stock, Joseph; Liu, Bin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015188197 A2 2015-12-10

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2-Pyridinyldithio)methyl]-3-furanmethanol
C11H11NO2S2
1773531-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7710 0.0 0
M  V30 2 S 5.3900 3.7710 0.0 0
M  V30 3 S 4.6200 5.1048 0.0 0
M  V30 4 C 10.2621 3.4208 0.0 0
M  V30 5 O 11.7684 3.1006 0.0 0
M  V30 6 C 7.7000 2.4374 0.0 0
M  V30 7 C 9.2315 2.2764 0.0 0
M  V30 8 C 7.0737 1.0306 0.0 0
M  V30 9 C 9.5517 0.7700 0.0 0
M  V30 10 O 8.2181 0.0000 0.0 0
M  V30 11 C 3.0800 5.1048 0.0 0
M  V30 12 C 2.3100 6.4384 0.0 0
M  V30 13 N 2.3100 3.7710 0.0 0
M  V30 14 C 0.7700 6.4384 0.0 0
M  V30 15 C 0.7700 3.7710 0.0 0
M  V30 16 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 1 4 7
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[(1,1-Dimethylethyl)dithio]methyl]-3-furanmethanol
C10H16O2S2
1773531-91-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.8738 0.0 0
M  V30 2 S 3.8500 2.8738 0.0 0
M  V30 3 S 3.0800 1.5400 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 8.7221 3.2240 0.0 0
M  V30 9 O 10.2284 3.5442 0.0 0
M  V30 10 C 6.1600 4.2074 0.0 0
M  V30 11 C 7.6915 4.3684 0.0 0
M  V30 12 C 5.5337 5.6142 0.0 0
M  V30 13 C 8.0117 5.8748 0.0 0
M  V30 14 O 6.6781 6.6448 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 11
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1773531-90-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1773531-91-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-511-CAS-18258013
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of polynucleotide RNA duplexes modified conjugates having
disulfide groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bradshaw, Curt W.; Eltepu, Laxman; Kabakibi, Ayman; Lam, Son; Liu, Bin;
Liu, Dingguo; Meade, Bryan R.; Sakamuri, Sukumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015069932 A1 2015-05-14

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethylbis(2-methyl-2-propen-1-yl)germane
C12H24Ge
1788033-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Ge 4.0011 2.6675 0.0 0
M  V30 2 C 2.6675 3.4375 0.0 0
M  V30 3 C 5.3348 1.8975 0.0 0
M  V30 4 C 4.7711 4.0011 0.0 0
M  V30 5 C 3.2311 1.3338 0.0 0
M  V30 6 C 1.3337 2.6675 0.0 0
M  V30 7 C 6.6686 2.6675 0.0 0
M  V30 8 C 4.0011 5.3349 0.0 0
M  V30 9 C 4.0011 0.0000 0.0 0
M  V30 10 C 1.3337 1.1274 0.0 0
M  V30 11 C 0.0000 3.4375 0.0 0
M  V30 12 C 8.0022 1.8975 0.0 0
M  V30 13 C 6.6686 4.2075 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethylbis[(3-methylbutyl)thio]germane
C14H32GeS2
1788032-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Ge 6.6685 2.6675 0.0 0
M  V30 2 S 5.3348 3.4375 0.0 0
M  V30 3 S 8.0022 1.8975 0.0 0
M  V30 4 C 5.8985 1.3338 0.0 0
M  V30 5 C 7.4385 4.0012 0.0 0
M  V30 6 C 4.0010 2.6675 0.0 0
M  V30 7 C 9.3360 2.6675 0.0 0
M  V30 8 C 6.6685 0.0000 0.0 0
M  V30 9 C 6.6685 5.3350 0.0 0
M  V30 10 C 2.6673 3.4375 0.0 0
M  V30 11 C 10.6697 1.8975 0.0 0
M  V30 12 C 1.3337 2.6675 0.0 0
M  V30 13 C 12.0033 2.6675 0.0 0
M  V30 14 C 0.0000 3.4375 0.0 0
M  V30 15 C 1.3337 1.1275 0.0 0
M  V30 16 C 13.3370 1.8975 0.0 0
M  V30 17 C 12.0033 4.2075 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1788033-02-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1788032-96-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-5024227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 144026-79-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal triflate-mediated coupling of allylgermanes with thiols: a facile
route to thiogermanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kucinski, K.; Pawluc, P.; Hreczycho, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2015), 44(24), 10943-10946

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-2-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-1-phenyle...
C19H25NO5
1802434-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=2
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 C 3.8500 5.3347 0.0 0
M  V30 5 O 3.0800 6.6684 0.0 0
M  V30 6 O 3.0800 4.0011 0.0 0
M  V30 7 C 1.5400 6.6684 0.0 0
M  V30 8 C 1.5400 8.2084 0.0 0
M  V30 9 C 0.0000 6.6684 0.0 0
M  V30 10 C 1.5400 5.1284 0.0 0
M  V30 11 C 11.9596 7.6583 0.0 0
M  V30 12 C 11.9596 5.6786 0.0 0
M  V30 13 O 7.7000 9.3358 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 C 6.1600 1.3336 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 5.3900 0.0000 0.0 0
M  V30 18 C 3.0800 1.3336 0.0 0
M  V30 19 C 3.8500 0.0000 0.0 0
M  V30 20 C 8.4700 5.3347 0.0 0
M  V30 21 O 10.0100 5.3347 0.0 0
M  V30 22 C 7.7000 6.6684 0.0 0
M  V30 23 C 10.7800 6.6684 0.0 0
M  V30 24 C 8.4700 8.0021 0.0 0
M  V30 25 O 10.0100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 23
M  V30 13 1 12 23
M  V30 14 2 13 24
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-(1-Methylethyl) (δR)-δ-[[(1,1-dimethylethoxy)carbonyl]amino]-β-oxobenzenepe...
C19H27NO4S
1802435-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=2
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 5.3900 5.3347 0.0 0
M  V30 4 C 8.4700 5.3347 0.0 0
M  V30 5 C 3.8500 5.3347 0.0 0
M  V30 6 C 10.0100 5.3347 0.0 0
M  V30 7 O 7.7000 6.6684 0.0 0
M  V30 8 O 3.0800 6.6684 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 C 10.7800 6.6684 0.0 0
M  V30 11 C 1.5400 6.6684 0.0 0
M  V30 12 S 12.3200 6.6684 0.0 0
M  V30 13 O 10.0100 8.0021 0.0 0
M  V30 14 C 1.5400 5.1284 0.0 0
M  V30 15 C 0.0000 6.6684 0.0 0
M  V30 16 C 1.5400 8.2084 0.0 0
M  V30 17 C 13.0900 8.0021 0.0 0
M  V30 18 C 14.6300 8.0021 0.0 0
M  V30 19 C 12.3200 9.3358 0.0 0
M  V30 20 C 5.3900 2.6674 0.0 0
M  V30 21 C 6.1600 1.3336 0.0 0
M  V30 22 C 3.8500 2.6674 0.0 0
M  V30 23 C 5.3900 0.0000 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1802434-53-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1802435-03-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-006-CAS-11733739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective (stereoretentive), reaction monitored by either TLC or 1H
NMR
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Disulfonimide-Catalyzed Synthesis of δ-Amino-β-Ketoester
Derivatives by Vinylogous Mukaiyama-Mannich Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Qinggang; van Gemmeren, Manuel; List, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2014), 53(49), 13592-13595

$RFMT $RIREG SCHEME127 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
181041-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Fluorophenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sul...
C24H28FNO4S2
951635-62-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 8.6443 0.0 0
M  V30 3 O 9.2154 5.5643 0.0 0
M  V30 4 C 7.2460 9.8149 0.0 0
M  V30 5 C 8.7525 10.1351 0.0 0
M  V30 6 C 6.2156 10.9593 0.0 0
M  V30 7 C 4.0596 5.4291 0.0 0
M  V30 8 O 4.2207 3.8976 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7796 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0583 0.0 0
M  V30 13 C 0.0000 8.4320 0.0 0
M  V30 14 F 8.6738 0.0000 0.0 0
M  V30 15 C 15.3754 7.1043 0.0 0
M  V30 16 N 7.6754 7.1043 0.0 0
M  V30 17 C 6.7702 5.8585 0.0 0 CFG=1
M  V30 18 C 6.7702 8.3502 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8743 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3938 0.0 0
M  V30 22 C 6.2156 3.2494 0.0 0
M  V30 23 C 8.7525 4.0736 0.0 0
M  V30 24 C 6.6915 1.7847 0.0 0
M  V30 25 C 9.2283 2.6091 0.0 0
M  V30 26 C 8.1977 1.4645 0.0 0
M  V30 27 C 10.7554 7.1043 0.0 0
M  V30 28 C 11.5254 8.4380 0.0 0
M  V30 29 C 11.5254 5.7707 0.0 0
M  V30 30 C 13.0654 8.4380 0.0 0
M  V30 31 C 13.0654 5.7707 0.0 0
M  V30 32 C 13.8354 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 181041-86-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-62-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086377
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME128 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
181041-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Fluorophenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-(...
C27H34FNO4S2
951636-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 F 0.0000 6.7017 0.0 0
M  V30 18 C 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 181041-86-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME129 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
181041-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C25H30FNO4S2
951636-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 F 8.6738 13.5684 0.0 0
M  V30 16 C 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 181041-86-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083394
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME130 STEP1
$RXN



  3  1
$MOL
2,3-Nonadienoic acid
C9H14O2
80472-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
181041-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-5-pentyl-4-...
C26H32FNO4S2
951636-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.9287 0.0 0 VAL=6
M  V30 2 O 9.2154 9.4687 0.0 0
M  V30 3 O 9.2154 6.3887 0.0 0
M  V30 4 C 7.2460 5.2181 0.0 0
M  V30 5 C 6.2156 4.0738 0.0 0
M  V30 6 C 6.6915 2.6091 0.0 0
M  V30 7 C 5.6610 1.4647 0.0 0
M  V30 8 C 6.1369 0.0000 0.0 0
M  V30 9 C 4.0596 9.6039 0.0 0
M  V30 10 O 2.6528 8.9776 0.0 0
M  V30 11 O 4.2207 11.1354 0.0 0
M  V30 12 S 4.0596 6.2535 0.0 0
M  V30 13 C 2.6528 6.8799 0.0 0
M  V30 14 C 1.4069 5.9747 0.0 0
M  V30 15 C 0.0000 6.6011 0.0 0
M  V30 16 F 8.6737 15.0332 0.0 0
M  V30 17 C 15.3754 7.9287 0.0 0
M  V30 18 N 7.6754 7.9287 0.0 0
M  V30 19 C 6.7701 9.1745 0.0 0 CFG=1
M  V30 20 C 6.7701 6.6828 0.0 0 CFG=2
M  V30 21 C 5.3055 8.6987 0.0 0 CFG=2
M  V30 22 C 5.3055 7.1587 0.0 0 CFG=1
M  V30 23 C 7.2460 10.6392 0.0 0
M  V30 24 C 6.2156 11.7836 0.0 0
M  V30 25 C 8.7524 10.9594 0.0 0
M  V30 26 C 6.6915 13.2483 0.0 0
M  V30 27 C 9.2283 12.4241 0.0 0
M  V30 28 C 8.1977 13.5685 0.0 0
M  V30 29 C 10.7554 7.9287 0.0 0
M  V30 30 C 11.5254 9.2623 0.0 0
M  V30 31 C 11.5254 6.5950 0.0 0
M  V30 32 C 13.0654 9.2623 0.0 0
M  V30 33 C 13.0654 6.5950 0.0 0
M  V30 34 C 13.8354 7.9287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 21 9 CFG=1
M  V30 13 1 12 13
M  V30 14 1 22 12 CFG=1
M  V30 15 1 13 14
M  V30 16 2 14 15
M  V30 17 1 16 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 80472-30-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 181041-86-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087447
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME131 STEP1
$RXN



  3  1
$MOL
5-Cyclopentyl-2,3-pentadienoic acid
C10H14O2
942283-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4384 2.6218 0.0 0
M  V30 4 C 7.7722 3.3918 0.0 0
M  V30 5 C 9.1059 2.6218 0.0 0
M  V30 6 O 10.4396 3.3918 0.0 0
M  V30 7 O 9.1059 1.0817 0.0 0
M  V30 8 C 2.4374 1.8517 0.0 0
M  V30 9 C 2.2763 0.3202 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3 CFG=2
M  V30 4 2 3 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
181041-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(Cyclopentylmethyl)-2-(4-fluorophenyl)-1-[(4-methylphenyl...
C27H32FNO4S2
951637-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5643 0.0 0
M  V30 3 O 9.2154 8.6443 0.0 0
M  V30 4 C 4.0596 5.4293 0.0 0
M  V30 5 O 4.2207 3.8976 0.0 0
M  V30 6 O 2.6528 6.0556 0.0 0
M  V30 7 C 7.2460 9.8149 0.0 0
M  V30 8 S 4.0596 8.7795 0.0 0
M  V30 9 C 2.6528 8.1532 0.0 0
M  V30 10 C 1.4069 9.0584 0.0 0
M  V30 11 C 0.0000 8.4320 0.0 0
M  V30 12 F 8.6737 0.0000 0.0 0
M  V30 13 C 15.3754 7.1043 0.0 0
M  V30 14 C 6.7701 5.8585 0.0 0 CFG=1
M  V30 15 N 7.6754 7.1043 0.0 0
M  V30 16 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 17 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 18 C 5.3055 7.8743 0.0 0 CFG=2
M  V30 19 C 7.2460 4.3939 0.0 0
M  V30 20 C 6.2156 3.2494 0.0 0
M  V30 21 C 8.7524 4.0738 0.0 0
M  V30 22 C 6.6915 1.7849 0.0 0
M  V30 23 C 9.2283 2.6091 0.0 0
M  V30 24 C 8.1977 1.4647 0.0 0
M  V30 25 C 10.7554 7.1043 0.0 0
M  V30 26 C 11.5254 5.7707 0.0 0
M  V30 27 C 11.5254 8.4381 0.0 0
M  V30 28 C 13.0654 5.7707 0.0 0
M  V30 29 C 13.0654 8.4381 0.0 0
M  V30 30 C 13.8354 7.1043 0.0 0
M  V30 31 C 6.2156 10.9594 0.0 0
M  V30 32 C 4.6841 10.7983 0.0 0
M  V30 33 C 6.5358 12.4657 0.0 0
M  V30 34 C 4.0576 12.2053 0.0 0
M  V30 35 C 5.2021 13.2357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=3
M  V30 8 1 17 7 CFG=1
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 1 18 8 CFG=3
M  V30 12 1 9 10
M  V30 13 2 10 11
M  V30 14 1 12 24
M  V30 15 1 13 30
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19 CFG=1
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 14 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 942283-78-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 181041-86-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951637-01-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088626
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Cyclopropyl-3,4-dinitro-1H-pyrazole
C6H6N4O4
1834584-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.4068 4.8820 0.0 0 VAL=5
M  V30 2 O 0.0000 4.2555 0.0 0
M  V30 3 O 1.5679 6.4135 0.0 0
M  V30 4 N 1.4068 1.5315 0.0 0 VAL=5
M  V30 5 O 1.5679 0.0000 0.0 0
M  V30 6 O 0.0000 2.1580 0.0 0
M  V30 7 N 5.0226 3.2068 0.0 0
M  V30 8 C 4.1174 4.4526 0.0 0
M  V30 9 N 4.1174 1.9609 0.0 0
M  V30 10 C 2.6527 3.9768 0.0 0
M  V30 11 C 2.6527 2.4368 0.0 0
M  V30 12 C 6.5626 3.2068 0.0 0
M  V30 13 C 7.8962 3.9768 0.0 0
M  V30 14 C 7.8962 2.4368 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Cyclopropyl-4-[(1-methylethyl)thio]-3-nitro-1H-pyrazole
C9H13N3O2S
1890144-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6873 3.8549 0.0 0
M  V30 2 C 7.4573 5.1887 0.0 0
M  V30 3 C 6.6873 6.5224 0.0 0
M  V30 4 C 8.9973 5.1887 0.0 0
M  V30 5 N 4.7179 1.1445 0.0 0 VAL=5
M  V30 6 O 3.6875 0.0000 0.0 0
M  V30 7 O 6.2244 0.8244 0.0 0
M  V30 8 C 5.1473 3.8549 0.0 0
M  V30 9 C 4.2421 2.6091 0.0 0
M  V30 10 C 4.2421 5.1009 0.0 0
M  V30 11 N 2.7774 3.0849 0.0 0
M  V30 12 N 2.7774 4.6249 0.0 0
M  V30 13 C 1.5315 5.5301 0.0 0
M  V30 14 C 0.9052 6.9371 0.0 0
M  V30 15 C 0.0000 5.6912 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 9
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1834584-36-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1890144-64-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-21176353
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as
potent anaplastic lymphoma kinase (ALK) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Peilong; Dong, Jiaqiang; Zhong, Boyu; Zhang, Deyi; Yuan, Hongbin;
Jin, Can; Xu, Xiangyuan; Li, Hailong; Zhou, Yong; Liang, Zhi; Ji,
Minghua; Xu, Tao; Song, Guowei; Zhang, Ling; Chen, Gang; Meng, Xuejing;
Sun, Desheng; Shih, Joe; Zhang, Ruihao; Hou, Guojun; Wang, Chengcheng;
Jin, Ying; Yang, Qiong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(8), 1910-1918

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-3-Octen-2-one
C8H14O
18402-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Ethylthio)-2-octanone
C10H20OS
1629455-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 S 2.3100 4.0011 0.0 0
M  V30 5 C 6.1600 5.3347 0.0 0
M  V30 6 C 3.8500 1.3338 0.0 0
M  V30 7 C 1.5400 5.3347 0.0 0
M  V30 8 C 6.9300 6.6685 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 O 2.3100 1.3338 0.0 0
M  V30 11 C 0.0000 5.3347 0.0 0
M  V30 12 C 8.4700 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18402-82-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629455-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2093963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Ethylsulfanyl-octan-2-one [41]: General protocol for synthesis of
thioethers: A mixture of alpha,beta-unsaturated ketone, ethanethiol (1
equiv.) and K3PO4 (0.25 equiv.) was stirred neat at room temperature. The
conversion was monitored by GC/MS. After no increase of conversion was
observed, chloroform was added to the reaction mixture and K3PO4 was
removed by filtration. Chloroform and excess ethanethiol were removed in
vacuo. Product 41 was prepared according to the General protocol for
synthesis of thioethers. Reaction conditions: 3-Oceten-2-one (504 mg, 4
mmol), ethanethiol (248 mg, 4 mmol, 1 equiv.), K3PO4 (338 mg, 1 mmol,
0.25 equiv.). The crude product 41 was obtained as yellow oil in 95 %
yield in > 95 % purity (GC/MS) and was not purified. Yield: 711 mg (95 %)
> 95 % purity (GC/MS), yellow oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biooxidation of Polycyclic and Linear Ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lengar, Alenka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2008), (20140701), No pp.

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C30H32NOPRuS2
1840995-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0662 26.0862 0.0 0
M  V30 2 C 4.8389 26.7937 0.0 0
M  V30 3 C 7.2935 26.7937 0.0 0
M  V30 4 C 10.9793 20.7548 0.0 0
M  V30 5 P 3.8930 8.2081 0.0 0 VAL=5
M  V30 6 S 2.6657 8.9156 0.0 0
M  V30 7 C 14.0867 7.4968 0.0 0
M  V30 8 O 10.1234 3.0175 0.0 0
M  V30 9 Ru 8.8960 11.2725 0.0 0 CHG=2 VAL=9
M  V30 10 C 6.0662 24.6674 0.0 0 VAL=5
M  V30 11 C 1.5400 22.0251 0.0 0 VAL=5
M  V30 12 C 11.3468 24.6674 0.0 0 VAL=5
M  V30 13 C 15.8729 22.0251 0.0 0 VAL=5
M  V30 14 C 6.0662 19.3868 0.0 0 VAL=5
M  V30 15 C 11.3468 19.3868 0.0 0 VAL=5
M  V30 16 C 5.1203 7.4968 0.0 0 CHG=-2 VAL=4
M  V30 17 N 12.6679 7.4968 0.0 0 VAL=4
M  V30 18 S 8.8960 3.7249 0.0 0 VAL=6
M  V30 19 C 8.8960 2.3100 0.0 0
M  V30 20 C 8.8960 0.7700 0.0 0
M  V30 21 C 7.5593 3.0761 0.0 0
M  V30 22 C 7.5593 0.0000 0.0 0
M  V30 23 C 6.2304 2.3100 0.0 0
M  V30 24 C 6.2304 0.7700 0.0 0
M  V30 25 C 2.6657 7.4968 0.0 0
M  V30 26 C 1.3368 8.2668 0.0 0
M  V30 27 C 2.6657 5.9607 0.0 0
M  V30 28 C 0.0000 7.4968 0.0 0
M  V30 29 C 1.3368 5.1907 0.0 0
M  V30 30 C 0.0000 5.9607 0.0 0
M  V30 31 C 3.8930 9.6230 0.0 0
M  V30 32 C 2.5602 10.3930 0.0 0
M  V30 33 C 5.2258 10.3930 0.0 0
M  V30 34 C 2.5602 11.9330 0.0 0
M  V30 35 C 5.2258 11.9330 0.0 0
M  V30 36 C 3.8930 12.7030 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 4 15
M  V30 5 2 5 6
M  V30 6 1 5 16
M  V30 7 1 5 25
M  V30 8 1 5 31
M  V30 9 1 7 17
M  V30 10 2 8 18
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 14
M  V30 16 1 9 15
M  V30 17 1 9 16
M  V30 18 2 9 17
M  V30 19 1 10 11
M  V30 20 2 10 12
M  V30 21 2 11 14
M  V30 22 1 12 13
M  V30 23 2 13 15
M  V30 24 1 14 15
M  V30 25 2 16 18
M  V30 26 1 17 18
M  V30 27 1 18 19
M  V30 28 2 19 20
M  V30 29 1 19 21
M  V30 30 1 20 22
M  V30 31 2 21 23
M  V30 32 2 22 24
M  V30 33 1 23 24
M  V30 34 2 25 26
M  V30 35 1 25 27
M  V30 36 1 26 28
M  V30 37 2 27 29
M  V30 38 2 28 30
M  V30 39 1 29 30
M  V30 40 2 31 32
M  V30 41 1 31 33
M  V30 42 1 32 34
M  V30 43 2 33 35
M  V30 44 2 34 36
M  V30 45 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C34H42NOPRuS3
1840995-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 11.3599 12.7051 0.0 0 CHG=-1 VAL=2
M  V30 2 C 12.5878 11.9973 0.0 0
M  V30 3 C 13.8157 12.7051 0.0 0
M  V30 4 C 13.2995 10.7694 0.0 0
M  V30 5 C 11.8800 10.7694 0.0 0
M  V30 6 C 6.0690 26.1219 0.0 0
M  V30 7 C 4.8412 26.8297 0.0 0
M  V30 8 C 7.3008 26.8297 0.0 0
M  V30 9 C 10.9884 20.7802 0.0 0
M  V30 10 P 3.8948 8.2159 0.0 0 VAL=5
M  V30 11 S 2.6669 8.9237 0.0 0
M  V30 12 C 14.1012 7.5081 0.0 0
M  V30 13 O 10.1320 3.0189 0.0 0
M  V30 14 Ru 8.9041 11.2895 0.0 0 CHG=2 VAL=9
M  V30 15 C 6.0690 24.7024 0.0 0 VAL=5
M  V30 16 C 1.5329 22.0550 0.0 0 VAL=5
M  V30 17 C 11.3560 24.7024 0.0 0 VAL=5
M  V30 18 C 15.8921 22.0550 0.0 0 VAL=5
M  V30 19 C 6.0690 19.4116 0.0 0 VAL=5
M  V30 20 C 11.3560 19.4116 0.0 0 VAL=5
M  V30 21 C 5.1227 7.5081 0.0 0 CHG=-1 VAL=4
M  V30 22 N 12.6817 7.5081 0.0 0 VAL=4
M  V30 23 S 8.9041 3.7267 0.0 0 VAL=6
M  V30 24 C 8.9041 2.3111 0.0 0
M  V30 25 C 8.9041 0.7704 0.0 0
M  V30 26 C 7.5707 3.0775 0.0 0
M  V30 27 C 7.5707 0.0000 0.0 0
M  V30 28 C 6.2411 2.3111 0.0 0
M  V30 29 C 6.2411 0.7704 0.0 0
M  V30 30 C 2.6669 7.5081 0.0 0
M  V30 31 C 1.3374 8.2746 0.0 0
M  V30 32 C 2.6669 5.9674 0.0 0
M  V30 33 C 0.0000 7.5081 0.0 0
M  V30 34 C 1.3374 5.1970 0.0 0
M  V30 35 C 0.0000 5.9674 0.0 0
M  V30 36 C 3.8948 9.6354 0.0 0
M  V30 37 C 2.5614 10.4058 0.0 0
M  V30 38 C 5.2283 10.4058 0.0 0
M  V30 39 C 2.5614 11.9426 0.0 0
M  V30 40 C 5.2283 11.9426 0.0 0
M  V30 41 C 3.8948 12.7129 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 9 20
M  V30 10 2 10 11
M  V30 11 1 10 21
M  V30 12 1 10 30
M  V30 13 1 10 36
M  V30 14 1 12 22
M  V30 15 2 13 23
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 20
M  V30 22 1 14 21
M  V30 23 1 14 22
M  V30 24 1 15 16
M  V30 25 2 15 17
M  V30 26 2 16 19
M  V30 27 1 17 18
M  V30 28 2 18 20
M  V30 29 1 19 20
M  V30 30 1 21 23
M  V30 31 2 22 23
M  V30 32 1 23 24
M  V30 33 2 24 25
M  V30 34 1 24 26
M  V30 35 1 25 27
M  V30 36 2 26 28
M  V30 37 2 27 29
M  V30 38 1 28 29
M  V30 39 2 30 31
M  V30 40 1 30 32
M  V30 41 1 31 33
M  V30 42 2 32 34
M  V30 43 2 33 35
M  V30 44 1 34 35
M  V30 45 2 36 37
M  V30 46 1 36 38
M  V30 47 1 37 39
M  V30 48 2 38 40
M  V30 49 2 39 41
M  V30 50 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1840995-78-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1840995-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-15643313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and isolation of a chiral methanediide and its application as
cooperative ligand in bond activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Feichtner, Kai-Stephan; Englert, Simon; Gessner, Viktoria H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(2), 506-510

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(5-Nitro-2-pyridinyl)dithio]ethyl N-[5-[[5-[5-[[(1,1-dimethylethoxy)carbon...
C58H86N6O14S2Si2
1887238-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  82 86 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0438 16.0080 0.0 0
M  V30 2 O 7.2738 17.3416 0.0 0
M  V30 3 N 9.5838 18.6753 0.0 0
M  V30 4 C 10.3538 20.0089 0.0 0
M  V30 5 O 9.5838 21.3427 0.0 0
M  V30 6 O 11.8938 20.0089 0.0 0
M  V30 7 C 10.3538 22.6764 0.0 0
M  V30 8 C 9.0202 23.4464 0.0 0
M  V30 9 C 11.1238 24.0100 0.0 0
M  V30 10 C 11.6875 21.9063 0.0 0
M  V30 11 O 12.6638 13.3405 0.0 0
M  V30 12 C 11.8938 12.0069 0.0 0
M  V30 13 O 14.2038 16.0080 0.0 0
M  V30 14 C 14.9738 14.6741 0.0 0
M  V30 15 C 16.5138 14.6741 0.0 0
M  V30 16 C 17.2839 13.3405 0.0 0
M  V30 17 C 18.8239 13.3405 0.0 0
M  V30 18 C 19.5939 12.0069 0.0 0
M  V30 19 O 21.1339 12.0069 0.0 0
M  V30 20 C 4.7118 15.6578 0.0 0
M  V30 21 O 3.2054 15.3376 0.0 0
M  V30 22 Si 2.1750 16.4820 0.0 0
M  V30 23 C 1.1444 17.6264 0.0 0
M  V30 24 C 3.3193 17.5124 0.0 0
M  V30 25 C 1.0304 15.4515 0.0 0
M  V30 26 C 0.0000 16.5959 0.0 0
M  V30 27 C 0.1140 18.7709 0.0 0
M  V30 28 C 2.2889 18.6569 0.0 0
M  V30 29 C 6.9167 10.7052 0.0 0
M  V30 30 O 19.5939 9.3394 0.0 0
M  V30 31 C 18.8239 8.0057 0.0 0
M  V30 32 N 25.7539 9.3394 0.0 0
M  V30 33 C 26.5239 10.6732 0.0 0
M  V30 34 O 28.0639 10.6732 0.0 0
M  V30 35 O 25.7539 12.0069 0.0 0
M  V30 36 C 28.8339 12.0069 0.0 0
M  V30 37 C 30.3739 12.0069 0.0 0
M  V30 38 S 31.1440 10.6732 0.0 0
M  V30 39 S 32.6840 10.6732 0.0 0
M  V30 40 C 24.2139 6.6721 0.0 0
M  V30 41 O 25.7539 6.6721 0.0 0
M  V30 42 C 25.5767 3.6113 0.0 0
M  V30 43 O 26.0525 2.1466 0.0 0
M  V30 44 Si 27.5590 1.8265 0.0 0
M  V30 45 C 29.0652 1.5063 0.0 0
M  V30 46 C 27.2386 0.3202 0.0 0
M  V30 47 C 27.8791 3.3329 0.0 0
M  V30 48 C 28.7451 0.0000 0.0 0
M  V30 49 C 30.5717 1.1861 0.0 0
M  V30 50 C 29.3854 3.0127 0.0 0
M  V30 51 C 20.1852 3.0446 0.0 0
M  V30 52 N 35.7640 16.0080 0.0 0 VAL=5
M  V30 53 O 34.9940 17.3416 0.0 0
M  V30 54 O 37.3040 16.0080 0.0 0
M  V30 55 C 9.5838 16.0080 0.0 0
M  V30 56 C 10.3538 17.3416 0.0 0
M  V30 57 C 10.3538 14.6741 0.0 0
M  V30 58 C 11.8938 17.3416 0.0 0
M  V30 59 C 11.8938 14.6741 0.0 0
M  V30 60 C 12.6638 16.0080 0.0 0
M  V30 61 N 7.2738 14.6741 0.0 0
M  V30 62 C 5.7422 14.5132 0.0 0 CFG=2
M  V30 63 C 7.9001 13.2673 0.0 0
M  V30 64 C 5.4221 13.0069 0.0 0
M  V30 65 C 6.7557 12.2369 0.0 0
M  V30 66 C 21.9039 10.6732 0.0 0
M  V30 67 C 21.1339 9.3394 0.0 0
M  V30 68 C 23.4439 10.6732 0.0 0
M  V30 69 C 21.9039 8.0057 0.0 0
M  V30 70 C 24.2139 9.3394 0.0 0
M  V30 71 C 23.4439 8.0057 0.0 0
M  V30 72 N 23.4439 5.3384 0.0 0
M  V30 73 C 24.0702 3.9315 0.0 0 CFG=2
M  V30 74 C 21.9124 5.1774 0.0 0
M  V30 75 C 22.9258 2.9011 0.0 0
M  V30 76 C 21.5922 3.6711 0.0 0
M  V30 77 C 33.4540 12.0069 0.0 0
M  V30 78 C 34.9940 12.0069 0.0 0
M  V30 79 N 32.6840 13.3405 0.0 0
M  V30 80 C 35.7640 13.3405 0.0 0
M  V30 81 C 33.4540 14.6741 0.0 0
M  V30 82 C 34.9940 14.6743 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 55
M  V30 3 1 1 61
M  V30 4 1 3 4
M  V30 5 1 3 56
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 59
M  V30 14 1 13 14
M  V30 15 1 13 60
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 66
M  V30 22 1 20 21
M  V30 23 1 62 20 CFG=1
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 23 27
M  V30 30 1 23 28
M  V30 31 2 29 65
M  V30 32 1 30 31
M  V30 33 1 30 67
M  V30 34 1 32 33
M  V30 35 1 32 70
M  V30 36 1 33 34
M  V30 37 2 33 35
M  V30 38 1 34 36
M  V30 39 1 36 37
M  V30 40 1 37 38
M  V30 41 1 38 39
M  V30 42 1 39 77
M  V30 43 2 40 41
M  V30 44 1 40 71
M  V30 45 1 40 72
M  V30 46 1 42 43
M  V30 47 1 73 42 CFG=3
M  V30 48 1 43 44
M  V30 49 1 44 45
M  V30 50 1 44 46
M  V30 51 1 44 47
M  V30 52 1 45 48
M  V30 53 1 45 49
M  V30 54 1 45 50
M  V30 55 2 51 76
M  V30 56 2 52 53
M  V30 57 2 52 54
M  V30 58 1 52 82
M  V30 59 2 55 56
M  V30 60 1 55 57
M  V30 61 1 56 58
M  V30 62 2 57 59
M  V30 63 2 58 60
M  V30 64 1 59 60
M  V30 65 1 61 62
M  V30 66 1 61 63
M  V30 67 1 62 64
M  V30 68 1 63 65
M  V30 69 1 64 65
M  V30 70 2 66 67
M  V30 71 1 66 68
M  V30 72 1 67 69
M  V30 73 2 68 70
M  V30 74 2 69 71
M  V30 75 1 70 71
M  V30 76 1 72 73
M  V30 77 1 72 74
M  V30 78 1 73 75
M  V30 79 1 74 76
M  V30 80 1 75 76
M  V30 81 2 77 78
M  V30 82 1 77 79
M  V30 83 1 78 80
M  V30 84 2 79 81
M  V30 85 2 80 82
M  V30 86 1 81 82
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 62 73)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[(1-Methylethyl)dithio]ethyl N-[5-[[5-[5-[[(1,1-dimethylethoxy)carbonyl]ami...
C56H90N4O12S2Si2
2187376-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  76 79 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0437 13.3406 0.0 0
M  V30 2 O 7.2737 14.6742 0.0 0
M  V30 3 N 9.5837 16.0078 0.0 0
M  V30 4 C 10.3537 17.3415 0.0 0
M  V30 5 O 9.5837 18.6753 0.0 0
M  V30 6 O 11.8937 17.3415 0.0 0
M  V30 7 C 10.3537 20.0089 0.0 0
M  V30 8 C 9.0201 20.7789 0.0 0
M  V30 9 C 11.1237 21.3426 0.0 0
M  V30 10 C 11.6874 19.2389 0.0 0
M  V30 11 O 12.6637 10.6731 0.0 0
M  V30 12 C 11.8937 9.3395 0.0 0
M  V30 13 O 14.2037 13.3404 0.0 0
M  V30 14 C 14.9737 12.0068 0.0 0
M  V30 15 C 16.5137 12.0068 0.0 0
M  V30 16 C 17.2837 13.3404 0.0 0
M  V30 17 C 18.8237 13.3404 0.0 0
M  V30 18 C 19.5937 12.0068 0.0 0
M  V30 19 O 21.1337 12.0068 0.0 0
M  V30 20 C 4.7118 12.9902 0.0 0
M  V30 21 O 3.2054 12.6700 0.0 0
M  V30 22 Si 2.1749 13.8146 0.0 0
M  V30 23 C 1.1444 14.9589 0.0 0
M  V30 24 C 1.0304 12.7840 0.0 0
M  V30 25 C 3.3193 14.8450 0.0 0
M  V30 26 C 2.2889 15.9895 0.0 0
M  V30 27 C 0.1140 16.1035 0.0 0
M  V30 28 C 0.0000 13.9285 0.0 0
M  V30 29 C 6.9166 8.0379 0.0 0
M  V30 30 O 19.5937 9.3395 0.0 0
M  V30 31 C 18.8237 8.0057 0.0 0
M  V30 32 N 25.7537 9.3395 0.0 0
M  V30 33 C 26.5237 10.6731 0.0 0
M  V30 34 O 28.0637 10.6731 0.0 0
M  V30 35 O 25.7537 12.0068 0.0 0
M  V30 36 C 28.8337 12.0068 0.0 0
M  V30 37 C 30.3737 12.0068 0.0 0
M  V30 38 S 31.1437 13.3404 0.0 0
M  V30 39 S 32.6837 13.3404 0.0 0
M  V30 40 C 33.4537 14.6742 0.0 0
M  V30 41 C 34.9937 14.6742 0.0 0
M  V30 42 C 32.6837 16.0078 0.0 0
M  V30 43 C 24.2137 6.6721 0.0 0
M  V30 44 O 25.7537 6.6721 0.0 0
M  V30 45 C 25.5765 3.6113 0.0 0
M  V30 46 O 26.0523 2.1468 0.0 0
M  V30 47 Si 27.5586 1.8266 0.0 0
M  V30 48 C 29.0650 1.5063 0.0 0
M  V30 49 C 27.2384 0.3202 0.0 0
M  V30 50 C 27.8789 3.3329 0.0 0
M  V30 51 C 29.3852 3.0127 0.0 0
M  V30 52 C 30.5713 1.1861 0.0 0
M  V30 53 C 28.7449 0.0000 0.0 0
M  V30 54 C 20.1851 3.0447 0.0 0
M  V30 55 C 9.5837 13.3404 0.0 0
M  V30 56 C 10.3537 14.6742 0.0 0
M  V30 57 C 10.3537 12.0068 0.0 0
M  V30 58 C 11.8937 14.6742 0.0 0
M  V30 59 C 11.8937 12.0068 0.0 0
M  V30 60 C 12.6637 13.3404 0.0 0
M  V30 61 N 7.2737 12.0068 0.0 0
M  V30 62 C 5.7422 11.8458 0.0 0 CFG=2
M  V30 63 C 7.9000 10.6000 0.0 0
M  V30 64 C 5.4220 10.3396 0.0 0
M  V30 65 C 6.7557 9.5694 0.0 0
M  V30 66 C 21.9037 10.6731 0.0 0
M  V30 67 C 21.1337 9.3395 0.0 0
M  V30 68 C 23.4437 10.6731 0.0 0
M  V30 69 C 21.9037 8.0057 0.0 0
M  V30 70 C 24.2137 9.3395 0.0 0
M  V30 71 C 23.4437 8.0057 0.0 0
M  V30 72 N 23.4437 5.3384 0.0 0
M  V30 73 C 24.0700 3.9315 0.0 0 CFG=2
M  V30 74 C 21.9122 5.1775 0.0 0
M  V30 75 C 22.9257 2.9011 0.0 0
M  V30 76 C 21.5920 3.6711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 55
M  V30 3 1 1 61
M  V30 4 1 3 4
M  V30 5 1 3 56
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 59
M  V30 14 1 13 14
M  V30 15 1 13 60
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 66
M  V30 22 1 20 21
M  V30 23 1 62 20 CFG=1
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 23 27
M  V30 30 1 23 28
M  V30 31 2 29 65
M  V30 32 1 30 31
M  V30 33 1 30 67
M  V30 34 1 32 33
M  V30 35 1 32 70
M  V30 36 1 33 34
M  V30 37 2 33 35
M  V30 38 1 34 36
M  V30 39 1 36 37
M  V30 40 1 37 38
M  V30 41 1 38 39
M  V30 42 1 39 40
M  V30 43 1 40 41
M  V30 44 1 40 42
M  V30 45 2 43 44
M  V30 46 1 43 71
M  V30 47 1 43 72
M  V30 48 1 45 46
M  V30 49 1 73 45 CFG=3
M  V30 50 1 46 47
M  V30 51 1 47 48
M  V30 52 1 47 49
M  V30 53 1 47 50
M  V30 54 1 48 51
M  V30 55 1 48 52
M  V30 56 1 48 53
M  V30 57 2 54 76
M  V30 58 2 55 56
M  V30 59 1 55 57
M  V30 60 1 56 58
M  V30 61 2 57 59
M  V30 62 2 58 60
M  V30 63 1 59 60
M  V30 64 1 61 62
M  V30 65 1 61 63
M  V30 66 1 62 64
M  V30 67 1 63 65
M  V30 68 1 64 65
M  V30 69 2 66 67
M  V30 70 1 66 68
M  V30 71 1 67 69
M  V30 72 2 68 70
M  V30 73 2 69 71
M  V30 74 1 70 71
M  V30 75 1 72 73
M  V30 76 1 72 74
M  V30 77 1 73 75
M  V30 78 1 74 76
M  V30 79 1 75 76
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 62 73)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1887238-60-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2187376-13-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28283543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1313-13-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic cleavage of disulfide bonds in small molecules and linkers of
antibody-drug conjugates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Donglu; Fourie-O'Donohue, Aimee; Dragovich, Peter S.; Pillow,
Thomas H.; Sadowsky, Jack D.; Kozak, Katherine R.; Cass, Robert T.; Liu,
Liling; Deng, Yuzhong; Liu, Yichin; Hop, Cornelis E. C. A.; Khojasteh, S.
Cyrus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Drug Metabolism & Disposition (2019), 47(10), 1156-1173

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(5-Nitro-2-pyridinyl)dithio]ethyl N-[5-[[5-[5-[[(1,1-dimethylethoxy)carbon...
C58H86N6O14S2Si2
1887238-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  82 86 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0438 16.0080 0.0 0
M  V30 2 O 7.2738 17.3416 0.0 0
M  V30 3 N 9.5838 18.6753 0.0 0
M  V30 4 C 10.3538 20.0089 0.0 0
M  V30 5 O 9.5838 21.3427 0.0 0
M  V30 6 O 11.8938 20.0089 0.0 0
M  V30 7 C 10.3538 22.6764 0.0 0
M  V30 8 C 9.0202 23.4464 0.0 0
M  V30 9 C 11.1238 24.0100 0.0 0
M  V30 10 C 11.6875 21.9063 0.0 0
M  V30 11 O 12.6638 13.3405 0.0 0
M  V30 12 C 11.8938 12.0069 0.0 0
M  V30 13 O 14.2038 16.0080 0.0 0
M  V30 14 C 14.9738 14.6741 0.0 0
M  V30 15 C 16.5138 14.6741 0.0 0
M  V30 16 C 17.2839 13.3405 0.0 0
M  V30 17 C 18.8239 13.3405 0.0 0
M  V30 18 C 19.5939 12.0069 0.0 0
M  V30 19 O 21.1339 12.0069 0.0 0
M  V30 20 C 4.7118 15.6578 0.0 0
M  V30 21 O 3.2054 15.3376 0.0 0
M  V30 22 Si 2.1750 16.4820 0.0 0
M  V30 23 C 1.1444 17.6264 0.0 0
M  V30 24 C 3.3193 17.5124 0.0 0
M  V30 25 C 1.0304 15.4515 0.0 0
M  V30 26 C 0.0000 16.5959 0.0 0
M  V30 27 C 0.1140 18.7709 0.0 0
M  V30 28 C 2.2889 18.6569 0.0 0
M  V30 29 C 6.9167 10.7052 0.0 0
M  V30 30 O 19.5939 9.3394 0.0 0
M  V30 31 C 18.8239 8.0057 0.0 0
M  V30 32 N 25.7539 9.3394 0.0 0
M  V30 33 C 26.5239 10.6732 0.0 0
M  V30 34 O 28.0639 10.6732 0.0 0
M  V30 35 O 25.7539 12.0069 0.0 0
M  V30 36 C 28.8339 12.0069 0.0 0
M  V30 37 C 30.3739 12.0069 0.0 0
M  V30 38 S 31.1440 10.6732 0.0 0
M  V30 39 S 32.6840 10.6732 0.0 0
M  V30 40 C 24.2139 6.6721 0.0 0
M  V30 41 O 25.7539 6.6721 0.0 0
M  V30 42 C 25.5767 3.6113 0.0 0
M  V30 43 O 26.0525 2.1466 0.0 0
M  V30 44 Si 27.5590 1.8265 0.0 0
M  V30 45 C 29.0652 1.5063 0.0 0
M  V30 46 C 27.2386 0.3202 0.0 0
M  V30 47 C 27.8791 3.3329 0.0 0
M  V30 48 C 28.7451 0.0000 0.0 0
M  V30 49 C 30.5717 1.1861 0.0 0
M  V30 50 C 29.3854 3.0127 0.0 0
M  V30 51 C 20.1852 3.0446 0.0 0
M  V30 52 N 35.7640 16.0080 0.0 0 VAL=5
M  V30 53 O 34.9940 17.3416 0.0 0
M  V30 54 O 37.3040 16.0080 0.0 0
M  V30 55 C 9.5838 16.0080 0.0 0
M  V30 56 C 10.3538 17.3416 0.0 0
M  V30 57 C 10.3538 14.6741 0.0 0
M  V30 58 C 11.8938 17.3416 0.0 0
M  V30 59 C 11.8938 14.6741 0.0 0
M  V30 60 C 12.6638 16.0080 0.0 0
M  V30 61 N 7.2738 14.6741 0.0 0
M  V30 62 C 5.7422 14.5132 0.0 0 CFG=2
M  V30 63 C 7.9001 13.2673 0.0 0
M  V30 64 C 5.4221 13.0069 0.0 0
M  V30 65 C 6.7557 12.2369 0.0 0
M  V30 66 C 21.9039 10.6732 0.0 0
M  V30 67 C 21.1339 9.3394 0.0 0
M  V30 68 C 23.4439 10.6732 0.0 0
M  V30 69 C 21.9039 8.0057 0.0 0
M  V30 70 C 24.2139 9.3394 0.0 0
M  V30 71 C 23.4439 8.0057 0.0 0
M  V30 72 N 23.4439 5.3384 0.0 0
M  V30 73 C 24.0702 3.9315 0.0 0 CFG=2
M  V30 74 C 21.9124 5.1774 0.0 0
M  V30 75 C 22.9258 2.9011 0.0 0
M  V30 76 C 21.5922 3.6711 0.0 0
M  V30 77 C 33.4540 12.0069 0.0 0
M  V30 78 C 34.9940 12.0069 0.0 0
M  V30 79 N 32.6840 13.3405 0.0 0
M  V30 80 C 35.7640 13.3405 0.0 0
M  V30 81 C 33.4540 14.6741 0.0 0
M  V30 82 C 34.9940 14.6743 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 55
M  V30 3 1 1 61
M  V30 4 1 3 4
M  V30 5 1 3 56
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 59
M  V30 14 1 13 14
M  V30 15 1 13 60
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 66
M  V30 22 1 20 21
M  V30 23 1 62 20 CFG=1
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 23 27
M  V30 30 1 23 28
M  V30 31 2 29 65
M  V30 32 1 30 31
M  V30 33 1 30 67
M  V30 34 1 32 33
M  V30 35 1 32 70
M  V30 36 1 33 34
M  V30 37 2 33 35
M  V30 38 1 34 36
M  V30 39 1 36 37
M  V30 40 1 37 38
M  V30 41 1 38 39
M  V30 42 1 39 77
M  V30 43 2 40 41
M  V30 44 1 40 71
M  V30 45 1 40 72
M  V30 46 1 42 43
M  V30 47 1 73 42 CFG=3
M  V30 48 1 43 44
M  V30 49 1 44 45
M  V30 50 1 44 46
M  V30 51 1 44 47
M  V30 52 1 45 48
M  V30 53 1 45 49
M  V30 54 1 45 50
M  V30 55 2 51 76
M  V30 56 2 52 53
M  V30 57 2 52 54
M  V30 58 1 52 82
M  V30 59 2 55 56
M  V30 60 1 55 57
M  V30 61 1 56 58
M  V30 62 2 57 59
M  V30 63 2 58 60
M  V30 64 1 59 60
M  V30 65 1 61 62
M  V30 66 1 61 63
M  V30 67 1 62 64
M  V30 68 1 63 65
M  V30 69 1 64 65
M  V30 70 2 66 67
M  V30 71 1 66 68
M  V30 72 1 67 69
M  V30 73 2 68 70
M  V30 74 2 69 71
M  V30 75 1 70 71
M  V30 76 1 72 73
M  V30 77 1 72 74
M  V30 78 1 73 75
M  V30 79 1 74 76
M  V30 80 1 75 76
M  V30 81 2 77 78
M  V30 82 1 77 79
M  V30 83 1 78 80
M  V30 84 2 79 81
M  V30 85 2 80 82
M  V30 86 1 81 82
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 62 73)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[(1-Methylethyl)dithio]ethyl N-[5-[[5-[5-[[(1,1-dimethylethoxy)carbonyl]ami...
C56H90N4O12S2Si2
2187376-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  76 79 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0437 13.3406 0.0 0
M  V30 2 O 7.2737 14.6742 0.0 0
M  V30 3 N 9.5837 16.0078 0.0 0
M  V30 4 C 10.3537 17.3415 0.0 0
M  V30 5 O 9.5837 18.6753 0.0 0
M  V30 6 O 11.8937 17.3415 0.0 0
M  V30 7 C 10.3537 20.0089 0.0 0
M  V30 8 C 9.0201 20.7789 0.0 0
M  V30 9 C 11.1237 21.3426 0.0 0
M  V30 10 C 11.6874 19.2389 0.0 0
M  V30 11 O 12.6637 10.6731 0.0 0
M  V30 12 C 11.8937 9.3395 0.0 0
M  V30 13 O 14.2037 13.3404 0.0 0
M  V30 14 C 14.9737 12.0068 0.0 0
M  V30 15 C 16.5137 12.0068 0.0 0
M  V30 16 C 17.2837 13.3404 0.0 0
M  V30 17 C 18.8237 13.3404 0.0 0
M  V30 18 C 19.5937 12.0068 0.0 0
M  V30 19 O 21.1337 12.0068 0.0 0
M  V30 20 C 4.7118 12.9902 0.0 0
M  V30 21 O 3.2054 12.6700 0.0 0
M  V30 22 Si 2.1749 13.8146 0.0 0
M  V30 23 C 1.1444 14.9589 0.0 0
M  V30 24 C 1.0304 12.7840 0.0 0
M  V30 25 C 3.3193 14.8450 0.0 0
M  V30 26 C 2.2889 15.9895 0.0 0
M  V30 27 C 0.1140 16.1035 0.0 0
M  V30 28 C 0.0000 13.9285 0.0 0
M  V30 29 C 6.9166 8.0379 0.0 0
M  V30 30 O 19.5937 9.3395 0.0 0
M  V30 31 C 18.8237 8.0057 0.0 0
M  V30 32 N 25.7537 9.3395 0.0 0
M  V30 33 C 26.5237 10.6731 0.0 0
M  V30 34 O 28.0637 10.6731 0.0 0
M  V30 35 O 25.7537 12.0068 0.0 0
M  V30 36 C 28.8337 12.0068 0.0 0
M  V30 37 C 30.3737 12.0068 0.0 0
M  V30 38 S 31.1437 13.3404 0.0 0
M  V30 39 S 32.6837 13.3404 0.0 0
M  V30 40 C 33.4537 14.6742 0.0 0
M  V30 41 C 34.9937 14.6742 0.0 0
M  V30 42 C 32.6837 16.0078 0.0 0
M  V30 43 C 24.2137 6.6721 0.0 0
M  V30 44 O 25.7537 6.6721 0.0 0
M  V30 45 C 25.5765 3.6113 0.0 0
M  V30 46 O 26.0523 2.1468 0.0 0
M  V30 47 Si 27.5586 1.8266 0.0 0
M  V30 48 C 29.0650 1.5063 0.0 0
M  V30 49 C 27.2384 0.3202 0.0 0
M  V30 50 C 27.8789 3.3329 0.0 0
M  V30 51 C 29.3852 3.0127 0.0 0
M  V30 52 C 30.5713 1.1861 0.0 0
M  V30 53 C 28.7449 0.0000 0.0 0
M  V30 54 C 20.1851 3.0447 0.0 0
M  V30 55 C 9.5837 13.3404 0.0 0
M  V30 56 C 10.3537 14.6742 0.0 0
M  V30 57 C 10.3537 12.0068 0.0 0
M  V30 58 C 11.8937 14.6742 0.0 0
M  V30 59 C 11.8937 12.0068 0.0 0
M  V30 60 C 12.6637 13.3404 0.0 0
M  V30 61 N 7.2737 12.0068 0.0 0
M  V30 62 C 5.7422 11.8458 0.0 0 CFG=2
M  V30 63 C 7.9000 10.6000 0.0 0
M  V30 64 C 5.4220 10.3396 0.0 0
M  V30 65 C 6.7557 9.5694 0.0 0
M  V30 66 C 21.9037 10.6731 0.0 0
M  V30 67 C 21.1337 9.3395 0.0 0
M  V30 68 C 23.4437 10.6731 0.0 0
M  V30 69 C 21.9037 8.0057 0.0 0
M  V30 70 C 24.2137 9.3395 0.0 0
M  V30 71 C 23.4437 8.0057 0.0 0
M  V30 72 N 23.4437 5.3384 0.0 0
M  V30 73 C 24.0700 3.9315 0.0 0 CFG=2
M  V30 74 C 21.9122 5.1775 0.0 0
M  V30 75 C 22.9257 2.9011 0.0 0
M  V30 76 C 21.5920 3.6711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 55
M  V30 3 1 1 61
M  V30 4 1 3 4
M  V30 5 1 3 56
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 59
M  V30 14 1 13 14
M  V30 15 1 13 60
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 19 66
M  V30 22 1 20 21
M  V30 23 1 62 20 CFG=1
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 23 27
M  V30 30 1 23 28
M  V30 31 2 29 65
M  V30 32 1 30 31
M  V30 33 1 30 67
M  V30 34 1 32 33
M  V30 35 1 32 70
M  V30 36 1 33 34
M  V30 37 2 33 35
M  V30 38 1 34 36
M  V30 39 1 36 37
M  V30 40 1 37 38
M  V30 41 1 38 39
M  V30 42 1 39 40
M  V30 43 1 40 41
M  V30 44 1 40 42
M  V30 45 2 43 44
M  V30 46 1 43 71
M  V30 47 1 43 72
M  V30 48 1 45 46
M  V30 49 1 73 45 CFG=3
M  V30 50 1 46 47
M  V30 51 1 47 48
M  V30 52 1 47 49
M  V30 53 1 47 50
M  V30 54 1 48 51
M  V30 55 1 48 52
M  V30 56 1 48 53
M  V30 57 2 54 76
M  V30 58 2 55 56
M  V30 59 1 55 57
M  V30 60 1 56 58
M  V30 61 2 57 59
M  V30 62 2 58 60
M  V30 63 1 59 60
M  V30 64 1 61 62
M  V30 65 1 61 63
M  V30 66 1 62 64
M  V30 67 1 63 65
M  V30 68 1 64 65
M  V30 69 2 66 67
M  V30 70 1 66 68
M  V30 71 1 67 69
M  V30 72 2 68 70
M  V30 73 2 69 71
M  V30 74 1 70 71
M  V30 75 1 72 73
M  V30 76 1 72 74
M  V30 77 1 73 75
M  V30 78 1 74 76
M  V30 79 1 75 76
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 62 73)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1887238-60-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2187376-13-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29511913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1313-13-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolobenzodiazepine prodrugs and antibody conjugates
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dragovich, Peter; Pei, Zhonghua; Pillow, Thomas; Sadowsky, Jack; Verma,
Vishal; Zhang, Donglu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018031662 A1 2018-02-15

$RFMT $RIREG SCHEME136 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Chlorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-[(2-methylpr...
C23H28ClNO4S2
951644-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 O 9.2400 8.2084 0.0 0
M  V30 3 O 9.2400 5.1284 0.0 0
M  V30 4 S 3.0800 6.6684 0.0 0
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 C 0.7700 5.3347 0.0 0
M  V30 7 C 0.0000 6.6684 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 O 3.0800 9.3358 0.0 0
M  V30 11 O 5.3900 10.6694 0.0 0
M  V30 12 Cl 10.0100 0.0000 0.0 0
M  V30 13 C 15.4000 6.6684 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 N 7.7000 6.6684 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 19 C 5.3900 8.0021 0.0 0 CFG=1
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 7.7000 1.3336 0.0 0
M  V30 24 C 10.0100 2.6673 0.0 0
M  V30 25 C 9.2400 1.3336 0.0 0
M  V30 26 C 10.7800 6.6684 0.0 0
M  V30 27 C 11.5500 5.3347 0.0 0
M  V30 28 C 11.5500 8.0021 0.0 0
M  V30 29 C 13.0900 5.3347 0.0 0
M  V30 30 C 13.0900 8.0020 0.0 0
M  V30 31 C 13.8600 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 19 9 CFG=3
M  V30 13 1 12 25
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=3
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-00-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16090597
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C11E21, yield 95%. MW: 482.06
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME137 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Chlorophenyl)-4-[(3-methylbutyl)thio]-1-[(4-methylphenyl)...
C24H30ClNO4S2
951644-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 C 10.7800 9.3358 0.0 0
M  V30 5 O 12.3200 9.3358 0.0 0
M  V30 6 O 10.0100 10.6694 0.0 0
M  V30 7 S 12.3200 6.6684 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 C 14.6300 5.3347 0.0 0
M  V30 10 C 15.4000 4.0011 0.0 0
M  V30 11 C 16.9400 4.0011 0.0 0
M  V30 12 C 14.6300 2.6673 0.0 0
M  V30 13 Cl 5.3900 0.0000 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 N 7.7000 6.6684 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 20 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 6.1600 4.0011 0.0 0
M  V30 23 C 8.4700 2.6673 0.0 0
M  V30 24 C 5.3900 2.6673 0.0 0
M  V30 25 C 7.7000 1.3336 0.0 0
M  V30 26 C 6.1600 1.3336 0.0 0
M  V30 27 C 4.6200 6.6684 0.0 0
M  V30 28 C 3.8500 8.0021 0.0 0
M  V30 29 C 3.8500 5.3347 0.0 0
M  V30 30 C 2.3100 8.0021 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 26
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-40-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16090691
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C11E23, yield 95%. MW: 496.08
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME138 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Chlorophenyl)-4-(ethylthio)-1-[(4-methylphenyl)sulfonyl]-...
C21H24ClNO4S2
951643-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 6.6684 0.0 0 VAL=6
M  V30 2 O 8.4700 5.1284 0.0 0
M  V30 3 O 8.4700 8.2084 0.0 0
M  V30 4 C 3.8500 9.3358 0.0 0
M  V30 5 O 4.6200 10.6694 0.0 0
M  V30 6 O 2.3100 9.3358 0.0 0
M  V30 7 S 2.3100 6.6684 0.0 0
M  V30 8 C 1.5400 5.3347 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 Cl 9.2400 0.0000 0.0 0
M  V30 11 C 14.6300 6.6684 0.0 0
M  V30 12 N 6.9300 6.6684 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 14 C 6.1600 8.0021 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 4.6200 8.0021 0.0 0 CFG=1
M  V30 17 C 3.8500 6.6684 0.0 0 CFG=1
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 6.1600 2.6673 0.0 0
M  V30 21 C 9.2400 2.6673 0.0 0
M  V30 22 C 6.9300 1.3336 0.0 0
M  V30 23 C 8.4700 1.3336 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 25 C 10.7800 8.0021 0.0 0
M  V30 26 C 10.7800 5.3347 0.0 0
M  V30 27 C 12.3200 8.0021 0.0 0
M  V30 28 C 12.3200 5.3347 0.0 0
M  V30 29 C 13.0900 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 17 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 10 23
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 18 CFG=3
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-59-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16083563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C11E16, yield 95%. MW: 454.00
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME139 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Chlorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1-...
C22H24ClNO4S2
951645-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 C 10.7800 9.3358 0.0 0
M  V30 5 O 12.3200 9.3358 0.0 0
M  V30 6 O 10.0100 10.6694 0.0 0
M  V30 7 S 12.3200 6.6684 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 C 14.6300 5.3347 0.0 0
M  V30 10 C 15.4000 4.0011 0.0 0
M  V30 11 Cl 5.3900 0.0000 0.0 0
M  V30 12 C 0.0000 6.6684 0.0 0
M  V30 13 N 7.7000 6.6684 0.0 0
M  V30 14 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 15 C 8.4700 8.0021 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 18 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 6.1600 4.0011 0.0 0
M  V30 21 C 8.4700 2.6673 0.0 0
M  V30 22 C 5.3900 2.6673 0.0 0
M  V30 23 C 7.7000 1.3336 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 4.6200 6.6684 0.0 0
M  V30 26 C 3.8500 5.3347 0.0 0
M  V30 27 C 3.8500 8.0021 0.0 0
M  V30 28 C 2.3100 5.3347 0.0 0
M  V30 29 C 2.3100 8.0021 0.0 0
M  V30 30 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 18 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 24
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-26-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16088520
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C11E30, yield 95%. MW: 466.01
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME140 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(phenylmethylene)benzenesulfonamide
C14H13NO2S
51608-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 13.0900 2.6673 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 1.3336 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Methylphenyl)sulfonyl]-4-[(2-methylpropyl)thio]-6-phenyl...
C23H29NO4S2
951643-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 4.0011 0.0 0 VAL=6
M  V30 2 O 9.2400 2.4611 0.0 0
M  V30 3 O 9.2400 5.5411 0.0 0
M  V30 4 S 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 C 0.7700 5.3347 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 0.0000 6.6684 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 O 3.0800 1.3336 0.0 0
M  V30 11 O 5.3900 0.0000 0.0 0
M  V30 12 C 15.4000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 14 N 7.7000 4.0011 0.0 0
M  V30 15 C 5.3900 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 18 C 5.3900 2.6674 0.0 0 CFG=1
M  V30 19 C 7.7000 6.6684 0.0 0
M  V30 20 C 6.9300 8.0021 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 7.7000 9.3358 0.0 0
M  V30 23 C 10.0100 8.0021 0.0 0
M  V30 24 C 9.2400 9.3358 0.0 0
M  V30 25 C 10.7800 4.0011 0.0 0
M  V30 26 C 11.5500 5.3347 0.0 0
M  V30 27 C 11.5500 2.6674 0.0 0
M  V30 28 C 13.0900 5.3347 0.0 0
M  V30 29 C 13.0900 2.6674 0.0 0
M  V30 30 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 17 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 18 9 CFG=1
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19 CFG=1
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51608-60-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-94-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16091051
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C01E21, yield 95%. MW: 447.61
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME141 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methylphenyl)methylene]benzenesulfonamide
C14H13NO2S
664985-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 13.0900 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 2.3100 0.2062 0.0 0
M  V30 9 C 2.3100 2.8736 0.0 0
M  V30 10 C 0.7700 0.2062 0.0 0
M  V30 11 C 0.7700 2.8736 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 14 C 9.2400 1.5400 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methylphenyl)-4-[(2-methylpropyl)thio]-1-(phenylsulfonyl)...
C23H29NO4S2
951644-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 S 10.7800 6.6684 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 C 13.0900 5.3347 0.0 0
M  V30 7 C 13.8600 4.0011 0.0 0
M  V30 8 C 13.8600 6.6684 0.0 0
M  V30 9 C 9.2400 9.3358 0.0 0
M  V30 10 O 8.4700 10.6694 0.0 0
M  V30 11 O 10.7800 9.3358 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 14 N 6.1600 6.6684 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0
M  V30 16 C 6.9300 8.0021 0.0 0
M  V30 17 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 18 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 19 C 6.1600 4.0011 0.0 0
M  V30 20 C 6.9300 2.6673 0.0 0
M  V30 21 C 4.6200 4.0011 0.0 0
M  V30 22 C 6.1600 1.3336 0.0 0
M  V30 23 C 3.8500 2.6673 0.0 0
M  V30 24 C 4.6200 1.3336 0.0 0
M  V30 25 C 3.0800 6.6684 0.0 0
M  V30 26 C 2.3100 8.0021 0.0 0
M  V30 27 C 2.3100 5.3347 0.0 0
M  V30 28 C 0.7700 8.0020 0.0 0
M  V30 29 C 0.7700 5.3347 0.0 0
M  V30 30 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 17 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 18 9 CFG=1
M  V30 13 1 12 24
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19 CFG=1
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-98-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16084918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C43E21, yield 95%. MW: 447.61
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME142 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]benzenesulfonamide
C14H13NO3S
664985-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 O 13.0900 2.8736 0.0 0
M  V30 7 C 13.8600 4.2073 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 2.3100 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.7700 2.8736 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 9.2400 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 19 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methoxyphenyl)-4-[(2-methylpropyl)thio]-1-(phenylsulfonyl...
C23H29NO5S2
951644-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.0020 0.0 0 VAL=6
M  V30 2 O 4.6200 6.4620 0.0 0
M  V30 3 O 4.6200 9.5420 0.0 0
M  V30 4 S 10.7800 8.0020 0.0 0
M  V30 5 C 11.5500 6.6684 0.0 0
M  V30 6 C 13.0900 6.6684 0.0 0
M  V30 7 C 13.8600 5.3347 0.0 0
M  V30 8 C 13.8600 8.0020 0.0 0
M  V30 9 C 9.2400 10.6694 0.0 0
M  V30 10 O 8.4700 12.0031 0.0 0
M  V30 11 O 10.7800 10.6694 0.0 0
M  V30 12 O 3.8500 1.3336 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 15 N 6.1600 8.0020 0.0 0
M  V30 16 C 8.4700 6.6684 0.0 0
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 9.2400 8.0020 0.0 0 CFG=1
M  V30 19 C 8.4700 9.3358 0.0 0 CFG=1
M  V30 20 C 6.1600 5.3347 0.0 0
M  V30 21 C 4.6200 5.3347 0.0 0
M  V30 22 C 6.9300 4.0011 0.0 0
M  V30 23 C 3.8500 4.0011 0.0 0
M  V30 24 C 6.1600 2.6673 0.0 0
M  V30 25 C 4.6200 2.6673 0.0 0
M  V30 26 C 3.0800 8.0020 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 28 C 2.3100 6.6684 0.0 0
M  V30 29 C 0.7700 9.3358 0.0 0
M  V30 30 C 0.7700 6.6684 0.0 0
M  V30 31 C 0.0000 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 19 9 CFG=1
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-99-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16092687
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C35E21, yield 95%. MW: 463.61
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME143 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Methoxyphenyl)methylene]-4-methylbenzenesulfonamide
C15H15NO3S
863401-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 4.5648 1.7464 0.0 0
M  V30 4 O 6.1048 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 O 13.3370 3.0801 0.0 0
M  V30 8 C 14.6707 2.3101 0.0 0
M  V30 9 C 4.0010 3.8501 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0010 5.3901 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 2.6673 6.1601 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3358 0.7700 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 10.6697 0.0000 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Methoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-4-[(2-methylp...
C24H31NO5S2
951644-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 8.0020 0.0 0 VAL=6
M  V30 2 O 9.2400 9.5420 0.0 0
M  V30 3 O 9.2400 6.4620 0.0 0
M  V30 4 S 3.0800 8.0020 0.0 0
M  V30 5 C 2.3100 6.6684 0.0 0
M  V30 6 C 0.7700 6.6684 0.0 0
M  V30 7 C 0.0000 8.0020 0.0 0
M  V30 8 C 0.0000 5.3347 0.0 0
M  V30 9 C 4.6200 10.6694 0.0 0
M  V30 10 O 3.0800 10.6694 0.0 0
M  V30 11 O 5.3900 12.0031 0.0 0
M  V30 12 O 6.9300 1.3336 0.0 0
M  V30 13 C 7.7000 0.0000 0.0 0
M  V30 14 C 15.4000 8.0020 0.0 0
M  V30 15 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 16 N 7.7000 8.0020 0.0 0
M  V30 17 C 5.3900 6.6684 0.0 0
M  V30 18 C 6.9300 9.3358 0.0 0
M  V30 19 C 4.6200 8.0020 0.0 0 CFG=1
M  V30 20 C 5.3900 9.3358 0.0 0 CFG=1
M  V30 21 C 7.7000 5.3347 0.0 0
M  V30 22 C 6.9300 4.0011 0.0 0
M  V30 23 C 9.2400 5.3347 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 10.0100 4.0011 0.0 0
M  V30 26 C 9.2400 2.6673 0.0 0
M  V30 27 C 10.7800 8.0020 0.0 0
M  V30 28 C 11.5500 9.3358 0.0 0
M  V30 29 C 11.5500 6.6684 0.0 0
M  V30 30 C 13.0900 9.3358 0.0 0
M  V30 31 C 13.0900 6.6684 0.0 0
M  V30 32 C 13.8600 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 20 9 CFG=3
M  V30 13 1 12 13
M  V30 14 1 12 24
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21 CFG=3
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-18-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-09-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16086225
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C39E21, yield 95%. MW: 477.64
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME144 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
863401-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Chlorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-[(2-methylpr...
C23H28ClNO4S2
951644-01-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 O 9.2400 5.1284 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 S 3.0800 6.6684 0.0 0
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 C 0.7700 5.3347 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 0.0000 6.6684 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 O 5.3900 10.6694 0.0 0
M  V30 11 O 3.0800 9.3358 0.0 0
M  V30 12 Cl 6.9300 0.0000 0.0 0
M  V30 13 C 15.4000 6.6684 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 N 7.7000 6.6684 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 19 C 5.3900 8.0021 0.0 0 CFG=1
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 7.7000 1.3336 0.0 0
M  V30 24 C 10.0100 2.6673 0.0 0
M  V30 25 C 9.2400 1.3336 0.0 0
M  V30 26 C 10.7800 6.6684 0.0 0
M  V30 27 C 11.5500 8.0020 0.0 0
M  V30 28 C 11.5500 5.3347 0.0 0
M  V30 29 C 13.0900 8.0020 0.0 0
M  V30 30 C 13.0900 5.3347 0.0 0
M  V30 31 C 13.8600 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 19 9 CFG=3
M  V30 13 1 12 23
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=3
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-19-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-01-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16092099
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C12E21, yield 95%. MW: 482.06
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME145 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
863401-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Bromophenyl)-1-[(4-methylphenyl)sulfonyl]-4-[(2-methylpro...
C23H28BrNO4S2
951644-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 O 9.2400 5.1284 0.0 0
M  V30 3 O 9.2400 8.2084 0.0 0
M  V30 4 S 3.0800 6.6684 0.0 0
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 C 0.7700 5.3347 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 0.0000 6.6684 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 O 5.3900 10.6694 0.0 0
M  V30 11 O 3.0800 9.3358 0.0 0
M  V30 12 Br 6.9300 0.0000 0.0 0
M  V30 13 C 15.4000 6.6684 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 N 7.7000 6.6684 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 19 C 5.3900 8.0021 0.0 0 CFG=1
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 7.7000 1.3336 0.0 0
M  V30 24 C 10.0100 2.6673 0.0 0
M  V30 25 C 9.2400 1.3336 0.0 0
M  V30 26 C 10.7800 6.6684 0.0 0
M  V30 27 C 11.5500 8.0020 0.0 0
M  V30 28 C 11.5500 5.3347 0.0 0
M  V30 29 C 13.0900 8.0020 0.0 0
M  V30 30 C 13.0900 5.3347 0.0 0
M  V30 31 C 13.8600 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 19 9 CFG=3
M  V30 13 1 12 23
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=3
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-20-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-02-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16086664
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C15E21, yield 95%. MW: 526.51
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME146 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
865060-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Chlorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-[(2-methylpr...
C23H28ClNO4S2
951644-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 S 10.7800 6.6684 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 C 13.0900 5.3347 0.0 0
M  V30 7 C 13.8600 6.6684 0.0 0
M  V30 8 C 13.8600 4.0011 0.0 0
M  V30 9 C 9.2400 9.3358 0.0 0
M  V30 10 O 8.4700 10.6694 0.0 0
M  V30 11 O 10.7800 9.3358 0.0 0
M  V30 12 C 3.0800 9.3358 0.0 0
M  V30 13 Cl 3.8500 0.0000 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 N 6.1600 6.6684 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 19 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 20 C 6.1600 4.0011 0.0 0
M  V30 21 C 4.6200 4.0011 0.0 0
M  V30 22 C 6.9300 2.6673 0.0 0
M  V30 23 C 3.8500 2.6673 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 4.6200 1.3336 0.0 0
M  V30 26 C 3.0800 6.6684 0.0 0
M  V30 27 C 2.3100 8.0021 0.0 0
M  V30 28 C 2.3100 5.3347 0.0 0
M  V30 29 C 0.7700 8.0020 0.0 0
M  V30 30 C 0.7700 5.3347 0.0 0
M  V30 31 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 19 9 CFG=1
M  V30 13 1 12 27
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865060-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16087749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C40E21, yield 95%. MW: 482.06
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME147 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Ethylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-[(2-methylpro...
C25H33NO4S2
951643-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 8.0020 0.0 0 VAL=6
M  V30 2 O 9.2400 6.4620 0.0 0
M  V30 3 O 9.2400 9.5420 0.0 0
M  V30 4 C 4.6200 10.6694 0.0 0
M  V30 5 O 3.0800 10.6694 0.0 0
M  V30 6 O 5.3900 12.0031 0.0 0
M  V30 7 S 3.0800 8.0020 0.0 0
M  V30 8 C 2.3100 6.6684 0.0 0
M  V30 9 C 0.7700 6.6684 0.0 0
M  V30 10 C 0.0000 5.3347 0.0 0
M  V30 11 C 0.0000 8.0020 0.0 0
M  V30 12 C 10.0100 1.3336 0.0 0
M  V30 13 C 9.2400 0.0000 0.0 0
M  V30 14 C 15.4000 8.0020 0.0 0
M  V30 15 N 7.7000 8.0020 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 5.3900 6.6684 0.0 0
M  V30 19 C 5.3900 9.3358 0.0 0 CFG=1
M  V30 20 C 4.6200 8.0020 0.0 0 CFG=1
M  V30 21 C 7.7000 5.3347 0.0 0
M  V30 22 C 9.2400 5.3347 0.0 0
M  V30 23 C 6.9300 4.0011 0.0 0
M  V30 24 C 10.0100 4.0011 0.0 0
M  V30 25 C 7.7000 2.6673 0.0 0
M  V30 26 C 9.2400 2.6673 0.0 0
M  V30 27 C 10.7800 8.0020 0.0 0
M  V30 28 C 11.5500 9.3358 0.0 0
M  V30 29 C 11.5500 6.6684 0.0 0
M  V30 30 C 13.0900 9.3358 0.0 0
M  V30 31 C 13.0900 6.6684 0.0 0
M  V30 32 C 13.8600 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16083061
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C03E21, yield 95%. MW: 475.66
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME148 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Ethoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-4-[(2-methylpr...
C25H33NO5S2
951643-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 9.3358 0.0 0 VAL=6
M  V30 2 O 9.2400 7.7958 0.0 0
M  V30 3 O 9.2400 10.8758 0.0 0
M  V30 4 C 4.6200 12.0031 0.0 0
M  V30 5 O 5.3900 13.3367 0.0 0
M  V30 6 O 3.0800 12.0031 0.0 0
M  V30 7 S 3.0800 9.3358 0.0 0
M  V30 8 C 2.3100 8.0020 0.0 0
M  V30 9 C 0.7700 8.0020 0.0 0
M  V30 10 C 0.0000 6.6684 0.0 0
M  V30 11 C 0.0000 9.3358 0.0 0
M  V30 12 O 10.0100 2.6673 0.0 0
M  V30 13 C 9.2400 1.3336 0.0 0
M  V30 14 C 10.0100 0.0000 0.0 0
M  V30 15 C 15.4000 9.3358 0.0 0
M  V30 16 N 7.7000 9.3358 0.0 0
M  V30 17 C 6.9300 8.0020 0.0 0 CFG=2
M  V30 18 C 6.9300 10.6694 0.0 0
M  V30 19 C 5.3900 8.0020 0.0 0
M  V30 20 C 5.3900 10.6694 0.0 0 CFG=1
M  V30 21 C 4.6200 9.3358 0.0 0 CFG=1
M  V30 22 C 7.7000 6.6684 0.0 0
M  V30 23 C 6.9300 5.3347 0.0 0
M  V30 24 C 9.2400 6.6684 0.0 0
M  V30 25 C 7.7000 4.0009 0.0 0
M  V30 26 C 10.0100 5.3347 0.0 0
M  V30 27 C 9.2400 4.0009 0.0 0
M  V30 28 C 10.7800 9.3358 0.0 0
M  V30 29 C 11.5500 10.6694 0.0 0
M  V30 30 C 11.5500 8.0020 0.0 0
M  V30 31 C 13.0900 10.6694 0.0 0
M  V30 32 C 13.0900 8.0020 0.0 0
M  V30 33 C 13.8600 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 15 33
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16086064
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C05E21, yield 95%. MW: 491.66
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME149 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 N 5.3900 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 13.0900 4.0009 0.0 0
M  V30 7 F 3.0800 0.0000 0.0 0
M  V30 8 C 8.4700 4.0009 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 9.2400 2.6673 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 10.7800 2.6673 0.0 0
M  V30 13 C 11.5500 4.0009 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 C 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0009 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(2-Fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-[(2-methylpr...
C23H28FNO4S2
951643-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 4.0011 0.0 0 VAL=6
M  V30 2 O 9.2400 2.4611 0.0 0
M  V30 3 O 9.2400 5.5411 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 O 3.0800 1.3336 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 F 5.3900 8.0021 0.0 0
M  V30 8 S 3.0800 4.0011 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 C 0.0000 6.6684 0.0 0
M  V30 13 C 15.4000 4.0011 0.0 0
M  V30 14 N 7.7000 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 5.3900 5.3347 0.0 0
M  V30 18 C 5.3900 2.6674 0.0 0 CFG=1
M  V30 19 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 20 C 7.7000 6.6684 0.0 0
M  V30 21 C 6.9300 8.0021 0.0 0
M  V30 22 C 9.2400 6.6684 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 10.0100 8.0021 0.0 0
M  V30 25 C 9.2400 9.3358 0.0 0
M  V30 26 C 10.7800 4.0011 0.0 0
M  V30 27 C 11.5500 5.3347 0.0 0
M  V30 28 C 11.5500 2.6674 0.0 0
M  V30 29 C 13.0900 5.3347 0.0 0
M  V30 30 C 13.0900 2.6674 0.0 0
M  V30 31 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 1 19 8 CFG=3
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 20 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-62-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-99-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16075988
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C10E21, yield 95%. MW: 465.6
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME150 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3,4,5-trimethoxyphenyl)methylene]benzenesulfonamide
C17H19NO5S
951762-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 2.6674 0.0 0
M  V30 3 O 2.3100 6.6685 0.0 0
M  V30 4 C 3.0800 8.0021 0.0 0
M  V30 5 O 2.3100 1.3336 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 N 7.7000 5.3347 0.0 0
M  V30 9 S 9.2400 5.3347 0.0 0 VAL=6
M  V30 10 O 9.2400 3.7947 0.0 0
M  V30 11 O 9.2400 6.8747 0.0 0
M  V30 12 C 15.4000 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 3.0800 2.6674 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 5.3900 4.0011 0.0 0
M  V30 19 C 10.7800 5.3347 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 11.5500 4.0011 0.0 0
M  V30 22 C 13.0900 6.6685 0.0 0
M  V30 23 C 13.0900 4.0011 0.0 0
M  V30 24 C 13.8600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 19
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Methylphenyl)sulfonyl]-4-[(2-methylpropyl)thio]-6-(3,4,5...
C26H35NO7S2
951644-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 6.4620 0.0 0
M  V30 3 O 6.1600 9.5420 0.0 0
M  V30 4 S 12.3200 8.0020 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 14.6300 6.6684 0.0 0
M  V30 7 C 15.4000 5.3347 0.0 0
M  V30 8 C 15.4000 8.0020 0.0 0
M  V30 9 C 10.7800 10.6694 0.0 0
M  V30 10 O 10.0100 12.0031 0.0 0
M  V30 11 O 12.3200 10.6694 0.0 0
M  V30 12 O 8.4700 1.3336 0.0 0
M  V30 13 C 10.0100 1.3336 0.0 0
M  V30 14 O 3.8500 4.0011 0.0 0
M  V30 15 C 3.0800 2.6673 0.0 0
M  V30 16 O 5.3900 1.3336 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 18 C 0.0000 8.0020 0.0 0
M  V30 19 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 20 N 7.7000 8.0020 0.0 0
M  V30 21 C 10.0100 6.6684 0.0 0
M  V30 22 C 8.4700 9.3358 0.0 0
M  V30 23 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 24 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 25 C 7.7000 5.3347 0.0 0
M  V30 26 C 8.4700 4.0011 0.0 0
M  V30 27 C 6.1600 5.3347 0.0 0
M  V30 28 C 7.7000 2.6673 0.0 0
M  V30 29 C 5.3900 4.0011 0.0 0
M  V30 30 C 6.1600 2.6673 0.0 0
M  V30 31 C 4.6200 8.0020 0.0 0
M  V30 32 C 3.8500 6.6684 0.0 0
M  V30 33 C 3.8500 9.3358 0.0 0
M  V30 34 C 2.3100 6.6684 0.0 0
M  V30 35 C 2.3100 9.3358 0.0 0
M  V30 36 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 1 23 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 24 9 CFG=1
M  V30 13 1 12 13
M  V30 14 1 12 28
M  V30 15 1 14 15
M  V30 16 1 14 29
M  V30 17 1 16 17
M  V30 18 1 16 30
M  V30 19 1 18 36
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 25 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 19 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-67-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16089690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C25E21, yield 95%. MW: 537.69
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME151 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Chlorophenyl)sulfonyl]-6-(4-methylphenyl)-4-[(2-methylpr...
C23H28ClNO4S2
951644-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 6.6684 0.0 0 VAL=6
M  V30 2 O 9.2400 8.2084 0.0 0
M  V30 3 O 9.2400 5.1284 0.0 0
M  V30 4 S 3.0800 6.6684 0.0 0
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 C 0.7700 5.3347 0.0 0
M  V30 7 C 0.0000 6.6684 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 O 3.0800 9.3358 0.0 0
M  V30 11 O 5.3900 10.6694 0.0 0
M  V30 12 C 10.0100 0.0000 0.0 0
M  V30 13 Cl 15.4000 6.6684 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 N 7.7000 6.6684 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 19 C 5.3900 8.0021 0.0 0 CFG=1
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 7.7000 1.3336 0.0 0
M  V30 24 C 10.0100 2.6673 0.0 0
M  V30 25 C 9.2400 1.3336 0.0 0
M  V30 26 C 10.7800 6.6684 0.0 0
M  V30 27 C 11.5500 5.3347 0.0 0
M  V30 28 C 11.5500 8.0021 0.0 0
M  V30 29 C 13.0900 5.3347 0.0 0
M  V30 30 C 13.0900 8.0020 0.0 0
M  V30 31 C 13.8600 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 19 9 CFG=3
M  V30 13 1 12 25
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=3
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-72-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-05-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16091218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C30E21, yield 95%. MW: 482.06
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME152 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methoxyphenyl)methylene]benzenesulfonamide
C14H12ClNO3S
951762-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 0.2062 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 2.3100 0.2062 0.0 0
M  V30 13 C 2.3100 2.8736 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 4.2073 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 12.3200 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Chlorophenyl)sulfonyl]-6-(4-methoxyphenyl)-4-[(2-methylp...
C23H28ClNO5S2
951644-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 8.0020 0.0 0 VAL=6
M  V30 2 O 9.2400 6.4620 0.0 0
M  V30 3 O 9.2400 9.5420 0.0 0
M  V30 4 C 4.6200 10.6694 0.0 0
M  V30 5 O 5.3900 12.0031 0.0 0
M  V30 6 O 3.0800 10.6694 0.0 0
M  V30 7 S 3.0800 8.0020 0.0 0
M  V30 8 C 2.3100 6.6684 0.0 0
M  V30 9 C 0.7700 6.6684 0.0 0
M  V30 10 C 0.0000 8.0020 0.0 0
M  V30 11 C 0.0000 5.3347 0.0 0
M  V30 12 O 10.0100 1.3336 0.0 0
M  V30 13 C 9.2400 0.0000 0.0 0
M  V30 14 Cl 15.4000 8.0020 0.0 0
M  V30 15 N 7.7000 8.0020 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 5.3900 6.6684 0.0 0
M  V30 19 C 5.3900 9.3358 0.0 0 CFG=1
M  V30 20 C 4.6200 8.0020 0.0 0 CFG=1
M  V30 21 C 7.7000 5.3347 0.0 0
M  V30 22 C 6.9300 4.0011 0.0 0
M  V30 23 C 9.2400 5.3347 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 10.0100 4.0011 0.0 0
M  V30 26 C 9.2400 2.6673 0.0 0
M  V30 27 C 10.7800 8.0020 0.0 0
M  V30 28 C 11.5500 6.6684 0.0 0
M  V30 29 C 11.5500 9.3358 0.0 0
M  V30 30 C 13.0900 6.6684 0.0 0
M  V30 31 C 13.0900 9.3358 0.0 0
M  V30 32 C 13.8600 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 1 12 26
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-77-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16083220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C37E21, yield 95%. MW: 498.06
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME153 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]-2-methylbenzenesulfonamide
C15H15NO3S
951762-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 O 13.0900 4.0011 0.0 0
M  V30 8 C 13.8600 5.3349 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 0.7700 1.3338 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.0000 2.6674 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 10.7800 2.6674 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methoxyphenyl)-1-[(2-methylphenyl)sulfonyl]-4-[(2-methylp...
C24H31NO5S2
951644-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.0020 0.0 0 VAL=6
M  V30 2 O 4.6200 6.4620 0.0 0
M  V30 3 O 4.6200 9.5420 0.0 0
M  V30 4 C 9.2400 10.6694 0.0 0
M  V30 5 O 8.4700 12.0031 0.0 0
M  V30 6 O 10.7800 10.6694 0.0 0
M  V30 7 S 10.7800 8.0020 0.0 0
M  V30 8 C 11.5500 6.6684 0.0 0
M  V30 9 C 13.0900 6.6684 0.0 0
M  V30 10 C 13.8600 5.3347 0.0 0
M  V30 11 C 13.8600 8.0020 0.0 0
M  V30 12 C 3.0800 10.6694 0.0 0
M  V30 13 O 3.8500 1.3336 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 N 6.1600 8.0020 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 8.4700 6.6684 0.0 0
M  V30 19 C 8.4700 9.3358 0.0 0 CFG=1
M  V30 20 C 9.2400 8.0020 0.0 0 CFG=1
M  V30 21 C 6.1600 5.3347 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 6.9300 4.0011 0.0 0
M  V30 24 C 3.8500 4.0011 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 4.6200 2.6673 0.0 0
M  V30 27 C 3.0800 8.0020 0.0 0
M  V30 28 C 2.3100 9.3358 0.0 0
M  V30 29 C 2.3100 6.6684 0.0 0
M  V30 30 C 0.7700 9.3358 0.0 0
M  V30 31 C 0.7700 6.6684 0.0 0
M  V30 32 C 0.0000 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 12 28
M  V30 14 1 13 14
M  V30 15 1 13 26
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-78-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16075880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C38E21, yield 95%. MW: 477.64
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME154 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methylphenyl)-1-[(2-methylphenyl)sulfonyl]-4-[(2-methylpr...
C24H31NO4S2
951644-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 S 10.7800 6.6684 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 C 13.0900 5.3347 0.0 0
M  V30 7 C 13.8600 4.0011 0.0 0
M  V30 8 C 13.8600 6.6684 0.0 0
M  V30 9 C 9.2400 9.3358 0.0 0
M  V30 10 O 8.4700 10.6694 0.0 0
M  V30 11 O 10.7800 9.3358 0.0 0
M  V30 12 C 3.0800 9.3358 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 N 6.1600 6.6684 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 19 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 20 C 6.1600 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 4.6200 4.0011 0.0 0
M  V30 23 C 6.1600 1.3336 0.0 0
M  V30 24 C 3.8500 2.6673 0.0 0
M  V30 25 C 4.6200 1.3336 0.0 0
M  V30 26 C 3.0800 6.6684 0.0 0
M  V30 27 C 2.3100 8.0021 0.0 0
M  V30 28 C 2.3100 5.3347 0.0 0
M  V30 29 C 0.7700 8.0021 0.0 0
M  V30 30 C 0.7700 5.3347 0.0 0
M  V30 31 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 19 9 CFG=1
M  V30 13 1 12 27
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-79-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-11-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16089281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C41E21, yield 95%. MW: 461.64
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME155 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methylphenyl)methylene]methanesulfonamide
C9H11NO2S
951762-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0
M  V30 3 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 3.0800 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 5.3900 2.8736 0.0 0
M  V30 9 C 6.1600 4.2073 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 7.7000 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methylphenyl)-4-[(2-methylpropyl)thio]-1-(methylsulfonyl)...
C18H27NO4S2
951644-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0022 6.9302 0.0 0 VAL=6
M  V30 2 C 9.3360 7.7002 0.0 0
M  V30 3 O 7.2322 8.2638 0.0 0
M  V30 4 O 8.7722 5.5965 0.0 0
M  V30 5 S 2.6673 3.8501 0.0 0
M  V30 6 C 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 2.6673 6.9302 0.0 0
M  V30 11 O 1.3337 6.1601 0.0 0
M  V30 12 O 2.6673 8.4702 0.0 0
M  V30 13 C 12.0033 1.5400 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0 CFG=2
M  V30 15 N 6.6685 6.1601 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 17 C 5.3348 6.9302 0.0 0
M  V30 18 C 4.0012 4.6201 0.0 0 CFG=1
M  V30 19 C 4.0012 6.1601 0.0 0 CFG=1
M  V30 20 C 8.0022 3.8501 0.0 0
M  V30 21 C 9.3360 4.6201 0.0 0
M  V30 22 C 8.0022 2.3101 0.0 0
M  V30 23 C 10.6697 3.8501 0.0 0
M  V30 24 C 9.3360 1.5400 0.0 0
M  V30 25 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 18 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 19 10 CFG=3
M  V30 13 1 13 25
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20 CFG=3
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-83-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-13-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16086430
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C46E21, yield 95%. MW: 385.54
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME156 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(phenylmethylene)benzenesulfonamide
C14H13NO2S
51608-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 13.0900 2.6673 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 1.3336 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-[(3-Methylbutyl)thio]-1-[(4-methylphenyl)sulfonyl]-6-phenyl-...
C24H31NO4S2
951644-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 4.0011 0.0 0 VAL=6
M  V30 2 O 6.1600 2.4611 0.0 0
M  V30 3 O 6.1600 5.5411 0.0 0
M  V30 4 C 10.7800 1.3336 0.0 0
M  V30 5 O 10.0100 0.0000 0.0 0
M  V30 6 O 12.3200 1.3336 0.0 0
M  V30 7 S 12.3200 4.0011 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 C 14.6300 5.3347 0.0 0
M  V30 10 C 15.4000 6.6684 0.0 0
M  V30 11 C 16.9400 6.6684 0.0 0
M  V30 12 C 14.6300 8.0021 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 N 7.7000 4.0011 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 10.0100 2.6674 0.0 0 CFG=1
M  V30 19 C 10.7800 4.0011 0.0 0 CFG=1
M  V30 20 C 7.7000 6.6684 0.0 0
M  V30 21 C 8.4700 8.0021 0.0 0
M  V30 22 C 6.1600 6.6684 0.0 0
M  V30 23 C 7.7000 9.3358 0.0 0
M  V30 24 C 5.3900 8.0021 0.0 0
M  V30 25 C 6.1600 9.3358 0.0 0
M  V30 26 C 4.6200 4.0011 0.0 0
M  V30 27 C 3.8500 5.3347 0.0 0
M  V30 28 C 3.8500 2.6674 0.0 0
M  V30 29 C 2.3100 5.3347 0.0 0
M  V30 30 C 2.3100 2.6674 0.0 0
M  V30 31 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 20 CFG=3
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51608-60-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-34-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16085950
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C01E23, yield 95%. MW: 461.64
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME157 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(phenylmethylene)benzenesulfonamide
C14H13NO2S
51608-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 13.0900 2.6673 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 1.3336 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-1-[(4-methylphenyl)sulfonyl]-6-phenyl-3-piperidi...
C21H25NO4S2
951643-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 5.3347 0.0 0 VAL=6
M  V30 2 O 8.4700 3.7947 0.0 0
M  V30 3 O 8.4700 6.8747 0.0 0
M  V30 4 C 3.8500 8.0021 0.0 0
M  V30 5 O 4.6200 9.3358 0.0 0
M  V30 6 O 2.3100 8.0021 0.0 0
M  V30 7 S 2.3100 5.3347 0.0 0
M  V30 8 C 1.5400 4.0011 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 C 14.6300 5.3347 0.0 0
M  V30 11 N 6.9300 5.3347 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0 CFG=2
M  V30 13 C 6.1600 6.6684 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0 CFG=1
M  V30 16 C 3.8500 5.3347 0.0 0 CFG=1
M  V30 17 C 6.9300 2.6674 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 6.1600 1.3336 0.0 0
M  V30 20 C 9.2400 1.3336 0.0 0
M  V30 21 C 6.9300 0.0000 0.0 0
M  V30 22 C 8.4700 0.0000 0.0 0
M  V30 23 C 10.0100 5.3347 0.0 0
M  V30 24 C 10.7800 6.6684 0.0 0
M  V30 25 C 10.7800 4.0011 0.0 0
M  V30 26 C 12.3200 6.6684 0.0 0
M  V30 27 C 12.3200 4.0011 0.0 0
M  V30 28 C 13.0900 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 15 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 16 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 17 CFG=3
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51608-60-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16089831
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C01E16, yield 95%. MW: 419.56
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME158 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(phenylmethylene)benzenesulfonamide
C14H13NO2S
51608-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 13.0900 2.6673 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 1.3336 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Methylphenyl)sulfonyl]-6-phenyl-4-(2-propen-1-ylthio)-3-...
C22H25NO4S2
951645-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 4.0011 0.0 0 VAL=6
M  V30 2 O 6.1600 5.5411 0.0 0
M  V30 3 O 6.1600 2.4611 0.0 0
M  V30 4 C 10.7800 1.3336 0.0 0
M  V30 5 O 12.3200 1.3336 0.0 0
M  V30 6 O 10.0100 0.0000 0.0 0
M  V30 7 S 12.3200 4.0011 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 C 14.6300 5.3347 0.0 0
M  V30 10 C 15.4000 6.6684 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 N 7.7000 4.0011 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 14 C 8.4700 2.6674 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 10.0100 2.6674 0.0 0 CFG=1
M  V30 17 C 10.7800 4.0011 0.0 0 CFG=1
M  V30 18 C 7.7000 6.6684 0.0 0
M  V30 19 C 6.1600 6.6684 0.0 0
M  V30 20 C 8.4700 8.0021 0.0 0
M  V30 21 C 5.3900 8.0021 0.0 0
M  V30 22 C 7.7000 9.3358 0.0 0
M  V30 23 C 6.1600 9.3358 0.0 0
M  V30 24 C 4.6200 4.0011 0.0 0
M  V30 25 C 3.8500 5.3347 0.0 0
M  V30 26 C 3.8500 2.6674 0.0 0
M  V30 27 C 2.3100 5.3347 0.0 0
M  V30 28 C 2.3100 2.6674 0.0 0
M  V30 29 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 17 7 CFG=1
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 18 CFG=3
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51608-60-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16083773
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C01E30, yield 95%. MW: 431.57
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME159 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methylphenyl)methylene]benzenesulfonamide
C14H13NO2S
664985-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 13.0900 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 2.3100 0.2062 0.0 0
M  V30 9 C 2.3100 2.8736 0.0 0
M  V30 10 C 0.7700 0.2062 0.0 0
M  V30 11 C 0.7700 2.8736 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 14 C 9.2400 1.5400 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-[(3-Methylbutyl)thio]-6-(4-methylphenyl)-1-(phenylsulfonyl)-...
C24H31NO4S2
951644-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 C 9.2400 9.3358 0.0 0
M  V30 5 O 10.7800 9.3358 0.0 0
M  V30 6 O 8.4700 10.6694 0.0 0
M  V30 7 S 10.7800 6.6684 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 C 13.8600 4.0011 0.0 0
M  V30 11 C 15.4000 4.0011 0.0 0
M  V30 12 C 13.0900 2.6673 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 N 6.1600 6.6684 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 16 C 6.9300 8.0021 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 19 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 20 C 6.1600 4.0011 0.0 0
M  V30 21 C 4.6200 4.0011 0.0 0
M  V30 22 C 6.9300 2.6673 0.0 0
M  V30 23 C 3.8500 2.6673 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 4.6200 1.3336 0.0 0
M  V30 26 C 3.0800 6.6684 0.0 0
M  V30 27 C 2.3100 8.0021 0.0 0
M  V30 28 C 2.3100 5.3347 0.0 0
M  V30 29 C 0.7700 8.0021 0.0 0
M  V30 30 C 0.7700 5.3347 0.0 0
M  V30 31 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 25
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 20 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-98-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16071419
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C43E23, yield 95%. MW: 461.64
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME160 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]benzenesulfonamide
C14H13NO3S
664985-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 O 13.0900 2.8736 0.0 0
M  V30 7 C 13.8600 4.2073 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 2.3100 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.7700 2.8736 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 9.2400 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 19 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methoxyphenyl)-4-[(3-methylbutyl)thio]-1-(phenylsulfonyl)...
C24H31NO5S2
951644-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.0020 0.0 0 VAL=6
M  V30 2 O 4.6200 9.5420 0.0 0
M  V30 3 O 4.6200 6.4620 0.0 0
M  V30 4 C 9.2400 10.6694 0.0 0
M  V30 5 O 8.4700 12.0031 0.0 0
M  V30 6 O 10.7800 10.6694 0.0 0
M  V30 7 S 10.7800 8.0020 0.0 0
M  V30 8 C 11.5500 6.6684 0.0 0
M  V30 9 C 13.0900 6.6684 0.0 0
M  V30 10 C 13.8600 5.3347 0.0 0
M  V30 11 C 15.4000 5.3347 0.0 0
M  V30 12 C 13.0900 4.0011 0.0 0
M  V30 13 O 3.8500 1.3336 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 N 6.1600 8.0020 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 8.4700 6.6684 0.0 0
M  V30 19 C 8.4700 9.3358 0.0 0 CFG=1
M  V30 20 C 9.2400 8.0020 0.0 0 CFG=1
M  V30 21 C 6.1600 5.3347 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 6.9300 4.0011 0.0 0
M  V30 24 C 3.8500 4.0011 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 4.6200 2.6673 0.0 0
M  V30 27 C 3.0800 8.0020 0.0 0
M  V30 28 C 2.3100 6.6684 0.0 0
M  V30 29 C 2.3100 9.3358 0.0 0
M  V30 30 C 0.7700 6.6684 0.0 0
M  V30 31 C 0.7700 9.3358 0.0 0
M  V30 32 C 0.0000 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 26
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-99-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-46-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16088759
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C35E23, yield 95%. MW: 477.64
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME161 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Methoxyphenyl)methylene]-4-methylbenzenesulfonamide
C15H15NO3S
863401-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 4.5648 1.7464 0.0 0
M  V30 4 O 6.1048 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 O 13.3370 3.0801 0.0 0
M  V30 8 C 14.6707 2.3101 0.0 0
M  V30 9 C 4.0010 3.8501 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0010 5.3901 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 2.6673 6.1601 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3358 0.7700 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 10.6697 0.0000 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Methoxyphenyl)-4-[(3-methylbutyl)thio]-1-[(4-methylphenyl...
C25H33NO5S2
951644-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 6.4620 0.0 0
M  V30 3 O 6.1600 9.5420 0.0 0
M  V30 4 S 12.3200 8.0020 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 14.6300 6.6684 0.0 0
M  V30 7 C 15.4000 5.3347 0.0 0
M  V30 8 C 16.9400 5.3347 0.0 0
M  V30 9 C 14.6300 4.0011 0.0 0
M  V30 10 C 10.7800 10.6694 0.0 0
M  V30 11 O 12.3200 10.6694 0.0 0
M  V30 12 O 10.0100 12.0031 0.0 0
M  V30 13 O 8.4700 1.3336 0.0 0
M  V30 14 C 7.7000 0.0000 0.0 0
M  V30 15 C 0.0000 8.0020 0.0 0
M  V30 16 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 17 N 7.7000 8.0020 0.0 0
M  V30 18 C 10.0100 6.6684 0.0 0
M  V30 19 C 8.4700 9.3358 0.0 0
M  V30 20 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 21 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 22 C 7.7000 5.3347 0.0 0
M  V30 23 C 8.4700 4.0011 0.0 0
M  V30 24 C 6.1600 5.3347 0.0 0
M  V30 25 C 7.7000 2.6673 0.0 0
M  V30 26 C 5.3900 4.0011 0.0 0
M  V30 27 C 6.1600 2.6673 0.0 0
M  V30 28 C 4.6200 8.0020 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 3.8500 9.3358 0.0 0
M  V30 31 C 2.3100 6.6684 0.0 0
M  V30 32 C 2.3100 9.3358 0.0 0
M  V30 33 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 21 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 13 25
M  V30 16 1 15 33
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 22 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-18-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16082308
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C39E23, yield 95%. MW: 491.66
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME162 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
863401-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Chlorophenyl)-4-[(3-methylbutyl)thio]-1-[(4-methylphenyl)...
C24H30ClNO4S2
951644-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 S 12.3200 6.6684 0.0 0
M  V30 5 C 13.0900 5.3347 0.0 0
M  V30 6 C 14.6300 5.3347 0.0 0
M  V30 7 C 15.4000 4.0011 0.0 0
M  V30 8 C 16.9400 4.0011 0.0 0
M  V30 9 C 14.6300 2.6673 0.0 0
M  V30 10 C 10.7800 9.3358 0.0 0
M  V30 11 O 12.3200 9.3358 0.0 0
M  V30 12 O 10.0100 10.6694 0.0 0
M  V30 13 Cl 8.4700 0.0000 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 16 N 7.7000 6.6684 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 8.4700 8.0021 0.0 0
M  V30 19 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 20 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 8.4700 2.6673 0.0 0
M  V30 23 C 6.1600 4.0011 0.0 0
M  V30 24 C 7.7000 1.3336 0.0 0
M  V30 25 C 5.3900 2.6673 0.0 0
M  V30 26 C 6.1600 1.3336 0.0 0
M  V30 27 C 4.6200 6.6684 0.0 0
M  V30 28 C 3.8500 8.0021 0.0 0
M  V30 29 C 3.8500 5.3347 0.0 0
M  V30 30 C 2.3100 8.0021 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 20 10 CFG=1
M  V30 14 1 13 24
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-19-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-41-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16092186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C12E23, yield 95%. MW: 496.08
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME163 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
863401-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Bromophenyl)-4-[(3-methylbutyl)thio]-1-[(4-methylphenyl)s...
C24H30BrNO4S2
951644-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 S 12.3200 6.6684 0.0 0
M  V30 5 C 13.0900 5.3347 0.0 0
M  V30 6 C 14.6300 5.3347 0.0 0
M  V30 7 C 15.4000 4.0011 0.0 0
M  V30 8 C 16.9400 4.0011 0.0 0
M  V30 9 C 14.6300 2.6673 0.0 0
M  V30 10 C 10.7800 9.3358 0.0 0
M  V30 11 O 10.0100 10.6694 0.0 0
M  V30 12 O 12.3200 9.3358 0.0 0
M  V30 13 Br 8.4700 0.0000 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 16 N 7.7000 6.6684 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 8.4700 8.0021 0.0 0
M  V30 19 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 20 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 8.4700 2.6673 0.0 0
M  V30 23 C 6.1600 4.0011 0.0 0
M  V30 24 C 7.7000 1.3336 0.0 0
M  V30 25 C 5.3900 2.6673 0.0 0
M  V30 26 C 6.1600 1.3336 0.0 0
M  V30 27 C 4.6200 6.6684 0.0 0
M  V30 28 C 3.8500 8.0021 0.0 0
M  V30 29 C 3.8500 5.3347 0.0 0
M  V30 30 C 2.3100 8.0021 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 20 10 CFG=1
M  V30 14 1 13 24
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-20-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-42-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16070709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C15E23, yield 95%. MW: 540.53
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME164 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
865060-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Chlorophenyl)-4-[(3-methylbutyl)thio]-1-[(2-methylphenyl)...
C24H30ClNO4S2
951644-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 C 9.2400 9.3358 0.0 0
M  V30 5 O 8.4700 10.6694 0.0 0
M  V30 6 O 10.7800 9.3358 0.0 0
M  V30 7 S 10.7800 6.6684 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 C 13.8600 4.0011 0.0 0
M  V30 11 C 15.4000 4.0011 0.0 0
M  V30 12 C 13.0900 2.6673 0.0 0
M  V30 13 C 3.0800 9.3358 0.0 0
M  V30 14 Cl 3.8500 0.0000 0.0 0
M  V30 15 N 6.1600 6.6684 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 20 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 21 C 6.1600 4.0011 0.0 0
M  V30 22 C 6.9300 2.6673 0.0 0
M  V30 23 C 4.6200 4.0011 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 3.8500 2.6673 0.0 0
M  V30 26 C 4.6200 1.3336 0.0 0
M  V30 27 C 3.0800 6.6684 0.0 0
M  V30 28 C 2.3100 8.0021 0.0 0
M  V30 29 C 2.3100 5.3347 0.0 0
M  V30 30 C 0.7700 8.0021 0.0 0
M  V30 31 C 0.7700 5.3347 0.0 0
M  V30 32 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 28
M  V30 15 1 14 26
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865060-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-52-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16088963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C40E23, yield 95%. MW: 496.08
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME165 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Ethylphenyl)-4-[(3-methylbutyl)thio]-1-[(4-methylphenyl)s...
C26H35NO4S2
951644-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 6.4620 0.0 0
M  V30 3 O 6.1600 9.5420 0.0 0
M  V30 4 C 10.7800 10.6694 0.0 0
M  V30 5 O 12.3200 10.6694 0.0 0
M  V30 6 O 10.0100 12.0031 0.0 0
M  V30 7 S 12.3200 8.0020 0.0 0
M  V30 8 C 13.0900 6.6684 0.0 0
M  V30 9 C 14.6300 6.6684 0.0 0
M  V30 10 C 15.4000 5.3347 0.0 0
M  V30 11 C 16.9400 5.3347 0.0 0
M  V30 12 C 14.6300 4.0011 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 6.1600 0.0000 0.0 0
M  V30 15 C 0.0000 8.0020 0.0 0
M  V30 16 N 7.7000 8.0020 0.0 0
M  V30 17 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 18 C 8.4700 9.3358 0.0 0
M  V30 19 C 10.0100 6.6684 0.0 0
M  V30 20 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 21 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 22 C 7.7000 5.3347 0.0 0
M  V30 23 C 8.4700 4.0011 0.0 0
M  V30 24 C 6.1600 5.3347 0.0 0
M  V30 25 C 7.7000 2.6673 0.0 0
M  V30 26 C 5.3900 4.0011 0.0 0
M  V30 27 C 6.1600 2.6673 0.0 0
M  V30 28 C 4.6200 8.0020 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 3.8500 9.3358 0.0 0
M  V30 31 C 2.3100 6.6684 0.0 0
M  V30 32 C 2.3100 9.3358 0.0 0
M  V30 33 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 27
M  V30 16 1 15 33
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-35-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16089004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C03E23, yield 95%. MW: 489.69
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME166 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Ethoxyphenyl)-4-[(3-methylbutyl)thio]-1-[(4-methylphenyl)...
C26H35NO5S2
951644-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 9.3358 0.0 0 VAL=6
M  V30 2 O 6.1600 10.8758 0.0 0
M  V30 3 O 6.1600 7.7958 0.0 0
M  V30 4 C 10.7800 12.0031 0.0 0
M  V30 5 O 12.3200 12.0031 0.0 0
M  V30 6 O 10.0100 13.3367 0.0 0
M  V30 7 S 12.3200 9.3358 0.0 0
M  V30 8 C 13.0900 8.0020 0.0 0
M  V30 9 C 14.6300 8.0020 0.0 0
M  V30 10 C 15.4000 6.6684 0.0 0
M  V30 11 C 16.9400 6.6684 0.0 0
M  V30 12 C 14.6300 5.3347 0.0 0
M  V30 13 O 5.3900 2.6673 0.0 0
M  V30 14 C 6.1600 1.3336 0.0 0
M  V30 15 C 5.3900 0.0000 0.0 0
M  V30 16 C 0.0000 9.3358 0.0 0
M  V30 17 N 7.7000 9.3358 0.0 0
M  V30 18 C 8.4700 8.0020 0.0 0 CFG=2
M  V30 19 C 8.4700 10.6694 0.0 0
M  V30 20 C 10.0100 8.0020 0.0 0
M  V30 21 C 10.0100 10.6694 0.0 0 CFG=1
M  V30 22 C 10.7800 9.3358 0.0 0 CFG=1
M  V30 23 C 7.7000 6.6684 0.0 0
M  V30 24 C 8.4700 5.3347 0.0 0
M  V30 25 C 6.1600 6.6684 0.0 0
M  V30 26 C 7.7000 4.0009 0.0 0
M  V30 27 C 5.3900 5.3347 0.0 0
M  V30 28 C 6.1600 4.0009 0.0 0
M  V30 29 C 4.6200 9.3358 0.0 0
M  V30 30 C 3.8500 8.0020 0.0 0
M  V30 31 C 3.8500 10.6694 0.0 0
M  V30 32 C 2.3100 8.0020 0.0 0
M  V30 33 C 2.3100 10.6694 0.0 0
M  V30 34 C 1.5400 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 28
M  V30 16 1 14 15
M  V30 17 1 16 34
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 18 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-37-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16092003
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C05E23, yield 95%. MW: 505.59
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME167 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 N 5.3900 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 13.0900 4.0009 0.0 0
M  V30 7 F 3.0800 0.0000 0.0 0
M  V30 8 C 8.4700 4.0009 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 9.2400 2.6673 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 10.7800 2.6673 0.0 0
M  V30 13 C 11.5500 4.0009 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 C 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0009 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(2-Fluorophenyl)-4-[(3-methylbutyl)thio]-1-[(4-methylphenyl)...
C24H30FNO4S2
951644-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 4.0011 0.0 0 VAL=6
M  V30 2 O 6.1600 2.4611 0.0 0
M  V30 3 O 6.1600 5.5411 0.0 0
M  V30 4 F 10.0100 8.0021 0.0 0
M  V30 5 S 12.3200 4.0011 0.0 0
M  V30 6 C 13.0900 5.3347 0.0 0
M  V30 7 C 14.6300 5.3347 0.0 0
M  V30 8 C 15.4000 6.6684 0.0 0
M  V30 9 C 16.9400 6.6684 0.0 0
M  V30 10 C 14.6300 8.0021 0.0 0
M  V30 11 C 10.7800 1.3336 0.0 0
M  V30 12 O 10.0100 0.0000 0.0 0
M  V30 13 O 12.3200 1.3336 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 16 N 7.7000 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0 CFG=1
M  V30 20 C 10.0100 2.6674 0.0 0 CFG=1
M  V30 21 C 7.7000 6.6684 0.0 0
M  V30 22 C 8.4700 8.0021 0.0 0
M  V30 23 C 6.1600 6.6684 0.0 0
M  V30 24 C 7.7000 9.3358 0.0 0
M  V30 25 C 5.3900 8.0021 0.0 0
M  V30 26 C 6.1600 9.3358 0.0 0
M  V30 27 C 4.6200 4.0011 0.0 0
M  V30 28 C 3.8500 5.3347 0.0 0
M  V30 29 C 3.8500 2.6674 0.0 0
M  V30 30 C 2.3100 5.3347 0.0 0
M  V30 31 C 2.3100 2.6674 0.0 0
M  V30 32 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 22
M  V30 6 1 5 6
M  V30 7 1 19 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 20 11 CFG=3
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21 CFG=3
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-62-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16084015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C10E23, yield 95%. MW: 479.63
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME168 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3,4,5-trimethoxyphenyl)methylene]benzenesulfonamide
C17H19NO5S
951762-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 2.6674 0.0 0
M  V30 3 O 2.3100 6.6685 0.0 0
M  V30 4 C 3.0800 8.0021 0.0 0
M  V30 5 O 2.3100 1.3336 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 N 7.7000 5.3347 0.0 0
M  V30 9 S 9.2400 5.3347 0.0 0 VAL=6
M  V30 10 O 9.2400 3.7947 0.0 0
M  V30 11 O 9.2400 6.8747 0.0 0
M  V30 12 C 15.4000 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 3.0800 2.6674 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 5.3900 4.0011 0.0 0
M  V30 19 C 10.7800 5.3347 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 11.5500 4.0011 0.0 0
M  V30 22 C 13.0900 6.6685 0.0 0
M  V30 23 C 13.0900 4.0011 0.0 0
M  V30 24 C 13.8600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 19
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-[(3-Methylbutyl)thio]-1-[(4-methylphenyl)sulfonyl]-6-(3,4,5-...
C27H37NO7S2
951644-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 9.5420 0.0 0
M  V30 3 O 6.1600 6.4620 0.0 0
M  V30 4 S 12.3200 8.0020 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 14.6300 6.6684 0.0 0
M  V30 7 C 15.4000 5.3347 0.0 0
M  V30 8 C 16.9400 5.3347 0.0 0
M  V30 9 C 14.6300 4.0011 0.0 0
M  V30 10 C 10.7800 10.6694 0.0 0
M  V30 11 O 10.0100 12.0031 0.0 0
M  V30 12 O 12.3200 10.6694 0.0 0
M  V30 13 O 3.8500 4.0011 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 O 8.4700 1.3336 0.0 0
M  V30 16 C 10.0100 1.3336 0.0 0
M  V30 17 O 5.3900 1.3336 0.0 0
M  V30 18 C 6.1600 0.0000 0.0 0
M  V30 19 C 0.0000 8.0020 0.0 0
M  V30 20 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 21 N 7.7000 8.0020 0.0 0
M  V30 22 C 10.0100 6.6684 0.0 0
M  V30 23 C 8.4700 9.3358 0.0 0
M  V30 24 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 25 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 26 C 7.7000 5.3347 0.0 0
M  V30 27 C 6.1600 5.3347 0.0 0
M  V30 28 C 8.4700 4.0011 0.0 0
M  V30 29 C 5.3900 4.0011 0.0 0
M  V30 30 C 7.7000 2.6673 0.0 0
M  V30 31 C 6.1600 2.6673 0.0 0
M  V30 32 C 4.6200 8.0020 0.0 0
M  V30 33 C 3.8500 9.3358 0.0 0
M  V30 34 C 3.8500 6.6684 0.0 0
M  V30 35 C 2.3100 9.3358 0.0 0
M  V30 36 C 2.3100 6.6684 0.0 0
M  V30 37 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 32
M  V30 5 1 4 5
M  V30 6 1 24 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 25 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 13 29
M  V30 16 1 15 16
M  V30 17 1 15 30
M  V30 18 1 17 18
M  V30 19 1 17 31
M  V30 20 1 19 37
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 26 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 20 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-67-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16065211
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C25E23, yield 95%. MW: 551.72
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME169 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Chlorophenyl)sulfonyl]-4-[(3-methylbutyl)thio]-6-(4-meth...
C24H30ClNO4S2
951644-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 C 10.7800 9.3358 0.0 0
M  V30 5 O 12.3200 9.3358 0.0 0
M  V30 6 O 10.0100 10.6694 0.0 0
M  V30 7 S 12.3200 6.6684 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 C 14.6300 5.3347 0.0 0
M  V30 10 C 15.4000 4.0011 0.0 0
M  V30 11 C 16.9400 4.0011 0.0 0
M  V30 12 C 14.6300 2.6673 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 Cl 0.0000 6.6684 0.0 0
M  V30 15 N 7.7000 6.6684 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 17 C 8.4700 8.0021 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 20 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 6.1600 4.0011 0.0 0
M  V30 23 C 8.4700 2.6673 0.0 0
M  V30 24 C 5.3900 2.6673 0.0 0
M  V30 25 C 7.7000 1.3336 0.0 0
M  V30 26 C 6.1600 1.3336 0.0 0
M  V30 27 C 4.6200 6.6684 0.0 0
M  V30 28 C 3.8500 8.0021 0.0 0
M  V30 29 C 3.8500 5.3347 0.0 0
M  V30 30 C 2.3100 8.0021 0.0 0
M  V30 31 C 2.3100 5.3347 0.0 0
M  V30 32 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 26
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-72-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16087254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C30E23, yield 95%. MW: 456.08
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME170 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methoxyphenyl)methylene]benzenesulfonamide
C14H12ClNO3S
951762-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 0.2062 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 2.3100 0.2062 0.0 0
M  V30 13 C 2.3100 2.8736 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 4.2073 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 12.3200 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Chlorophenyl)sulfonyl]-6-(4-methoxyphenyl)-4-[(3-methylb...
C24H30ClNO5S2
951644-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 6.4620 0.0 0
M  V30 3 O 6.1600 9.5420 0.0 0
M  V30 4 C 10.7800 10.6694 0.0 0
M  V30 5 O 12.3200 10.6694 0.0 0
M  V30 6 O 10.0100 12.0031 0.0 0
M  V30 7 S 12.3200 8.0020 0.0 0
M  V30 8 C 13.0900 6.6684 0.0 0
M  V30 9 C 14.6300 6.6684 0.0 0
M  V30 10 C 15.4000 5.3347 0.0 0
M  V30 11 C 16.9400 5.3347 0.0 0
M  V30 12 C 14.6300 4.0011 0.0 0
M  V30 13 O 5.3900 1.3336 0.0 0
M  V30 14 C 6.1600 0.0000 0.0 0
M  V30 15 Cl 0.0000 8.0020 0.0 0
M  V30 16 N 7.7000 8.0020 0.0 0
M  V30 17 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 18 C 8.4700 9.3358 0.0 0
M  V30 19 C 10.0100 6.6684 0.0 0
M  V30 20 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 21 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 22 C 7.7000 5.3347 0.0 0
M  V30 23 C 6.1600 5.3347 0.0 0
M  V30 24 C 8.4700 4.0011 0.0 0
M  V30 25 C 5.3900 4.0011 0.0 0
M  V30 26 C 7.7000 2.6673 0.0 0
M  V30 27 C 6.1600 2.6673 0.0 0
M  V30 28 C 4.6200 8.0020 0.0 0
M  V30 29 C 3.8500 6.6684 0.0 0
M  V30 30 C 3.8500 9.3358 0.0 0
M  V30 31 C 2.3100 6.6684 0.0 0
M  V30 32 C 2.3100 9.3358 0.0 0
M  V30 33 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 27
M  V30 16 1 15 33
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-77-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-47-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16090254
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C37E23, yield 95%. MW: 512.08
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME171 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]-2-methylbenzenesulfonamide
C15H15NO3S
951762-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 O 13.0900 4.0011 0.0 0
M  V30 8 C 13.8600 5.3349 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 0.7700 1.3338 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.0000 2.6674 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 10.7800 2.6674 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methoxyphenyl)-4-[(3-methylbutyl)thio]-1-[(2-methylphenyl...
C25H33NO5S2
951644-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.0020 0.0 0 VAL=6
M  V30 2 O 4.6200 9.5420 0.0 0
M  V30 3 O 4.6200 6.4620 0.0 0
M  V30 4 C 9.2400 10.6694 0.0 0
M  V30 5 O 8.4700 12.0031 0.0 0
M  V30 6 O 10.7800 10.6694 0.0 0
M  V30 7 S 10.7800 8.0020 0.0 0
M  V30 8 C 11.5500 6.6684 0.0 0
M  V30 9 C 13.0900 6.6684 0.0 0
M  V30 10 C 13.8600 5.3347 0.0 0
M  V30 11 C 15.4000 5.3347 0.0 0
M  V30 12 C 13.0900 4.0011 0.0 0
M  V30 13 C 3.0800 10.6694 0.0 0
M  V30 14 O 3.8500 1.3336 0.0 0
M  V30 15 C 4.6200 0.0000 0.0 0
M  V30 16 N 6.1600 8.0020 0.0 0
M  V30 17 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 18 C 6.9300 9.3358 0.0 0
M  V30 19 C 8.4700 6.6684 0.0 0
M  V30 20 C 8.4700 9.3358 0.0 0 CFG=1
M  V30 21 C 9.2400 8.0020 0.0 0 CFG=1
M  V30 22 C 6.1600 5.3347 0.0 0
M  V30 23 C 6.9300 4.0011 0.0 0
M  V30 24 C 4.6200 5.3347 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 3.8500 4.0011 0.0 0
M  V30 27 C 4.6200 2.6673 0.0 0
M  V30 28 C 3.0800 8.0020 0.0 0
M  V30 29 C 2.3100 9.3358 0.0 0
M  V30 30 C 2.3100 6.6684 0.0 0
M  V30 31 C 0.7700 9.3358 0.0 0
M  V30 32 C 0.7700 6.6684 0.0 0
M  V30 33 C 0.0000 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 29
M  V30 15 1 14 15
M  V30 16 1 14 27
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 17 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-78-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16091782
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C38E23, yield 95%. MW: 491.66
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME172 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-[(3-Methylbutyl)thio]-6-(4-methylphenyl)-1-[(2-methylphenyl)...
C25H33NO4S2
951644-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 C 9.2400 9.3358 0.0 0
M  V30 5 O 8.4700 10.6694 0.0 0
M  V30 6 O 10.7800 9.3358 0.0 0
M  V30 7 S 10.7800 6.6684 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 C 13.8600 4.0011 0.0 0
M  V30 11 C 15.4000 4.0011 0.0 0
M  V30 12 C 13.0900 2.6673 0.0 0
M  V30 13 C 3.0800 9.3358 0.0 0
M  V30 14 C 3.8500 0.0000 0.0 0
M  V30 15 N 6.1600 6.6684 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 20 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 21 C 6.1600 4.0011 0.0 0
M  V30 22 C 6.9300 2.6673 0.0 0
M  V30 23 C 4.6200 4.0011 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 3.8500 2.6673 0.0 0
M  V30 26 C 4.6200 1.3336 0.0 0
M  V30 27 C 3.0800 6.6684 0.0 0
M  V30 28 C 2.3100 8.0021 0.0 0
M  V30 29 C 2.3100 5.3347 0.0 0
M  V30 30 C 0.7700 8.0021 0.0 0
M  V30 31 C 0.7700 5.3347 0.0 0
M  V30 32 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 13 28
M  V30 15 1 14 26
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-79-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16090443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C41E23, yield 95%. MW: 475.66
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME173 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methylphenyl)methylene]methanesulfonamide
C9H11NO2S
951762-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0
M  V30 3 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 3.0800 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 5.3900 2.8736 0.0 0
M  V30 9 C 6.1600 4.2073 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 7.7000 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-[(3-Methylbutyl)thio]-6-(4-methylphenyl)-1-(methylsulfonyl)-...
C19H29NO4S2
951644-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 6.6684 0.0 0 VAL=6
M  V30 2 C 0.0000 6.6684 0.0 0
M  V30 3 O 1.5400 8.2084 0.0 0
M  V30 4 O 1.5400 5.1284 0.0 0
M  V30 5 S 7.7000 6.6684 0.0 0
M  V30 6 C 8.4700 5.3347 0.0 0
M  V30 7 C 10.0100 5.3347 0.0 0
M  V30 8 C 10.7800 4.0011 0.0 0
M  V30 9 C 12.3200 4.0011 0.0 0
M  V30 10 C 10.0100 2.6673 0.0 0
M  V30 11 C 6.1600 9.3358 0.0 0
M  V30 12 O 5.3900 10.6694 0.0 0
M  V30 13 O 7.7000 9.3358 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 3.8500 5.3347 0.0 0 CFG=2
M  V30 16 N 3.0800 6.6684 0.0 0
M  V30 17 C 5.3900 5.3347 0.0 0
M  V30 18 C 3.8500 8.0021 0.0 0
M  V30 19 C 6.1600 6.6684 0.0 0 CFG=1
M  V30 20 C 5.3900 8.0021 0.0 0 CFG=1
M  V30 21 C 3.0800 4.0011 0.0 0
M  V30 22 C 1.5400 4.0011 0.0 0
M  V30 23 C 3.8500 2.6673 0.0 0
M  V30 24 C 0.7700 2.6673 0.0 0
M  V30 25 C 3.0800 1.3336 0.0 0
M  V30 26 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 5 6
M  V30 6 1 19 5 CFG=3
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 20 11 CFG=1
M  V30 14 1 14 26
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 21 CFG=1
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-83-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951644-59-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16082488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C46E23, yield 95%. MW: 399.57
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME174 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methylphenyl)methylene]benzenesulfonamide
C14H13NO2S
664985-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 13.0900 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 2.3100 0.2062 0.0 0
M  V30 9 C 2.3100 2.8736 0.0 0
M  V30 10 C 0.7700 0.2062 0.0 0
M  V30 11 C 0.7700 2.8736 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 14 C 9.2400 1.5400 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-6-(4-methylphenyl)-1-(phenylsulfonyl)-3-piperidi...
C21H25NO4S2
951643-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 C 9.2400 9.3358 0.0 0
M  V30 5 O 10.7800 9.3358 0.0 0
M  V30 6 O 8.4700 10.6694 0.0 0
M  V30 7 S 10.7800 6.6684 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 N 6.1600 6.6684 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 13 C 6.9300 8.0021 0.0 0
M  V30 14 C 8.4700 5.3347 0.0 0
M  V30 15 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 16 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 17 C 6.1600 4.0011 0.0 0
M  V30 18 C 4.6200 4.0011 0.0 0
M  V30 19 C 6.9300 2.6673 0.0 0
M  V30 20 C 3.8500 2.6673 0.0 0
M  V30 21 C 6.1600 1.3336 0.0 0
M  V30 22 C 4.6200 1.3336 0.0 0
M  V30 23 C 3.0800 6.6684 0.0 0
M  V30 24 C 2.3100 5.3347 0.0 0
M  V30 25 C 2.3100 8.0021 0.0 0
M  V30 26 C 0.7700 5.3347 0.0 0
M  V30 27 C 0.7700 8.0021 0.0 0
M  V30 28 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 15 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 17 CFG=1
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-98-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16084828
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C43E16, yield 95%. MW: 419.56
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME175 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methylphenyl)methylene]benzenesulfonamide
C14H13NO2S
664985-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 13.0900 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 2.3100 0.2062 0.0 0
M  V30 9 C 2.3100 2.8736 0.0 0
M  V30 10 C 0.7700 0.2062 0.0 0
M  V30 11 C 0.7700 2.8736 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 14 C 9.2400 1.5400 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methylphenyl)-1-(phenylsulfonyl)-4-(2-propen-1-ylthio)-3-...
C22H25NO4S2
951645-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 C 9.2400 9.3358 0.0 0
M  V30 5 O 10.7800 9.3358 0.0 0
M  V30 6 O 8.4700 10.6694 0.0 0
M  V30 7 S 10.7800 6.6684 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 C 13.8600 4.0011 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 N 6.1600 6.6684 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 14 C 6.9300 8.0021 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0
M  V30 16 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 17 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 18 C 6.1600 4.0011 0.0 0
M  V30 19 C 4.6200 4.0011 0.0 0
M  V30 20 C 6.9300 2.6673 0.0 0
M  V30 21 C 3.8500 2.6673 0.0 0
M  V30 22 C 6.1600 1.3336 0.0 0
M  V30 23 C 4.6200 1.3336 0.0 0
M  V30 24 C 3.0800 6.6684 0.0 0
M  V30 25 C 2.3100 5.3347 0.0 0
M  V30 26 C 2.3100 8.0021 0.0 0
M  V30 27 C 0.7700 5.3347 0.0 0
M  V30 28 C 0.7700 8.0020 0.0 0
M  V30 29 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 17 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 18 CFG=1
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-98-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-40-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16089787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C43E30, yield 95%. MW: 431.57
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME176 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]benzenesulfonamide
C14H13NO3S
664985-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 O 13.0900 2.8736 0.0 0
M  V30 7 C 13.8600 4.2073 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 2.3100 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.7700 2.8736 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 9.2400 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 19 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-6-(4-methoxyphenyl)-1-(phenylsulfonyl)-3-piperid...
C21H25NO5S2
951643-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.0020 0.0 0 VAL=6
M  V30 2 O 4.6200 6.4620 0.0 0
M  V30 3 O 4.6200 9.5420 0.0 0
M  V30 4 C 9.2400 10.6694 0.0 0
M  V30 5 O 8.4700 12.0031 0.0 0
M  V30 6 O 10.7800 10.6694 0.0 0
M  V30 7 S 10.7800 8.0020 0.0 0
M  V30 8 C 11.5500 6.6684 0.0 0
M  V30 9 C 13.0900 6.6684 0.0 0
M  V30 10 O 3.8500 1.3336 0.0 0
M  V30 11 C 4.6200 0.0000 0.0 0
M  V30 12 N 6.1600 8.0020 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 14 C 6.9300 9.3358 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0
M  V30 16 C 8.4700 9.3358 0.0 0 CFG=1
M  V30 17 C 9.2400 8.0020 0.0 0 CFG=1
M  V30 18 C 6.1600 5.3347 0.0 0
M  V30 19 C 4.6200 5.3347 0.0 0
M  V30 20 C 6.9300 4.0011 0.0 0
M  V30 21 C 3.8500 4.0011 0.0 0
M  V30 22 C 6.1600 2.6673 0.0 0
M  V30 23 C 4.6200 2.6673 0.0 0
M  V30 24 C 3.0800 8.0020 0.0 0
M  V30 25 C 2.3100 9.3358 0.0 0
M  V30 26 C 2.3100 6.6684 0.0 0
M  V30 27 C 0.7700 9.3358 0.0 0
M  V30 28 C 0.7700 6.6684 0.0 0
M  V30 29 C 0.0000 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 17 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 18 CFG=1
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-99-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-66-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16065071
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C35E16, yield 95%. MW: 435.56
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME177 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]benzenesulfonamide
C14H13NO3S
664985-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 O 13.0900 2.8736 0.0 0
M  V30 7 C 13.8600 4.2073 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 2.3100 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.7700 2.8736 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 9.2400 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 19 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methoxyphenyl)-1-(phenylsulfonyl)-4-(2-propen-1-ylthio)-3...
C22H25NO5S2
951645-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.0020 0.0 0 VAL=6
M  V30 2 O 4.6200 9.5420 0.0 0
M  V30 3 O 4.6200 6.4620 0.0 0
M  V30 4 C 9.2400 10.6694 0.0 0
M  V30 5 O 8.4700 12.0031 0.0 0
M  V30 6 O 10.7800 10.6694 0.0 0
M  V30 7 S 10.7800 8.0020 0.0 0
M  V30 8 C 11.5500 6.6684 0.0 0
M  V30 9 C 13.0900 6.6684 0.0 0
M  V30 10 C 13.8600 5.3347 0.0 0
M  V30 11 O 3.8500 1.3336 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 N 6.1600 8.0020 0.0 0
M  V30 14 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 15 C 6.9300 9.3358 0.0 0
M  V30 16 C 8.4700 6.6684 0.0 0
M  V30 17 C 8.4700 9.3358 0.0 0 CFG=1
M  V30 18 C 9.2400 8.0020 0.0 0 CFG=1
M  V30 19 C 6.1600 5.3347 0.0 0
M  V30 20 C 4.6200 5.3347 0.0 0
M  V30 21 C 6.9300 4.0011 0.0 0
M  V30 22 C 3.8500 4.0011 0.0 0
M  V30 23 C 6.1600 2.6673 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 3.0800 8.0020 0.0 0
M  V30 26 C 2.3100 9.3358 0.0 0
M  V30 27 C 2.3100 6.6684 0.0 0
M  V30 28 C 0.7700 9.3358 0.0 0
M  V30 29 C 0.7700 6.6684 0.0 0
M  V30 30 C 0.0000 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 18 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-99-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-34-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16091735
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C35E30, yield 95%. MW: 447.57
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME178 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Methoxyphenyl)methylene]-4-methylbenzenesulfonamide
C15H15NO3S
863401-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 4.5648 1.7464 0.0 0
M  V30 4 O 6.1048 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 O 13.3370 3.0801 0.0 0
M  V30 8 C 14.6707 2.3101 0.0 0
M  V30 9 C 4.0010 3.8501 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0010 5.3901 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 2.6673 6.1601 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3358 0.7700 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 10.6697 0.0000 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-6-(3-methoxyphenyl)-1-[(4-methylphenyl)sulfonyl]...
C22H27NO5S2
951643-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 8.0020 0.0 0 VAL=6
M  V30 2 O 8.4700 9.5420 0.0 0
M  V30 3 O 8.4700 6.4620 0.0 0
M  V30 4 S 2.3100 8.0020 0.0 0
M  V30 5 C 1.5400 6.6684 0.0 0
M  V30 6 C 0.0000 6.6684 0.0 0
M  V30 7 C 3.8500 10.6694 0.0 0
M  V30 8 O 4.6200 12.0031 0.0 0
M  V30 9 O 2.3100 10.6694 0.0 0
M  V30 10 O 6.1600 1.3336 0.0 0
M  V30 11 C 6.9300 0.0000 0.0 0
M  V30 12 C 14.6300 8.0020 0.0 0
M  V30 13 C 6.1600 6.6684 0.0 0 CFG=2
M  V30 14 N 6.9300 8.0020 0.0 0
M  V30 15 C 4.6200 6.6684 0.0 0
M  V30 16 C 6.1600 9.3358 0.0 0
M  V30 17 C 3.8500 8.0020 0.0 0 CFG=1
M  V30 18 C 4.6200 9.3358 0.0 0 CFG=1
M  V30 19 C 6.9300 5.3347 0.0 0
M  V30 20 C 6.1600 4.0011 0.0 0
M  V30 21 C 8.4700 5.3347 0.0 0
M  V30 22 C 6.9300 2.6673 0.0 0
M  V30 23 C 9.2400 4.0011 0.0 0
M  V30 24 C 8.4700 2.6673 0.0 0
M  V30 25 C 10.0100 8.0020 0.0 0
M  V30 26 C 10.7800 9.3358 0.0 0
M  V30 27 C 10.7800 6.6684 0.0 0
M  V30 28 C 12.3200 9.3358 0.0 0
M  V30 29 C 12.3200 6.6684 0.0 0
M  V30 30 C 13.0900 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 17 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 18 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 10 22
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19 CFG=3
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-18-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-70-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16091328
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C39E16, yield 95%. MW: 449.58
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME179 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
863401-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Chlorophenyl)-4-(ethylthio)-1-[(4-methylphenyl)sulfonyl]-...
C21H24ClNO4S2
951643-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 6.6684 0.0 0 VAL=6
M  V30 2 O 8.4700 8.2084 0.0 0
M  V30 3 O 8.4700 5.1284 0.0 0
M  V30 4 S 2.3100 6.6684 0.0 0
M  V30 5 C 1.5400 5.3347 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 C 3.8500 9.3358 0.0 0
M  V30 8 O 2.3100 9.3358 0.0 0
M  V30 9 O 4.6200 10.6694 0.0 0
M  V30 10 Cl 6.1600 0.0000 0.0 0
M  V30 11 C 14.6300 6.6684 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 13 N 6.9300 6.6684 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 6.1600 8.0021 0.0 0
M  V30 16 C 3.8500 6.6684 0.0 0 CFG=1
M  V30 17 C 4.6200 8.0021 0.0 0 CFG=1
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 6.1600 2.6673 0.0 0
M  V30 20 C 8.4700 4.0011 0.0 0
M  V30 21 C 6.9300 1.3336 0.0 0
M  V30 22 C 9.2400 2.6673 0.0 0
M  V30 23 C 8.4700 1.3336 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 25 C 10.7800 5.3347 0.0 0
M  V30 26 C 10.7800 8.0021 0.0 0
M  V30 27 C 12.3200 5.3347 0.0 0
M  V30 28 C 12.3200 8.0021 0.0 0
M  V30 29 C 13.0900 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 17 7 CFG=3
M  V30 11 1 10 21
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=3
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-19-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-60-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16085065
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C12E16, yield 95%. MW: 454.00
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME180 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
863401-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Bromophenyl)-4-(ethylthio)-1-[(4-methylphenyl)sulfonyl]-3...
C21H24BrNO4S2
951643-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 6.6684 0.0 0 VAL=6
M  V30 2 O 8.4700 8.2084 0.0 0
M  V30 3 O 8.4700 5.1284 0.0 0
M  V30 4 S 2.3100 6.6684 0.0 0
M  V30 5 C 1.5400 5.3347 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 C 3.8500 9.3358 0.0 0
M  V30 8 O 2.3100 9.3358 0.0 0
M  V30 9 O 4.6200 10.6694 0.0 0
M  V30 10 Br 6.1600 0.0000 0.0 0
M  V30 11 C 14.6300 6.6684 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 13 N 6.9300 6.6684 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 6.1600 8.0021 0.0 0
M  V30 16 C 3.8500 6.6684 0.0 0 CFG=1
M  V30 17 C 4.6200 8.0021 0.0 0 CFG=1
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 6.1600 2.6673 0.0 0
M  V30 20 C 8.4700 4.0011 0.0 0
M  V30 21 C 6.9300 1.3336 0.0 0
M  V30 22 C 9.2400 2.6673 0.0 0
M  V30 23 C 8.4700 1.3336 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 25 C 10.7800 5.3347 0.0 0
M  V30 26 C 10.7800 8.0021 0.0 0
M  V30 27 C 12.3200 5.3347 0.0 0
M  V30 28 C 12.3200 8.0021 0.0 0
M  V30 29 C 13.0900 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 17 7 CFG=3
M  V30 11 1 10 21
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=3
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-20-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-61-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16086577
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C15E16, yield 95%. MW: 498.45
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME181 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
865060-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Chlorophenyl)-4-(ethylthio)-1-[(2-methylphenyl)sulfonyl]-...
C21H24ClNO4S2
951643-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 S 10.7800 6.6684 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 C 13.0900 5.3347 0.0 0
M  V30 7 C 9.2400 9.3358 0.0 0
M  V30 8 O 8.4700 10.6694 0.0 0
M  V30 9 O 10.7800 9.3358 0.0 0
M  V30 10 C 3.0800 9.3358 0.0 0
M  V30 11 Cl 3.8500 0.0000 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 13 N 6.1600 6.6684 0.0 0
M  V30 14 C 8.4700 5.3347 0.0 0
M  V30 15 C 6.9300 8.0021 0.0 0
M  V30 16 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 17 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 18 C 6.1600 4.0011 0.0 0
M  V30 19 C 6.9300 2.6673 0.0 0
M  V30 20 C 4.6200 4.0011 0.0 0
M  V30 21 C 6.1600 1.3336 0.0 0
M  V30 22 C 3.8500 2.6673 0.0 0
M  V30 23 C 4.6200 1.3336 0.0 0
M  V30 24 C 3.0800 6.6684 0.0 0
M  V30 25 C 2.3100 8.0021 0.0 0
M  V30 26 C 2.3100 5.3347 0.0 0
M  V30 27 C 0.7700 8.0021 0.0 0
M  V30 28 C 0.7700 5.3347 0.0 0
M  V30 29 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 17 7 CFG=1
M  V30 11 1 10 25
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=1
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865060-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-71-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16081812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C40E16, yield 95%. MW: 454.00
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME182 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Ethylphenyl)-4-(ethylthio)-1-[(4-methylphenyl)sulfonyl]-3...
C23H29NO4S2
951643-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 6.4620 0.0 0
M  V30 3 O 6.1600 9.5420 0.0 0
M  V30 4 C 10.7800 10.6694 0.0 0
M  V30 5 O 12.3200 10.6694 0.0 0
M  V30 6 O 10.0100 12.0031 0.0 0
M  V30 7 S 12.3200 8.0020 0.0 0
M  V30 8 C 13.0900 6.6684 0.0 0
M  V30 9 C 14.6300 6.6684 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 C 6.1600 0.0000 0.0 0
M  V30 12 C 0.0000 8.0020 0.0 0
M  V30 13 N 7.7000 8.0020 0.0 0
M  V30 14 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 15 C 8.4700 9.3358 0.0 0
M  V30 16 C 10.0100 6.6684 0.0 0
M  V30 17 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 18 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 6.1600 5.3347 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 5.3900 4.0011 0.0 0
M  V30 23 C 7.7000 2.6673 0.0 0
M  V30 24 C 6.1600 2.6673 0.0 0
M  V30 25 C 4.6200 8.0020 0.0 0
M  V30 26 C 3.8500 9.3358 0.0 0
M  V30 27 C 3.8500 6.6684 0.0 0
M  V30 28 C 2.3100 9.3358 0.0 0
M  V30 29 C 2.3100 6.6684 0.0 0
M  V30 30 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 18 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-54-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16065769
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C03E16, yield 95%. MW: 447.61
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME183 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Ethoxyphenyl)-4-(ethylthio)-1-[(4-methylphenyl)sulfonyl]-...
C23H29NO5S2
951643-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 9.3358 0.0 0 VAL=6
M  V30 2 O 6.1600 10.8758 0.0 0
M  V30 3 O 6.1600 7.7958 0.0 0
M  V30 4 C 10.7800 12.0031 0.0 0
M  V30 5 O 10.0100 13.3367 0.0 0
M  V30 6 O 12.3200 12.0031 0.0 0
M  V30 7 S 12.3200 9.3358 0.0 0
M  V30 8 C 13.0900 8.0020 0.0 0
M  V30 9 C 14.6300 8.0020 0.0 0
M  V30 10 O 5.3900 2.6673 0.0 0
M  V30 11 C 6.1600 1.3336 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 0.0000 9.3356 0.0 0
M  V30 14 N 7.7000 9.3358 0.0 0
M  V30 15 C 8.4700 8.0020 0.0 0 CFG=2
M  V30 16 C 8.4700 10.6694 0.0 0
M  V30 17 C 10.0100 8.0020 0.0 0
M  V30 18 C 10.0100 10.6694 0.0 0 CFG=1
M  V30 19 C 10.7800 9.3358 0.0 0 CFG=1
M  V30 20 C 7.7000 6.6684 0.0 0
M  V30 21 C 8.4700 5.3347 0.0 0
M  V30 22 C 6.1600 6.6684 0.0 0
M  V30 23 C 7.7000 4.0009 0.0 0
M  V30 24 C 5.3900 5.3347 0.0 0
M  V30 25 C 6.1600 4.0009 0.0 0
M  V30 26 C 4.6200 9.3358 0.0 0
M  V30 27 C 3.8500 8.0020 0.0 0
M  V30 28 C 3.8500 10.6694 0.0 0
M  V30 29 C 2.3100 8.0020 0.0 0
M  V30 30 C 2.3100 10.6694 0.0 0
M  V30 31 C 1.5400 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 20 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-56-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16090025
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C05E16, yield 95%. MW: 463.61
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME184 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 N 5.3900 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 13.0900 4.0009 0.0 0
M  V30 7 F 3.0800 0.0000 0.0 0
M  V30 8 C 8.4700 4.0009 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 9.2400 2.6673 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 10.7800 2.6673 0.0 0
M  V30 13 C 11.5500 4.0009 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 C 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0009 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-6-(2-fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-...
C21H24FNO4S2
951643-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0011 0.0 0 VAL=6
M  V30 2 O 8.4700 2.4611 0.0 0
M  V30 3 O 8.4700 5.5411 0.0 0
M  V30 4 C 3.8500 1.3336 0.0 0
M  V30 5 O 2.3100 1.3336 0.0 0
M  V30 6 O 4.6200 0.0000 0.0 0
M  V30 7 F 4.6200 8.0021 0.0 0
M  V30 8 S 2.3100 4.0011 0.0 0
M  V30 9 C 1.5400 5.3347 0.0 0
M  V30 10 C 0.0000 5.3347 0.0 0
M  V30 11 C 14.6300 4.0011 0.0 0
M  V30 12 N 6.9300 4.0011 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 14 C 6.1600 2.6674 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0 CFG=1
M  V30 17 C 3.8500 4.0011 0.0 0 CFG=1
M  V30 18 C 6.9300 6.6684 0.0 0
M  V30 19 C 6.1600 8.0021 0.0 0
M  V30 20 C 8.4700 6.6684 0.0 0
M  V30 21 C 6.9300 9.3358 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 8.4700 9.3358 0.0 0
M  V30 24 C 10.0100 4.0011 0.0 0
M  V30 25 C 10.7800 5.3347 0.0 0
M  V30 26 C 10.7800 2.6674 0.0 0
M  V30 27 C 12.3200 5.3347 0.0 0
M  V30 28 C 12.3200 2.6674 0.0 0
M  V30 29 C 13.0900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=1
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 1 17 8 CFG=3
M  V30 11 1 9 10
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 18 CFG=1
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-62-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-58-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16071061
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C10E16, yield 95%. MW: 437.55
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME185 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3,4,5-trimethoxyphenyl)methylene]benzenesulfonamide
C17H19NO5S
951762-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 2.6674 0.0 0
M  V30 3 O 2.3100 6.6685 0.0 0
M  V30 4 C 3.0800 8.0021 0.0 0
M  V30 5 O 2.3100 1.3336 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 N 7.7000 5.3347 0.0 0
M  V30 9 S 9.2400 5.3347 0.0 0 VAL=6
M  V30 10 O 9.2400 3.7947 0.0 0
M  V30 11 O 9.2400 6.8747 0.0 0
M  V30 12 C 15.4000 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 3.0800 2.6674 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 5.3900 4.0011 0.0 0
M  V30 19 C 10.7800 5.3347 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 11.5500 4.0011 0.0 0
M  V30 22 C 13.0900 6.6685 0.0 0
M  V30 23 C 13.0900 4.0011 0.0 0
M  V30 24 C 13.8600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 19
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-1-[(4-methylphenyl)sulfonyl]-6-(3,4,5-trimethoxy...
C24H31NO7S2
951643-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 6.4620 0.0 0
M  V30 3 O 6.1600 9.5420 0.0 0
M  V30 4 S 12.3200 8.0020 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 14.6300 6.6684 0.0 0
M  V30 7 C 10.7800 10.6694 0.0 0
M  V30 8 O 10.0100 12.0031 0.0 0
M  V30 9 O 12.3200 10.6694 0.0 0
M  V30 10 O 8.4700 1.3336 0.0 0
M  V30 11 C 10.0100 1.3336 0.0 0
M  V30 12 O 3.8500 4.0011 0.0 0
M  V30 13 C 3.0800 2.6673 0.0 0
M  V30 14 O 5.3900 1.3336 0.0 0
M  V30 15 C 6.1600 0.0000 0.0 0
M  V30 16 C 0.0000 8.0020 0.0 0
M  V30 17 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 18 N 7.7000 8.0020 0.0 0
M  V30 19 C 10.0100 6.6684 0.0 0
M  V30 20 C 8.4700 9.3358 0.0 0
M  V30 21 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 22 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 23 C 7.7000 5.3347 0.0 0
M  V30 24 C 8.4700 4.0011 0.0 0
M  V30 25 C 6.1600 5.3347 0.0 0
M  V30 26 C 7.7000 2.6673 0.0 0
M  V30 27 C 5.3900 4.0011 0.0 0
M  V30 28 C 6.1600 2.6673 0.0 0
M  V30 29 C 4.6200 8.0020 0.0 0
M  V30 30 C 3.8500 9.3358 0.0 0
M  V30 31 C 3.8500 6.6684 0.0 0
M  V30 32 C 2.3100 9.3358 0.0 0
M  V30 33 C 2.3100 6.6684 0.0 0
M  V30 34 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 22 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 27
M  V30 15 1 14 15
M  V30 16 1 14 28
M  V30 17 1 16 34
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 23 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 17 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-67-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16083752
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C25E16, yield 95%. MW: 509.64
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME186 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Chlorophenyl)sulfonyl]-4-(ethylthio)-6-(4-methylphenyl)-...
C21H24ClNO4S2
951643-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 6.6684 0.0 0 VAL=6
M  V30 2 O 8.4700 5.1284 0.0 0
M  V30 3 O 8.4700 8.2084 0.0 0
M  V30 4 C 3.8500 9.3358 0.0 0
M  V30 5 O 4.6200 10.6694 0.0 0
M  V30 6 O 2.3100 9.3358 0.0 0
M  V30 7 S 2.3100 6.6684 0.0 0
M  V30 8 C 1.5400 5.3347 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 C 9.2400 0.0000 0.0 0
M  V30 11 Cl 14.6300 6.6684 0.0 0
M  V30 12 N 6.9300 6.6684 0.0 0
M  V30 13 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 14 C 6.1600 8.0021 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 4.6200 8.0021 0.0 0 CFG=1
M  V30 17 C 3.8500 6.6684 0.0 0 CFG=1
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 6.1600 2.6673 0.0 0
M  V30 21 C 9.2400 2.6673 0.0 0
M  V30 22 C 6.9300 1.3336 0.0 0
M  V30 23 C 8.4700 1.3336 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 25 C 10.7800 8.0021 0.0 0
M  V30 26 C 10.7800 5.3347 0.0 0
M  V30 27 C 12.3200 8.0021 0.0 0
M  V30 28 C 12.3200 5.3347 0.0 0
M  V30 29 C 13.0900 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 17 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 10 23
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 18 CFG=3
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-72-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16085244
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C30E16, yield 95%. MW: 454.00
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME187 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methoxyphenyl)methylene]benzenesulfonamide
C14H12ClNO3S
951762-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 0.2062 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 2.3100 0.2062 0.0 0
M  V30 13 C 2.3100 2.8736 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 4.2073 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 12.3200 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Chlorophenyl)sulfonyl]-4-(ethylthio)-6-(4-methoxyphenyl)...
C21H24ClNO5S2
951643-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 6.4620 0.0 0
M  V30 3 O 6.1600 9.5420 0.0 0
M  V30 4 C 10.7800 10.6694 0.0 0
M  V30 5 O 10.0100 12.0031 0.0 0
M  V30 6 O 12.3200 10.6694 0.0 0
M  V30 7 S 12.3200 8.0020 0.0 0
M  V30 8 C 13.0900 6.6684 0.0 0
M  V30 9 C 14.6300 6.6684 0.0 0
M  V30 10 O 5.3900 1.3336 0.0 0
M  V30 11 C 6.1600 0.0000 0.0 0
M  V30 12 Cl 0.0000 8.0020 0.0 0
M  V30 13 N 7.7000 8.0020 0.0 0
M  V30 14 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 15 C 8.4700 9.3358 0.0 0
M  V30 16 C 10.0100 6.6684 0.0 0
M  V30 17 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 18 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 6.1600 5.3347 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 5.3900 4.0011 0.0 0
M  V30 23 C 7.7000 2.6673 0.0 0
M  V30 24 C 6.1600 2.6673 0.0 0
M  V30 25 C 4.6200 8.0020 0.0 0
M  V30 26 C 3.8500 9.3358 0.0 0
M  V30 27 C 3.8500 6.6684 0.0 0
M  V30 28 C 2.3100 9.3358 0.0 0
M  V30 29 C 2.3100 6.6684 0.0 0
M  V30 30 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 18 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-77-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16088302
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C37E16, yield 95%. MW: 470.00
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME188 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]-2-methylbenzenesulfonamide
C15H15NO3S
951762-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 O 13.0900 4.0011 0.0 0
M  V30 8 C 13.8600 5.3349 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 0.7700 1.3338 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.0000 2.6674 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 10.7800 2.6674 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-6-(4-methoxyphenyl)-1-[(2-methylphenyl)sulfonyl]...
C22H27NO5S2
951643-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.0020 0.0 0 VAL=6
M  V30 2 O 4.6200 6.4620 0.0 0
M  V30 3 O 4.6200 9.5420 0.0 0
M  V30 4 S 10.7800 8.0020 0.0 0
M  V30 5 C 11.5500 6.6684 0.0 0
M  V30 6 C 13.0900 6.6684 0.0 0
M  V30 7 C 9.2400 10.6694 0.0 0
M  V30 8 O 8.4700 12.0031 0.0 0
M  V30 9 O 10.7800 10.6694 0.0 0
M  V30 10 C 3.0800 10.6694 0.0 0
M  V30 11 O 3.8500 1.3336 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 14 N 6.1600 8.0020 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0
M  V30 16 C 6.9300 9.3358 0.0 0
M  V30 17 C 9.2400 8.0020 0.0 0 CFG=1
M  V30 18 C 8.4700 9.3358 0.0 0 CFG=1
M  V30 19 C 6.1600 5.3347 0.0 0
M  V30 20 C 4.6200 5.3347 0.0 0
M  V30 21 C 6.9300 4.0011 0.0 0
M  V30 22 C 3.8500 4.0011 0.0 0
M  V30 23 C 6.1600 2.6673 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 3.0800 8.0020 0.0 0
M  V30 26 C 2.3100 9.3358 0.0 0
M  V30 27 C 2.3100 6.6684 0.0 0
M  V30 28 C 0.7700 9.3358 0.0 0
M  V30 29 C 0.7700 6.6684 0.0 0
M  V30 30 C 0.0000 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 17 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 18 7 CFG=1
M  V30 11 1 10 26
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19 CFG=1
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-78-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-69-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16089804
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C38E16, yield 95%. MW: 449.58
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME189 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-6-(4-methylphenyl)-1-[(2-methylphenyl)sulfonyl]-...
C22H27NO4S2
951643-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 S 10.7800 6.6684 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 C 13.0900 5.3347 0.0 0
M  V30 7 C 9.2400 9.3358 0.0 0
M  V30 8 O 8.4700 10.6694 0.0 0
M  V30 9 O 10.7800 9.3358 0.0 0
M  V30 10 C 3.0800 9.3358 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 13 N 6.1600 6.6684 0.0 0
M  V30 14 C 8.4700 5.3347 0.0 0
M  V30 15 C 6.9300 8.0021 0.0 0
M  V30 16 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 17 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 18 C 6.1600 4.0011 0.0 0
M  V30 19 C 6.9300 2.6673 0.0 0
M  V30 20 C 4.6200 4.0011 0.0 0
M  V30 21 C 6.1600 1.3336 0.0 0
M  V30 22 C 3.8500 2.6673 0.0 0
M  V30 23 C 4.6200 1.3336 0.0 0
M  V30 24 C 3.0800 6.6684 0.0 0
M  V30 25 C 2.3100 8.0021 0.0 0
M  V30 26 C 2.3100 5.3347 0.0 0
M  V30 27 C 0.7700 8.0021 0.0 0
M  V30 28 C 0.7700 5.3347 0.0 0
M  V30 29 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 24
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 17 7 CFG=1
M  V30 11 1 10 25
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=1
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-79-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-72-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16083330
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C41E16, yield 95%. MW: 433.58
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME190 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methylphenyl)methylene]methanesulfonamide
C9H11NO2S
951762-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0
M  V30 3 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 3.0800 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 5.3900 2.8736 0.0 0
M  V30 9 C 6.1600 4.2073 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 7.7000 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-4-(Ethylthio)-6-(4-methylphenyl)-1-(methylsulfonyl)-3-piperidi...
C16H23NO4S2
951643-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3901 8.0023 0.0 0 VAL=6
M  V30 2 C 6.1601 9.3360 0.0 0
M  V30 3 O 4.0564 8.7723 0.0 0
M  V30 4 O 6.7238 7.2323 0.0 0
M  V30 5 S 2.3101 2.6675 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 5.3348 0.0 0
M  V30 9 O 0.0000 4.0012 0.0 0
M  V30 10 O 0.0000 6.6685 0.0 0
M  V30 11 C 11.5503 5.3348 0.0 0
M  V30 12 C 5.3901 5.3348 0.0 0 CFG=2
M  V30 13 N 4.6201 6.6685 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.0801 6.6685 0.0 0
M  V30 16 C 3.0801 4.0012 0.0 0 CFG=1
M  V30 17 C 2.3101 5.3348 0.0 0 CFG=1
M  V30 18 C 6.9302 5.3348 0.0 0
M  V30 19 C 7.7002 6.6685 0.0 0
M  V30 20 C 7.7002 4.0012 0.0 0
M  V30 21 C 9.2402 6.6685 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 1 16 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 17 8 CFG=3
M  V30 11 1 11 23
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18 CFG=3
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-83-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951643-74-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16086336
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C46E16, yield 95%. MW: 357.49
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME191 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Methoxyphenyl)methylene]-4-methylbenzenesulfonamide
C15H15NO3S
863401-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 4.5648 1.7464 0.0 0
M  V30 4 O 6.1048 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 O 13.3370 3.0801 0.0 0
M  V30 8 C 14.6707 2.3101 0.0 0
M  V30 9 C 4.0010 3.8501 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 4.0010 5.3901 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 2.6673 6.1601 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 9.3358 2.3101 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3358 0.7700 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 10.6697 0.0000 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 18
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Methoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1...
C23H27NO5S2
951645-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 9.5420 0.0 0
M  V30 3 O 6.1600 6.4620 0.0 0
M  V30 4 S 12.3200 8.0020 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 14.6300 6.6684 0.0 0
M  V30 7 C 15.4000 5.3347 0.0 0
M  V30 8 C 10.7800 10.6694 0.0 0
M  V30 9 O 10.0100 12.0031 0.0 0
M  V30 10 O 12.3200 10.6694 0.0 0
M  V30 11 O 8.4700 1.3336 0.0 0
M  V30 12 C 7.7000 0.0000 0.0 0
M  V30 13 C 0.0000 8.0020 0.0 0
M  V30 14 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 15 N 7.7000 8.0020 0.0 0
M  V30 16 C 10.0100 6.6684 0.0 0
M  V30 17 C 8.4700 9.3358 0.0 0
M  V30 18 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 19 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 6.1600 5.3347 0.0 0
M  V30 23 C 7.7000 2.6673 0.0 0
M  V30 24 C 5.3900 4.0011 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 4.6200 8.0020 0.0 0
M  V30 27 C 3.8500 9.3358 0.0 0
M  V30 28 C 3.8500 6.6684 0.0 0
M  V30 29 C 2.3100 9.3358 0.0 0
M  V30 30 C 2.3100 6.6684 0.0 0
M  V30 31 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 19 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 11 23
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-18-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16085240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C39E30, yield 95%. MW: 461.59
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME192 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
863401-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Chlorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1-...
C22H24ClNO4S2
951645-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 S 12.3200 6.6684 0.0 0
M  V30 5 C 13.0900 5.3347 0.0 0
M  V30 6 C 14.6300 5.3347 0.0 0
M  V30 7 C 15.4000 4.0011 0.0 0
M  V30 8 C 10.7800 9.3358 0.0 0
M  V30 9 O 12.3200 9.3358 0.0 0
M  V30 10 O 10.0100 10.6694 0.0 0
M  V30 11 Cl 8.4700 0.0000 0.0 0
M  V30 12 C 0.0000 6.6684 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 14 N 7.7000 6.6684 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 8.4700 8.0021 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 18 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 8.4700 2.6673 0.0 0
M  V30 21 C 6.1600 4.0011 0.0 0
M  V30 22 C 7.7000 1.3336 0.0 0
M  V30 23 C 5.3900 2.6673 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 4.6200 6.6684 0.0 0
M  V30 26 C 3.8500 5.3347 0.0 0
M  V30 27 C 3.8500 8.0020 0.0 0
M  V30 28 C 2.3100 5.3347 0.0 0
M  V30 29 C 2.3100 8.0020 0.0 0
M  V30 30 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 17 4 CFG=3
M  V30 7 1 5 6
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 18 8 CFG=1
M  V30 12 1 11 22
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19 CFG=1
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-19-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-27-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16090014
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C12E30, yield 95%. MW: 466.01
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME193 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
863401-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(3-Bromophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1-y...
C22H24BrNO4S2
951645-28-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 S 12.3200 6.6684 0.0 0
M  V30 5 C 13.0900 5.3347 0.0 0
M  V30 6 C 14.6300 5.3347 0.0 0
M  V30 7 C 15.4000 4.0011 0.0 0
M  V30 8 C 10.7800 9.3358 0.0 0
M  V30 9 O 12.3200 9.3358 0.0 0
M  V30 10 O 10.0100 10.6694 0.0 0
M  V30 11 Br 8.4700 0.0000 0.0 0
M  V30 12 C 0.0000 6.6684 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 14 N 7.7000 6.6684 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 8.4700 8.0021 0.0 0
M  V30 17 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 18 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 8.4700 2.6673 0.0 0
M  V30 21 C 6.1600 4.0011 0.0 0
M  V30 22 C 7.7000 1.3336 0.0 0
M  V30 23 C 5.3900 2.6673 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 4.6200 6.6684 0.0 0
M  V30 26 C 3.8500 5.3347 0.0 0
M  V30 27 C 3.8500 8.0020 0.0 0
M  V30 28 C 2.3100 5.3347 0.0 0
M  V30 29 C 2.3100 8.0020 0.0 0
M  V30 30 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 17 4 CFG=3
M  V30 7 1 5 6
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 18 8 CFG=1
M  V30 12 1 11 22
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 19 CFG=1
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-20-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-28-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16091540
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C15E30, yield 95%. MW: 510.46
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME194 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
865060-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Chlorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen-1-...
C22H24ClNO4S2
951645-38-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 C 9.2400 9.3358 0.0 0
M  V30 5 O 10.7800 9.3358 0.0 0
M  V30 6 O 8.4700 10.6694 0.0 0
M  V30 7 S 10.7800 6.6684 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 C 13.8600 4.0011 0.0 0
M  V30 11 C 3.0800 9.3358 0.0 0
M  V30 12 Cl 3.8500 0.0000 0.0 0
M  V30 13 N 6.1600 6.6684 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 C 6.9300 8.0021 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 18 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 19 C 6.1600 4.0011 0.0 0
M  V30 20 C 4.6200 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 3.8500 2.6673 0.0 0
M  V30 23 C 6.1600 1.3336 0.0 0
M  V30 24 C 4.6200 1.3336 0.0 0
M  V30 25 C 3.0800 6.6684 0.0 0
M  V30 26 C 2.3100 8.0021 0.0 0
M  V30 27 C 2.3100 5.3347 0.0 0
M  V30 28 C 0.7700 8.0021 0.0 0
M  V30 29 C 0.7700 5.3347 0.0 0
M  V30 30 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 18 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 26
M  V30 13 1 12 24
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865060-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-38-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16086754
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C40E30, yield 95%. MW: 466.01
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME195 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Ethylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1-y...
C24H29NO4S2
951645-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 9.5420 0.0 0
M  V30 3 O 6.1600 6.4620 0.0 0
M  V30 4 C 10.7800 10.6694 0.0 0
M  V30 5 O 12.3200 10.6694 0.0 0
M  V30 6 O 10.0100 12.0031 0.0 0
M  V30 7 S 12.3200 8.0020 0.0 0
M  V30 8 C 13.0900 6.6684 0.0 0
M  V30 9 C 14.6300 6.6684 0.0 0
M  V30 10 C 15.4000 5.3347 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 6.1600 0.0000 0.0 0
M  V30 13 C 0.0000 8.0020 0.0 0
M  V30 14 N 7.7000 8.0020 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 16 C 8.4700 9.3358 0.0 0
M  V30 17 C 10.0100 6.6684 0.0 0
M  V30 18 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 19 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 6.1600 5.3347 0.0 0
M  V30 22 C 8.4700 4.0011 0.0 0
M  V30 23 C 5.3900 4.0011 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 4.6200 8.0020 0.0 0
M  V30 27 C 3.8500 9.3358 0.0 0
M  V30 28 C 3.8500 6.6684 0.0 0
M  V30 29 C 2.3100 9.3358 0.0 0
M  V30 30 C 2.3100 6.6684 0.0 0
M  V30 31 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 20 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16086789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C03E30, yield 95%. MW: 459.62
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME196 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Ethoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1-...
C24H29NO5S2
951645-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 9.3358 0.0 0 VAL=6
M  V30 2 O 6.1600 10.8758 0.0 0
M  V30 3 O 6.1600 7.7958 0.0 0
M  V30 4 C 10.7800 12.0031 0.0 0
M  V30 5 O 12.3200 12.0031 0.0 0
M  V30 6 O 10.0100 13.3367 0.0 0
M  V30 7 S 12.3200 9.3358 0.0 0
M  V30 8 C 13.0900 8.0020 0.0 0
M  V30 9 C 14.6300 8.0020 0.0 0
M  V30 10 C 15.4000 6.6684 0.0 0
M  V30 11 O 5.3900 2.6673 0.0 0
M  V30 12 C 6.1600 1.3336 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 C 0.0000 9.3356 0.0 0
M  V30 15 N 7.7000 9.3358 0.0 0
M  V30 16 C 8.4700 8.0020 0.0 0 CFG=2
M  V30 17 C 8.4700 10.6694 0.0 0
M  V30 18 C 10.0100 8.0020 0.0 0
M  V30 19 C 10.0100 10.6694 0.0 0 CFG=1
M  V30 20 C 10.7800 9.3358 0.0 0 CFG=1
M  V30 21 C 7.7000 6.6684 0.0 0
M  V30 22 C 6.1600 6.6684 0.0 0
M  V30 23 C 8.4700 5.3347 0.0 0
M  V30 24 C 5.3900 5.3347 0.0 0
M  V30 25 C 7.7000 4.0009 0.0 0
M  V30 26 C 6.1600 4.0009 0.0 0
M  V30 27 C 4.6200 9.3358 0.0 0
M  V30 28 C 3.8500 10.6694 0.0 0
M  V30 29 C 3.8500 8.0020 0.0 0
M  V30 30 C 2.3100 10.6694 0.0 0
M  V30 31 C 2.3100 8.0020 0.0 0
M  V30 32 C 1.5400 9.3356 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 26
M  V30 14 1 12 13
M  V30 15 1 14 32
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 16 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16083971
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C05E30, yield 95%. MW: 475.62
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME197 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 N 5.3900 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 13.0900 4.0009 0.0 0
M  V30 7 F 3.0800 0.0000 0.0 0
M  V30 8 C 8.4700 4.0009 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 9.2400 2.6673 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 10.7800 2.6673 0.0 0
M  V30 13 C 11.5500 4.0009 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 C 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0009 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(2-Fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1-...
C22H24FNO4S2
951645-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 4.0011 0.0 0 VAL=6
M  V30 2 O 9.2400 5.5411 0.0 0
M  V30 3 O 9.2400 2.4611 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 O 3.0800 1.3336 0.0 0
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 F 5.3900 8.0021 0.0 0
M  V30 8 S 3.0800 4.0011 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 0.0000 6.6684 0.0 0
M  V30 12 C 15.4000 4.0011 0.0 0
M  V30 13 N 7.7000 4.0011 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 5.3900 2.6674 0.0 0 CFG=1
M  V30 18 C 4.6200 4.0011 0.0 0 CFG=1
M  V30 19 C 7.7000 6.6684 0.0 0
M  V30 20 C 6.9300 8.0021 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 7.7000 9.3358 0.0 0
M  V30 23 C 10.0100 8.0021 0.0 0
M  V30 24 C 9.2400 9.3358 0.0 0
M  V30 25 C 10.7800 4.0011 0.0 0
M  V30 26 C 11.5500 5.3347 0.0 0
M  V30 27 C 11.5500 2.6674 0.0 0
M  V30 28 C 13.0900 5.3347 0.0 0
M  V30 29 C 13.0900 2.6674 0.0 0
M  V30 30 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 1 18 8 CFG=3
M  V30 11 1 9 10
M  V30 12 2 10 11
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-62-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-25-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16086998
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C10E30, yield 95%. MW: 449.56
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME198 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3,4,5-trimethoxyphenyl)methylene]benzenesulfonamide
C17H19NO5S
951762-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 2.6674 0.0 0
M  V30 3 O 2.3100 6.6685 0.0 0
M  V30 4 C 3.0800 8.0021 0.0 0
M  V30 5 O 2.3100 1.3336 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 N 7.7000 5.3347 0.0 0
M  V30 9 S 9.2400 5.3347 0.0 0 VAL=6
M  V30 10 O 9.2400 3.7947 0.0 0
M  V30 11 O 9.2400 6.8747 0.0 0
M  V30 12 C 15.4000 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 3.0800 2.6674 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 5.3900 4.0011 0.0 0
M  V30 19 C 10.7800 5.3347 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 11.5500 4.0011 0.0 0
M  V30 22 C 13.0900 6.6685 0.0 0
M  V30 23 C 13.0900 4.0011 0.0 0
M  V30 24 C 13.8600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 2 7 8
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 19
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Methylphenyl)sulfonyl]-4-(2-propen-1-ylthio)-6-(3,4,5-tr...
C25H31NO7S2
951645-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 6.4620 0.0 0
M  V30 3 O 6.1600 9.5420 0.0 0
M  V30 4 S 12.3200 8.0020 0.0 0
M  V30 5 C 13.0900 6.6684 0.0 0
M  V30 6 C 14.6300 6.6684 0.0 0
M  V30 7 C 15.4000 5.3347 0.0 0
M  V30 8 C 10.7800 10.6694 0.0 0
M  V30 9 O 10.0100 12.0031 0.0 0
M  V30 10 O 12.3200 10.6694 0.0 0
M  V30 11 O 3.8500 4.0011 0.0 0
M  V30 12 C 3.0800 2.6673 0.0 0
M  V30 13 O 8.4700 1.3336 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 O 5.3900 1.3336 0.0 0
M  V30 16 C 6.1600 0.0000 0.0 0
M  V30 17 C 0.0000 8.0020 0.0 0
M  V30 18 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 19 N 7.7000 8.0020 0.0 0
M  V30 20 C 10.0100 6.6684 0.0 0
M  V30 21 C 8.4700 9.3358 0.0 0
M  V30 22 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 23 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 24 C 7.7000 5.3347 0.0 0
M  V30 25 C 6.1600 5.3347 0.0 0
M  V30 26 C 8.4700 4.0011 0.0 0
M  V30 27 C 5.3900 4.0011 0.0 0
M  V30 28 C 7.7000 2.6673 0.0 0
M  V30 29 C 6.1600 2.6673 0.0 0
M  V30 30 C 4.6200 8.0020 0.0 0
M  V30 31 C 3.8500 6.6684 0.0 0
M  V30 32 C 3.8500 9.3358 0.0 0
M  V30 33 C 2.3100 6.6684 0.0 0
M  V30 34 C 2.3100 9.3358 0.0 0
M  V30 35 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 22 4 CFG=3
M  V30 7 1 5 6
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 23 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 11 27
M  V30 14 1 13 14
M  V30 15 1 13 28
M  V30 16 1 15 16
M  V30 17 1 15 29
M  V30 18 1 17 35
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 24 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 18 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-67-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-31-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16083551
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C25E30, yield 95%. MW: 521.65
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME199 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Chlorophenyl)sulfonyl]-6-(4-methylphenyl)-4-(2-propen-1-...
C22H24ClNO4S2
951645-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.6684 0.0 0 VAL=6
M  V30 2 O 6.1600 5.1284 0.0 0
M  V30 3 O 6.1600 8.2084 0.0 0
M  V30 4 C 10.7800 9.3358 0.0 0
M  V30 5 O 12.3200 9.3358 0.0 0
M  V30 6 O 10.0100 10.6694 0.0 0
M  V30 7 S 12.3200 6.6684 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 C 14.6300 5.3347 0.0 0
M  V30 10 C 15.4000 4.0011 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 Cl 0.0000 6.6684 0.0 0
M  V30 13 N 7.7000 6.6684 0.0 0
M  V30 14 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 15 C 8.4700 8.0021 0.0 0
M  V30 16 C 10.0100 5.3347 0.0 0
M  V30 17 C 10.0100 8.0021 0.0 0 CFG=1
M  V30 18 C 10.7800 6.6684 0.0 0 CFG=1
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 6.1600 4.0011 0.0 0
M  V30 21 C 8.4700 2.6673 0.0 0
M  V30 22 C 5.3900 2.6673 0.0 0
M  V30 23 C 7.7000 1.3336 0.0 0
M  V30 24 C 6.1600 1.3336 0.0 0
M  V30 25 C 4.6200 6.6684 0.0 0
M  V30 26 C 3.8500 5.3347 0.0 0
M  V30 27 C 3.8500 8.0021 0.0 0
M  V30 28 C 2.3100 5.3347 0.0 0
M  V30 29 C 2.3100 8.0021 0.0 0
M  V30 30 C 1.5400 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 18 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 24
M  V30 13 1 12 30
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-72-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-33-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16085055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C30E30, yield 95%. MW: 466.01
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME200 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methoxyphenyl)methylene]benzenesulfonamide
C14H12ClNO3S
951762-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 0.2062 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 2.3100 0.2062 0.0 0
M  V30 13 C 2.3100 2.8736 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 4.2073 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 12.3200 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-1-[(4-Chlorophenyl)sulfonyl]-6-(4-methoxyphenyl)-4-(2-propen-1...
C22H24ClNO5S2
951645-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.0020 0.0 0 VAL=6
M  V30 2 O 6.1600 9.5420 0.0 0
M  V30 3 O 6.1600 6.4620 0.0 0
M  V30 4 C 10.7800 10.6694 0.0 0
M  V30 5 O 12.3200 10.6694 0.0 0
M  V30 6 O 10.0100 12.0031 0.0 0
M  V30 7 S 12.3200 8.0020 0.0 0
M  V30 8 C 13.0900 6.6684 0.0 0
M  V30 9 C 14.6300 6.6684 0.0 0
M  V30 10 C 15.4000 5.3347 0.0 0
M  V30 11 O 5.3900 1.3336 0.0 0
M  V30 12 C 6.1600 0.0000 0.0 0
M  V30 13 Cl 0.0000 8.0020 0.0 0
M  V30 14 N 7.7000 8.0020 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0 CFG=2
M  V30 16 C 8.4700 9.3358 0.0 0
M  V30 17 C 10.0100 6.6684 0.0 0
M  V30 18 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 19 C 10.7800 8.0020 0.0 0 CFG=1
M  V30 20 C 7.7000 5.3347 0.0 0
M  V30 21 C 8.4700 4.0011 0.0 0
M  V30 22 C 6.1600 5.3347 0.0 0
M  V30 23 C 7.7000 2.6673 0.0 0
M  V30 24 C 5.3900 4.0011 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 4.6200 8.0020 0.0 0
M  V30 27 C 3.8500 9.3358 0.0 0
M  V30 28 C 3.8500 6.6684 0.0 0
M  V30 29 C 2.3100 9.3358 0.0 0
M  V30 30 C 2.3100 6.6684 0.0 0
M  V30 31 C 1.5400 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 20 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 15 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-77-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-35-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16082272
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C37E30, yield 95%. MW: 482.01
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME201 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]-2-methylbenzenesulfonamide
C15H15NO3S
951762-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 O 13.0900 4.0011 0.0 0
M  V30 8 C 13.8600 5.3349 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 0.7700 1.3338 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.0000 2.6674 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 10.7800 2.6674 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methoxyphenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen-1...
C23H27NO5S2
951645-36-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.0020 0.0 0 VAL=6
M  V30 2 O 4.6200 6.4620 0.0 0
M  V30 3 O 4.6200 9.5420 0.0 0
M  V30 4 S 10.7800 8.0020 0.0 0
M  V30 5 C 11.5500 6.6684 0.0 0
M  V30 6 C 13.0900 6.6684 0.0 0
M  V30 7 C 13.8600 5.3347 0.0 0
M  V30 8 C 9.2400 10.6694 0.0 0
M  V30 9 O 8.4700 12.0031 0.0 0
M  V30 10 O 10.7800 10.6694 0.0 0
M  V30 11 C 3.0800 10.6694 0.0 0
M  V30 12 O 3.8500 1.3336 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 6.9300 6.6684 0.0 0 CFG=2
M  V30 15 N 6.1600 8.0020 0.0 0
M  V30 16 C 8.4700 6.6684 0.0 0
M  V30 17 C 6.9300 9.3358 0.0 0
M  V30 18 C 9.2400 8.0020 0.0 0 CFG=1
M  V30 19 C 8.4700 9.3358 0.0 0 CFG=1
M  V30 20 C 6.1600 5.3347 0.0 0
M  V30 21 C 6.9300 4.0011 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 6.1600 2.6673 0.0 0
M  V30 24 C 3.8500 4.0011 0.0 0
M  V30 25 C 4.6200 2.6673 0.0 0
M  V30 26 C 3.0800 8.0020 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 28 C 2.3100 6.6684 0.0 0
M  V30 29 C 0.7700 9.3358 0.0 0
M  V30 30 C 0.7700 6.6684 0.0 0
M  V30 31 C 0.0000 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 19 8 CFG=1
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-78-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-36-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16076207
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C38E30, yield 95%. MW: 461.59
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME202 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methylphenyl)-1-[(2-methylphenyl)sulfonyl]-4-(2-propen-1-...
C23H27NO4S2
951645-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.6684 0.0 0 VAL=6
M  V30 2 O 4.6200 5.1284 0.0 0
M  V30 3 O 4.6200 8.2084 0.0 0
M  V30 4 C 9.2400 9.3358 0.0 0
M  V30 5 O 8.4700 10.6694 0.0 0
M  V30 6 O 10.7800 9.3358 0.0 0
M  V30 7 S 10.7800 6.6684 0.0 0
M  V30 8 C 11.5500 5.3347 0.0 0
M  V30 9 C 13.0900 5.3347 0.0 0
M  V30 10 C 13.8600 4.0011 0.0 0
M  V30 11 C 3.0800 9.3358 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 N 6.1600 6.6684 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0 CFG=2
M  V30 15 C 6.9300 8.0021 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 8.4700 8.0021 0.0 0 CFG=1
M  V30 18 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 19 C 6.1600 4.0011 0.0 0
M  V30 20 C 4.6200 4.0011 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 3.8500 2.6673 0.0 0
M  V30 23 C 6.1600 1.3336 0.0 0
M  V30 24 C 4.6200 1.3336 0.0 0
M  V30 25 C 3.0800 6.6684 0.0 0
M  V30 26 C 2.3100 8.0021 0.0 0
M  V30 27 C 2.3100 5.3347 0.0 0
M  V30 28 C 0.7700 8.0020 0.0 0
M  V30 29 C 0.7700 5.3347 0.0 0
M  V30 30 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 18 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 11 26
M  V30 13 1 12 24
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 19 CFG=1
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-79-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-39-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16071557
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C41E30, yield 95%. MW: 445.59
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME203 STEP1
$RXN



  3  1
$MOL
2-Methyl-2,3-butadienoic acid
C5H6O2
18913-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methylphenyl)methylene]methanesulfonamide
C9H11NO2S
951762-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0
M  V30 3 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 3.0800 0.0 0
M  V30 7 C 10.0100 2.8736 0.0 0
M  V30 8 C 5.3900 2.8736 0.0 0
M  V30 9 C 6.1600 4.2073 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 7.7000 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4S,6R)-6-(4-Methylphenyl)-1-(methylsulfonyl)-4-(2-propen-1-ylthio)-3-...
C17H23NO4S2
951645-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3900 9.3358 0.0 0 VAL=6
M  V30 2 C 6.1600 10.6694 0.0 0
M  V30 3 O 4.0564 10.1058 0.0 0
M  V30 4 O 6.7236 8.5658 0.0 0
M  V30 5 S 2.3100 4.0011 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 C 0.7700 6.6684 0.0 0
M  V30 10 O 0.0000 8.0021 0.0 0
M  V30 11 O 0.0000 5.3347 0.0 0
M  V30 12 C 11.5500 6.6684 0.0 0
M  V30 13 C 5.3900 6.6684 0.0 0 CFG=2
M  V30 14 N 4.6200 8.0021 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 3.0800 8.0021 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0 CFG=1
M  V30 18 C 2.3100 6.6684 0.0 0 CFG=1
M  V30 19 C 6.9300 6.6684 0.0 0
M  V30 20 C 7.7000 8.0021 0.0 0
M  V30 21 C 7.7000 5.3347 0.0 0
M  V30 22 C 9.2400 8.0021 0.0 0
M  V30 23 C 9.2400 5.3347 0.0 0
M  V30 24 C 10.0100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 5 6
M  V30 6 1 17 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 12 24
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19 CFG=3
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 18913-36-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-83-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951645-41-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-244-CAS-16091308
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. B01C46E30, yield 95%. MW: 369.5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
(2E)-2-(Cyclohexylmethylene)-1-phenyl-1-hexanone
C19H26O
1939157-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 3.0800 5.3347 0.0 0
M  V30 3 C 5.3900 6.6684 0.0 0
M  V30 4 C 5.3900 4.0011 0.0 0
M  V30 5 O 2.3100 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 5.3900 1.3336 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 C 2.3100 6.6684 0.0 0
M  V30 10 C 3.0800 8.0021 0.0 0
M  V30 11 C 0.7700 6.6684 0.0 0
M  V30 12 C 2.3100 9.3358 0.0 0
M  V30 13 C 0.0000 8.0021 0.0 0
M  V30 14 C 0.7700 9.3358 0.0 0
M  V30 15 C 6.9300 6.6684 0.0 0
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 9.2400 8.0021 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 10.0100 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 9
M  V30 6 1 3 15
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-2-[(S)-Cyclohexyl[(1-methylethyl)thio]methyl]-1-phenyl-1-hexanone
C22H34OS
1939157-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 3 S 4.0012 2.3101 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 5.3348 6.1601 0.0 0
M  V30 6 C 2.6673 1.5400 0.0 0
M  V30 7 O 6.6685 2.3101 0.0 0
M  V30 8 C 6.6685 6.9302 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 6.6685 8.4702 0.0 0
M  V30 12 C 5.3348 9.2402 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 15 C 2.6673 6.1601 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 1.3337 6.9302 0.0 0
M  V30 18 C 0.0000 6.1601 0.0 0
M  V30 19 C 8.0023 4.6201 0.0 0
M  V30 20 C 9.3360 3.8501 0.0 0
M  V30 21 C 8.0023 6.1601 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 9.3360 6.9302 0.0 0
M  V30 24 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 1 4 19
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 8 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1939157-18-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1939157-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-15729442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1289400-89-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, syn:anti >50:1, sulfa-Michael addition, catalyst
prepared and used, 96% ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Catalysis with Iron-Salen Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shaw, Subrata; White, James D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2016), 48(17), 2768-2780

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Lyxose
C5H10O5
1949-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=1
M  V30 2 C 2.6674 2.3100 0.0 0 CFG=1
M  V30 3 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 2.6674 3.8500 0.0 0
M  V30 7 C 6.6685 1.5400 0.0 0
M  V30 8 O 5.3347 3.8500 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 O 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=1
M  V30 8 1 5 9
M  V30 9 2 7 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
L-Lyxose, diethyl dithioacetal
C9H20O4S2
22249-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.8500 0.0 0
M  V30 2 C 5.3347 4.6200 0.0 0 CFG=2
M  V30 3 S 2.6673 4.6200 0.0 0
M  V30 4 S 4.0011 2.3100 0.0 0
M  V30 5 C 6.6684 3.8500 0.0 0 CFG=2
M  V30 6 O 5.3347 6.1600 0.0 0
M  V30 7 C 1.3336 3.8500 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 8.0021 4.6200 0.0 0 CFG=1
M  V30 10 O 6.6684 2.3100 0.0 0
M  V30 11 C 0.0000 4.6200 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 9.3358 3.8500 0.0 0
M  V30 14 O 8.0021 6.1600 0.0 0
M  V30 15 O 10.6694 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 5 10 CFG=1
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14 CFG=1
M  V30 14 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 5 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1949-78-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22249-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-22770978
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of L-glycero- and D-glycero-D-manno-Heptose Building Blocks for
Stereoselective Assembly of the Lipopolysaccharide Core Trisaccharide of
Vibrio parahemolyticus O2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Junchang; Rong, Jingjing; Lou, Qixin; Zhu, Yirong; Yang, You
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2020), 22(20), 8018-8022

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-[4-(phenylmethyl)-1-piperazinyl]benzaldehyde
C18H19ClN2O
199671-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 O 1.3337 5.3901 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 4.0010 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 4.0010 0.7700 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 N 5.3348 3.0801 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 6.6685 5.3901 0.0 0
M  V30 16 N 8.0022 4.6201 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 13.3370 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 16
M  V30 5 1 4 17
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1,1-Dimethylethyl)thio]-6-[4-(phenylmethyl)-1-piperazinyl]benzaldehyde
C22H28N2OS
2091105-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 O 4.0011 5.3901 0.0 0
M  V30 3 S 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 2.1038 0.9764 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 0.5638 3.6437 0.0 0
M  V30 8 C 12.0034 5.3901 0.0 0
M  V30 9 C 6.6686 2.3100 0.0 0
M  V30 10 C 5.3348 3.0800 0.0 0
M  V30 11 C 6.6686 0.7700 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0011 0.7700 0.0 0
M  V30 15 N 8.0022 3.0800 0.0 0
M  V30 16 C 9.3359 2.3100 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 10.6697 3.0800 0.0 0
M  V30 19 C 9.3359 5.3901 0.0 0
M  V30 20 N 10.6697 4.6201 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 14.6707 5.3901 0.0 0
M  V30 23 C 13.3370 3.0800 0.0 0
M  V30 24 C 16.0045 4.6201 0.0 0
M  V30 25 C 14.6707 2.3100 0.0 0
M  V30 26 C 16.0045 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 20
M  V30 9 1 8 21
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 199671-87-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2091105-89-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-19501631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of benzothiophene derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Perez Encabo, Alfonso; Turiel Hernandez, Jose Angel; Fernandez Sainz,
Yolanda; Lorente Bonde-Larsen, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017055543 A1 2017-04-06

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-[4-(phenylmethyl)-1-piperazinyl]benzaldehyde
C18H19ClN2O
199671-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0
M  V30 2 O 1.3337 5.3901 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 4.0010 2.3101 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 4.0010 0.7700 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 N 5.3348 3.0801 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 C 6.6685 5.3901 0.0 0
M  V30 16 N 8.0022 4.6201 0.0 0
M  V30 17 C 10.6697 4.6201 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 20 C 12.0033 2.3101 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 13.3370 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 1 4 16
M  V30 5 1 4 17
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1,1-Dimethylethyl)thio]-6-[4-(phenylmethyl)-1-piperazinyl]benzaldehyde
C22H28N2OS
2091105-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 O 4.0011 5.3901 0.0 0
M  V30 3 S 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 2.1038 0.9764 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 0.5638 3.6437 0.0 0
M  V30 8 C 12.0034 5.3901 0.0 0
M  V30 9 C 6.6686 2.3100 0.0 0
M  V30 10 C 5.3348 3.0800 0.0 0
M  V30 11 C 6.6686 0.7700 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 C 4.0011 0.7700 0.0 0
M  V30 15 N 8.0022 3.0800 0.0 0
M  V30 16 C 9.3359 2.3100 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 10.6697 3.0800 0.0 0
M  V30 19 C 9.3359 5.3901 0.0 0
M  V30 20 N 10.6697 4.6201 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 14.6707 5.3901 0.0 0
M  V30 23 C 13.3370 3.0800 0.0 0
M  V30 24 C 16.0045 4.6201 0.0 0
M  V30 25 C 14.6707 2.3100 0.0 0
M  V30 26 C 16.0045 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 20
M  V30 9 1 8 21
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 199671-87-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2091105-89-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-19555367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of benzothiophene derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Perez Encabo, Alfonso; Turiel Hernandez, Jose Angel; Fernandez Sainz,
Yolanda; Lorente Bonde-Larsen, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3150591 A1 2017-04-05

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,4,5-Tetrabromo-3,6-didodecylbenzene
C30H50Br4
201812-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.6708 4.6201 0.0 0
M  V30 2 C 13.3370 3.8501 0.0 0
M  V30 3 C 12.0033 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 C 9.3358 4.6201 0.0 0
M  V30 6 C 8.0022 3.8501 0.0 0
M  V30 7 C 6.6685 4.6201 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0010 4.6201 0.0 0
M  V30 10 C 2.6673 3.8501 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 Br 17.3382 6.1601 0.0 0
M  V30 14 Br 14.6708 1.5400 0.0 0
M  V30 15 Br 20.0057 4.6201 0.0 0
M  V30 16 Br 17.3382 0.0000 0.0 0
M  V30 17 C 20.0057 1.5400 0.0 0
M  V30 18 C 21.3393 2.3101 0.0 0
M  V30 19 C 22.6730 1.5400 0.0 0
M  V30 20 C 24.0067 2.3101 0.0 0
M  V30 21 C 25.3405 1.5400 0.0 0
M  V30 22 C 26.6742 2.3101 0.0 0
M  V30 23 C 28.0078 1.5400 0.0 0
M  V30 24 C 29.3415 2.3101 0.0 0
M  V30 25 C 30.6753 1.5400 0.0 0
M  V30 26 C 32.0090 2.3101 0.0 0
M  V30 27 C 33.3427 1.5400 0.0 0
M  V30 28 C 34.6763 2.3101 0.0 0
M  V30 29 C 16.0045 3.8501 0.0 0
M  V30 30 C 17.3382 4.6201 0.0 0
M  V30 31 C 16.0045 2.3101 0.0 0
M  V30 32 C 18.6718 3.8501 0.0 0
M  V30 33 C 17.3382 1.5400 0.0 0
M  V30 34 C 18.6718 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 29
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 30
M  V30 14 1 14 31
M  V30 15 1 15 32
M  V30 16 1 16 33
M  V30 17 1 17 18
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 2 29 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 2 31 33
M  V30 33 2 32 34
M  V30 34 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Dibromo-2,5-didodecyl-3,6-bis[(1-methylethyl)thio]benzene
C36H64Br2S2
1043877-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.6708 6.9302 0.0 0
M  V30 2 C 13.3370 6.1601 0.0 0
M  V30 3 C 12.0033 6.9302 0.0 0
M  V30 4 C 10.6697 6.1601 0.0 0
M  V30 5 C 9.3358 6.9302 0.0 0
M  V30 6 C 8.0022 6.1601 0.0 0
M  V30 7 C 6.6685 6.9302 0.0 0
M  V30 8 C 5.3348 6.1601 0.0 0
M  V30 9 C 4.0010 6.9302 0.0 0
M  V30 10 C 2.6673 6.1601 0.0 0
M  V30 11 C 1.3337 6.9302 0.0 0
M  V30 12 C 0.0000 6.1601 0.0 0
M  V30 13 S 17.3382 8.4702 0.0 0
M  V30 14 C 18.6718 9.2402 0.0 0
M  V30 15 C 18.6718 10.7802 0.0 0
M  V30 16 C 20.0057 8.4702 0.0 0
M  V30 17 Br 14.6708 3.8501 0.0 0
M  V30 18 Br 20.0057 6.9302 0.0 0
M  V30 19 S 17.3382 2.3101 0.0 0
M  V30 20 C 16.0045 1.5400 0.0 0
M  V30 21 C 14.6708 2.3101 0.0 0
M  V30 22 C 16.0045 0.0000 0.0 0
M  V30 23 C 20.0057 3.8501 0.0 0
M  V30 24 C 21.3393 4.6201 0.0 0
M  V30 25 C 22.6730 3.8501 0.0 0
M  V30 26 C 24.0067 4.6201 0.0 0
M  V30 27 C 25.3405 3.8501 0.0 0
M  V30 28 C 26.6742 4.6201 0.0 0
M  V30 29 C 28.0078 3.8501 0.0 0
M  V30 30 C 29.3415 4.6201 0.0 0
M  V30 31 C 30.6753 3.8501 0.0 0
M  V30 32 C 32.0090 4.6201 0.0 0
M  V30 33 C 33.3427 3.8501 0.0 0
M  V30 34 C 34.6763 4.6201 0.0 0
M  V30 35 C 16.0045 6.1601 0.0 0
M  V30 36 C 17.3382 6.9302 0.0 0
M  V30 37 C 16.0045 4.6201 0.0 0
M  V30 38 C 18.6718 6.1601 0.0 0
M  V30 39 C 17.3382 3.8501 0.0 0
M  V30 40 C 18.6718 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 35
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 36
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 17 37
M  V30 18 1 18 38
M  V30 19 1 19 20
M  V30 20 1 19 39
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 23 24
M  V30 24 1 23 40
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 2 35 36
M  V30 36 1 35 37
M  V30 37 1 36 38
M  V30 38 2 37 39
M  V30 39 2 38 40
M  V30 40 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 201812-92-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1043877-65-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-7559373
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Compound 3c. 2-propanethiol (2.98mL, 0.032mol)
was added drop-wise into an oven-dried Schlenk flask containing sodium
hydride (0.897g, 0.022mol) and anhydrous DMF (30mL). After stirring for
30min, compound 4a (6.00g, 0.0107mol) was added and the whole was sparged
with argon and then stirred at 50°C overnight. The whole was diluted with
pentane, treated with 10% KOH, and dried over anhydrous magnesium
sulfate, and concentrated via rotary evaporation to yield compound 3c as
a pale yellow solid (5.91g, 100%). Compound 3d. Prepared as described
above for 3c, but from 4b (2.00g, 2.738mmol), sodium hydride (0.23g,
5.75mmol), 2-propylthiol (0.625g, 8.21mmol), Yield (1.88g, 95.2%). 1H NMR
(400MHz, CDCl3) δ : 3.52 (sept, 2H), 3.29 (t, 4H), 1.52 (m, 4H), 1.43 (m,
4H), 1.37-1.23 (overlapping br, m, and d 44H), 0.89 (t, 6H). 13C NMR
(100MHz, CDCl3) δ : 147.51, 137.58, 134.71, 40.45, 39.52, 31.93, 29.82,
29.71, 29.68, 29.66, 29.59, 29.55, 29.36, 29.29, 22.97, 22.70, 14.12..
GC-MS: m/z: 720 (C36H64Br2S2 +), 468(100%). MP:64°C.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Fluorinated Benzobisbenzothiophenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Yongfeng; Parkin, Sean R.; Gierschner, Johannes; Watson, Mark D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(15), 3307-3310

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
(-)-Methoxyphenylacetic acid
C9H10O3
3966-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0 CFG=1
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 O 1.5400 4.0010 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 C 0.0000 4.0010 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 6.1601 4.0010 0.0 0
M  V30 11 C 6.1601 1.3337 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Butanethiol, (2S)-
C4H10S
20407-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0 CFG=1
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-[(1S)-1-Methylpropyl] (αR)-α-methoxybenzeneethanethioate
C13H18O2S
960500-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0 CFG=1
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 S 6.6684 2.3100 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 C 8.0022 3.0800 0.0 0 CFG=1
M  V30 8 C 9.3359 2.3100 0.0 0
M  V30 9 C 8.0022 4.6201 0.0 0
M  V30 10 C 10.6695 3.0800 0.0 0
M  V30 11 C 2.6673 3.0800 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3966-32-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20407-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 960500-90-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-1504597
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing chiral derivatizing agents (CDA) for the NMR assignment of the
absolute configuration: a theoretical and experimental approach with
thiols as a case study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Porto, Silvia; Quinoa, Emilio; Riguera, Ricardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(20), 3276-3283

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
(-)-Methoxyphenylacetic acid
C9H10O3
3966-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0 CFG=1
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 O 1.5400 4.0010 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 0.0000 1.3337 0.0 0
M  V30 6 C 0.0000 4.0010 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 6.1601 4.0010 0.0 0
M  V30 11 C 6.1601 1.3337 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Butanethiol, (2S)-
C4H10S
20407-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0 CFG=1
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-[(1S)-1-Methylpropyl] (αS)-α-methoxybenzeneethanethioate
C13H18O2S
960500-91-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 S 6.6684 2.3100 0.0 0
M  V30 5 O 5.3348 4.6201 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 C 8.0022 3.0800 0.0 0 CFG=1
M  V30 8 C 9.3359 2.3100 0.0 0
M  V30 9 C 8.0022 4.6201 0.0 0
M  V30 10 C 10.6695 3.0800 0.0 0
M  V30 11 C 2.6673 3.0800 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 1.3337 2.3100 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 1 7 9 CFG=1
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3966-32-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20407-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 960500-91-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-1063101
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing chiral derivatizing agents (CDA) for the NMR assignment of the
absolute configuration: a theoretical and experimental approach with
thiols as a case study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Porto, Silvia; Quinoa, Emilio; Riguera, Ricardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(20), 3276-3283

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
2-Butanethiol, (2S)-
C4H10S
20407-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0 CFG=1
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-(1,1-Dimethylethoxy)benzeneacetic acid
C12H16O3
960500-73-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0 CFG=2
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 C 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 O 3.8500 5.5409 0.0 0
M  V30 6 O 1.5400 4.2073 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 1.5400 3.0800 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-[(1S)-1-Methylpropyl] (αR)-α-(1,1-dimethylethoxy)benzeneethanethioate
C16H24O2S
960501-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.6437 0.0 0 CFG=1
M  V30 2 C 5.3348 4.4137 0.0 0
M  V30 3 O 4.0012 2.1037 0.0 0
M  V30 4 S 6.6685 3.6437 0.0 0
M  V30 5 O 5.3348 5.9538 0.0 0
M  V30 6 C 2.6673 1.3337 0.0 0
M  V30 7 C 8.0023 4.4137 0.0 0 CFG=1
M  V30 8 C 3.4374 0.0000 0.0 0
M  V30 9 C 1.3337 0.5637 0.0 0
M  V30 10 C 1.8973 2.6673 0.0 0
M  V30 11 C 9.3360 3.6437 0.0 0
M  V30 12 C 8.0023 5.9538 0.0 0
M  V30 13 C 10.6697 4.4137 0.0 0
M  V30 14 C 2.6673 4.4137 0.0 0
M  V30 15 C 1.3337 3.6437 0.0 0
M  V30 16 C 2.6673 5.9538 0.0 0
M  V30 17 C 0.0000 4.4137 0.0 0
M  V30 18 C 1.3337 6.7238 0.0 0
M  V30 19 C 0.0000 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12 CFG=1
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 20407-74-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960500-73-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 960501-12-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-12313310
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing chiral derivatizing agents (CDA) for the NMR assignment of the
absolute configuration: a theoretical and experimental approach with
thiols as a case study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Porto, Silvia; Quinoa, Emilio; Riguera, Ricardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(20), 3276-3283

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
2-Butanethiol, (2S)-
C4H10S
20407-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0 CFG=1
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-(1,1-Dimethylethoxy)-2-naphthaleneacetic acid
C16H18O3
960500-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.6673 0.0 0 CFG=2
M  V30 2 O 3.0800 4.0009 0.0 0
M  V30 3 C 3.0800 1.3336 0.0 0
M  V30 4 C 1.5400 4.0009 0.0 0
M  V30 5 O 3.8500 0.0000 0.0 0
M  V30 6 O 1.5400 1.3336 0.0 0
M  V30 7 C 1.5400 2.4609 0.0 0
M  V30 8 C 0.0000 4.0009 0.0 0
M  V30 9 C 1.5400 5.5409 0.0 0
M  V30 10 C 5.3900 2.6673 0.0 0
M  V30 11 C 6.1600 4.0009 0.0 0
M  V30 12 C 6.1600 1.3336 0.0 0
M  V30 13 C 7.7000 4.0009 0.0 0
M  V30 14 C 7.7000 1.3336 0.0 0
M  V30 15 C 8.4700 2.6673 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 10.0100 2.6673 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 19 C 10.7800 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 15
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-[(1S)-1-Methylpropyl] (αR)-α-(1,1-dimethylethoxy)-2-naphthaleneethanethioate
C20H26O2S
960501-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 4.0011 0.0 0 CFG=1
M  V30 2 C 7.7001 5.3348 0.0 0
M  V30 3 O 7.7001 2.6675 0.0 0
M  V30 4 S 9.2401 5.3348 0.0 0
M  V30 5 O 6.9301 6.6686 0.0 0
M  V30 6 C 6.9301 1.3337 0.0 0
M  V30 7 C 10.0101 6.6686 0.0 0 CFG=1
M  V30 8 C 5.5964 2.1037 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 8.2637 0.5636 0.0 0
M  V30 11 C 11.5501 6.6686 0.0 0
M  V30 12 C 9.2401 8.0022 0.0 0
M  V30 13 C 12.3201 8.0022 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 4.6201 5.3348 0.0 0
M  V30 16 C 4.6201 2.6675 0.0 0
M  V30 17 C 3.0800 5.3348 0.0 0
M  V30 18 C 3.0800 2.6675 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 6.6686 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.7700 6.6686 0.0 0
M  V30 23 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12 CFG=1
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 17 20
M  V30 20 1 18 19
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 20407-74-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960500-75-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 960501-14-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-14442763
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing chiral derivatizing agents (CDA) for the NMR assignment of the
absolute configuration: a theoretical and experimental approach with
thiols as a case study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Porto, Silvia; Quinoa, Emilio; Riguera, Ricardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(20), 3276-3283

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Piperidinylsulfonyl)-3-(2-propen-1-yl)pyridine
C13H18N2O2S
2064141-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 5.3349 0.0 0 VAL=6
M  V30 2 O 4.6200 6.8749 0.0 0
M  V30 3 O 4.6200 3.7949 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 2.3100 6.6685 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.7700 6.6685 0.0 0
M  V30 12 C 0.0000 5.3349 0.0 0
M  V30 13 N 6.1600 5.3349 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 6.9300 6.6685 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 8.4700 6.6685 0.0 0
M  V30 18 C 9.2400 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 13
M  V30 5 1 4 5
M  V30 6 1 4 8
M  V30 7 2 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1-Methylethyl)thio]-3-(2-propen-1-yl)pyridine
C11H15NS
2376281-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 1.5400 0.0 0
M  V30 3 C 0.0000 2.3100 0.0 0
M  V30 4 C 1.3336 0.0000 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 N 1.3336 4.6200 0.0 0
M  V30 11 C 4.0011 6.1600 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 2 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2064141-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376281-14-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28322705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 745038-86-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiolation of Pyridine-2-sulfonamides using Magnesium Thiolates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heinz, Benjamin; Balkenhohl, Moritz; Knochel, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2019), 51(23), 4452-4462

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
3-Methyl-2-butanethiol
C5H12S
2084-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 S 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-3,4-dinitro-1H-pyrazole
C4H4N4O4
66296-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.8385 0.0 0 VAL=5
M  V30 2 O 1.3337 6.3785 0.0 0
M  V30 3 O 0.0000 4.0685 0.0 0
M  V30 4 N 1.6839 1.5063 0.0 0 VAL=5
M  V30 5 O 0.2193 1.9823 0.0 0
M  V30 6 O 2.0040 0.0000 0.0 0
M  V30 7 C 6.6363 3.7113 0.0 0
M  V30 8 C 2.6673 4.0685 0.0 0
M  V30 9 C 2.8284 2.5369 0.0 0
M  V30 10 C 4.0743 4.6948 0.0 0
M  V30 11 N 4.3347 2.2167 0.0 0
M  V30 12 N 5.1048 3.5504 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1,2-Dimethylpropyl)thio]-1-methyl-3-nitro-1H-pyrazole
C9H15N3O2S
1890144-74-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5063 4.9524 0.0 0 VAL=5
M  V30 2 O 0.0000 4.6323 0.0 0
M  V30 3 O 1.9823 6.4170 0.0 0
M  V30 4 S 4.8385 5.3026 0.0 0
M  V30 5 C 6.3785 5.3026 0.0 0
M  V30 6 C 7.1485 6.6363 0.0 0
M  V30 7 C 7.1485 3.9690 0.0 0
M  V30 8 C 6.3785 7.9700 0.0 0
M  V30 9 C 8.6886 6.6363 0.0 0
M  V30 10 C 3.7113 0.0000 0.0 0
M  V30 11 C 2.5369 3.8079 0.0 0
M  V30 12 C 4.0685 3.9690 0.0 0
M  V30 13 N 2.2167 2.3016 0.0 0
M  V30 14 C 4.6948 2.5620 0.0 0
M  V30 15 N 3.5504 1.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 15
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2084-18-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 66296-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1890144-74-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-21169583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as
potent anaplastic lymphoma kinase (ALK) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Peilong; Dong, Jiaqiang; Zhong, Boyu; Zhang, Deyi; Yuan, Hongbin;
Jin, Can; Xu, Xiangyuan; Li, Hailong; Zhou, Yong; Liang, Zhi; Ji,
Minghua; Xu, Tao; Song, Guowei; Zhang, Ling; Chen, Gang; Meng, Xuejing;
Sun, Desheng; Shih, Joe; Zhang, Ruihao; Hou, Guojun; Wang, Chengcheng;
Jin, Ying; Yang, Qiong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(8), 1910-1918

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-Cinnamyl acetate
C11H12O2
21040-45-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 O 9.3360 0.0000 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[(1E)-3-(Ethylthio)-1-propen-1-yl]benzene
C11H14S
59277-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 S 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 0.7700 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21040-45-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59277-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-10033360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14839-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical experimental procedure for the
formation of primary allylic sulfides 3: benzenethiol (4a) (0.99 M in
DMF, 0.36 mL, 0.36 mmol) was added to a flask charged with sodium hydride
(55 wt% in mineral oil, 16 mg, 0.36 mmol) under argon and the mixture was
stirred for 10 min at room temperature. Tetrakis(triethyl
phosphite)nickel(0) (1) (11 mg, 0.015 mmol), THF (1.2 mL), and a DMF (0.3
mL) solution of (E)-3-phenyl-2-propenyl acetate (2a) (53 mg, 0.3 mmol)
were successively added to the mixture, which was refluxed for 20 h. The
reaction was quenched by addition of 1M NaOH and organic materials were
extracted with ether. The organic layer was washed with 1M NaOH and dried
over Na2SO4. The solvent was evaporated under reduced pressure and the
residue was purified by PTLC (hexane) to afford 3a (65 mg, 96%). When
alkanethiols were used instead of benzenethiol, the reaction was carried
out at 50 °C for 20 h and quenched by addition of 1M KOH.
(E)-3-(Ethylthio)-1-phenylpropene (3b)3. IR (neat) 3026, 2966, 2945,
1448, 1219, 963, 750, 691; 1H NMR 1.26 (t, J = 7.4 Hz, 3H), 2.52 (q, J =
7.4 Hz, 2H), 3.32 (d, J = 7.2 Hz, 2H), 6.19 (dt, J = 15.2, 7.5 Hz, 1H),
6.43 (d, J = 15.9 Hz, 1H), 7.23-7.43 (m, 5H); 13C NMR 14.5, 24.5, 33.8,
126.1, 126.2, 127.5, 128.5, 131.8, 136.7.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel(0) Triethyl Phosphite Complex-Catalyzed Allylic Substitution with
Retention of Regio- and Stereochemistry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yatsumonji, Yasutaka; Ishida, Yusuke; Tsubouchi, Akira; Takeda, Takeshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2007), 9(22), 4603-4606

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonamide, N-[3-O-[4-O-benzoyl-6-deoxy-2,3-bis-O-(phenylmethyl)-α-L-...
C56H70INO12SSi
210427-12-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  72 78 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6694 10.0100 0.0 0
M  V30 2 O 13.3369 11.5500 0.0 0
M  V30 3 C 14.6705 12.3200 0.0 0
M  V30 4 I 8.0020 11.5500 0.0 0
M  V30 5 C 13.3369 14.6300 0.0 0
M  V30 6 O 13.3369 16.1700 0.0 0
M  V30 7 Si 14.6705 16.9400 0.0 0
M  V30 8 C 16.0041 17.7100 0.0 0
M  V30 9 C 13.9005 18.2736 0.0 0
M  V30 10 C 15.4405 15.6064 0.0 0
M  V30 11 C 17.3378 16.9400 0.0 0
M  V30 12 C 16.0041 19.2500 0.0 0
M  V30 13 C 14.6705 19.6073 0.0 0
M  V30 14 C 12.3605 18.2736 0.0 0
M  V30 15 C 16.9805 15.6064 0.0 0
M  V30 16 C 14.6705 14.2726 0.0 0
M  V30 17 N 8.0021 14.6300 0.0 0
M  V30 18 S 8.0021 16.1700 0.0 0 VAL=6
M  V30 19 O 9.5421 16.1700 0.0 0
M  V30 20 O 6.4621 16.1700 0.0 0
M  V30 21 O 10.6694 6.9300 0.0 0
M  V30 22 C 10.6694 5.3900 0.0 0
M  V30 23 O 8.0020 5.3900 0.0 0
M  V30 24 C 6.6684 4.6200 0.0 0
M  V30 25 C 5.3347 10.0100 0.0 0
M  V30 26 O 5.3347 6.9300 0.0 0
M  V30 27 C 4.0011 7.7000 0.0 0
M  V30 28 O 4.0011 9.2400 0.0 0
M  V30 29 O 20.0052 9.2400 0.0 0
M  V30 30 C 21.3389 10.0100 0.0 0
M  V30 31 C 10.6694 11.5500 0.0 0 CFG=2
M  V30 32 C 12.0031 12.3200 0.0 0 CFG=2
M  V30 33 C 9.3358 12.3200 0.0 0 CFG=2
M  V30 34 C 12.0031 13.8600 0.0 0 CFG=1
M  V30 35 C 9.3358 13.8600 0.0 0 CFG=1
M  V30 36 O 10.6694 14.6300 0.0 0
M  V30 37 C 9.3358 9.2400 0.0 0 CFG=2
M  V30 38 C 9.3358 7.7000 0.0 0 CFG=1
M  V30 39 O 8.0020 10.0100 0.0 0
M  V30 40 C 8.0020 6.9300 0.0 0 CFG=2
M  V30 41 C 6.6684 9.2400 0.0 0 CFG=1
M  V30 42 C 6.6684 7.7000 0.0 0 CFG=2
M  V30 43 C 16.0041 11.5500 0.0 0
M  V30 44 C 17.3378 12.3200 0.0 0
M  V30 45 C 16.0041 10.0100 0.0 0
M  V30 46 C 18.6716 11.5500 0.0 0
M  V30 47 C 17.3378 9.2400 0.0 0
M  V30 48 C 18.6716 10.0100 0.0 0
M  V30 49 C 8.0021 17.7100 0.0 0
M  V30 50 C 9.3358 18.4800 0.0 0
M  V30 51 C 6.6684 18.4800 0.0 0
M  V30 52 C 9.3358 20.0200 0.0 0
M  V30 53 C 6.6684 20.0200 0.0 0
M  V30 54 C 8.0021 20.7900 0.0 0
M  V30 55 C 12.0031 4.6200 0.0 0
M  V30 56 C 13.3369 5.3900 0.0 0
M  V30 57 C 12.0031 3.0800 0.0 0
M  V30 58 C 14.6705 4.6200 0.0 0
M  V30 59 C 13.3367 2.3100 0.0 0
M  V30 60 C 14.6705 3.0800 0.0 0
M  V30 61 C 6.6684 3.0800 0.0 0
M  V30 62 C 5.3347 2.3100 0.0 0
M  V30 63 C 8.0020 2.3100 0.0 0
M  V30 64 C 5.3347 0.7700 0.0 0
M  V30 65 C 8.0020 0.7700 0.0 0
M  V30 66 C 6.6684 0.0000 0.0 0
M  V30 67 C 2.6673 6.9300 0.0 0
M  V30 68 C 1.3336 7.7000 0.0 0
M  V30 69 C 2.6673 5.3900 0.0 0
M  V30 70 C 0.0000 6.9300 0.0 0
M  V30 71 C 1.3336 4.6200 0.0 0
M  V30 72 C 0.0000 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 31 1 CFG=3
M  V30 2 1 37 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 32 2 CFG=1
M  V30 5 1 3 43
M  V30 6 1 33 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 34 5 CFG=3
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 1 7 9
M  V30 12 1 7 10
M  V30 13 1 8 11
M  V30 14 1 8 12
M  V30 15 1 9 13
M  V30 16 1 9 14
M  V30 17 1 10 15
M  V30 18 1 10 16
M  V30 19 1 17 18
M  V30 20 1 35 17 CFG=1
M  V30 21 2 18 19
M  V30 22 2 18 20
M  V30 23 1 18 49
M  V30 24 1 21 22
M  V30 25 1 38 21 CFG=1
M  V30 26 1 22 55
M  V30 27 1 23 24
M  V30 28 1 40 23 CFG=3
M  V30 29 1 24 61
M  V30 30 1 41 25 CFG=3
M  V30 31 1 26 27
M  V30 32 1 42 26 CFG=3
M  V30 33 2 27 28
M  V30 34 1 27 67
M  V30 35 1 29 30
M  V30 36 1 29 48
M  V30 37 1 31 32
M  V30 38 1 31 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 1 35 36
M  V30 43 1 37 38
M  V30 44 1 37 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 1 41 42
M  V30 49 2 43 44
M  V30 50 1 43 45
M  V30 51 1 44 46
M  V30 52 2 45 47
M  V30 53 2 46 48
M  V30 54 1 47 48
M  V30 55 2 49 50
M  V30 56 1 49 51
M  V30 57 1 50 52
M  V30 58 2 51 53
M  V30 59 2 52 54
M  V30 60 1 53 54
M  V30 61 2 55 56
M  V30 62 1 55 57
M  V30 63 1 56 58
M  V30 64 2 57 59
M  V30 65 2 58 60
M  V30 66 1 59 60
M  V30 67 2 61 62
M  V30 68 1 61 63
M  V30 69 1 62 64
M  V30 70 2 63 65
M  V30 71 2 64 66
M  V30 72 1 65 66
M  V30 73 2 67 68
M  V30 74 1 67 69
M  V30 75 1 68 70
M  V30 76 2 69 71
M  V30 77 2 70 72
M  V30 78 1 71 72
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 31 32 33 34 35 37 38 40 41 42)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethyl 3-O-[4-O-benzoyl-6-deoxy-2,3-bis-O-(phenylmethyl)-α-L-galactopyranosyl]...
C58H75NO12S2Si
210427-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  74 80 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 10.6695 9.2401 0.0 0
M  V30 2 O 13.3370 10.7801 0.0 0
M  V30 3 C 14.6707 11.5501 0.0 0
M  V30 4 N 8.0021 10.7801 0.0 0
M  V30 5 S 6.6684 11.5501 0.0 0 VAL=6
M  V30 6 O 7.4384 12.8838 0.0 0
M  V30 7 O 5.8984 10.2163 0.0 0
M  V30 8 C 13.3370 13.8602 0.0 0
M  V30 9 O 13.3370 15.4002 0.0 0
M  V30 10 Si 14.6707 16.1702 0.0 0
M  V30 11 C 16.0043 16.9402 0.0 0
M  V30 12 C 13.9007 17.5038 0.0 0
M  V30 13 C 15.4407 14.8364 0.0 0
M  V30 14 C 17.3380 16.1702 0.0 0
M  V30 15 C 16.0043 18.4802 0.0 0
M  V30 16 C 14.6707 18.8375 0.0 0
M  V30 17 C 12.3606 17.5038 0.0 0
M  V30 18 C 14.6707 13.5027 0.0 0
M  V30 19 C 16.9807 14.8364 0.0 0
M  V30 20 S 8.0021 13.8602 0.0 0
M  V30 21 C 8.0021 15.4002 0.0 0
M  V30 22 C 6.6684 16.1702 0.0 0
M  V30 23 O 10.6695 6.1601 0.0 0
M  V30 24 C 10.6695 4.6201 0.0 0
M  V30 25 O 8.0022 4.6201 0.0 0
M  V30 26 C 8.0022 3.0800 0.0 0
M  V30 27 C 5.3348 9.2401 0.0 0
M  V30 28 O 5.3348 6.1601 0.0 0
M  V30 29 C 4.0011 6.9301 0.0 0
M  V30 30 O 4.0011 8.4701 0.0 0
M  V30 31 O 20.0054 8.4701 0.0 0
M  V30 32 C 21.3391 9.2401 0.0 0
M  V30 33 C 10.6695 10.7801 0.0 0 CFG=2
M  V30 34 C 12.0032 11.5501 0.0 0 CFG=2
M  V30 35 C 9.3359 11.5501 0.0 0 CFG=1
M  V30 36 C 12.0032 13.0901 0.0 0 CFG=1
M  V30 37 C 9.3359 13.0901 0.0 0 CFG=2
M  V30 38 O 10.6695 13.8602 0.0 0
M  V30 39 C 9.3359 8.4701 0.0 0 CFG=2
M  V30 40 C 9.3359 6.9301 0.0 0 CFG=1
M  V30 41 O 8.0022 9.2401 0.0 0
M  V30 42 C 8.0021 6.1601 0.0 0 CFG=2
M  V30 43 C 6.6684 8.4701 0.0 0 CFG=1
M  V30 44 C 6.6684 6.9301 0.0 0 CFG=2
M  V30 45 C 16.0043 10.7801 0.0 0
M  V30 46 C 16.0043 9.2401 0.0 0
M  V30 47 C 17.3380 11.5501 0.0 0
M  V30 48 C 17.3380 8.4701 0.0 0
M  V30 49 C 18.6718 10.7801 0.0 0
M  V30 50 C 18.6718 9.2401 0.0 0
M  V30 51 C 5.3348 12.3201 0.0 0
M  V30 52 C 4.0011 11.5501 0.0 0
M  V30 53 C 5.3348 13.8602 0.0 0
M  V30 54 C 2.6673 12.3201 0.0 0
M  V30 55 C 4.0011 14.6302 0.0 0
M  V30 56 C 2.6673 13.8602 0.0 0
M  V30 57 C 12.0032 3.8500 0.0 0
M  V30 58 C 12.0032 2.3100 0.0 0
M  V30 59 C 13.3370 4.6201 0.0 0
M  V30 60 C 13.3370 1.5400 0.0 0
M  V30 61 C 14.6707 3.8500 0.0 0
M  V30 62 C 14.6707 2.3100 0.0 0
M  V30 63 C 6.6684 2.3100 0.0 0
M  V30 64 C 5.3348 3.0800 0.0 0
M  V30 65 C 6.6684 0.7700 0.0 0
M  V30 66 C 4.0011 2.3100 0.0 0
M  V30 67 C 5.3348 0.0000 0.0 0
M  V30 68 C 4.0011 0.7700 0.0 0
M  V30 69 C 2.6673 6.1601 0.0 0
M  V30 70 C 1.3337 6.9301 0.0 0
M  V30 71 C 2.6673 4.6201 0.0 0
M  V30 72 C 0.0000 6.1601 0.0 0
M  V30 73 C 1.3337 3.8500 0.0 0
M  V30 74 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 33 1 CFG=3
M  V30 2 1 39 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 34 2 CFG=1
M  V30 5 1 3 45
M  V30 6 1 4 5
M  V30 7 1 35 4 CFG=1
M  V30 8 2 5 6
M  V30 9 2 5 7
M  V30 10 1 5 51
M  V30 11 1 8 9
M  V30 12 1 36 8 CFG=3
M  V30 13 1 9 10
M  V30 14 1 10 11
M  V30 15 1 10 12
M  V30 16 1 10 13
M  V30 17 1 11 14
M  V30 18 1 11 15
M  V30 19 1 12 16
M  V30 20 1 12 17
M  V30 21 1 13 18
M  V30 22 1 13 19
M  V30 23 1 20 21
M  V30 24 1 37 20 CFG=3
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 40 23 CFG=1
M  V30 28 1 24 57
M  V30 29 1 25 26
M  V30 30 1 42 25 CFG=3
M  V30 31 1 26 63
M  V30 32 1 43 27 CFG=3
M  V30 33 1 28 29
M  V30 34 1 44 28 CFG=3
M  V30 35 2 29 30
M  V30 36 1 29 69
M  V30 37 1 31 32
M  V30 38 1 31 50
M  V30 39 1 33 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 1 37 38
M  V30 45 1 39 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 44
M  V30 51 2 45 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 2 47 49
M  V30 55 2 48 50
M  V30 56 1 49 50
M  V30 57 2 51 52
M  V30 58 1 51 53
M  V30 59 1 52 54
M  V30 60 2 53 55
M  V30 61 2 54 56
M  V30 62 1 55 56
M  V30 63 2 57 58
M  V30 64 1 57 59
M  V30 65 1 58 60
M  V30 66 2 59 61
M  V30 67 2 60 62
M  V30 68 1 61 62
M  V30 69 2 63 64
M  V30 70 1 63 65
M  V30 71 1 64 66
M  V30 72 2 65 67
M  V30 73 2 66 68
M  V30 74 1 67 68
M  V30 75 2 69 70
M  V30 76 1 69 71
M  V30 77 1 70 72
M  V30 78 2 71 73
M  V30 79 2 72 74
M  V30 80 1 73 74
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 33 34 35 36 37 39 40 42 43 44)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 210427-12-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 210427-10-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-041-CAS-11398801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 4039-32-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Thioglycoside 27. To a solution of iodosulfonamide 26 (0.515 g, 0.460
mmol) in dry DMF (1.5 mL) was added EtSH (0.170 mL, 2.30 mmol) at -40°C.
Immediately, LHMDS (1M in THF, 1.38 mL, 1.38 mmol) was added to the
reaction mixture at -40°C. The reaction mixture was stirred at -40 --15°C
for 30 min, allowed to warm to RT and stirred for additional 30 min. The
reaction mixture was diluted with EtOAc (30 mL), washed with sat.
NH4Cl(aq) (2 x 20 mL), H2O (3 x 20 mL), and brine (20 mL), dried over
Na2SO4 and concentrated to dryness. Careful flash chromatography of crude
material with 15% EtOAc in hexanes gave 27 (0.462 g, 95%) as a colorless
glass. [α]23 D = -76.6° (c 1.01, CHCl3); FTIR (CHCl3 film) 3200, 2940,
2866, 1722, 1612, 1515, 1453, 1321, 1271, 1159,1091 cm-1; 1H NMR (400
MHz, CDCl3) δ 8.11 (d, 2H, J =7.4 Hz), 7.61-7.55 (m, 3H), 7.50-7.18 (m,
17H), 6.90 (d, 2H, J = 8.5 Hz), 6.54 (d, 1H, J = 4.2 Hz), 5.74 (d, 1H, J
= 3.0 Hz), 5.57 (d, 1H, J = 3.4 Hz), 4.97 (d, 1H, J = 9.4 Hz), 4.95 (d,
1H, J = 10.5 Hz), 4.88 (d, 1H, J = 10.1 Hz), 4.79 (d, 1H, J = 10.1 Hz),
4.75 (dd, 1H, J = 10.0, 3.2 Hz), 4.67-4.58 (m, 3H), 4.02 (dd, 1H, J =
10.0, 3.4 Hz), 3.94 (d, 1H, J = 2.6 Hz), 3.83 (d, 1H, J = 9.5 Hz), 3.81
(s, 3H), 3.72-3.62 (m, 3H), 3.22 (d, 1H, J = 8.9 Hz), 2.39-2.32 (m, 2H),
1.26 (d, 3H, J = 6.5 Hz), 1.51-1.05 (m, 21H), 0.90 (t, 3H, J = 7.5 Hz);
13C NMR (100 MHz, CDCl3) δ 166.3, 159.5, 142.8, 138.6, 137.6, 133.0,
131.6, 130.33, 130.26, 130.2, 129.9, 128.7, 128.5, 128.44, 128.36,
128.04, 127.99, 127.96, 127.3, 127.0, 113.9, 100.1, 85.4, 82.4, 80.3,
78.1, 77.9, 76.9, 75.0, 72.2, 71.3, 71.2, 66.7, 62.2, 57.7, 55.2, 23.3,
18.01, 17.97, 16.7, 14.0, 11.9; HRMS (FAB) calcd for C58H75NO12S2SiNa [M
+ Na]+ 1092.4400, found 1092.4440.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Syntheses of Tumor-Related Antigens N3: Probing the Feasibility
Limits of the Glycal Assembly Method
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Hyunjin M.; Kim, In Jong; Danishefsky, Samuel J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2001), 123(1), 35-48

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenyl isothiocyanate
C7H4N2O2S
2131-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 6.6685 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 S 9.3360 3.0801 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-(4-nitrophenyl)carbamodithioate
C9H10N2O2S2
13037-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 S 9.3360 4.6201 0.0 0
M  V30 4 S 8.0022 2.3101 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2131-61-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13037-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-304-CAS-4928752
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 77-58-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Preparation of Ethyl
Alkyl/Aryl Dithiocarbamate Derivatives (7). A solution of the different
aliphatic isothiocyanates (6) (26.0 mmol) was reacted with 3.3 mL (39.0
mmol) of ethanethiol in the presence of Et3N (0.3 mL, 26.0 mmol) in 40 mL
of dry THF and was refluxed for 20 h to form 7 in about 95% yields. In
the case of aromatic dithiocarbamates the reaction was carried out under
the same conditions with toluene as a solvent and in the presence of
catalytic amount of dibutyltin dilaurate. In both cases, evaporation of
the solvent followed by flash chromatography yielded the desired product.
Ethyl 4-nitrophenyldithiocarbamate (7j) 8 was prepared as described in
the general procedure in 95% yield: 3.8 g, yellow crystals, the
tautomerization of a hydrogen atom doesn’t occur in aromatic amine
dithiocarbamates, since NO2 moiety on aromatic ring withdraws electrons
more than the sulfur atom and hydrogen chose to remain on nitrogen. m.p.
= 105.5 - 106.4 ºC; 1H NMR 8.84 (1 H, s), 8.27 (2 H, d, J = 8.0 Hz), 7.88
(2 H, d, J = 8.0 Hz), 3.34 (2 H, q, J = 7.0 Hz), 0.88 ppm (3 H, t, J =
7.0 Hz); 13C NMR 199.3, 145.5, 144.7, 125.6, 123.7, 31.4, 14.4 ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Toward the Synthesis of the Rare N-(Trifluoromethyl)amides and the
N-(Difluoromethylene)-N-(trifluoromethyl)amines [RN(CF3)CF2R'] Using BrF3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hagooly, Youlia; Gatenyo, Julia; Hagooly, Aviv; Rozen, Shlomo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(22), 8578-8582

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
1,3-Bis(1,1-dimethylethyl) 2-[2-(4-fluorophenyl)-2-oxoethylidene]propanedioate
C19H23FO5
2137856-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4136 5.3347 0.0 0
M  V30 2 C 5.9536 5.3347 0.0 0
M  V30 3 C 3.6436 6.6684 0.0 0
M  V30 4 C 3.6436 4.0011 0.0 0
M  V30 5 C 6.7236 6.6684 0.0 0
M  V30 6 O 2.1036 6.6684 0.0 0
M  V30 7 O 4.4136 8.0021 0.0 0
M  V30 8 O 4.4136 2.6674 0.0 0
M  V30 9 O 2.1036 4.0011 0.0 0
M  V30 10 O 5.9536 8.0021 0.0 0
M  V30 11 C 1.3336 8.0021 0.0 0
M  V30 12 C 3.6436 1.3336 0.0 0
M  V30 13 C 0.0000 7.2321 0.0 0
M  V30 14 C 0.5636 9.3358 0.0 0
M  V30 15 C 2.6673 8.7721 0.0 0
M  V30 16 C 4.9773 0.5636 0.0 0
M  V30 17 C 2.8736 0.0000 0.0 0
M  V30 18 C 2.3100 2.1036 0.0 0
M  V30 19 F 12.8836 6.6684 0.0 0
M  V30 20 C 8.2636 6.6684 0.0 0
M  V30 21 C 9.0336 8.0021 0.0 0
M  V30 22 C 9.0336 5.3347 0.0 0
M  V30 23 C 10.5736 8.0021 0.0 0
M  V30 24 C 10.5736 5.3347 0.0 0
M  V30 25 C 11.3436 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 2 5 10
M  V30 10 1 5 20
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 19 25
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Bis(1,1-dimethylethyl) 2-[(1S)-2-(4-fluorophenyl)-1-[(1-methylethyl)thio]...
C22H31FO5S
2191369-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5870 6.1600 0.0 0 CFG=2
M  V30 2 C 5.2532 5.3900 0.0 0
M  V30 3 C 7.9207 5.3900 0.0 0
M  V30 4 S 6.5870 7.7000 0.0 0
M  V30 5 C 3.7191 5.5243 0.0 0
M  V30 6 C 5.2532 3.8500 0.0 0
M  V30 7 O 7.9207 3.8500 0.0 0
M  V30 8 C 5.2532 8.4700 0.0 0
M  V30 9 O 3.0683 6.9200 0.0 0
M  V30 10 O 2.8359 4.2627 0.0 0
M  V30 11 O 3.9196 3.0800 0.0 0
M  V30 12 O 6.5870 3.0800 0.0 0
M  V30 13 C 5.2532 10.0100 0.0 0
M  V30 14 C 3.9196 7.7000 0.0 0
M  V30 15 C 1.5341 7.0541 0.0 0
M  V30 16 C 3.9196 1.5400 0.0 0
M  V30 17 C 1.4000 5.5200 0.0 0
M  V30 18 C 0.0000 7.1884 0.0 0
M  V30 19 C 1.6684 8.5883 0.0 0
M  V30 20 C 2.3796 1.5400 0.0 0
M  V30 21 C 3.9196 0.0000 0.0 0
M  V30 22 C 5.4596 1.5400 0.0 0
M  V30 23 F 13.2554 8.4700 0.0 0
M  V30 24 C 9.2543 6.1600 0.0 0
M  V30 25 C 10.5880 5.3900 0.0 0
M  V30 26 C 9.2543 7.7000 0.0 0
M  V30 27 C 11.9218 6.1600 0.0 0
M  V30 28 C 10.5880 8.4700 0.0 0
M  V30 29 C 11.9218 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 1 3 24
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 6 11
M  V30 12 2 6 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 1 11 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 16 21
M  V30 22 1 16 22
M  V30 23 1 23 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2137856-79-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2191369-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18566204
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1476029-80-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, er= 97:3, sulfa-Michael reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Organocatalytic Sulfa-Michael Addition to Enone Diesters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fulton, Jennifer L.; Horwitz, Matthew A.; Bruske, Ericka L.; Johnson,
Jeffrey S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(6), 3385-3391

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
1,3-Bis(1,1-dimethylethyl) 2-[2-oxo-2-(2-thienyl)ethylidene]propanedioate
C17H22O5S
2137856-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 5.3901 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 C 4.0012 3.8501 0.0 0
M  V30 4 C 2.6673 6.1601 0.0 0
M  V30 5 C 6.6685 5.3901 0.0 0
M  V30 6 O 2.6673 3.0801 0.0 0
M  V30 7 O 5.3348 3.0801 0.0 0
M  V30 8 O 2.6673 7.7002 0.0 0
M  V30 9 O 1.3337 5.3901 0.0 0
M  V30 10 O 6.6685 3.8501 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 1.3337 8.4702 0.0 0
M  V30 13 C 4.2074 1.5400 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.1273 1.5400 0.0 0
M  V30 16 C 0.5637 7.1365 0.0 0
M  V30 17 C 0.0000 9.2402 0.0 0
M  V30 18 C 2.1037 9.8039 0.0 0
M  V30 19 C 8.0022 6.1601 0.0 0
M  V30 20 C 8.1633 7.6917 0.0 0
M  V30 21 S 9.4091 5.5338 0.0 0
M  V30 22 C 9.6696 8.0119 0.0 0
M  V30 23 C 10.4396 6.6782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 2 5 10
M  V30 10 1 5 19
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Bis(1,1-dimethylethyl) 2-[(1S)-1-[(1-methylethyl)thio]-2-oxo-2-(2-thienyl...
C20H30O5S2
2191372-98-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9543 5.3348 0.0 0
M  V30 2 C 5.1843 6.6684 0.0 0 CFG=2
M  V30 3 C 7.4943 5.3348 0.0 0
M  V30 4 C 5.1843 4.0011 0.0 0
M  V30 5 C 3.6443 6.6684 0.0 0
M  V30 6 S 5.9543 8.0022 0.0 0
M  V30 7 O 8.2643 6.6684 0.0 0
M  V30 8 O 8.2643 4.0011 0.0 0
M  V30 9 O 5.9543 2.6673 0.0 0
M  V30 10 O 3.6443 4.0011 0.0 0
M  V30 11 O 2.8743 5.3348 0.0 0
M  V30 12 C 5.1843 9.3359 0.0 0
M  V30 13 C 9.8043 6.6684 0.0 0
M  V30 14 C 5.1843 1.3336 0.0 0
M  V30 15 C 3.6443 9.3359 0.0 0
M  V30 16 C 5.9543 10.6695 0.0 0
M  V30 17 C 9.8043 8.2084 0.0 0
M  V30 18 C 11.3443 6.6684 0.0 0
M  V30 19 C 9.8043 5.1284 0.0 0
M  V30 20 C 6.5181 0.5636 0.0 0
M  V30 21 C 4.4143 0.0000 0.0 0
M  V30 22 C 3.8506 2.1037 0.0 0
M  V30 23 C 2.3829 7.5518 0.0 0
M  V30 24 C 0.9268 7.0503 0.0 0
M  V30 25 S 2.3559 9.0915 0.0 0
M  V30 26 C 0.0000 8.2803 0.0 0
M  V30 27 C 0.8832 9.5418 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 2 4 10
M  V30 10 2 5 11
M  V30 11 1 5 23
M  V30 12 1 6 12
M  V30 13 1 7 13
M  V30 14 1 9 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 13 19
M  V30 20 1 14 20
M  V30 21 1 14 21
M  V30 22 1 14 22
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2137856-89-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2191372-98-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18566209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1476029-80-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, er= 98:2, sulfa-Michael reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Organocatalytic Sulfa-Michael Addition to Enone Diesters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fulton, Jennifer L.; Horwitz, Matthew A.; Bruske, Ericka L.; Johnson,
Jeffrey S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(6), 3385-3391

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
2-Butanethiol
C4H10S
513-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromoacetophenone
C8H7BrO
2142-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 C 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Br 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-[(1-Methylpropyl)thio]phenyl]ethanone
C12H16OS
1114567-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6684 1.5400 0.0 0
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 C 9.3359 1.5400 0.0 0
M  V30 4 C 8.0022 3.8500 0.0 0
M  V30 5 C 10.6695 2.3100 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 513-53-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2142-63-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1114567-71-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-2525510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 950982-61-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Coupling of
Functionalized Aryl Bromides and Iodides with Aliphatic and Aromatic
Thiols. The appropriate quantity of stock solution A or B was added to a
4 mL vial containing the aryl bromide or iodide (1.00 mmol) and LiHMDS or
Cs2CO3 (2.4 mmol) as base, unless otherwise stated, in DME (1.5 mL). The
thiol (1.00 mmol) was then added and the vial was sealed with a cap
containing a PTFE septum. The mixture was heated at the temperature
indicated in Tables 6 and 7 until the aryl halide was consumed, as
determined by GC. Silica gel (0.5 g) was added, and the solvents were
evaporated under reduced pressure. The crude residue was purified by
column chromatography on silica gel with hexane or a mixture of hexane
and ethyl acetate as eluent. Aryl sulfides were isolated in the yields
reported in Tables 6 and 7. Reactions of haloarenes bearing aromatic or
aliphatic hydroxyl groups and LiHMDS as base initially form the
corresponding sulfide with the hydroxyl group protected as the silyl
ether. However the silyl group was removed by treatment with acid (1 N
HCl) prior to the chromatographic purification. 3-Acetylphenyl
1-Methylpropyl sulfide (Table 6, entry 24). Colorless liquid, yield 95%
1H NMR (CDCl3): δ 7.89 (t, J = 1.8 Hz, 2H), 7.71 (m, 1H), 7.50 (m, 1H),
7.31 (t, J = 7.7 Hz, 1H), 3.17 (hex, J = 6.7 Hz, 1H), 2.53 (s, 3H),
1.66-1.44 (m, 2H), 1.22 (d, J = 6.8 Hz, 3H), 0.95 (t, J = 7.3 Hz, 3H).
13C NMR (CDCl3): δ 197.4, 137.5, 136.8, 135.6, 130.7, 128.8, 126.2, 44.6,
29.3, 26.5, 20.3, 11.3. Elem. Anal. Calcd for C12H16OS: C, 69.19; H,
7.74. Found: C, 69.15; H, 7.75.
$DTYPE RXN:VAR(1):NOTES
$DATUM silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A General, Efficient, and Functional-Group-Tolerant Catalyst System for
the Palladium-Catalyzed Thioetherification of Aryl Bromides and Iodides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fernandez-Rodriguez, Manuel A.; Hartwig, John F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(4), 1663-1672

$RFMT $RIREG SCHEME220 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
254428-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sulf...
C24H28BrNO4S2
951635-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 8.6443 0.0 0
M  V30 3 O 9.2154 5.5643 0.0 0
M  V30 4 C 7.2460 9.8149 0.0 0
M  V30 5 C 8.7525 10.1351 0.0 0
M  V30 6 C 6.2156 10.9593 0.0 0
M  V30 7 C 4.0596 5.4291 0.0 0
M  V30 8 O 4.2207 3.8976 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7796 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0583 0.0 0
M  V30 13 C 0.0000 8.4320 0.0 0
M  V30 14 Br 8.6738 0.0000 0.0 0
M  V30 15 C 15.3754 7.1043 0.0 0
M  V30 16 N 7.6754 7.1043 0.0 0
M  V30 17 C 6.7702 5.8585 0.0 0 CFG=1
M  V30 18 C 6.7702 8.3502 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8743 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3938 0.0 0
M  V30 22 C 6.2156 3.2494 0.0 0
M  V30 23 C 8.7525 4.0736 0.0 0
M  V30 24 C 6.6915 1.7847 0.0 0
M  V30 25 C 9.2283 2.6091 0.0 0
M  V30 26 C 8.1977 1.4645 0.0 0
M  V30 27 C 10.7554 7.1043 0.0 0
M  V30 28 C 11.5254 8.4380 0.0 0
M  V30 29 C 11.5254 5.7707 0.0 0
M  V30 30 C 13.0654 8.4380 0.0 0
M  V30 31 C 13.0654 5.7707 0.0 0
M  V30 32 C 13.8354 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 254428-47-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-58-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME221 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sul...
C25H32ClNO4S2
951336-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 8.6443 0.0 0
M  V30 3 O 9.2154 5.5643 0.0 0
M  V30 4 C 4.0596 5.4291 0.0 0
M  V30 5 O 2.6528 6.0556 0.0 0
M  V30 6 O 4.2207 3.8976 0.0 0
M  V30 7 C 7.2460 9.8149 0.0 0
M  V30 8 C 8.7524 10.1350 0.0 0
M  V30 9 C 6.2156 10.9593 0.0 0
M  V30 10 S 4.0596 8.7795 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0583 0.0 0
M  V30 13 C 1.5679 10.5900 0.0 0
M  V30 14 C 0.0000 8.4320 0.0 0
M  V30 15 Cl 8.6737 0.0000 0.0 0
M  V30 16 C 15.3754 7.1043 0.0 0
M  V30 17 C 6.7701 5.8585 0.0 0 CFG=1
M  V30 18 N 7.6754 7.1043 0.0 0
M  V30 19 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 20 C 6.7701 8.3502 0.0 0 CFG=2
M  V30 21 C 5.3055 7.8743 0.0 0 CFG=2
M  V30 22 C 7.2460 4.3938 0.0 0
M  V30 23 C 6.2156 3.2494 0.0 0
M  V30 24 C 8.7524 4.0736 0.0 0
M  V30 25 C 6.6915 1.7847 0.0 0
M  V30 26 C 9.2283 2.6091 0.0 0
M  V30 27 C 8.1979 1.4645 0.0 0
M  V30 28 C 10.7554 7.1043 0.0 0
M  V30 29 C 11.5254 5.7707 0.0 0
M  V30 30 C 11.5254 8.4380 0.0 0
M  V30 31 C 13.0654 5.7707 0.0 0
M  V30 32 C 13.0654 8.4380 0.0 0
M  V30 33 C 13.8354 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 20 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951336-92-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090202
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME222 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-4-[(1,1-dimethylethyl)thio]-5-(1-methyle...
C25H32ClNO4S2
951333-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.9695 7.1043 0.0 0 VAL=6
M  V30 2 O 7.9695 8.6443 0.0 0
M  V30 3 O 7.9695 5.5643 0.0 0
M  V30 4 C 2.8137 5.4291 0.0 0
M  V30 5 O 2.9747 3.8976 0.0 0
M  V30 6 O 1.4069 6.0556 0.0 0
M  V30 7 C 6.0001 9.8149 0.0 0
M  V30 8 C 7.5066 10.1350 0.0 0
M  V30 9 C 4.9697 10.9593 0.0 0
M  V30 10 S 2.8137 8.7795 0.0 0
M  V30 11 C 1.4069 8.1532 0.0 0
M  V30 12 C 2.0333 6.7463 0.0 0
M  V30 13 C 0.0000 7.5268 0.0 0
M  V30 14 C 0.7805 9.5600 0.0 0
M  V30 15 Cl 7.4279 0.0000 0.0 0
M  V30 16 C 14.1295 7.1043 0.0 0
M  V30 17 C 5.5243 5.8585 0.0 0 CFG=1
M  V30 18 N 6.4295 7.1043 0.0 0
M  V30 19 C 4.0596 6.3343 0.0 0 CFG=2
M  V30 20 C 5.5243 8.3502 0.0 0 CFG=2
M  V30 21 C 4.0596 7.8743 0.0 0 CFG=2
M  V30 22 C 6.0001 4.3938 0.0 0
M  V30 23 C 7.5066 4.0736 0.0 0
M  V30 24 C 4.9697 3.2494 0.0 0
M  V30 25 C 7.9824 2.6091 0.0 0
M  V30 26 C 5.4456 1.7847 0.0 0
M  V30 27 C 6.9519 1.4645 0.0 0
M  V30 28 C 9.5095 7.1043 0.0 0
M  V30 29 C 10.2795 5.7707 0.0 0
M  V30 30 C 10.2795 8.4380 0.0 0
M  V30 31 C 11.8195 5.7707 0.0 0
M  V30 32 C 11.8195 8.4380 0.0 0
M  V30 33 C 12.5895 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 20 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951333-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME223 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sul...
C24H28ClNO4S2
951635-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5643 0.0 0
M  V30 3 O 9.2154 8.6443 0.0 0
M  V30 4 C 7.2460 9.8149 0.0 0
M  V30 5 C 6.2156 10.9593 0.0 0
M  V30 6 C 8.7525 10.1351 0.0 0
M  V30 7 C 4.0596 5.4291 0.0 0
M  V30 8 O 4.2207 3.8976 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7796 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0583 0.0 0
M  V30 13 C 0.0000 8.4320 0.0 0
M  V30 14 Cl 8.6738 0.0000 0.0 0
M  V30 15 C 15.3754 7.1043 0.0 0
M  V30 16 N 7.6754 7.1043 0.0 0
M  V30 17 C 6.7702 5.8585 0.0 0 CFG=1
M  V30 18 C 6.7702 8.3502 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8743 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3938 0.0 0
M  V30 22 C 6.2156 3.2494 0.0 0
M  V30 23 C 8.7525 4.0736 0.0 0
M  V30 24 C 6.6915 1.7847 0.0 0
M  V30 25 C 9.2283 2.6091 0.0 0
M  V30 26 C 8.1977 1.4645 0.0 0
M  V30 27 C 10.7554 7.1043 0.0 0
M  V30 28 C 11.5254 5.7707 0.0 0
M  V30 29 C 11.5254 8.4380 0.0 0
M  V30 30 C 13.0654 5.7707 0.0 0
M  V30 31 C 13.0654 8.4380 0.0 0
M  V30 32 C 13.8354 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-55-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME224 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(phenylmethylene)benzenesulfonamide
C14H13NO2S
51608-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 13.0900 2.6673 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 1.3336 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(1-Methylethyl)-1-[(4-methylphenyl)sulfonyl]-2-phenyl-4-(...
C24H29NO4S2
951635-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.6398 0.0 0 VAL=6
M  V30 2 O 9.2154 4.0998 0.0 0
M  V30 3 O 9.2154 7.1798 0.0 0
M  V30 4 C 7.2460 8.3503 0.0 0
M  V30 5 C 8.7524 8.6705 0.0 0
M  V30 6 C 6.2156 9.4947 0.0 0
M  V30 7 C 4.0596 3.9646 0.0 0
M  V30 8 O 2.6528 4.5909 0.0 0
M  V30 9 O 4.2207 2.4330 0.0 0
M  V30 10 S 4.0596 7.3150 0.0 0
M  V30 11 C 2.6528 6.6885 0.0 0
M  V30 12 C 1.4069 7.5937 0.0 0
M  V30 13 C 0.0000 6.9674 0.0 0
M  V30 14 C 15.3754 5.6398 0.0 0
M  V30 15 N 7.6754 5.6398 0.0 0
M  V30 16 C 6.7701 4.3939 0.0 0 CFG=1
M  V30 17 C 6.7701 6.8856 0.0 0 CFG=2
M  V30 18 C 5.3055 4.8698 0.0 0 CFG=2
M  V30 19 C 5.3055 6.4098 0.0 0 CFG=1
M  V30 20 C 7.2460 2.9292 0.0 0
M  V30 21 C 6.2156 1.7849 0.0 0
M  V30 22 C 8.7524 2.6091 0.0 0
M  V30 23 C 6.6915 0.3202 0.0 0
M  V30 24 C 9.2283 1.1444 0.0 0
M  V30 25 C 8.1977 0.0000 0.0 0
M  V30 26 C 10.7554 5.6398 0.0 0
M  V30 27 C 11.5254 4.3061 0.0 0
M  V30 28 C 11.5254 6.9734 0.0 0
M  V30 29 C 13.0654 4.3061 0.0 0
M  V30 30 C 13.0654 6.9734 0.0 0
M  V30 31 C 13.8354 5.6398 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 18 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 19 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 31
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 20 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51608-60-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-44-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME225 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
738626-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-4-[(3-Methylbutyl)thio]-5-(1-methylethyl)-2-(3-methylphenyl...
C27H37NO4S2
951340-54-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 6.4640 0.0 0 VAL=6
M  V30 2 O 6.1600 4.9240 0.0 0
M  V30 3 O 6.1600 8.0040 0.0 0
M  V30 4 C 11.3158 4.7888 0.0 0
M  V30 5 O 12.7226 5.4153 0.0 0
M  V30 6 O 11.1547 3.2573 0.0 0
M  V30 7 C 8.1294 9.1746 0.0 0
M  V30 8 C 6.6229 9.4947 0.0 0
M  V30 9 C 9.1598 10.3190 0.0 0
M  V30 10 S 11.3158 8.1392 0.0 0
M  V30 11 C 12.7226 7.5128 0.0 0
M  V30 12 C 13.9685 8.4180 0.0 0
M  V30 13 C 15.3754 7.7916 0.0 0
M  V30 14 C 16.6213 8.6969 0.0 0
M  V30 15 C 15.5363 6.2601 0.0 0
M  V30 16 C 9.7143 0.0000 0.0 0
M  V30 17 C 0.0000 6.4640 0.0 0
M  V30 18 C 8.6052 5.2181 0.0 0 CFG=1
M  V30 19 N 7.7000 6.4640 0.0 0
M  V30 20 C 10.0698 5.6940 0.0 0 CFG=2
M  V30 21 C 8.6052 7.7099 0.0 0 CFG=2
M  V30 22 C 10.0698 7.2340 0.0 0 CFG=2
M  V30 23 C 8.1294 3.7535 0.0 0
M  V30 24 C 9.1598 2.6091 0.0 0
M  V30 25 C 6.6229 3.4333 0.0 0
M  V30 26 C 8.6839 1.1444 0.0 0
M  V30 27 C 6.1471 1.9687 0.0 0
M  V30 28 C 7.1775 0.8242 0.0 0
M  V30 29 C 4.6200 6.4640 0.0 0
M  V30 30 C 3.8500 5.1304 0.0 0
M  V30 31 C 3.8500 7.7977 0.0 0
M  V30 32 C 2.3100 5.1304 0.0 0
M  V30 33 C 2.3100 7.7977 0.0 0
M  V30 34 C 1.5400 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 21 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 22 10 CFG=1
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 16 26
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951340-54-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083502
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME226 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]benzenesulfonamide
C14H13NO3S
664985-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 O 13.0900 2.8736 0.0 0
M  V30 7 C 13.8600 4.2073 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 2.3100 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.7700 2.8736 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 9.2400 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 19 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Methoxyphenyl)-5-(1-methylethyl)-1-(phenylsulfonyl)-4-...
C24H29NO5S2
951635-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 8.2489 0.0 0 VAL=6
M  V30 2 O 4.6200 6.7089 0.0 0
M  V30 3 O 4.6200 9.7889 0.0 0
M  V30 4 C 6.5894 10.9594 0.0 0
M  V30 5 C 7.6198 12.1038 0.0 0
M  V30 6 C 5.0829 11.2796 0.0 0
M  V30 7 C 9.7758 6.5736 0.0 0
M  V30 8 O 9.6147 5.0421 0.0 0
M  V30 9 O 11.1826 7.2000 0.0 0
M  V30 10 S 9.7758 9.9241 0.0 0
M  V30 11 C 11.1826 9.2976 0.0 0
M  V30 12 C 12.4284 10.2028 0.0 0
M  V30 13 C 13.8354 9.5765 0.0 0
M  V30 14 O 5.1616 1.1444 0.0 0
M  V30 15 C 6.1922 0.0000 0.0 0
M  V30 16 N 6.1600 8.2489 0.0 0
M  V30 17 C 7.0652 7.0030 0.0 0 CFG=1
M  V30 18 C 7.0652 9.4947 0.0 0 CFG=2
M  V30 19 C 8.5299 7.4789 0.0 0 CFG=2
M  V30 20 C 8.5299 9.0189 0.0 0 CFG=1
M  V30 21 C 6.5894 5.5383 0.0 0
M  V30 22 C 5.0829 5.2181 0.0 0
M  V30 23 C 7.6198 4.3939 0.0 0
M  V30 24 C 4.6071 3.7534 0.0 0
M  V30 25 C 7.1439 2.9292 0.0 0
M  V30 26 C 5.6376 2.6091 0.0 0
M  V30 27 C 3.0800 8.2489 0.0 0
M  V30 28 C 2.3100 9.5825 0.0 0
M  V30 29 C 2.3100 6.9152 0.0 0
M  V30 30 C 0.7700 9.5825 0.0 0
M  V30 31 C 0.7700 6.9152 0.0 0
M  V30 32 C 0.0000 8.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-99-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-69-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME227 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]benzenesulfonamide
C13H10ClNO2S
664986-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 Cl 13.0900 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 2.3100 2.8736 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 0.7700 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 14 C 9.2400 1.5400 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-5-(1-methylethyl)-1-(phenylsulfonyl)-4-(...
C23H26ClNO4S2
951635-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1044 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5644 0.0 0
M  V30 3 O 4.6200 8.6444 0.0 0
M  V30 4 C 6.5894 9.8149 0.0 0
M  V30 5 C 7.6198 10.9593 0.0 0
M  V30 6 C 5.0829 10.1351 0.0 0
M  V30 7 C 9.7758 5.4291 0.0 0
M  V30 8 O 9.6147 3.8976 0.0 0
M  V30 9 O 11.1826 6.0556 0.0 0
M  V30 10 S 9.7758 8.7796 0.0 0
M  V30 11 C 11.1826 8.1533 0.0 0
M  V30 12 C 12.4285 9.0583 0.0 0
M  V30 13 C 13.8354 8.4320 0.0 0
M  V30 14 Cl 5.1616 0.0000 0.0 0
M  V30 15 N 6.1600 7.1044 0.0 0
M  V30 16 C 7.0652 5.8585 0.0 0 CFG=1
M  V30 17 C 7.0652 8.3502 0.0 0 CFG=2
M  V30 18 C 8.5299 6.3344 0.0 0 CFG=2
M  V30 19 C 8.5299 7.8744 0.0 0 CFG=1
M  V30 20 C 6.5894 4.3938 0.0 0
M  V30 21 C 7.6198 3.2494 0.0 0
M  V30 22 C 5.0829 4.0736 0.0 0
M  V30 23 C 7.1439 1.7847 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 5.6377 1.4645 0.0 0
M  V30 26 C 3.0800 7.1044 0.0 0
M  V30 27 C 2.3100 5.7707 0.0 0
M  V30 28 C 2.3100 8.4380 0.0 0
M  V30 29 C 0.7700 5.7707 0.0 0
M  V30 30 C 0.7700 8.4380 0.0 0
M  V30 31 C 0.0000 7.1044 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 17 4 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 18 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 19 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 20 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664986-03-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-66-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME228 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
738626-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(1-Methylethyl)-2-(3-methylphenyl)-1-[(4-methylphenyl)sul...
C25H31NO4S2
951635-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 4.9240 0.0 0
M  V30 3 O 9.2154 8.0040 0.0 0
M  V30 4 C 4.0596 4.7888 0.0 0
M  V30 5 O 4.2207 3.2573 0.0 0
M  V30 6 O 2.6528 5.4153 0.0 0
M  V30 7 C 7.2460 9.1746 0.0 0
M  V30 8 C 6.2156 10.3189 0.0 0
M  V30 9 C 8.7525 9.4947 0.0 0
M  V30 10 S 4.0596 8.1392 0.0 0
M  V30 11 C 2.6528 7.5128 0.0 0
M  V30 12 C 1.4069 8.4180 0.0 0
M  V30 13 C 0.0000 7.7916 0.0 0
M  V30 14 C 5.6611 0.0000 0.0 0
M  V30 15 C 15.3754 6.4640 0.0 0
M  V30 16 C 6.7702 5.2181 0.0 0 CFG=1
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 19 C 6.7702 7.7099 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 7.2460 3.7535 0.0 0
M  V30 22 C 6.2156 2.6091 0.0 0
M  V30 23 C 8.7525 3.4333 0.0 0
M  V30 24 C 6.6915 1.1444 0.0 0
M  V30 25 C 9.2283 1.9687 0.0 0
M  V30 26 C 8.1977 0.8242 0.0 0
M  V30 27 C 10.7554 6.4640 0.0 0
M  V30 28 C 11.5254 5.1304 0.0 0
M  V30 29 C 11.5254 7.7977 0.0 0
M  V30 30 C 13.0654 5.1304 0.0 0
M  V30 31 C 13.0654 7.7977 0.0 0
M  V30 32 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-68-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084417
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME229 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(1-naphthalenylmethylene)benzenesulfonamide
C18H15NO2S
738626-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 S 8.0022 3.0801 0.0 0 VAL=6
M  V30 4 O 8.7722 1.7464 0.0 0
M  V30 5 O 7.2322 4.4137 0.0 0
M  V30 6 C 13.3370 6.1601 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 4.0010 0.7700 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 18 C 9.3360 5.3901 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 10.6697 6.1601 0.0 0
M  V30 21 C 12.0033 3.8501 0.0 0
M  V30 22 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(1-Methylethyl)-1-[(4-methylphenyl)sulfonyl]-2-(1-naphtha...
C28H31NO4S2
951635-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1202 7.0618 0.0 0 VAL=6
M  V30 2 O 6.8000 8.5683 0.0 0
M  V30 3 O 7.4404 5.5555 0.0 0
M  V30 4 C 2.4254 4.3512 0.0 0
M  V30 5 O 2.9013 2.8866 0.0 0
M  V30 6 O 0.9191 4.6715 0.0 0
M  V30 7 C 4.6304 9.3038 0.0 0
M  V30 8 C 6.0372 9.9301 0.0 0
M  V30 9 C 3.3845 10.2089 0.0 0
M  V30 10 S 1.7288 7.6286 0.0 0
M  V30 11 C 1.5678 9.1601 0.0 0
M  V30 12 C 0.1609 9.7865 0.0 0
M  V30 13 C 0.0000 11.3180 0.0 0
M  V30 14 C 13.1457 8.3427 0.0 0
M  V30 15 C 4.9876 5.3348 0.0 0 CFG=1
M  V30 16 N 5.6139 6.7417 0.0 0
M  V30 17 C 3.4558 5.4958 0.0 0 CFG=2
M  V30 18 C 4.4693 7.7721 0.0 0 CFG=2
M  V30 19 C 3.1357 7.0021 0.0 0 CFG=2
M  V30 20 C 5.7576 4.0010 0.0 0
M  V30 21 C 4.9876 2.6673 0.0 0
M  V30 22 C 7.2976 4.0010 0.0 0
M  V30 23 C 5.7576 1.3337 0.0 0
M  V30 24 C 3.4475 2.6673 0.0 0
M  V30 25 C 8.0676 2.6673 0.0 0
M  V30 26 C 7.2976 1.3337 0.0 0
M  V30 27 C 4.9876 0.0000 0.0 0
M  V30 28 C 2.6775 1.3337 0.0 0
M  V30 29 C 3.4475 0.0000 0.0 0
M  V30 30 C 8.6267 7.3820 0.0 0
M  V30 31 C 9.6571 6.2376 0.0 0
M  V30 32 C 9.1025 8.8467 0.0 0
M  V30 33 C 11.1636 6.5578 0.0 0
M  V30 34 C 10.6088 9.1669 0.0 0
M  V30 35 C 11.6394 8.0223 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 17 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 18 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 19 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 35
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 20 CFG=1
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 21 24
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 1 23 27
M  V30 29 2 24 28
M  V30 30 2 25 26
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 15 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-22-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-59-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME230 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
865060-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-4-(ethylthio)-5-(1-methylethyl)-1-[(2-me...
C23H28ClNO4S2
951300-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1043 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5643 0.0 0
M  V30 3 O 4.6200 8.6443 0.0 0
M  V30 4 C 6.5894 9.8149 0.0 0
M  V30 5 C 7.6198 10.9593 0.0 0
M  V30 6 C 5.0829 10.1350 0.0 0
M  V30 7 C 9.7756 5.4291 0.0 0
M  V30 8 O 9.6147 3.8976 0.0 0
M  V30 9 O 11.1826 6.0556 0.0 0
M  V30 10 S 9.7756 8.7795 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0583 0.0 0
M  V30 13 C 3.0800 9.7718 0.0 0
M  V30 14 Cl 5.1616 0.0000 0.0 0
M  V30 15 N 6.1600 7.1043 0.0 0
M  V30 16 C 7.0652 5.8585 0.0 0 CFG=1
M  V30 17 C 7.0652 8.3502 0.0 0 CFG=2
M  V30 18 C 8.5298 6.3343 0.0 0 CFG=2
M  V30 19 C 8.5298 7.8743 0.0 0 CFG=1
M  V30 20 C 6.5894 4.3938 0.0 0
M  V30 21 C 7.6198 3.2494 0.0 0
M  V30 22 C 5.0829 4.0736 0.0 0
M  V30 23 C 7.1439 1.7847 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 5.6375 1.4645 0.0 0
M  V30 26 C 3.0800 7.1043 0.0 0
M  V30 27 C 2.3100 8.4380 0.0 0
M  V30 28 C 2.3100 5.7707 0.0 0
M  V30 29 C 0.7700 8.4380 0.0 0
M  V30 30 C 0.7700 5.7707 0.0 0
M  V30 31 C 0.0000 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 17 4 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 18 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 19 10 CFG=1
M  V30 13 1 11 12
M  V30 14 1 13 27
M  V30 15 1 14 25
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 20 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865060-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951300-27-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME231 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethylphenyl)-4-(ethylthio)-5-(1-methylethyl)-1-[(4-met...
C25H33NO4S2
951304-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.8084 8.2489 0.0 0 VAL=6
M  V30 2 O 7.8084 6.7089 0.0 0
M  V30 3 O 7.8084 9.7889 0.0 0
M  V30 4 C 2.6528 6.5736 0.0 0
M  V30 5 O 1.2459 7.2000 0.0 0
M  V30 6 O 2.8137 5.0421 0.0 0
M  V30 7 C 5.8391 10.9594 0.0 0
M  V30 8 C 4.8087 12.1038 0.0 0
M  V30 9 C 7.3455 11.2796 0.0 0
M  V30 10 S 2.6528 9.9241 0.0 0
M  V30 11 C 1.2459 9.2976 0.0 0
M  V30 12 C 0.0000 10.2028 0.0 0
M  V30 13 C 7.2668 1.1444 0.0 0
M  V30 14 C 6.2364 0.0000 0.0 0
M  V30 15 C 13.9684 8.2489 0.0 0
M  V30 16 C 5.3632 7.0030 0.0 0 CFG=1
M  V30 17 N 6.2684 8.2489 0.0 0
M  V30 18 C 3.8987 7.4789 0.0 0 CFG=2
M  V30 19 C 5.3632 9.4947 0.0 0 CFG=2
M  V30 20 C 3.8987 9.0189 0.0 0 CFG=2
M  V30 21 C 5.8391 5.5383 0.0 0
M  V30 22 C 7.3455 5.2181 0.0 0
M  V30 23 C 4.8087 4.3939 0.0 0
M  V30 24 C 7.8214 3.7534 0.0 0
M  V30 25 C 5.2845 2.9292 0.0 0
M  V30 26 C 6.7909 2.6091 0.0 0
M  V30 27 C 9.3484 8.2489 0.0 0
M  V30 28 C 10.1184 6.9152 0.0 0
M  V30 29 C 10.1184 9.5825 0.0 0
M  V30 30 C 11.6584 6.9152 0.0 0
M  V30 31 C 11.6584 9.5825 0.0 0
M  V30 32 C 12.4284 8.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951304-47-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME232 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethoxyphenyl)-5-(1-methylethyl)-4-[(1-methylethyl)thio...
C26H35NO5S2
951302-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6814 5.3348 0.0 0 VAL=6
M  V30 2 O 5.3477 4.5648 0.0 0
M  V30 3 O 8.0152 6.1048 0.0 0
M  V30 4 C 5.5542 10.6375 0.0 0
M  V30 5 O 6.9612 11.2638 0.0 0
M  V30 6 O 4.3083 11.5427 0.0 0
M  V30 7 C 3.3494 5.6851 0.0 0
M  V30 8 C 1.8429 6.0053 0.0 0
M  V30 9 C 3.8252 4.2204 0.0 0
M  V30 10 S 2.6527 8.9623 0.0 0
M  V30 11 C 1.2459 9.5886 0.0 0
M  V30 12 C 0.0000 8.6834 0.0 0
M  V30 13 C 1.0849 11.1201 0.0 0
M  V30 14 O 12.5633 9.3562 0.0 0
M  V30 15 C 13.0392 10.8208 0.0 0
M  V30 16 C 14.5455 11.1409 0.0 0
M  V30 17 C 9.7614 0.0000 0.0 0
M  V30 18 C 6.5378 8.0754 0.0 0 CFG=1
M  V30 19 N 5.9114 6.6686 0.0 0
M  V30 20 C 5.3933 9.1058 0.0 0 CFG=2
M  V30 21 C 4.3798 6.8295 0.0 0 CFG=2
M  V30 22 C 4.0596 8.3358 0.0 0 CFG=2
M  V30 23 C 8.0441 8.3956 0.0 0
M  V30 24 C 9.0745 7.2512 0.0 0
M  V30 25 C 8.5200 9.8603 0.0 0
M  V30 26 C 10.5810 7.5713 0.0 0
M  V30 27 C 10.0264 10.1804 0.0 0
M  V30 28 C 11.0569 9.0360 0.0 0
M  V30 29 C 7.4514 4.0011 0.0 0
M  V30 30 C 6.6814 2.6675 0.0 0
M  V30 31 C 8.9914 4.0011 0.0 0
M  V30 32 C 7.4514 1.3338 0.0 0
M  V30 33 C 9.7614 2.6675 0.0 0
M  V30 34 C 8.9914 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 21 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 22 10 CFG=1
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 28
M  V30 17 1 15 16
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951302-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085043
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME233 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Cyanophenyl)methylene]-4-methylbenzenesulfonamide
C15H12N2O2S
848005-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 N 16.1700 2.8736 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 3 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Cyanophenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sulf...
C25H28N2O4S2
951635-53-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.5690 0.0 0 VAL=6
M  V30 2 O 6.1600 10.1090 0.0 0
M  V30 3 O 6.1600 7.0290 0.0 0
M  V30 4 C 8.1294 11.2796 0.0 0
M  V30 5 C 6.6229 11.5997 0.0 0
M  V30 6 C 9.1598 12.4241 0.0 0
M  V30 7 C 11.3158 6.8940 0.0 0
M  V30 8 O 11.1547 5.3623 0.0 0
M  V30 9 O 12.7226 7.5203 0.0 0
M  V30 10 S 11.3158 10.2442 0.0 0
M  V30 11 C 12.7226 9.6179 0.0 0
M  V30 12 C 13.9684 10.5231 0.0 0
M  V30 13 C 15.3754 9.8967 0.0 0
M  V30 14 C 6.7016 1.4647 0.0 0
M  V30 15 N 6.2258 0.0000 0.0 0
M  V30 16 C 0.0000 8.5690 0.0 0
M  V30 17 N 7.7000 8.5690 0.0 0
M  V30 18 C 8.6052 7.3232 0.0 0 CFG=1
M  V30 19 C 8.6052 9.8150 0.0 0 CFG=2
M  V30 20 C 10.0699 7.7990 0.0 0 CFG=2
M  V30 21 C 10.0699 9.3390 0.0 0 CFG=1
M  V30 22 C 8.1294 5.8586 0.0 0
M  V30 23 C 9.1598 4.7141 0.0 0
M  V30 24 C 6.6229 5.5385 0.0 0
M  V30 25 C 8.6839 3.2496 0.0 0
M  V30 26 C 6.1471 4.0738 0.0 0
M  V30 27 C 7.1776 2.9294 0.0 0
M  V30 28 C 4.6200 8.5690 0.0 0
M  V30 29 C 3.8500 7.2354 0.0 0
M  V30 30 C 3.8500 9.9028 0.0 0
M  V30 31 C 2.3100 7.2354 0.0 0
M  V30 32 C 2.3100 9.9028 0.0 0
M  V30 33 C 1.5400 8.5690 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 19 4 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 20 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 3 14 15
M  V30 16 1 14 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848005-24-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-53-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089596
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME234 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
863401-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sul...
C24H28ClNO4S2
951635-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 4.9240 0.0 0
M  V30 3 O 9.2154 8.0040 0.0 0
M  V30 4 C 4.0596 4.7888 0.0 0
M  V30 5 O 4.2207 3.2573 0.0 0
M  V30 6 O 2.6528 5.4153 0.0 0
M  V30 7 C 7.2460 9.1746 0.0 0
M  V30 8 C 6.2156 10.3189 0.0 0
M  V30 9 C 8.7525 9.4947 0.0 0
M  V30 10 S 4.0596 8.1392 0.0 0
M  V30 11 C 2.6528 7.5128 0.0 0
M  V30 12 C 1.4069 8.4180 0.0 0
M  V30 13 C 0.0000 7.7916 0.0 0
M  V30 14 Cl 5.6611 0.0000 0.0 0
M  V30 15 C 15.3754 6.4640 0.0 0
M  V30 16 C 6.7702 5.2181 0.0 0 CFG=1
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 19 C 6.7702 7.7099 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 7.2460 3.7535 0.0 0
M  V30 22 C 6.2156 2.6091 0.0 0
M  V30 23 C 8.7525 3.4333 0.0 0
M  V30 24 C 6.6915 1.1444 0.0 0
M  V30 25 C 9.2283 1.9687 0.0 0
M  V30 26 C 8.1977 0.8242 0.0 0
M  V30 27 C 10.7554 6.4640 0.0 0
M  V30 28 C 11.5254 5.1304 0.0 0
M  V30 29 C 11.5254 7.7977 0.0 0
M  V30 30 C 13.0654 5.1304 0.0 0
M  V30 31 C 13.0654 7.7977 0.0 0
M  V30 32 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-19-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME235 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
865060-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-5-(1-methylethyl)-1-[(2-methylphenyl)sul...
C24H28ClNO4S2
951635-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1043 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6443 0.0 0
M  V30 3 O 4.6200 5.5643 0.0 0
M  V30 4 C 6.5894 9.8149 0.0 0
M  V30 5 C 7.6198 10.9593 0.0 0
M  V30 6 C 5.0829 10.1351 0.0 0
M  V30 7 C 9.7758 5.4291 0.0 0
M  V30 8 O 9.6147 3.8976 0.0 0
M  V30 9 O 11.1826 6.0556 0.0 0
M  V30 10 S 9.7758 8.7796 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0583 0.0 0
M  V30 13 C 13.8354 8.4320 0.0 0
M  V30 14 C 3.0800 9.7718 0.0 0
M  V30 15 Cl 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1043 0.0 0
M  V30 17 C 7.0652 5.8585 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3502 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3343 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8743 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3938 0.0 0
M  V30 22 C 7.6198 3.2494 0.0 0
M  V30 23 C 5.0829 4.0736 0.0 0
M  V30 24 C 7.1439 1.7847 0.0 0
M  V30 25 C 4.6071 2.6091 0.0 0
M  V30 26 C 5.6376 1.4645 0.0 0
M  V30 27 C 3.0800 7.1043 0.0 0
M  V30 28 C 2.3100 8.4380 0.0 0
M  V30 29 C 2.3100 5.7707 0.0 0
M  V30 30 C 0.7700 8.4380 0.0 0
M  V30 31 C 0.7700 5.7707 0.0 0
M  V30 32 C 0.0000 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865060-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087464
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME236 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethylphenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sulf...
C26H33NO4S2
951635-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 8.2489 0.0 0 VAL=6
M  V30 2 O 9.2154 6.7089 0.0 0
M  V30 3 O 9.2154 9.7889 0.0 0
M  V30 4 C 7.2460 10.9594 0.0 0
M  V30 5 C 8.7524 11.2796 0.0 0
M  V30 6 C 6.2156 12.1038 0.0 0
M  V30 7 C 4.0596 6.5736 0.0 0
M  V30 8 O 2.6528 7.2000 0.0 0
M  V30 9 O 4.2207 5.0421 0.0 0
M  V30 10 S 4.0596 9.9241 0.0 0
M  V30 11 C 2.6528 9.2976 0.0 0
M  V30 12 C 1.4069 10.2028 0.0 0
M  V30 13 C 0.0000 9.5765 0.0 0
M  V30 14 C 8.6737 1.1444 0.0 0
M  V30 15 C 7.6432 0.0000 0.0 0
M  V30 16 C 15.3754 8.2489 0.0 0
M  V30 17 N 7.6754 8.2489 0.0 0
M  V30 18 C 6.7701 7.0030 0.0 0 CFG=1
M  V30 19 C 6.7701 9.4947 0.0 0 CFG=2
M  V30 20 C 5.3055 7.4789 0.0 0 CFG=2
M  V30 21 C 5.3055 9.0189 0.0 0 CFG=1
M  V30 22 C 7.2460 5.5383 0.0 0
M  V30 23 C 6.2156 4.3939 0.0 0
M  V30 24 C 8.7524 5.2181 0.0 0
M  V30 25 C 6.6915 2.9292 0.0 0
M  V30 26 C 9.2283 3.7534 0.0 0
M  V30 27 C 8.1977 2.6091 0.0 0
M  V30 28 C 10.7554 8.2489 0.0 0
M  V30 29 C 11.5254 6.9152 0.0 0
M  V30 30 C 11.5254 9.5825 0.0 0
M  V30 31 C 13.0654 6.9152 0.0 0
M  V30 32 C 13.0654 9.5825 0.0 0
M  V30 33 C 13.8354 8.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 20 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-48-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089455
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME237 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethoxyphenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sul...
C26H33NO5S2
951635-51-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 9.7134 0.0 0 VAL=6
M  V30 2 O 9.2154 8.1734 0.0 0
M  V30 3 O 9.2154 11.2534 0.0 0
M  V30 4 C 4.0596 8.0382 0.0 0
M  V30 5 O 2.6528 8.6647 0.0 0
M  V30 6 O 4.2207 6.5067 0.0 0
M  V30 7 C 7.2460 12.4240 0.0 0
M  V30 8 C 8.7525 12.7441 0.0 0
M  V30 9 C 6.2156 13.5684 0.0 0
M  V30 10 S 4.0596 11.3886 0.0 0
M  V30 11 C 2.6528 10.7623 0.0 0
M  V30 12 C 1.4069 11.6674 0.0 0
M  V30 13 C 0.0000 11.0411 0.0 0
M  V30 14 O 8.6738 2.6091 0.0 0
M  V30 15 C 7.6432 1.4645 0.0 0
M  V30 16 C 8.1192 0.0000 0.0 0
M  V30 17 C 15.3754 9.7134 0.0 0
M  V30 18 C 6.7702 8.4676 0.0 0 CFG=1
M  V30 19 N 7.6754 9.7134 0.0 0
M  V30 20 C 5.3055 8.9434 0.0 0 CFG=2
M  V30 21 C 6.7702 10.9593 0.0 0 CFG=2
M  V30 22 C 5.3055 10.4834 0.0 0 CFG=2
M  V30 23 C 7.2460 7.0029 0.0 0
M  V30 24 C 8.7525 6.6827 0.0 0
M  V30 25 C 6.2156 5.8585 0.0 0
M  V30 26 C 9.2283 5.2181 0.0 0
M  V30 27 C 6.6915 4.3938 0.0 0
M  V30 28 C 8.1977 4.0736 0.0 0
M  V30 29 C 10.7554 9.7134 0.0 0
M  V30 30 C 11.5254 11.0471 0.0 0
M  V30 31 C 11.5254 8.3798 0.0 0
M  V30 32 C 13.0654 11.0471 0.0 0
M  V30 33 C 13.0654 8.3798 0.0 0
M  V30 34 C 13.8354 9.7134 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 21 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 22 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 28
M  V30 17 1 15 16
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-51-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME238 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 N 5.3900 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 13.0900 4.0009 0.0 0
M  V30 7 F 3.0800 0.0000 0.0 0
M  V30 8 C 8.4700 4.0009 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 9.2400 2.6673 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 10.7800 2.6673 0.0 0
M  V30 13 C 11.5500 4.0009 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 C 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0009 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(2-Fluorophenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sul...
C24H28FNO4S2
951635-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 5.8691 0.0 0 VAL=6
M  V30 2 O 4.5648 4.5352 0.0 0
M  V30 3 O 6.1048 7.2027 0.0 0
M  V30 4 C 8.3956 7.2317 0.0 0
M  V30 5 C 7.2512 8.2623 0.0 0
M  V30 6 C 9.8603 7.7077 0.0 0
M  V30 7 C 8.9624 1.8403 0.0 0
M  V30 8 O 10.4939 1.6794 0.0 0
M  V30 9 O 8.0571 0.5945 0.0 0
M  V30 10 S 10.6376 4.7419 0.0 0
M  V30 11 C 11.2639 6.1487 0.0 0
M  V30 12 C 12.7955 6.3098 0.0 0
M  V30 13 C 13.4220 7.7166 0.0 0
M  V30 14 F 7.4699 0.5546 0.0 0
M  V30 15 C 0.0000 8.9491 0.0 0
M  V30 16 N 6.6686 5.0990 0.0 0
M  V30 17 C 6.8296 3.5673 0.0 0 CFG=1
M  V30 18 C 8.0754 5.7254 0.0 0 CFG=2
M  V30 19 C 8.3359 3.2472 0.0 0 CFG=2
M  V30 20 C 9.1059 4.5810 0.0 0 CFG=1
M  V30 21 C 5.6852 2.5369 0.0 0
M  V30 22 C 6.0053 1.0306 0.0 0
M  V30 23 C 4.2204 3.0128 0.0 0
M  V30 24 C 4.8608 0.0000 0.0 0
M  V30 25 C 3.0759 1.9823 0.0 0
M  V30 26 C 3.3962 0.4760 0.0 0
M  V30 27 C 4.0011 6.6391 0.0 0
M  V30 28 C 2.6675 5.8691 0.0 0
M  V30 29 C 4.0011 8.1791 0.0 0
M  V30 30 C 1.3338 6.6391 0.0 0
M  V30 31 C 2.6675 8.9491 0.0 0
M  V30 32 C 1.3338 8.1791 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 22
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-62-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-54-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091173
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME239 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 C 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-5-(1-methylethyl)-1-[(4-methylphenyl...
C24H27Cl2NO4S2
951635-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1044 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5644 0.0 0
M  V30 3 O 9.2154 8.6444 0.0 0
M  V30 4 C 4.0596 5.4291 0.0 0
M  V30 5 O 4.2207 3.8976 0.0 0
M  V30 6 O 2.6528 6.0556 0.0 0
M  V30 7 C 7.2460 9.8149 0.0 0
M  V30 8 C 6.2156 10.9593 0.0 0
M  V30 9 C 8.7525 10.1351 0.0 0
M  V30 10 S 4.0596 8.7796 0.0 0
M  V30 11 C 2.6528 8.1533 0.0 0
M  V30 12 C 1.4070 9.0583 0.0 0
M  V30 13 C 0.0000 8.4320 0.0 0
M  V30 14 Cl 5.6611 0.6403 0.0 0
M  V30 15 Cl 8.6738 0.0000 0.0 0
M  V30 16 C 15.3754 7.1044 0.0 0
M  V30 17 C 6.7702 5.8585 0.0 0 CFG=1
M  V30 18 N 7.6754 7.1044 0.0 0
M  V30 19 C 5.3055 6.3344 0.0 0 CFG=2
M  V30 20 C 6.7702 8.3502 0.0 0 CFG=2
M  V30 21 C 5.3055 7.8744 0.0 0 CFG=2
M  V30 22 C 7.2460 4.3938 0.0 0
M  V30 23 C 6.2156 3.2494 0.0 0
M  V30 24 C 8.7525 4.0736 0.0 0
M  V30 25 C 6.6915 1.7847 0.0 0
M  V30 26 C 9.2283 2.6091 0.0 0
M  V30 27 C 8.1978 1.4645 0.0 0
M  V30 28 C 10.7554 7.1044 0.0 0
M  V30 29 C 11.5254 5.7707 0.0 0
M  V30 30 C 11.5254 8.4380 0.0 0
M  V30 31 C 13.0654 5.7707 0.0 0
M  V30 32 C 13.0654 8.4380 0.0 0
M  V30 33 C 13.8354 7.1044 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 20 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 21 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 25
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-63-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084658
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME240 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(2-thienylmethylene)benzenesulfonamide
C12H11NO2S2
951762-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.2198 2.5795 0.0 0 VAL=6
M  V30 2 N 4.6798 2.5795 0.0 0
M  V30 3 O 6.2198 1.0395 0.0 0
M  V30 4 O 6.2198 4.1195 0.0 0
M  V30 5 C 3.9098 1.2459 0.0 0
M  V30 6 C 12.3798 2.5795 0.0 0
M  V30 7 C 7.7598 2.5795 0.0 0
M  V30 8 C 8.5298 1.2459 0.0 0
M  V30 9 C 8.5298 3.9132 0.0 0
M  V30 10 C 10.0698 1.2459 0.0 0
M  V30 11 C 10.0698 3.9132 0.0 0
M  V30 12 C 10.8398 2.5795 0.0 0
M  V30 13 C 2.3698 1.2459 0.0 0
M  V30 14 C 1.4645 2.4917 0.0 0
M  V30 15 S 1.4645 0.0000 0.0 0
M  V30 16 C 0.0000 2.0159 0.0 0
M  V30 17 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(1-Methylethyl)-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-...
C22H27NO4S3
951635-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 5.2023 0.0 0 VAL=6
M  V30 2 O 9.2154 6.7423 0.0 0
M  V30 3 O 9.2154 3.6623 0.0 0
M  V30 4 C 7.2460 7.9128 0.0 0
M  V30 5 C 6.2156 9.0574 0.0 0
M  V30 6 C 8.7524 8.2330 0.0 0
M  V30 7 C 4.0596 3.5272 0.0 0
M  V30 8 O 4.2207 1.9955 0.0 0
M  V30 9 O 2.6528 4.1535 0.0 0
M  V30 10 S 4.0596 6.8775 0.0 0
M  V30 11 C 2.6528 6.2512 0.0 0
M  V30 12 C 1.4069 7.1564 0.0 0
M  V30 13 C 0.0000 6.5299 0.0 0
M  V30 14 C 15.3754 5.2023 0.0 0
M  V30 15 N 7.6754 5.2023 0.0 0
M  V30 16 C 6.7701 3.9564 0.0 0 CFG=1
M  V30 17 C 6.7701 6.4483 0.0 0 CFG=2
M  V30 18 C 5.3055 4.4323 0.0 0 CFG=2
M  V30 19 C 5.3055 5.9723 0.0 0 CFG=1
M  V30 20 C 7.2460 2.4919 0.0 0
M  V30 21 C 8.7107 2.0160 0.0 0
M  V30 22 S 6.3408 1.2460 0.0 0
M  V30 23 C 8.7107 0.4760 0.0 0
M  V30 24 C 7.2460 0.0000 0.0 0
M  V30 25 C 10.7554 5.2023 0.0 0
M  V30 26 C 11.5254 3.8686 0.0 0
M  V30 27 C 11.5254 6.5361 0.0 0
M  V30 28 C 13.0654 3.8686 0.0 0
M  V30 29 C 13.0654 6.5361 0.0 0
M  V30 30 C 13.8354 5.2023 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 17 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 18 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 19 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 30
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 16 20 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-64-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-61-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29924533
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME241 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[[4-(1-methylethyl)phenyl]methylene]benzenesulfonamide
C17H19NO2S
951762-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 9.2400 0.0000 0.0 0
M  V30 4 O 9.2400 3.0800 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 15.4000 1.5400 0.0 0
M  V30 7 C 0.7700 2.8736 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 0.0000 4.2073 0.0 0
M  V30 10 C 10.7800 1.5400 0.0 0
M  V30 11 C 11.5500 2.8736 0.0 0
M  V30 12 C 11.5500 0.2062 0.0 0
M  V30 13 C 13.0900 2.8736 0.0 0
M  V30 14 C 13.0900 0.2062 0.0 0
M  V30 15 C 13.8600 1.5400 0.0 0
M  V30 16 C 5.3900 2.8736 0.0 0
M  V30 17 C 4.6200 4.2073 0.0 0
M  V30 18 C 4.6200 1.5400 0.0 0
M  V30 19 C 3.0800 4.2073 0.0 0
M  V30 20 C 3.0800 1.5400 0.0 0
M  V30 21 C 2.3100 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(1-Methylethyl)-2-[4-(1-methylethyl)phenyl]-1-[(4-methylp...
C27H35NO4S2
951635-63-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 8.2489 0.0 0 VAL=6
M  V30 2 O 6.1600 6.7089 0.0 0
M  V30 3 O 6.1600 9.7889 0.0 0
M  V30 4 C 11.3158 6.5736 0.0 0
M  V30 5 O 11.1547 5.0421 0.0 0
M  V30 6 O 12.7226 7.2000 0.0 0
M  V30 7 C 8.1294 10.9594 0.0 0
M  V30 8 C 6.6229 11.2796 0.0 0
M  V30 9 C 9.1598 12.1038 0.0 0
M  V30 10 S 11.3158 9.9241 0.0 0
M  V30 11 C 12.7226 9.2976 0.0 0
M  V30 12 C 13.9684 10.2028 0.0 0
M  V30 13 C 15.3754 9.5765 0.0 0
M  V30 14 C 6.7016 1.1444 0.0 0
M  V30 15 C 5.1953 0.8242 0.0 0
M  V30 16 C 7.7322 0.0000 0.0 0
M  V30 17 C 0.0000 8.2489 0.0 0
M  V30 18 C 8.6052 7.0030 0.0 0 CFG=1
M  V30 19 N 7.7000 8.2489 0.0 0
M  V30 20 C 10.0699 7.4789 0.0 0 CFG=2
M  V30 21 C 8.6052 9.4947 0.0 0 CFG=2
M  V30 22 C 10.0699 9.0189 0.0 0 CFG=2
M  V30 23 C 8.1294 5.5383 0.0 0
M  V30 24 C 6.6229 5.2181 0.0 0
M  V30 25 C 9.1598 4.3939 0.0 0
M  V30 26 C 6.1471 3.7534 0.0 0
M  V30 27 C 8.6839 2.9292 0.0 0
M  V30 28 C 7.1776 2.6091 0.0 0
M  V30 29 C 4.6200 8.2489 0.0 0
M  V30 30 C 3.8500 6.9152 0.0 0
M  V30 31 C 3.8500 9.5825 0.0 0
M  V30 32 C 2.3100 6.9152 0.0 0
M  V30 33 C 2.3100 9.5825 0.0 0
M  V30 34 C 1.5400 8.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 21 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 22 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-66-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-63-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087903
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME242 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Fluorophenyl)-5-(1-methylethyl)-1-[(4-methylphenyl)sul...
C24H28FNO4S2
951635-64-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 4.9240 0.0 0
M  V30 3 O 9.2154 8.0040 0.0 0
M  V30 4 C 4.0596 4.7888 0.0 0
M  V30 5 O 4.2207 3.2573 0.0 0
M  V30 6 O 2.6528 5.4153 0.0 0
M  V30 7 C 7.2460 9.1746 0.0 0
M  V30 8 C 6.2156 10.3189 0.0 0
M  V30 9 C 8.7525 9.4947 0.0 0
M  V30 10 S 4.0596 8.1392 0.0 0
M  V30 11 C 2.6528 7.5128 0.0 0
M  V30 12 C 1.4069 8.4180 0.0 0
M  V30 13 C 0.0000 7.7916 0.0 0
M  V30 14 F 5.6611 0.0000 0.0 0
M  V30 15 C 15.3754 6.4640 0.0 0
M  V30 16 C 6.7702 5.2181 0.0 0 CFG=1
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 19 C 6.7702 7.7099 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 7.2460 3.7535 0.0 0
M  V30 22 C 6.2156 2.6091 0.0 0
M  V30 23 C 8.7525 3.4333 0.0 0
M  V30 24 C 6.6915 1.1444 0.0 0
M  V30 25 C 9.2283 1.9687 0.0 0
M  V30 26 C 8.1977 0.8242 0.0 0
M  V30 27 C 10.7554 6.4640 0.0 0
M  V30 28 C 11.5254 5.1304 0.0 0
M  V30 29 C 11.5254 7.7977 0.0 0
M  V30 30 C 13.0654 5.1304 0.0 0
M  V30 31 C 13.0654 7.7977 0.0 0
M  V30 32 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=1
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-68-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-64-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089415
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME243 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951762-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(4-chlorophenyl)sulfonyl]-5-(1-methyl...
C23H25Cl2NO4S2
951635-65-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 8.6443 0.0 0
M  V30 3 O 9.2154 5.5643 0.0 0
M  V30 4 C 7.2460 9.8149 0.0 0
M  V30 5 C 8.7525 10.1351 0.0 0
M  V30 6 C 6.2156 10.9593 0.0 0
M  V30 7 C 4.0596 5.4291 0.0 0
M  V30 8 O 4.2207 3.8976 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7796 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0583 0.0 0
M  V30 13 C 0.0000 8.4320 0.0 0
M  V30 14 Cl 8.6738 0.0000 0.0 0
M  V30 15 Cl 15.3754 7.1043 0.0 0
M  V30 16 N 7.6754 7.1043 0.0 0
M  V30 17 C 6.7702 5.8585 0.0 0 CFG=1
M  V30 18 C 6.7702 8.3502 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8743 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3938 0.0 0
M  V30 22 C 6.2156 3.2494 0.0 0
M  V30 23 C 8.7525 4.0736 0.0 0
M  V30 24 C 6.6915 1.7847 0.0 0
M  V30 25 C 9.2283 2.6091 0.0 0
M  V30 26 C 8.1977 1.4645 0.0 0
M  V30 27 C 10.7554 7.1043 0.0 0
M  V30 28 C 11.5254 8.4380 0.0 0
M  V30 29 C 11.5254 5.7707 0.0 0
M  V30 30 C 13.0654 8.4380 0.0 0
M  V30 31 C 13.0654 5.7707 0.0 0
M  V30 32 C 13.8354 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-69-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-65-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090927
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME244 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-5-(1-methylethyl)-2-(4-methylp...
C24H28ClNO4S2
951635-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 8.6443 0.0 0
M  V30 3 O 9.2154 5.5643 0.0 0
M  V30 4 C 7.2460 9.8149 0.0 0
M  V30 5 C 8.7525 10.1351 0.0 0
M  V30 6 C 6.2156 10.9593 0.0 0
M  V30 7 C 4.0596 5.4291 0.0 0
M  V30 8 O 4.2207 3.8976 0.0 0
M  V30 9 O 2.6528 6.0556 0.0 0
M  V30 10 S 4.0596 8.7796 0.0 0
M  V30 11 C 2.6528 8.1532 0.0 0
M  V30 12 C 1.4069 9.0583 0.0 0
M  V30 13 C 0.0000 8.4320 0.0 0
M  V30 14 C 8.6738 0.0000 0.0 0
M  V30 15 Cl 15.3754 7.1043 0.0 0
M  V30 16 N 7.6754 7.1043 0.0 0
M  V30 17 C 6.7702 5.8585 0.0 0 CFG=1
M  V30 18 C 6.7702 8.3502 0.0 0 CFG=2
M  V30 19 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 20 C 5.3055 7.8743 0.0 0 CFG=1
M  V30 21 C 7.2460 4.3938 0.0 0
M  V30 22 C 6.2156 3.2494 0.0 0
M  V30 23 C 8.7525 4.0736 0.0 0
M  V30 24 C 6.6915 1.7847 0.0 0
M  V30 25 C 9.2283 2.6091 0.0 0
M  V30 26 C 8.1977 1.4645 0.0 0
M  V30 27 C 10.7554 7.1043 0.0 0
M  V30 28 C 11.5254 8.4380 0.0 0
M  V30 29 C 11.5254 5.7707 0.0 0
M  V30 30 C 13.0654 8.4380 0.0 0
M  V30 31 C 13.0654 5.7707 0.0 0
M  V30 32 C 13.8354 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=3
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 26
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-72-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082941
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME245 STEP1
$RXN



  3  1
$MOL
5-Methyl-2,3-hexadienoic acid
C7H10O2
22104-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 8.0022 0.7700 0.0 0
M  V30 9 O 6.6686 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-(1-Methylethyl)-2-(4-methylphenyl)-1-[(2-methylphenyl)sul...
C25H31NO4S2
951635-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1043 0.0 0 VAL=6
M  V30 2 O 4.6200 8.6443 0.0 0
M  V30 3 O 4.6200 5.5643 0.0 0
M  V30 4 C 6.5894 9.8149 0.0 0
M  V30 5 C 7.6198 10.9593 0.0 0
M  V30 6 C 5.0829 10.1351 0.0 0
M  V30 7 C 9.7758 5.4291 0.0 0
M  V30 8 O 9.6147 3.8976 0.0 0
M  V30 9 O 11.1826 6.0556 0.0 0
M  V30 10 S 9.7758 8.7796 0.0 0
M  V30 11 C 11.1826 8.1532 0.0 0
M  V30 12 C 12.4284 9.0583 0.0 0
M  V30 13 C 13.8354 8.4320 0.0 0
M  V30 14 C 3.0800 9.7718 0.0 0
M  V30 15 C 5.1616 0.0000 0.0 0
M  V30 16 N 6.1600 7.1043 0.0 0
M  V30 17 C 7.0652 5.8585 0.0 0 CFG=1
M  V30 18 C 7.0652 8.3502 0.0 0 CFG=2
M  V30 19 C 8.5299 6.3343 0.0 0 CFG=2
M  V30 20 C 8.5299 7.8743 0.0 0 CFG=1
M  V30 21 C 6.5894 4.3938 0.0 0
M  V30 22 C 5.0829 4.0736 0.0 0
M  V30 23 C 7.6198 3.2494 0.0 0
M  V30 24 C 4.6071 2.6091 0.0 0
M  V30 25 C 7.1439 1.7847 0.0 0
M  V30 26 C 5.6376 1.4645 0.0 0
M  V30 27 C 3.0800 7.1043 0.0 0
M  V30 28 C 2.3100 8.4380 0.0 0
M  V30 29 C 2.3100 5.7707 0.0 0
M  V30 30 C 0.7700 8.4380 0.0 0
M  V30 31 C 0.7700 5.7707 0.0 0
M  V30 32 C 0.0000 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 18 4 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 19 7 CFG=1
M  V30 11 1 10 11
M  V30 12 1 20 10 CFG=1
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 14 28
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22104-88-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-79-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
(3E)-4-(4-Hydroxy-3-methoxyphenyl)-3-buten-2-one
C11H12O3
22214-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4R)-4-(4-Hydroxy-3-methoxyphenyl)-4-[(1-methylethyl)thio]-2-butanone
C14H20O3S
1800187-60-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3901 0.0 0 CFG=2
M  V30 2 C 6.6684 4.6201 0.0 0
M  V30 3 S 5.3348 6.9301 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 C 4.0011 7.7001 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 O 8.0022 6.9301 0.0 0
M  V30 8 C 2.6675 6.9301 0.0 0
M  V30 9 C 4.0011 9.2401 0.0 0
M  V30 10 O 2.6675 0.7700 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 O 0.0000 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 3.0800 0.0 0
M  V30 15 C 2.6675 5.3901 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 1.3337 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 1 10 16
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22214-42-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1800187-60-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-15729431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1289400-89-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sulfa-Michael addition, catalyst prepared and used, 96%
ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Catalysis with Iron-Salen Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shaw, Subrata; White, James D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2016), 48(17), 2768-2780

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
(3E)-4-(4-Hydroxy-3-methoxyphenyl)-3-buten-2-one
C11H12O3
22214-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 9.3359 2.3100 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 1.3337 2.3100 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4R)-4-(4-Hydroxy-3-methoxyphenyl)-4-[(1-methylethyl)thio]-2-butanone
C14H20O3S
1800187-60-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3901 0.0 0 CFG=2
M  V30 2 C 6.6684 4.6201 0.0 0
M  V30 3 S 5.3348 6.9301 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 C 4.0011 7.7001 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 O 8.0022 6.9301 0.0 0
M  V30 8 C 2.6675 6.9301 0.0 0
M  V30 9 C 4.0011 9.2401 0.0 0
M  V30 10 O 2.6675 0.7700 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 O 0.0000 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 3.0800 0.0 0
M  V30 15 C 2.6675 5.3901 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 1.3337 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 1 10 16
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22214-42-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1800187-60-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-4586886
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1289400-89-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sulfa-Michael addition, 96% ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iron catalyzed enantioselective sulfa-Michael addition: a four-step
synthesis of the anti-asthma agent Montelukast
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM White, James D.; Shaw, Subrata
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2014), 5(6), 2200-2204

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-(difluoromethoxy)-4-[4-nitro-1-[[2-(trimethylsilyl)ethoxy]methyl]-...
C17H20ClF2N3O5Si
2231628-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3592 6.5655 0.0 0
M  V30 2 O 8.3898 7.7100 0.0 0
M  V30 3 C 9.8960 7.3898 0.0 0
M  V30 4 C 10.9265 8.5342 0.0 0
M  V30 5 Si 12.4329 8.2141 0.0 0
M  V30 6 C 13.9392 7.8939 0.0 0
M  V30 7 C 12.1127 6.7078 0.0 0
M  V30 8 C 12.7530 9.7205 0.0 0
M  V30 9 N 7.3592 1.1445 0.0 0 VAL=5
M  V30 10 O 8.3898 0.0000 0.0 0
M  V30 11 O 5.8529 0.8244 0.0 0
M  V30 12 O 5.3900 6.5224 0.0 0
M  V30 13 C 4.6200 7.8560 0.0 0
M  V30 14 F 5.3900 9.1898 0.0 0
M  V30 15 F 3.0800 7.8560 0.0 0
M  V30 16 Cl 2.3100 1.1876 0.0 0
M  V30 17 C 0.7700 3.8551 0.0 0
M  V30 18 O 0.0000 5.1887 0.0 0
M  V30 19 C 6.9300 3.8551 0.0 0
M  V30 20 N 7.8351 5.1009 0.0 0
M  V30 21 C 7.8351 2.6091 0.0 0
M  V30 22 N 9.2998 4.6251 0.0 0
M  V30 23 C 9.2998 3.0851 0.0 0
M  V30 24 C 5.3900 3.8551 0.0 0
M  V30 25 C 4.6200 5.1887 0.0 0
M  V30 26 C 4.6200 2.5213 0.0 0
M  V30 27 C 3.0800 5.1887 0.0 0
M  V30 28 C 3.0800 2.5213 0.0 0
M  V30 29 C 2.3100 3.8551 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 21
M  V30 12 1 12 13
M  V30 13 1 12 25
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 16 28
M  V30 17 2 17 18
M  V30 18 1 17 29
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 19 24
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Difluoromethoxy)-2-[(1,1-dimethylethyl)thio]-4-[4-nitro-1-[[2-(trimethylsi...
C21H29F2N3O5SSi
2231628-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.6018 6.2011 0.0 0
M  V30 2 O 10.0665 6.6770 0.0 0
M  V30 3 C 11.2109 5.6466 0.0 0
M  V30 4 C 12.6756 6.1224 0.0 0
M  V30 5 Si 13.8200 5.0920 0.0 0
M  V30 6 C 14.9645 4.0614 0.0 0
M  V30 7 C 14.8504 6.2364 0.0 0
M  V30 8 C 12.7895 3.9475 0.0 0
M  V30 9 N 5.8913 1.5063 0.0 0 VAL=5
M  V30 10 O 4.4267 1.9823 0.0 0
M  V30 11 O 6.2114 0.0000 0.0 0
M  V30 12 O 6.8747 7.1484 0.0 0
M  V30 13 C 6.8747 8.6884 0.0 0
M  V30 14 F 5.5411 9.4584 0.0 0
M  V30 15 F 8.2085 9.4584 0.0 0
M  V30 16 S 1.5400 4.0684 0.0 0
M  V30 17 C 1.5400 2.5284 0.0 0
M  V30 18 C 3.0800 2.5284 0.0 0
M  V30 19 C 1.5400 0.9884 0.0 0
M  V30 20 C 0.0000 2.5284 0.0 0
M  V30 21 C 1.5400 7.1484 0.0 0
M  V30 22 O 1.5400 8.6884 0.0 0
M  V30 23 C 6.8747 4.0684 0.0 0
M  V30 24 N 8.2817 4.6947 0.0 0
M  V30 25 C 7.0358 2.5368 0.0 0
M  V30 26 N 9.3121 3.5503 0.0 0
M  V30 27 C 8.5421 2.2167 0.0 0
M  V30 28 C 5.5411 4.8384 0.0 0
M  V30 29 C 5.5411 6.3784 0.0 0
M  V30 30 C 4.2074 4.0684 0.0 0
M  V30 31 C 4.2074 7.1484 0.0 0
M  V30 32 C 2.8738 4.8384 0.0 0
M  V30 33 C 2.8738 6.3784 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 25
M  V30 12 1 12 13
M  V30 13 1 12 29
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 1 16 32
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 2 21 22
M  V30 22 1 21 33
M  V30 23 1 23 24
M  V30 24 2 23 25
M  V30 25 1 23 28
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2231628-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2231628-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-20203613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidine carboxamides as Janus kinase inhibitors
for the treatment and prophylaxis of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romero, F. Anthony; Zak, Mark; Zhao, Guiling; Gibbons, Paul; Li, Wei;
Cheng, Yun-Xing; Yuen, Po-Wai; Cheng, Limin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018122212 A1 2018-07-05

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(+)-Carvone
C10H14O
2244-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 0.0000 1.3337 0.0 0
M  V30 4 O 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0 CFG=1
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=1
M  V30 4 2 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5S)-3-(Ethylthio)-2-methyl-5-(1-methylethenyl)cyclohexanone
C12H20OS
898541-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 8.4700 2.6674 0.0 0
M  V30 4 C 4.6200 6.6685 0.0 0
M  V30 5 C 1.5400 1.3338 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 0.0000 1.3338 0.0 0
M  V30 8 O 1.5400 6.6685 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0 CFG=3
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0 CFG=3
M  V30 12 C 2.3100 2.6674 0.0 0 CFG=1
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 12 5 CFG=1
M  V30 8 2 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2244-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 898541-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-15405982
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7601-90-3
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica-supported
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, solid-supported catalyst, Michael addition, catalyst
reusable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Perchloric acid impregnated on silica gel (HClO4/SiO2): a versatile
catalyst for Michael addition of thiols to the electron-deficient alkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khan, Abu T.; Ghosh, Subrata; Choudhury, Lokman H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2006), (9), 2226-2231

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-Bis(chloromethyl)-9,9′-dimethyl-1,1′-bi-9H-pyrido[3,4-b]indole
C26H20Cl2N4
2374280-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6252 8.0408 0.0 0
M  V30 2 C 4.9149 0.7700 0.0 0
M  V30 3 Cl 3.5811 0.0000 0.0 0
M  V30 4 C 8.2056 1.9692 0.0 0
M  V30 5 C 8.9159 9.2400 0.0 0
M  V30 6 Cl 10.2497 10.0101 0.0 0
M  V30 7 C 4.9149 5.3900 0.0 0
M  V30 8 C 6.2486 4.6200 0.0 0
M  V30 9 C 3.5811 4.6200 0.0 0
M  V30 10 N 4.5946 6.8963 0.0 0
M  V30 11 N 6.2486 3.0800 0.0 0
M  V30 12 C 2.4368 5.6504 0.0 0
M  V30 13 C 3.5811 3.0800 0.0 0
M  V30 14 C 3.0631 7.0574 0.0 0
M  V30 15 C 4.9149 2.3100 0.0 0
M  V30 16 C 0.9052 5.4895 0.0 0
M  V30 17 C 2.1579 8.3033 0.0 0
M  V30 18 C 0.0000 6.7354 0.0 0
M  V30 19 C 0.6263 8.1423 0.0 0
M  V30 20 C 7.5822 5.3900 0.0 0
M  V30 21 C 8.9159 4.6200 0.0 0
M  V30 22 N 7.5822 6.9300 0.0 0
M  V30 23 C 10.2497 5.3900 0.0 0
M  V30 24 N 9.2362 3.1137 0.0 0
M  V30 25 C 8.9159 7.7000 0.0 0
M  V30 26 C 11.3941 4.3596 0.0 0
M  V30 27 C 10.2497 6.9300 0.0 0
M  V30 28 C 10.7677 2.9527 0.0 0
M  V30 29 C 12.9256 4.5205 0.0 0
M  V30 30 C 11.6730 1.7068 0.0 0
M  V30 31 C 13.8308 3.2747 0.0 0
M  V30 32 C 13.2045 1.8677 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 4 24
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 20
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 2 12 16
M  V30 18 1 13 15
M  V30 19 2 14 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 2 22 25
M  V30 28 1 23 26
M  V30 29 2 23 27
M  V30 30 1 24 28
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 26 29
M  V30 34 2 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9,9′-Dimethyl-3,3′-bis[[(1-methylethyl)thio]methyl]-1,1′-bi-9H-pyrido[3,4-b]i...
C32H34N4S2
2374280-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6531 9.6504 0.0 0
M  V30 2 C 4.0011 6.6301 0.0 0
M  V30 3 S 2.6675 7.4001 0.0 0
M  V30 4 C 1.3338 6.6301 0.0 0
M  V30 5 C 0.0000 7.4001 0.0 0
M  V30 6 C 1.3338 5.0901 0.0 0
M  V30 7 C 6.6851 4.3798 0.0 0
M  V30 8 C 13.3371 7.4001 0.0 0
M  V30 9 S 14.6707 6.6301 0.0 0
M  V30 10 C 16.0044 7.4001 0.0 0
M  V30 11 C 16.0044 8.9401 0.0 0
M  V30 12 C 17.3382 6.6301 0.0 0
M  V30 13 C 8.0023 7.4001 0.0 0
M  V30 14 C 8.0023 8.9401 0.0 0
M  V30 15 N 6.6686 6.6301 0.0 0
M  V30 16 C 6.6686 9.7101 0.0 0
M  V30 17 N 9.1467 9.9706 0.0 0
M  V30 18 C 5.3348 7.4001 0.0 0
M  V30 19 C 6.9888 11.2164 0.0 0
M  V30 20 C 5.3348 8.9401 0.0 0
M  V30 21 C 8.5203 11.3775 0.0 0
M  V30 22 C 6.0835 12.4625 0.0 0
M  V30 23 C 9.1467 12.7843 0.0 0
M  V30 24 C 6.7099 13.8693 0.0 0
M  V30 25 C 8.2414 14.0302 0.0 0
M  V30 26 C 9.3359 6.6301 0.0 0
M  V30 27 C 9.3359 5.0901 0.0 0
M  V30 28 N 10.6696 7.4001 0.0 0
M  V30 29 C 10.6696 4.3201 0.0 0
M  V30 30 N 8.1915 4.0597 0.0 0
M  V30 31 C 12.0034 6.6301 0.0 0
M  V30 32 C 10.3494 2.8138 0.0 0
M  V30 33 C 12.0034 5.0901 0.0 0
M  V30 34 C 8.8179 2.6527 0.0 0
M  V30 35 C 11.2546 1.5677 0.0 0
M  V30 36 C 8.1915 1.2459 0.0 0
M  V30 37 C 10.6283 0.1609 0.0 0
M  V30 38 C 9.0968 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 30
M  V30 8 1 8 9
M  V30 9 1 8 31
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 26
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 19 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 27 30
M  V30 33 2 28 31
M  V30 34 1 29 32
M  V30 35 2 29 33
M  V30 36 1 30 34
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 32 35
M  V30 40 2 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2374280-07-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2374280-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-20439553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and application of axially chiral biscarbolines with functional
N-O and sulfone for 1,2-transfer hydrogenations of ketimines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xing, Yongfei; Wu, Shijie; Dong, Mengxian; Wang, Jie; Liu, Li; Zhu,
Huajie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2019), 75(36), 130495pp.

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[(3-formyl-2-methyl-1H-indol-1-yl)methyl]-α-(methoxyimino)benze...
C21H20N2O4
2394951-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 4.0011 0.0 0
M  V30 2 C 4.5932 6.7116 0.0 0
M  V30 3 C 1.4068 5.6763 0.0 0
M  V30 4 O 0.0000 5.0498 0.0 0
M  V30 5 C 9.6426 4.0011 0.0 0
M  V30 6 C 8.8726 2.6674 0.0 0
M  V30 7 N 11.1826 4.0011 0.0 0
M  V30 8 O 9.6426 1.3336 0.0 0
M  V30 9 O 7.3326 2.6674 0.0 0
M  V30 10 O 11.9526 5.3347 0.0 0
M  V30 11 C 8.8726 0.0000 0.0 0
M  V30 12 C 13.4926 5.3347 0.0 0
M  V30 13 C 4.1173 2.7552 0.0 0
M  V30 14 N 5.0226 4.0011 0.0 0
M  V30 15 C 2.6528 3.2311 0.0 0
M  V30 16 C 4.4375 1.2488 0.0 0
M  V30 17 C 4.1173 5.2469 0.0 0
M  V30 18 C 2.6528 4.7711 0.0 0
M  V30 19 C 1.5083 2.2007 0.0 0
M  V30 20 C 3.2931 0.2184 0.0 0
M  V30 21 C 1.8284 0.6942 0.0 0
M  V30 22 C 7.3326 5.3347 0.0 0
M  V30 23 C 8.8726 5.3347 0.0 0
M  V30 24 C 6.5626 6.6685 0.0 0
M  V30 25 C 9.6426 6.6685 0.0 0
M  V30 26 C 7.3326 8.0021 0.0 0
M  V30 27 C 8.8726 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 22
M  V30 3 1 2 17
M  V30 4 2 3 4
M  V30 5 1 3 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 23
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[3-[bis(ethylthio)methyl]-2-methyl-1H-indol-1-yl]methyl]-α-(me...
C25H30N2O3S2
2394951-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 3.9683 0.0 0
M  V30 2 S 2.6528 4.5946 0.0 0
M  V30 3 S 4.2207 2.4367 0.0 0
M  V30 4 C 1.4069 3.6894 0.0 0
M  V30 5 C 2.9747 1.5315 0.0 0
M  V30 6 C 0.0000 4.3159 0.0 0
M  V30 7 C 3.1358 0.0000 0.0 0
M  V30 8 C 7.2460 2.9329 0.0 0
M  V30 9 C 9.2154 5.6435 0.0 0
M  V30 10 C 12.2954 5.6435 0.0 0
M  V30 11 C 11.5254 6.9771 0.0 0
M  V30 12 N 13.8354 5.6435 0.0 0
M  V30 13 O 12.2954 8.3108 0.0 0
M  V30 14 O 9.9854 6.9771 0.0 0
M  V30 15 O 14.6054 4.3097 0.0 0
M  V30 16 C 11.5254 9.6444 0.0 0
M  V30 17 C 16.1454 4.3097 0.0 0
M  V30 18 C 5.3055 4.8735 0.0 0
M  V30 19 C 5.3055 6.4135 0.0 0
M  V30 20 C 6.7702 4.3976 0.0 0
M  V30 21 C 6.7702 6.8894 0.0 0
M  V30 22 C 4.1611 7.4439 0.0 0
M  V30 23 N 7.6754 5.6435 0.0 0
M  V30 24 C 7.0903 8.3956 0.0 0
M  V30 25 C 4.4813 8.9502 0.0 0
M  V30 26 C 5.9460 9.4262 0.0 0
M  V30 27 C 9.9854 4.3097 0.0 0
M  V30 28 C 11.5254 4.3097 0.0 0
M  V30 29 C 9.2154 2.9761 0.0 0
M  V30 30 C 12.2954 2.9761 0.0 0
M  V30 31 C 9.9854 1.6424 0.0 0
M  V30 32 C 11.5254 1.6424 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 20
M  V30 9 1 9 23
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 1 22 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2394951-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2394951-81-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-20778979
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7681-38-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition, selective reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Antiviral Activity, and Induction of Plant Resistance of
Indole Analogues Bearing Dithioacetal Moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wei, Chunle; Zhang, Jian; Shi, Jing; Gan, Xiuhai; Hu, Deyu; Song, Baoan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Agricultural and Food Chemistry (2019), 67(50), 13882-13891

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloropyridine
C5H3Cl2N
2402-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0800 0.0 0
M  V30 2 Cl 5.3349 3.0800 0.0 0
M  V30 3 N 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-[(1-methylethyl)thio]pyridine
C8H10ClNS
77145-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 2.3100 0.0 0
M  V30 3 C 6.6685 0.7700 0.0 0
M  V30 4 C 8.0021 3.0800 0.0 0
M  V30 5 Cl 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2402-78-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 77145-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-7926527
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of biaryl derivatives as GPR120 agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Young Kwan; Park, Sang Yun; Joo, Hyun Woo; Choi, Eun Sil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014209034 A1 2014-12-31

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
1-[[(3,4,5-Trichloro-2-thienyl)carbonyl]amino]cyclopropanecarboxylic acid
C9H6Cl3NO3S
2407937-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6363 3.2587 0.0 0
M  V30 2 C 5.3026 4.0287 0.0 0
M  V30 3 O 5.3026 5.5687 0.0 0
M  V30 4 C 8.9599 2.8489 0.0 0
M  V30 5 O 8.4332 1.4019 0.0 0
M  V30 6 O 10.4765 3.1164 0.0 0
M  V30 7 Cl 2.2418 5.3915 0.0 0
M  V30 8 Cl 0.0000 2.9016 0.0 0
M  V30 9 Cl 1.6752 0.0000 0.0 0
M  V30 10 C 7.9700 4.0287 0.0 0
M  V30 11 C 7.4433 5.4759 0.0 0
M  V30 12 C 8.9599 5.2084 0.0 0
M  V30 13 C 3.9690 3.2587 0.0 0
M  V30 14 C 2.5620 3.8850 0.0 0
M  V30 15 S 3.8079 1.7271 0.0 0
M  V30 16 C 1.5316 2.7406 0.0 0
M  V30 17 C 2.3016 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 1 7 14
M  V30 9 1 8 16
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopropanecarbothioic acid, 1-[[(3,4,5-trichloro-2-thienyl)carbonyl]amino]-...
C11H10Cl3NO2S2
2656404-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6362 3.2587 0.0 0
M  V30 2 C 5.3026 4.0287 0.0 0
M  V30 3 O 5.3026 5.5687 0.0 0
M  V30 4 C 8.9598 2.8489 0.0 0
M  V30 5 S 10.4764 3.1164 0.0 0
M  V30 6 O 8.4331 1.4019 0.0 0
M  V30 7 C 11.4663 1.9366 0.0 0
M  V30 8 C 12.9829 2.2041 0.0 0
M  V30 9 Cl 2.2418 5.3914 0.0 0
M  V30 10 Cl 0.0000 2.9015 0.0 0
M  V30 11 Cl 1.6752 0.0000 0.0 0
M  V30 12 C 7.9699 4.0287 0.0 0
M  V30 13 C 8.9598 5.2083 0.0 0
M  V30 14 C 7.4432 5.4758 0.0 0
M  V30 15 C 3.9689 3.2587 0.0 0
M  V30 16 C 2.5620 3.8850 0.0 0
M  V30 17 S 3.8078 1.7271 0.0 0
M  V30 18 C 1.5315 2.7406 0.0 0
M  V30 19 C 2.3015 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 9 16
M  V30 11 1 10 18
M  V30 12 1 11 19
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2407937-28-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2656404-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-23886431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted thiophenecarboxamides and derivatives thereof for controlling
phytopathogenic microorganisms and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dufour, Jeremy; Nicolas, Lionel; Knobloch, Thomas; Brunet, Stephane;
Lamprecht, Sybille
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021122976 A1 2021-06-24

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[(4-Bromophenyl)methoxy]-4-oxo-4H-1-benzopyran-3-carboxaldehyde
C17H11BrO4
2411008-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 4.0011 0.0 0
M  V30 2 O 9.2400 2.6674 0.0 0
M  V30 3 C 10.0100 4.0011 0.0 0
M  V30 4 C 0.7700 1.3338 0.0 0
M  V30 5 O 0.0000 0.0000 0.0 0
M  V30 6 Br 16.1700 4.0011 0.0 0
M  V30 7 C 5.3900 1.3338 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 6.9300 1.3338 0.0 0
M  V30 10 O 4.6200 0.0000 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 18 C 12.3200 2.6674 0.0 0
M  V30 19 C 12.3200 5.3349 0.0 0
M  V30 20 C 13.8600 2.6674 0.0 0
M  V30 21 C 13.8600 5.3349 0.0 0
M  V30 22 C 14.6300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 1 4 15
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 2 14 15
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[Bis(ethylthio)methyl]-7-[(4-bromophenyl)methoxy]-4H-1-benzopyran-4-one
C21H21BrO3S2
2411008-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 2.3101 0.0 0
M  V30 2 O 12.0035 6.9302 0.0 0
M  V30 3 C 13.3372 6.1601 0.0 0
M  V30 4 C 4.0012 3.8501 0.0 0
M  V30 5 S 2.6675 4.6201 0.0 0
M  V30 6 S 4.0012 2.3101 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 Br 18.6720 9.2402 0.0 0
M  V30 12 C 8.0023 6.1601 0.0 0
M  V30 13 C 8.0023 4.6201 0.0 0
M  V30 14 C 9.3360 6.9302 0.0 0
M  V30 15 O 6.6685 6.9302 0.0 0
M  V30 16 C 6.6685 3.8501 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 5.3348 6.1601 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 14.6708 6.9302 0.0 0
M  V30 23 C 14.6708 8.4702 0.0 0
M  V30 24 C 16.0045 6.1601 0.0 0
M  V30 25 C 16.0045 9.2402 0.0 0
M  V30 26 C 17.3383 6.9302 0.0 0
M  V30 27 C 17.3383 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 20
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 2 18 21
M  V30 23 2 19 20
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2411008-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411008-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-22350960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7681-38-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reagent (silica supported sodium bisulfate used as
reagent (stage 2))
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and anti-TMV activities of novel chromone derivatives
containing dithioacetal moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Miao; Zan, Ningning; Huang, Maoxi; Jiang, Donghao; Hu, Deyu; Song,
Baoan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(5), 126945

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL

C36H52O4S2Si
2417793-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 6.9300 0.0 0 CFG=2
M  V30 2 C 9.3358 7.7000 0.0 0 CFG=1
M  V30 3 C 8.0021 5.3900 0.0 0 CFG=2
M  V30 4 O 6.6685 7.7000 0.0 0
M  V30 5 C 9.3358 9.2400 0.0 0
M  V30 6 O 10.6696 6.9300 0.0 0
M  V30 7 C 6.6685 4.6200 0.0 0
M  V30 8 O 9.3358 4.6200 0.0 0
M  V30 9 C 6.6685 9.2400 0.0 0
M  V30 10 S 10.6696 10.0100 0.0 0
M  V30 11 S 8.0021 10.0100 0.0 0
M  V30 12 C 12.0032 7.7000 0.0 0
M  V30 13 O 5.3347 5.3900 0.0 0
M  V30 14 Si 9.3358 3.0800 0.0 0
M  V30 15 C 10.6696 11.5500 0.0 0
M  V30 16 C 8.0021 11.5500 0.0 0
M  V30 17 C 4.0011 4.6200 0.0 0
M  V30 18 C 9.3358 1.5400 0.0 0
M  V30 19 C 7.7958 3.0800 0.0 0
M  V30 20 C 10.8758 3.0800 0.0 0
M  V30 21 C 12.0032 12.3200 0.0 0
M  V30 22 C 9.3358 12.3200 0.0 0
M  V30 23 C 7.7958 1.5400 0.0 0
M  V30 24 C 9.3358 0.0000 0.0 0
M  V30 25 C 10.8758 1.5400 0.0 0
M  V30 26 C 5.3347 10.0100 0.0 0
M  V30 27 C 4.0011 9.2400 0.0 0
M  V30 28 C 5.3347 11.5500 0.0 0
M  V30 29 C 2.6674 10.0100 0.0 0
M  V30 30 C 4.0011 12.3200 0.0 0
M  V30 31 C 2.6674 11.5500 0.0 0
M  V30 32 C 13.3369 6.9300 0.0 0
M  V30 33 C 14.6705 7.7000 0.0 0
M  V30 34 C 13.3369 5.3900 0.0 0
M  V30 35 C 16.0043 6.9300 0.0 0
M  V30 36 C 14.6705 4.6200 0.0 0
M  V30 37 C 16.0043 5.3900 0.0 0
M  V30 38 C 2.6674 5.3900 0.0 0
M  V30 39 C 2.6674 6.9300 0.0 0
M  V30 40 C 1.3338 4.6200 0.0 0
M  V30 41 C 1.3338 7.7000 0.0 0
M  V30 42 C 0.0000 5.3900 0.0 0
M  V30 43 C 0.0000 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 26
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 32
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 20
M  V30 22 1 15 21
M  V30 23 1 16 22
M  V30 24 1 17 38
M  V30 25 1 18 23
M  V30 26 1 18 24
M  V30 27 1 18 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 2 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 2 40 42
M  V30 44 2 41 43
M  V30 45 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C40H60O4S2Si
2417793-67-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 6.9302 0.0 0 CFG=2
M  V30 2 C 5.3348 7.7002 0.0 0 CFG=1
M  V30 3 C 8.0023 7.7002 0.0 0 CFG=2
M  V30 4 O 6.6687 5.3901 0.0 0
M  V30 5 C 4.0012 6.9302 0.0 0
M  V30 6 O 5.3348 9.2402 0.0 0
M  V30 7 C 9.3360 6.9302 0.0 0
M  V30 8 O 8.0023 9.2402 0.0 0
M  V30 9 C 8.0023 4.6201 0.0 0
M  V30 10 S 4.0012 5.3901 0.0 0
M  V30 11 S 2.6675 7.7002 0.0 0
M  V30 12 C 4.0012 10.0102 0.0 0
M  V30 13 O 10.6698 7.7002 0.0 0
M  V30 14 Si 9.3360 10.0102 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 1.3338 8.4702 0.0 0
M  V30 17 C 12.0035 6.9302 0.0 0
M  V30 18 C 10.6698 10.7802 0.0 0
M  V30 19 C 8.5660 11.3439 0.0 0
M  V30 20 C 10.1060 8.6766 0.0 0
M  V30 21 C 1.8975 5.9538 0.0 0
M  V30 22 C 1.3338 3.8501 0.0 0
M  V30 23 C 3.4375 3.2864 0.0 0
M  V30 24 C 2.1038 9.8039 0.0 0
M  V30 25 C 0.0000 9.2402 0.0 0
M  V30 26 C 0.5638 7.1365 0.0 0
M  V30 27 C 11.4398 9.4466 0.0 0
M  V30 28 C 12.0035 11.5503 0.0 0
M  V30 29 C 9.8998 12.1139 0.0 0
M  V30 30 C 8.0023 3.0801 0.0 0
M  V30 31 C 6.6687 2.3101 0.0 0
M  V30 32 C 9.3360 2.3101 0.0 0
M  V30 33 C 6.6687 0.7700 0.0 0
M  V30 34 C 9.3360 0.7700 0.0 0
M  V30 35 C 8.0023 0.0000 0.0 0
M  V30 36 C 4.0012 11.5503 0.0 0
M  V30 37 C 2.6675 12.3203 0.0 0
M  V30 38 C 5.3348 12.3203 0.0 0
M  V30 39 C 2.6675 13.8603 0.0 0
M  V30 40 C 5.3348 13.8603 0.0 0
M  V30 41 C 4.0012 14.6303 0.0 0
M  V30 42 C 13.3372 7.7002 0.0 0
M  V30 43 C 14.6708 6.9302 0.0 0
M  V30 44 C 13.3372 9.2402 0.0 0
M  V30 45 C 16.0046 7.7002 0.0 0
M  V30 46 C 14.6708 10.0102 0.0 0
M  V30 47 C 16.0046 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 30
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 36
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 14 20
M  V30 22 1 15 21
M  V30 23 1 15 22
M  V30 24 1 15 23
M  V30 25 1 16 24
M  V30 26 1 16 25
M  V30 27 1 16 26
M  V30 28 1 17 42
M  V30 29 1 18 27
M  V30 30 1 18 28
M  V30 31 1 18 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 38 2 36 37
M  V30 39 1 36 38
M  V30 40 1 37 39
M  V30 41 2 38 40
M  V30 42 2 39 41
M  V30 43 1 40 41
M  V30 44 2 42 43
M  V30 45 1 42 44
M  V30 46 1 43 45
M  V30 47 2 44 46
M  V30 48 2 45 47
M  V30 49 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2417793-66-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417793-67-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28415404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-48-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128-08-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 109-63-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereoselective and regioselective synthesis of adenosine
thionucleoside analogues using an acyclic approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cardinal-David, Benoit; Labbe, Marc-Olivier; Prevost, Michel; Dostie,
Starr; Guindon, Yvan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canadian Journal of Chemistry (2020), 98(9), 466-470

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
3-Amino-4-methylbenzoic acid
C8H9NO2
2458-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(1E)-2-[(1,1-Dimethylethyl)thio]diazenyl]-4-methylbenzoic acid
C12H16N2O2S
478169-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6675 0.0 0
M  V30 2 N 6.9302 4.0012 0.0 0
M  V30 3 S 8.4702 4.0012 0.0 0
M  V30 4 C 9.2402 5.3348 0.0 0
M  V30 5 C 7.9065 6.1048 0.0 0
M  V30 6 C 10.0102 6.6687 0.0 0
M  V30 7 C 10.5739 4.5648 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 1.5400 5.3348 0.0 0
M  V30 10 O 2.3101 6.6687 0.0 0
M  V30 11 O 0.0000 5.3348 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 3.8501 4.0012 0.0 0
M  V30 14 C 3.8501 1.3338 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 2.3101 1.3338 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2458-12-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478169-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28748358
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7632-00-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Treatment of diseases with alpha-7 NACh receptor full agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Groppi, Vincent Edward, Jr.; Rogers, Bruce Nelsen; Rudmann, Daniel
Gregory
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004064836 A2 2004-08-05

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
3-Amino-4-methylbenzoic acid
C8H9NO2
2458-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(1E)-2-[(1,1-Dimethylethyl)thio]diazenyl]-4-methylbenzoic acid
C12H16N2O2S
478169-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6675 0.0 0
M  V30 2 N 6.9302 4.0012 0.0 0
M  V30 3 S 8.4702 4.0012 0.0 0
M  V30 4 C 9.2402 5.3348 0.0 0
M  V30 5 C 7.9065 6.1048 0.0 0
M  V30 6 C 10.0102 6.6687 0.0 0
M  V30 7 C 10.5739 4.5648 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 1.5400 5.3348 0.0 0
M  V30 10 O 2.3101 6.6687 0.0 0
M  V30 11 O 0.0000 5.3348 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 3.8501 4.0012 0.0 0
M  V30 14 C 3.8501 1.3338 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 2.3101 1.3338 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2458-12-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478169-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27113161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7632-00-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred solution of 3-amino-4-methylbenzoic acid (5.0 g, 33 mmol) in
a mixture of water (50 mL) and concentrated hydrochloric acid (15 mL) in
an acetonecrushed ice bath is added a solution of sodium nitrite in water
(12 mL) dropwise. The solution is stirred for 10 min, followed by the
addition of tert-butyl mercaptan (1.8 mL, 16 mmol). The mixture is
stirred for 1 h. The solid precipitate is filtered, washed with water and
dried in vacuo to obtain 3-[(E)-(tert-butylthio)
diazenyl]-4-methylbenzoic acid. Tan solid, yield 3.85 g, 95%. 1H NMR (400
MHz, DMSO-d6) δ 13.2, 7.8, 7.5, 7.3, 2.1, 1.6.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A preparation of azabicycloalkane derivatives, useful as α7 nicotinic
acetylcholine receptor (α7 nAChR) agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Corbett, Jeffrey Wayne; Groppi, Vincent Edward, Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052348 A2 2004-06-24

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
3-Amino-4-methylbenzoic acid
C8H9NO2
2458-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(1E)-2-[(1,1-Dimethylethyl)thio]diazenyl]-4-methylbenzoic acid
C12H16N2O2S
478169-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6675 0.0 0
M  V30 2 N 6.9302 4.0012 0.0 0
M  V30 3 S 8.4702 4.0012 0.0 0
M  V30 4 C 9.2402 5.3348 0.0 0
M  V30 5 C 7.9065 6.1048 0.0 0
M  V30 6 C 10.0102 6.6687 0.0 0
M  V30 7 C 10.5739 4.5648 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 1.5400 5.3348 0.0 0
M  V30 10 O 2.3101 6.6687 0.0 0
M  V30 11 O 0.0000 5.3348 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 3.8501 4.0012 0.0 0
M  V30 14 C 3.8501 1.3338 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 2.3101 1.3338 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2458-12-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478169-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27195600
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a stirred solution of 3-amino-4-methylbenzoic acid (5.0 g, 33 mmol) in
a mixture of water (50 mL) and concentrated hydrochloric acid (15 mL) in
an acetone-crushed ice bath is added a solution of sodium nitrite in
water (12 mL) dropwise. The solution is stirred for 10 min, followed by
the addition of tert-butyl mercaptan (1.8 mL, 16 mmol). The mixture is
stirred for 1 h. The solid precipitate is filtered, washed with water and
dried in vacuo to obtain 3-[(B)-(tert-butylthio)diazenyl]-4-methylbenzoic
acid. Tan solid, yield 3.85 g, 95% 1H NMR (400 MHz, DMSO-d6) δ 13.2, 7.8,
7.5, 7.3, 2.1, 1.6.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(quinuclidinyl)heteroarylamides as nicotinic
acetylcholine receptor agonists for use in combination therapy for the
treatment of ADHD
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Groppi, Vincent Edward, Jr.; Jacobsen, Eric Jon; Myers, Jason Kenneth;
Piotrowski, David Walter; Rogers, Bruce Nelsen; Walker, Daniel Patrick;
Wishka, Donn Gregory
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052461 A1 2004-06-24

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
3-Amino-4-methylbenzoic acid
C8H9NO2
2458-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(1E)-2-[(1,1-Dimethylethyl)thio]diazenyl]-4-methylbenzoic acid
C12H16N2O2S
478169-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6675 0.0 0
M  V30 2 N 6.9302 4.0012 0.0 0
M  V30 3 S 8.4702 4.0012 0.0 0
M  V30 4 C 9.2402 5.3348 0.0 0
M  V30 5 C 7.9065 6.1048 0.0 0
M  V30 6 C 10.0102 6.6687 0.0 0
M  V30 7 C 10.5739 4.5648 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 1.5400 5.3348 0.0 0
M  V30 10 O 2.3101 6.6687 0.0 0
M  V30 11 O 0.0000 5.3348 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 3.8501 4.0012 0.0 0
M  V30 14 C 3.8501 1.3338 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 2.3101 1.3338 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2458-12-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478169-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28628400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7632-00-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azabicyclic α7 nicotinic acetylcholine agonists for the
treatment of glaucoma and retinal neuropathy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Linn, David Martin; Wong, Erik Ho Fong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004039366 A1 2004-05-13

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
3-Amino-4-methylbenzoic acid
C8H9NO2
2458-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(1E)-2-[(1,1-Dimethylethyl)thio]diazenyl]-4-methylbenzoic acid
C12H16N2O2S
478169-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 2.6675 0.0 0
M  V30 2 N 6.9302 4.0012 0.0 0
M  V30 3 S 8.4702 4.0012 0.0 0
M  V30 4 C 9.2402 5.3348 0.0 0
M  V30 5 C 7.9065 6.1048 0.0 0
M  V30 6 C 10.0102 6.6687 0.0 0
M  V30 7 C 10.5739 4.5648 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 1.5400 5.3348 0.0 0
M  V30 10 O 2.3101 6.6687 0.0 0
M  V30 11 O 0.0000 5.3348 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 3.8501 4.0012 0.0 0
M  V30 14 C 3.8501 1.3338 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 2.3101 1.3338 0.0 0
M  V30 17 C 1.5400 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2458-12-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 478169-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26280501
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7632-00-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation and formulation of N-quinuclidinyl-heteroaryls as nicotinic
acetylcholinergic receptor modulators for the treatment of a variety of
central nervous system disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Walker, Daniel P.; Wishka, Donn G.; Corbett, Jeffrey W.; Rauckhorst, Mark
R.; Piotrowski, David W.; Groppi, Vincent E., Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002100858 A2 2002-12-19

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1,3-bis(bromomethyl)benzene
C8H7Br3
25006-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 1.5400 0.0 0
M  V30 2 Br 8.0023 2.3101 0.0 0
M  V30 3 Br 4.0012 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 Br 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1,3-bis[[(1,1-dimethylethyl)thio]methyl]benzene
C16H25BrS2
2822550-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 S 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 3.0801 0.0 0
M  V30 4 C 2.1037 4.4137 0.0 0
M  V30 5 C 0.0000 3.8501 0.0 0
M  V30 6 C 0.5637 1.7464 0.0 0
M  V30 7 Br 6.6685 4.6201 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 S 10.6697 2.3101 0.0 0
M  V30 10 C 12.0033 3.0801 0.0 0
M  V30 11 C 11.2333 4.4137 0.0 0
M  V30 12 C 13.3370 3.8501 0.0 0
M  V30 13 C 12.7733 1.7464 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 6.6685 0.0000 0.0 0
M  V30 19 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25006-88-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2822550-85-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33891492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and characterization of cobalt SCS pincer complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pecak, Jan; Kaefer, Matthias; Fleissner, Sarah; Artner, Werner; Kirchner,
Karl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2022), 153(7-8), 545-549

$RFMT $RIREG SCHEME257 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
254428-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-(2...
C27H34BrNO4S2
951636-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Br 0.0000 6.7017 0.0 0
M  V30 18 C 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 254428-47-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16081784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME258 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
254428-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-butyl-1-[(4-methylphenyl)sulfonyl]-4-(2...
C25H30BrNO4S2
951636-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Br 8.6738 13.5684 0.0 0
M  V30 16 C 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 254428-47-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME259 STEP1
$RXN



  3  1
$MOL
2,3-Nonadienoic acid
C9H14O2
80472-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
254428-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(4-methylphenyl)sulfonyl]-4-[(2-methyl...
C27H36BrNO4S2
951337-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.9287 0.0 0 VAL=6
M  V30 2 O 9.2154 6.3887 0.0 0
M  V30 3 O 9.2154 9.4687 0.0 0
M  V30 4 C 4.0596 9.6039 0.0 0
M  V30 5 O 2.6528 8.9776 0.0 0
M  V30 6 O 4.2207 11.1354 0.0 0
M  V30 7 C 7.2460 5.2181 0.0 0
M  V30 8 C 6.2156 4.0738 0.0 0
M  V30 9 C 6.6915 2.6091 0.0 0
M  V30 10 C 5.6610 1.4647 0.0 0
M  V30 11 C 6.1369 0.0000 0.0 0
M  V30 12 S 4.0596 6.2535 0.0 0
M  V30 13 C 2.6528 6.8799 0.0 0
M  V30 14 C 1.4069 5.9747 0.0 0
M  V30 15 C 1.5679 4.4432 0.0 0
M  V30 16 C 0.0000 6.6011 0.0 0
M  V30 17 Br 8.6737 15.0332 0.0 0
M  V30 18 C 15.3754 7.9287 0.0 0
M  V30 19 C 6.7701 9.1745 0.0 0 CFG=1
M  V30 20 N 7.6754 7.9287 0.0 0
M  V30 21 C 5.3055 8.6987 0.0 0 CFG=2
M  V30 22 C 6.7701 6.6828 0.0 0 CFG=2
M  V30 23 C 5.3055 7.1587 0.0 0 CFG=2
M  V30 24 C 7.2460 10.6392 0.0 0
M  V30 25 C 8.7524 10.9594 0.0 0
M  V30 26 C 6.2156 11.7836 0.0 0
M  V30 27 C 9.2283 12.4241 0.0 0
M  V30 28 C 6.6915 13.2483 0.0 0
M  V30 29 C 8.1979 13.5685 0.0 0
M  V30 30 C 10.7554 7.9287 0.0 0
M  V30 31 C 11.5254 9.2623 0.0 0
M  V30 32 C 11.5254 6.5950 0.0 0
M  V30 33 C 13.0654 9.2623 0.0 0
M  V30 34 C 13.0654 6.5950 0.0 0
M  V30 35 C 13.8354 7.9287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 23 12 CFG=1
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 80472-30-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 254428-47-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951337-70-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083134
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME260 STEP1
$RXN



  3  1
$MOL
2,3-Nonadienoic acid
C9H14O2
80472-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
254428-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(4-methylphenyl)sulfonyl]-5-pentyl-4-(...
C26H32BrNO4S2
951636-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.9287 0.0 0 VAL=6
M  V30 2 O 9.2154 9.4687 0.0 0
M  V30 3 O 9.2154 6.3887 0.0 0
M  V30 4 C 7.2460 5.2181 0.0 0
M  V30 5 C 6.2156 4.0738 0.0 0
M  V30 6 C 6.6915 2.6091 0.0 0
M  V30 7 C 5.6610 1.4647 0.0 0
M  V30 8 C 6.1369 0.0000 0.0 0
M  V30 9 C 4.0596 9.6039 0.0 0
M  V30 10 O 2.6528 8.9776 0.0 0
M  V30 11 O 4.2207 11.1354 0.0 0
M  V30 12 S 4.0596 6.2535 0.0 0
M  V30 13 C 2.6528 6.8799 0.0 0
M  V30 14 C 1.4069 5.9747 0.0 0
M  V30 15 C 0.0000 6.6011 0.0 0
M  V30 16 Br 8.6737 15.0332 0.0 0
M  V30 17 C 15.3754 7.9287 0.0 0
M  V30 18 N 7.6754 7.9287 0.0 0
M  V30 19 C 6.7701 9.1745 0.0 0 CFG=1
M  V30 20 C 6.7701 6.6828 0.0 0 CFG=2
M  V30 21 C 5.3055 8.6987 0.0 0 CFG=2
M  V30 22 C 5.3055 7.1587 0.0 0 CFG=1
M  V30 23 C 7.2460 10.6392 0.0 0
M  V30 24 C 6.2156 11.7836 0.0 0
M  V30 25 C 8.7524 10.9594 0.0 0
M  V30 26 C 6.6915 13.2483 0.0 0
M  V30 27 C 9.2283 12.4241 0.0 0
M  V30 28 C 8.1977 13.5685 0.0 0
M  V30 29 C 10.7554 7.9287 0.0 0
M  V30 30 C 11.5254 9.2623 0.0 0
M  V30 31 C 11.5254 6.5950 0.0 0
M  V30 32 C 13.0654 9.2623 0.0 0
M  V30 33 C 13.0654 6.5950 0.0 0
M  V30 34 C 13.8354 7.9287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 21 9 CFG=1
M  V30 13 1 12 13
M  V30 14 1 22 12 CFG=1
M  V30 15 1 13 14
M  V30 16 2 14 15
M  V30 17 1 16 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 80472-30-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 254428-47-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME261 STEP1
$RXN



  3  1
$MOL
5-Cyclopentyl-2,3-pentadienoic acid
C10H14O2
942283-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4384 2.6218 0.0 0
M  V30 4 C 7.7722 3.3918 0.0 0
M  V30 5 C 9.1059 2.6218 0.0 0
M  V30 6 O 10.4396 3.3918 0.0 0
M  V30 7 O 9.1059 1.0817 0.0 0
M  V30 8 C 2.4374 1.8517 0.0 0
M  V30 9 C 2.2763 0.3202 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3 CFG=2
M  V30 4 2 3 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-methylbenzenesulfonamide
C14H12BrNO2S
254428-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-(cyclopentylmethyl)-1-[(4-methylphenyl)...
C27H32BrNO4S2
951636-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5643 0.0 0
M  V30 3 O 9.2154 8.6443 0.0 0
M  V30 4 C 4.0596 5.4293 0.0 0
M  V30 5 O 4.2207 3.8976 0.0 0
M  V30 6 O 2.6528 6.0556 0.0 0
M  V30 7 C 7.2460 9.8149 0.0 0
M  V30 8 S 4.0596 8.7795 0.0 0
M  V30 9 C 2.6528 8.1532 0.0 0
M  V30 10 C 1.4069 9.0584 0.0 0
M  V30 11 C 0.0000 8.4320 0.0 0
M  V30 12 Br 8.6737 0.0000 0.0 0
M  V30 13 C 15.3754 7.1043 0.0 0
M  V30 14 C 6.7701 5.8585 0.0 0 CFG=1
M  V30 15 N 7.6754 7.1043 0.0 0
M  V30 16 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 17 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 18 C 5.3055 7.8743 0.0 0 CFG=2
M  V30 19 C 7.2460 4.3939 0.0 0
M  V30 20 C 6.2156 3.2494 0.0 0
M  V30 21 C 8.7524 4.0738 0.0 0
M  V30 22 C 6.6915 1.7849 0.0 0
M  V30 23 C 9.2283 2.6091 0.0 0
M  V30 24 C 8.1977 1.4647 0.0 0
M  V30 25 C 10.7554 7.1043 0.0 0
M  V30 26 C 11.5254 5.7707 0.0 0
M  V30 27 C 11.5254 8.4381 0.0 0
M  V30 28 C 13.0654 5.7707 0.0 0
M  V30 29 C 13.0654 8.4381 0.0 0
M  V30 30 C 13.8354 7.1043 0.0 0
M  V30 31 C 6.2156 10.9594 0.0 0
M  V30 32 C 4.6841 10.7983 0.0 0
M  V30 33 C 6.5358 12.4657 0.0 0
M  V30 34 C 4.0576 12.2053 0.0 0
M  V30 35 C 5.2021 13.2357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=3
M  V30 8 1 17 7 CFG=1
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 1 18 8 CFG=3
M  V30 12 1 9 10
M  V30 13 2 10 11
M  V30 14 1 12 24
M  V30 15 1 13 30
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19 CFG=1
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 14 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 942283-78-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 254428-47-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-94-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082582
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-(3,5-Dichlorophenyl)-1-methylethyl]-1,5-dihydro-5-hydroxy-4-methyl-3-phe...
C20H19Cl2NO2
263562-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 3.2862 6.1047 0.0 0
M  V30 3 C 5.3900 6.6684 0.0 0
M  V30 4 O 7.6806 6.6975 0.0 0
M  V30 5 O 4.9702 2.0028 0.0 0
M  V30 6 C 8.2474 1.3061 0.0 0
M  V30 7 Cl 0.0000 2.6674 0.0 0
M  V30 8 Cl 4.6200 0.0000 0.0 0
M  V30 9 N 5.9537 4.5647 0.0 0
M  V30 10 C 7.3605 5.1911 0.0 0
M  V30 11 C 6.1146 3.0332 0.0 0
M  V30 12 C 8.3910 4.0467 0.0 0
M  V30 13 C 7.6210 2.7130 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 1.5400 2.6674 0.0 0
M  V30 18 C 3.8500 1.3336 0.0 0
M  V30 19 C 2.3100 1.3336 0.0 0
M  V30 20 C 9.9226 4.2076 0.0 0
M  V30 21 C 10.8278 2.9617 0.0 0
M  V30 22 C 10.5489 5.6146 0.0 0
M  V30 23 C 12.3593 3.1227 0.0 0
M  V30 24 C 12.0804 5.7755 0.0 0
M  V30 25 C 12.9857 4.5296 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 1 14
M  V30 5 2 4 10
M  V30 6 1 5 11
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 12 20
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-(3,5-Dichlorophenyl)-1-methylethyl]-5-(ethylthio)-1,5-dihydro-4-methyl-3...
C22H23Cl2NOS
848030-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 8.3658 0.0 0
M  V30 2 C 6.6685 9.1358 0.0 0
M  V30 3 C 4.5648 9.6994 0.0 0
M  V30 4 S 8.6668 8.0156 0.0 0
M  V30 5 C 10.1733 7.6954 0.0 0
M  V30 6 C 11.2037 8.8398 0.0 0
M  V30 7 O 3.9721 5.3050 0.0 0
M  V30 8 C 9.3636 4.7384 0.0 0
M  V30 9 Cl 2.6673 3.7457 0.0 0
M  V30 10 Cl 0.0000 8.3658 0.0 0
M  V30 11 N 6.1048 7.0321 0.0 0
M  V30 12 C 7.6364 6.8712 0.0 0
M  V30 13 C 5.4784 5.6253 0.0 0
M  V30 14 C 7.9566 5.3647 0.0 0
M  V30 15 C 6.6229 4.5947 0.0 0
M  V30 16 C 4.0012 7.5958 0.0 0
M  V30 17 C 4.0012 6.0557 0.0 0
M  V30 18 C 2.6673 8.3658 0.0 0
M  V30 19 C 2.6673 5.2857 0.0 0
M  V30 20 C 1.3337 7.5958 0.0 0
M  V30 21 C 1.3337 6.0557 0.0 0
M  V30 22 C 6.4620 3.0631 0.0 0
M  V30 23 C 7.7079 2.1579 0.0 0
M  V30 24 C 5.0550 2.4368 0.0 0
M  V30 25 C 7.5469 0.6263 0.0 0
M  V30 26 C 4.8941 0.9051 0.0 0
M  V30 27 C 6.1400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 1 16
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 5 6
M  V30 8 2 7 13
M  V30 9 1 8 14
M  V30 10 1 9 19
M  V30 11 1 10 20
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 1 15 22
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 263562-06-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 848030-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-4985925
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Nonvolatile Alcohols and Thiols. To compound 10
(1 mmol) we added benzene (5 ml), the respective alcohol (2 mmol) (1.1
mmol of the thiol), and p-toluenesulfonic acid (0.019 g, 0.1 mmol). The
mixture was refluxed for 4 h, and triethylamine (0.1 ml, 0.72 mmol) and
ethyl acetate (10 ml) were added. The product was washed with water,
dried, evaporated, and purified by chromatography. C22H23Cl2NOS; 1H NMR
spectrum, δ, ppm (J, Hz): 1.16 (3H, t, J = 7.5); 1.87 (3H, s); 1.94 (3H,
s); 2.14 (2H, q, J = 7.5); 2.23 (3H, s); 5.18 (1H, s); 7.2-7.5 (8H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-substituted
5-alkoxy-3-aryl-4-methyl-2,5-dihydro-2-pyrrolones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nikitin, K. V.; Andryukhova, N. P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United
States)(Translation of Khimiya Geterotsiklicheskikh Soedinenii) (2004),
40(5), 561-569

$RFMT $RIREG SCHEME263 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-(...
C27H34ClNO4S2
951636-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 3.8976 11.1547 0.0 0
M  V30 12 O 6.0556 12.7226 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Cl 0.0000 6.7017 0.0 0
M  V30 18 C 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 8.4380 3.8500 0.0 0
M  V30 32 C 5.7707 3.8500 0.0 0
M  V30 33 C 8.4380 2.3100 0.0 0
M  V30 34 C 5.7707 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091948
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME264 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 C 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]...
C28H37Cl2NO4S2
951337-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1043 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5643 6.1600 0.0 0
M  V30 3 O 8.6443 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6839 0.0 0
M  V30 7 C 13.5683 9.7143 0.0 0
M  V30 8 C 15.0330 9.2385 0.0 0
M  V30 9 C 16.1774 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7795 11.3158 0.0 0
M  V30 14 C 8.1532 12.7226 0.0 0
M  V30 15 C 9.0583 13.9684 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 C 10.5900 13.8075 0.0 0
M  V30 18 Cl 0.6403 9.7143 0.0 0
M  V30 19 Cl 0.0000 6.7016 0.0 0
M  V30 20 C 7.1043 0.0000 0.0 0
M  V30 21 N 7.1043 7.7000 0.0 0
M  V30 22 C 5.8585 8.6052 0.0 0 CFG=1
M  V30 23 C 8.3502 8.6052 0.0 0 CFG=2
M  V30 24 C 6.3343 10.0699 0.0 0 CFG=2
M  V30 25 C 7.8743 10.0699 0.0 0 CFG=1
M  V30 26 C 4.3938 8.1294 0.0 0
M  V30 27 C 3.2494 9.1598 0.0 0
M  V30 28 C 4.0736 6.6229 0.0 0
M  V30 29 C 1.7847 8.6839 0.0 0
M  V30 30 C 2.6091 6.1471 0.0 0
M  V30 31 C 1.4645 7.1775 0.0 0
M  V30 32 C 7.1043 4.6200 0.0 0
M  V30 33 C 5.7707 3.8500 0.0 0
M  V30 34 C 8.4380 3.8500 0.0 0
M  V30 35 C 5.7707 2.3100 0.0 0
M  V30 36 C 8.4380 2.3100 0.0 0
M  V30 37 C 7.1043 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 32
M  V30 5 1 4 5
M  V30 6 1 23 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 24 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 25 13 CFG=3
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 18 29
M  V30 20 1 19 31
M  V30 21 1 20 37
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 22 26 CFG=1
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 22 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-63-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951337-97-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090843
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME265 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butanethiol
C4H10S
513-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethylphenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-[(...
C30H43NO4S2
951336-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.9298 8.0870 0.0 0 VAL=6
M  V30 2 O 9.2635 7.3170 0.0 0
M  V30 3 O 6.5962 8.8570 0.0 0
M  V30 4 C 3.9011 4.4596 0.0 0
M  V30 5 O 2.6553 5.3648 0.0 0
M  V30 6 O 3.7402 2.9280 0.0 0
M  V30 7 C 9.2926 5.0263 0.0 0
M  V30 8 C 10.3230 6.1707 0.0 0
M  V30 9 C 11.8294 5.8505 0.0 0
M  V30 10 C 12.8598 6.9950 0.0 0
M  V30 11 C 14.3663 6.6747 0.0 0
M  V30 12 C 15.3967 7.8192 0.0 0
M  V30 13 S 6.8027 2.7843 0.0 0
M  V30 14 C 8.2096 2.1580 0.0 0 CFG=3
M  V30 15 C 8.3706 0.6265 0.0 0
M  V30 16 C 9.4555 3.0632 0.0 0
M  V30 17 C 9.7774 0.0000 0.0 0
M  V30 18 C 1.5064 11.1701 0.0 0
M  V30 19 C 0.0000 10.8500 0.0 0
M  V30 20 C 11.0098 13.4218 0.0 0
M  V30 21 C 5.6283 6.5923 0.0 0 CFG=1
M  V30 22 N 7.1598 6.7532 0.0 0
M  V30 23 C 5.3081 5.0860 0.0 0 CFG=2
M  V30 24 C 7.7861 5.3464 0.0 0 CFG=2
M  V30 25 C 6.6417 4.3160 0.0 0 CFG=2
M  V30 26 C 4.5978 7.7368 0.0 0
M  V30 27 C 3.0914 7.4165 0.0 0
M  V30 28 C 5.0737 9.2014 0.0 0
M  V30 29 C 2.0610 8.5611 0.0 0
M  V30 30 C 4.0431 10.3459 0.0 0
M  V30 31 C 2.5369 10.0256 0.0 0
M  V30 32 C 8.6998 9.4207 0.0 0
M  V30 33 C 7.9298 10.7543 0.0 0
M  V30 34 C 10.2398 9.4207 0.0 0
M  V30 35 C 8.6998 12.0880 0.0 0
M  V30 36 C 11.0098 10.7543 0.0 0
M  V30 37 C 10.2398 12.0880 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 1 32
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 23 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 24 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 25 13 CFG=1
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 1 18 31
M  V30 21 1 20 37
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 21 26 CFG=3
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 21 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-53-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951336-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16075875
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME266 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(phenylmethylene)benzenesulfonamide
C14H13NO2S
51608-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 13.0900 2.6673 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 1.3336 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-4-[(3-methylbutyl)thio]-1-[(4-methylphenyl)sulfonyl...
C29H41NO4S2
951341-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 10.4612 9.0731 0.0 0 VAL=6
M  V30 2 O 10.4612 7.5331 0.0 0
M  V30 3 O 10.4612 10.6131 0.0 0
M  V30 4 C 8.4919 6.3625 0.0 0
M  V30 5 C 7.4615 5.2181 0.0 0
M  V30 6 C 7.9373 3.7535 0.0 0
M  V30 7 C 6.9069 2.6091 0.0 0
M  V30 8 C 7.3828 1.1444 0.0 0
M  V30 9 C 6.3524 0.0000 0.0 0
M  V30 10 C 5.3055 10.7483 0.0 0
M  V30 11 O 5.4666 12.2798 0.0 0
M  V30 12 O 3.8987 10.1220 0.0 0
M  V30 13 S 5.3055 7.3979 0.0 0
M  V30 14 C 3.8987 8.0243 0.0 0
M  V30 15 C 2.6528 7.1191 0.0 0
M  V30 16 C 1.2459 7.7454 0.0 0
M  V30 17 C 0.0000 6.8402 0.0 0
M  V30 18 C 1.0849 9.2770 0.0 0
M  V30 19 C 16.6213 9.0731 0.0 0
M  V30 20 N 8.9212 9.0731 0.0 0
M  V30 21 C 8.0160 10.3190 0.0 0 CFG=1
M  V30 22 C 8.0160 7.8272 0.0 0 CFG=2
M  V30 23 C 6.5515 9.8431 0.0 0 CFG=2
M  V30 24 C 6.5515 8.3031 0.0 0 CFG=1
M  V30 25 C 8.4919 11.7836 0.0 0
M  V30 26 C 9.9983 12.1038 0.0 0
M  V30 27 C 7.4615 12.9280 0.0 0
M  V30 28 C 10.4742 13.5685 0.0 0
M  V30 29 C 7.9373 14.3927 0.0 0
M  V30 30 C 9.4438 14.7129 0.0 0
M  V30 31 C 12.0013 9.0731 0.0 0
M  V30 32 C 12.7713 10.4067 0.0 0
M  V30 33 C 12.7713 7.7394 0.0 0
M  V30 34 C 14.3113 10.4067 0.0 0
M  V30 35 C 14.3113 7.7394 0.0 0
M  V30 36 C 15.0813 9.0731 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 1 22 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 23 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=1
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 19 36
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 21 25 CFG=3
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51608-60-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951341-33-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090044
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME267 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(phenylmethylene)benzenesulfonamide
C14H13NO2S
51608-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 13.0900 2.6673 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 1.3336 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-4-[(1-methylethyl)thio]-1-[(4-methylphenyl)sulfonyl...
C27H37NO4S2
951303-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8690 7.4606 0.0 0 VAL=6
M  V30 2 O 7.2027 6.6906 0.0 0
M  V30 3 O 4.5354 8.2307 0.0 0
M  V30 4 C 7.2318 4.3998 0.0 0
M  V30 5 C 8.2622 5.5444 0.0 0
M  V30 6 C 9.7685 5.2241 0.0 0
M  V30 7 C 10.7991 6.3686 0.0 0
M  V30 8 C 12.3054 6.0484 0.0 0
M  V30 9 C 13.3360 7.1928 0.0 0
M  V30 10 C 1.8403 3.8333 0.0 0
M  V30 11 O 1.6794 2.3016 0.0 0
M  V30 12 O 0.5944 4.7383 0.0 0
M  V30 13 S 4.7419 2.1580 0.0 0
M  V30 14 C 6.1487 1.5316 0.0 0
M  V30 15 C 7.3947 2.4368 0.0 0
M  V30 16 C 6.3098 0.0000 0.0 0
M  V30 17 C 8.9491 12.7954 0.0 0
M  V30 18 N 5.0990 6.1270 0.0 0
M  V30 19 C 3.5675 5.9659 0.0 0 CFG=1
M  V30 20 C 5.7253 4.7200 0.0 0 CFG=2
M  V30 21 C 3.2471 4.4596 0.0 0 CFG=2
M  V30 22 C 4.5810 3.6896 0.0 0 CFG=1
M  V30 23 C 2.5369 7.1104 0.0 0
M  V30 24 C 3.0127 8.5750 0.0 0
M  V30 25 C 1.0306 6.7903 0.0 0
M  V30 26 C 1.9823 9.7195 0.0 0
M  V30 27 C 0.0000 7.9347 0.0 0
M  V30 28 C 0.4760 9.3994 0.0 0
M  V30 29 C 6.6390 8.7943 0.0 0
M  V30 30 C 8.1791 8.7943 0.0 0
M  V30 31 C 5.8690 10.1280 0.0 0
M  V30 32 C 8.9491 10.1280 0.0 0
M  V30 33 C 6.6390 11.4618 0.0 0
M  V30 34 C 8.1791 11.4618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 21 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 22 13 CFG=1
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51608-60-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951303-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082464
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME268 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(phenylmethylene)benzenesulfonamide
C14H13NO2S
51608-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 13.0900 2.6673 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 1.3336 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-1-[(4-methylphenyl)sulfonyl]-2-phenyl-4-(2-propen-1...
C27H35NO4S2
951636-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 9.0731 0.0 0 VAL=6
M  V30 2 O 9.2154 10.6131 0.0 0
M  V30 3 O 9.2154 7.5331 0.0 0
M  V30 4 C 4.0596 10.7483 0.0 0
M  V30 5 O 4.2207 12.2798 0.0 0
M  V30 6 O 2.6528 10.1220 0.0 0
M  V30 7 C 7.2460 6.3625 0.0 0
M  V30 8 C 6.2156 5.2181 0.0 0
M  V30 9 C 6.6915 3.7534 0.0 0
M  V30 10 C 5.6610 2.6091 0.0 0
M  V30 11 C 6.1369 1.1444 0.0 0
M  V30 12 C 5.1065 0.0000 0.0 0
M  V30 13 S 4.0596 7.3979 0.0 0
M  V30 14 C 2.6528 8.0243 0.0 0
M  V30 15 C 1.4069 7.1191 0.0 0
M  V30 16 C 0.0000 7.7454 0.0 0
M  V30 17 C 15.3754 9.0731 0.0 0
M  V30 18 C 6.7701 10.3189 0.0 0 CFG=1
M  V30 19 N 7.6754 9.0731 0.0 0
M  V30 20 C 5.3055 9.8431 0.0 0 CFG=2
M  V30 21 C 6.7701 7.8272 0.0 0 CFG=2
M  V30 22 C 5.3055 8.3031 0.0 0 CFG=2
M  V30 23 C 7.2460 11.7836 0.0 0
M  V30 24 C 6.2156 12.9280 0.0 0
M  V30 25 C 8.7524 12.1038 0.0 0
M  V30 26 C 6.6915 14.3927 0.0 0
M  V30 27 C 9.2283 13.5685 0.0 0
M  V30 28 C 8.1977 14.7129 0.0 0
M  V30 29 C 10.7554 9.0731 0.0 0
M  V30 30 C 11.5254 7.7394 0.0 0
M  V30 31 C 11.5254 10.4067 0.0 0
M  V30 32 C 13.0654 7.7394 0.0 0
M  V30 33 C 13.0654 10.4067 0.0 0
M  V30 34 C 13.8354 9.0731 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 22 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51608-60-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME269 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]benzenesulfonamide
C14H13NO3S
664985-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 O 13.0900 2.8736 0.0 0
M  V30 7 C 13.8600 4.2073 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 2.3100 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.7700 2.8736 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 9.2400 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 19 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-2-(4-methoxyphenyl)-1-(phenylsulfonyl)-4-(2-propen-...
C27H35NO5S2
951636-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.2489 9.2154 0.0 0 VAL=6
M  V30 2 O 6.7089 9.2154 0.0 0
M  V30 3 O 9.7889 9.2154 0.0 0
M  V30 4 C 6.5736 4.0596 0.0 0
M  V30 5 O 7.2000 2.6528 0.0 0
M  V30 6 O 5.0421 4.2207 0.0 0
M  V30 7 C 10.9594 7.2460 0.0 0
M  V30 8 C 12.1038 6.2156 0.0 0
M  V30 9 C 13.5685 6.6915 0.0 0
M  V30 10 C 14.7129 5.6610 0.0 0
M  V30 11 C 16.1775 6.1369 0.0 0
M  V30 12 C 17.3219 5.1065 0.0 0
M  V30 13 S 9.9241 4.0596 0.0 0
M  V30 14 C 9.2976 2.6528 0.0 0
M  V30 15 C 10.2028 1.4069 0.0 0
M  V30 16 C 9.5765 0.0000 0.0 0
M  V30 17 O 1.1444 8.6737 0.0 0
M  V30 18 C 0.0000 7.6432 0.0 0
M  V30 19 C 7.0030 6.7701 0.0 0 CFG=1
M  V30 20 N 8.2489 7.6754 0.0 0
M  V30 21 C 7.4789 5.3055 0.0 0 CFG=2
M  V30 22 C 9.4947 6.7701 0.0 0 CFG=2
M  V30 23 C 9.0189 5.3055 0.0 0 CFG=2
M  V30 24 C 5.5383 7.2460 0.0 0
M  V30 25 C 5.2181 8.7524 0.0 0
M  V30 26 C 4.3939 6.2156 0.0 0
M  V30 27 C 3.7534 9.2283 0.0 0
M  V30 28 C 2.9292 6.6915 0.0 0
M  V30 29 C 2.6091 8.1977 0.0 0
M  V30 30 C 8.2489 10.7554 0.0 0
M  V30 31 C 6.9152 11.5254 0.0 0
M  V30 32 C 9.5825 11.5254 0.0 0
M  V30 33 C 6.9152 13.0654 0.0 0
M  V30 34 C 9.5825 13.0654 0.0 0
M  V30 35 C 8.2489 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 18
M  V30 19 1 17 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-99-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-80-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082364
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME270 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]benzenesulfonamide
C13H10ClNO2S
664986-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 Cl 13.0900 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 2.3100 2.8736 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 0.7700 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 14 C 9.2400 1.5400 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-5-hexyl-1-(phenylsulfonyl)-4-(2-propen-1...
C26H32ClNO4S2
951636-76-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 5.5644 9.2154 0.0 0
M  V30 3 O 8.6444 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 0.0000 8.6738 0.0 0
M  V30 18 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 19 N 7.1044 7.6754 0.0 0
M  V30 20 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 21 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 22 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 23 C 4.3938 7.2460 0.0 0
M  V30 24 C 3.2494 6.2156 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 1.7847 6.6915 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.4645 8.1978 0.0 0
M  V30 29 C 7.1044 10.7554 0.0 0
M  V30 30 C 5.7707 11.5254 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 13.0654 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 22 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664986-03-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-76-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME271 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
738626-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-4-[(1,1-Dimethylethyl)thio]-5-hexyl-2-(3-methylphenyl)-1-[(...
C29H41NO4S2
951334-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3753 5.3348 0.0 0 VAL=6
M  V30 2 O 8.7090 6.1048 0.0 0
M  V30 3 O 6.0415 4.5648 0.0 0
M  V30 4 C 3.3466 8.9622 0.0 0
M  V30 5 O 3.1855 10.4939 0.0 0
M  V30 6 O 2.1007 8.0571 0.0 0
M  V30 7 C 8.7379 8.3956 0.0 0
M  V30 8 C 9.7685 7.2510 0.0 0
M  V30 9 C 11.2748 7.5712 0.0 0
M  V30 10 C 12.3052 6.4268 0.0 0
M  V30 11 C 13.8117 6.7470 0.0 0
M  V30 12 C 14.8421 5.6026 0.0 0
M  V30 13 S 6.2482 10.6374 0.0 0
M  V30 14 C 7.6550 11.2639 0.0 0
M  V30 15 C 8.2815 9.8569 0.0 0
M  V30 16 C 9.0620 11.8902 0.0 0
M  V30 17 C 7.0287 12.6707 0.0 0
M  V30 18 C 0.0000 5.1809 0.0 0
M  V30 19 C 10.4554 0.0000 0.0 0
M  V30 20 C 5.0736 6.8295 0.0 0 CFG=1
M  V30 21 N 6.6053 6.6685 0.0 0
M  V30 22 C 4.7534 8.3358 0.0 0 CFG=2
M  V30 23 C 7.2316 8.0754 0.0 0 CFG=2
M  V30 24 C 6.0871 9.1058 0.0 0 CFG=2
M  V30 25 C 4.0432 5.6850 0.0 0
M  V30 26 C 2.5369 6.0052 0.0 0
M  V30 27 C 4.5190 4.2204 0.0 0
M  V30 28 C 1.5063 4.8608 0.0 0
M  V30 29 C 3.4886 3.0759 0.0 0
M  V30 30 C 1.9822 3.3961 0.0 0
M  V30 31 C 8.1453 4.0011 0.0 0
M  V30 32 C 9.6854 4.0011 0.0 0
M  V30 33 C 7.3753 2.6673 0.0 0
M  V30 34 C 10.4554 2.6673 0.0 0
M  V30 35 C 8.1453 1.3337 0.0 0
M  V30 36 C 9.6854 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=3
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 28
M  V30 20 1 19 36
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951334-61-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088983
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME272 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
738626-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-2-(3-methylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C28H37NO4S2
951636-79-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 C 0.0000 9.7144 0.0 0
M  V30 18 C 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-79-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083727
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME273 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(1-naphthalenylmethylene)benzenesulfonamide
C18H15NO2S
738626-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 S 8.0022 3.0801 0.0 0 VAL=6
M  V30 4 O 8.7722 1.7464 0.0 0
M  V30 5 O 7.2322 4.4137 0.0 0
M  V30 6 C 13.3370 6.1601 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 4.0010 0.7700 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 18 C 9.3360 5.3901 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 10.6697 6.1601 0.0 0
M  V30 21 C 12.0033 3.8501 0.0 0
M  V30 22 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-1-[(4-methylphenyl)sulfonyl]-2-(1-naphthalenyl)-4-(...
C31H37NO4S2
951636-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.0618 6.0255 0.0 0 VAL=6
M  V30 2 O 8.5682 6.3457 0.0 0
M  V30 3 O 5.5555 5.7053 0.0 0
M  V30 4 C 4.3512 10.7203 0.0 0
M  V30 5 O 2.8866 10.2444 0.0 0
M  V30 6 O 4.6714 12.2267 0.0 0
M  V30 7 C 9.3037 8.5153 0.0 0
M  V30 8 C 10.2088 9.7613 0.0 0
M  V30 9 C 11.7405 9.6002 0.0 0
M  V30 10 C 12.6456 10.8461 0.0 0
M  V30 11 C 14.1773 10.6852 0.0 0
M  V30 12 C 15.0824 11.9310 0.0 0
M  V30 13 S 7.6285 11.4168 0.0 0
M  V30 14 C 6.7233 12.6628 0.0 0
M  V30 15 C 7.3496 14.0697 0.0 0
M  V30 16 C 6.4444 15.3155 0.0 0
M  V30 17 C 8.3426 0.0000 0.0 0
M  V30 18 C 5.3348 8.1583 0.0 0 CFG=1
M  V30 19 N 6.7416 7.5318 0.0 0
M  V30 20 C 5.4957 9.6898 0.0 0 CFG=2
M  V30 21 C 7.7720 8.6763 0.0 0 CFG=2
M  V30 22 C 7.0020 10.0100 0.0 0 CFG=2
M  V30 23 C 4.0010 7.3883 0.0 0
M  V30 24 C 2.6673 8.1583 0.0 0
M  V30 25 C 4.0010 5.8482 0.0 0
M  V30 26 C 1.3337 7.3883 0.0 0
M  V30 27 C 2.6673 9.6983 0.0 0
M  V30 28 C 2.6673 5.0782 0.0 0
M  V30 29 C 1.3337 5.8482 0.0 0
M  V30 30 C 0.0000 8.1583 0.0 0
M  V30 31 C 1.3337 10.4683 0.0 0
M  V30 32 C 0.0000 9.6983 0.0 0
M  V30 33 C 7.3820 4.5190 0.0 0
M  V30 34 C 8.8467 4.0432 0.0 0
M  V30 35 C 6.2376 3.4886 0.0 0
M  V30 36 C 9.1668 2.5369 0.0 0
M  V30 37 C 6.5577 1.9822 0.0 0
M  V30 38 C 8.0223 1.5063 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 33
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 22 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 38
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 1 26 29
M  V30 31 1 26 30
M  V30 32 2 27 31
M  V30 33 2 28 29
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-22-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16059042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME274 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethylphenyl)-4-(ethylthio)-5-hexyl-1-[(4-methylphenyl)...
C28H39NO4S2
951301-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.2489 6.1600 0.0 0 VAL=6
M  V30 2 O 9.7889 6.1600 0.0 0
M  V30 3 O 6.7089 6.1600 0.0 0
M  V30 4 C 6.5736 11.3156 0.0 0
M  V30 5 O 7.2000 12.7226 0.0 0
M  V30 6 O 5.0421 11.1547 0.0 0
M  V30 7 C 10.9594 8.1294 0.0 0
M  V30 8 C 12.1038 9.1598 0.0 0
M  V30 9 C 13.5685 8.6839 0.0 0
M  V30 10 C 14.7129 9.7143 0.0 0
M  V30 11 C 16.1775 9.2385 0.0 0
M  V30 12 C 17.3219 10.2689 0.0 0
M  V30 13 S 9.9241 11.3156 0.0 0
M  V30 14 C 9.2976 12.7226 0.0 0
M  V30 15 C 10.2028 13.9684 0.0 0
M  V30 16 C 1.1444 6.7016 0.0 0
M  V30 17 C 0.0000 7.7320 0.0 0
M  V30 18 C 8.2489 0.0000 0.0 0
M  V30 19 C 7.0030 8.6052 0.0 0 CFG=1
M  V30 20 N 8.2489 7.7000 0.0 0
M  V30 21 C 7.4789 10.0698 0.0 0 CFG=2
M  V30 22 C 9.4947 8.6052 0.0 0 CFG=2
M  V30 23 C 9.0189 10.0698 0.0 0 CFG=2
M  V30 24 C 5.5383 8.1294 0.0 0
M  V30 25 C 5.2181 6.6229 0.0 0
M  V30 26 C 4.3939 9.1598 0.0 0
M  V30 27 C 3.7534 6.1471 0.0 0
M  V30 28 C 2.9292 8.6839 0.0 0
M  V30 29 C 2.6091 7.1775 0.0 0
M  V30 30 C 8.2489 4.6200 0.0 0
M  V30 31 C 6.9152 3.8500 0.0 0
M  V30 32 C 9.5825 3.8500 0.0 0
M  V30 33 C 6.9152 2.3100 0.0 0
M  V30 34 C 9.5825 2.3100 0.0 0
M  V30 35 C 8.2489 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951301-27-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME275 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Cyanophenyl)methylene]-4-methylbenzenesulfonamide
C15H12N2O2S
848005-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 N 16.1700 2.8736 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 3 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Cyanophenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-(2...
C28H34N2O4S2
951636-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.5690 6.1600 0.0 0 VAL=6
M  V30 2 O 10.1090 6.1600 0.0 0
M  V30 3 O 7.0290 6.1600 0.0 0
M  V30 4 C 11.2796 8.1294 0.0 0
M  V30 5 C 12.4241 9.1598 0.0 0
M  V30 6 C 13.8886 8.6839 0.0 0
M  V30 7 C 15.0332 9.7143 0.0 0
M  V30 8 C 16.4977 9.2385 0.0 0
M  V30 9 C 17.6422 10.2689 0.0 0
M  V30 10 C 6.8940 11.3158 0.0 0
M  V30 11 O 7.5203 12.7226 0.0 0
M  V30 12 O 5.3623 11.1547 0.0 0
M  V30 13 S 10.2442 11.3158 0.0 0
M  V30 14 C 9.6179 12.7226 0.0 0
M  V30 15 C 10.5231 13.9684 0.0 0
M  V30 16 C 9.8967 15.3754 0.0 0
M  V30 17 C 1.4647 6.7016 0.0 0
M  V30 18 N 0.0000 6.2258 0.0 0
M  V30 19 C 8.5690 0.0000 0.0 0
M  V30 20 N 8.5690 7.7000 0.0 0
M  V30 21 C 7.3232 8.6052 0.0 0 CFG=1
M  V30 22 C 9.8150 8.6052 0.0 0 CFG=2
M  V30 23 C 7.7990 10.0699 0.0 0 CFG=2
M  V30 24 C 9.3390 10.0699 0.0 0 CFG=1
M  V30 25 C 5.8586 8.1294 0.0 0
M  V30 26 C 5.5385 6.6229 0.0 0
M  V30 27 C 4.7141 9.1598 0.0 0
M  V30 28 C 4.0738 6.1471 0.0 0
M  V30 29 C 3.2496 8.6839 0.0 0
M  V30 30 C 2.9294 7.1776 0.0 0
M  V30 31 C 8.5690 4.6200 0.0 0
M  V30 32 C 7.2354 3.8500 0.0 0
M  V30 33 C 9.9028 3.8500 0.0 0
M  V30 34 C 7.2354 2.3100 0.0 0
M  V30 35 C 9.9028 2.3100 0.0 0
M  V30 36 C 8.5690 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 1 22 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 23 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 3 17 18
M  V30 19 1 17 30
M  V30 20 1 19 36
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 21 25 CFG=1
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848005-24-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-53-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088934
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME276 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
861145-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-5-hexyl-2-(4-methylphenyl)-4-(2...
C27H34BrNO4S2
951689-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 C 0.0000 6.7017 0.0 0
M  V30 18 Br 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 861145-18-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-82-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089729
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME277 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
863401-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-(...
C27H34ClNO4S2
951636-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 Cl 0.0000 9.7144 0.0 0
M  V30 18 C 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-19-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-57-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME278 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
865060-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-5-hexyl-1-[(2-methylphenyl)sulfonyl]-4-(...
C27H34ClNO4S2
951636-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 C 9.7718 10.7554 0.0 0
M  V30 18 Cl 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865060-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-81-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071162
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME279 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethylphenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-(2...
C29H39NO4S2
951636-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.2489 6.1600 0.0 0 VAL=6
M  V30 2 O 9.7889 6.1600 0.0 0
M  V30 3 O 6.7089 6.1600 0.0 0
M  V30 4 C 10.9594 8.1294 0.0 0
M  V30 5 C 12.1038 9.1598 0.0 0
M  V30 6 C 13.5685 8.6839 0.0 0
M  V30 7 C 14.7129 9.7143 0.0 0
M  V30 8 C 16.1775 9.2385 0.0 0
M  V30 9 C 17.3219 10.2689 0.0 0
M  V30 10 C 6.5736 11.3158 0.0 0
M  V30 11 O 5.0421 11.1547 0.0 0
M  V30 12 O 7.2000 12.7226 0.0 0
M  V30 13 S 9.9241 11.3158 0.0 0
M  V30 14 C 9.2976 12.7226 0.0 0
M  V30 15 C 10.2028 13.9684 0.0 0
M  V30 16 C 9.5765 15.3754 0.0 0
M  V30 17 C 1.1444 6.7016 0.0 0
M  V30 18 C 0.0000 7.7322 0.0 0
M  V30 19 C 8.2489 0.0000 0.0 0
M  V30 20 N 8.2489 7.7000 0.0 0
M  V30 21 C 7.0030 8.6052 0.0 0 CFG=1
M  V30 22 C 9.4947 8.6052 0.0 0 CFG=2
M  V30 23 C 7.4789 10.0699 0.0 0 CFG=2
M  V30 24 C 9.0189 10.0699 0.0 0 CFG=1
M  V30 25 C 5.5383 8.1294 0.0 0
M  V30 26 C 4.3939 9.1598 0.0 0
M  V30 27 C 5.2181 6.6229 0.0 0
M  V30 28 C 2.9292 8.6839 0.0 0
M  V30 29 C 3.7534 6.1471 0.0 0
M  V30 30 C 2.6091 7.1776 0.0 0
M  V30 31 C 8.2489 4.6200 0.0 0
M  V30 32 C 6.9152 3.8500 0.0 0
M  V30 33 C 9.5825 3.8500 0.0 0
M  V30 34 C 6.9152 2.3100 0.0 0
M  V30 35 C 9.5825 2.3100 0.0 0
M  V30 36 C 8.2489 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 1 22 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 23 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 18
M  V30 19 1 17 30
M  V30 20 1 19 36
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 21 25 CFG=1
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-49-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME280 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Ethoxyphenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-(...
C29H39NO5S2
951636-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.7134 6.1600 0.0 0 VAL=6
M  V30 2 O 8.1734 6.1600 0.0 0
M  V30 3 O 11.2535 6.1600 0.0 0
M  V30 4 C 12.4240 8.1294 0.0 0
M  V30 5 C 13.5684 9.1598 0.0 0
M  V30 6 C 15.0331 8.6840 0.0 0
M  V30 7 C 16.1775 9.7144 0.0 0
M  V30 8 C 17.6422 9.2385 0.0 0
M  V30 9 C 18.7866 10.2689 0.0 0
M  V30 10 C 8.0382 11.3158 0.0 0
M  V30 11 O 8.6647 12.7226 0.0 0
M  V30 12 O 6.5067 11.1547 0.0 0
M  V30 13 S 11.3887 11.3158 0.0 0
M  V30 14 C 10.7623 12.7226 0.0 0
M  V30 15 C 11.6674 13.9685 0.0 0
M  V30 16 C 11.0411 15.3754 0.0 0
M  V30 17 O 2.6091 6.7017 0.0 0
M  V30 18 C 1.4645 7.7322 0.0 0
M  V30 19 C 0.0000 7.2562 0.0 0
M  V30 20 C 9.7134 0.0000 0.0 0
M  V30 21 N 9.7134 7.7000 0.0 0
M  V30 22 C 8.4676 8.6053 0.0 0 CFG=1
M  V30 23 C 10.9593 8.6053 0.0 0 CFG=2
M  V30 24 C 8.9434 10.0700 0.0 0 CFG=2
M  V30 25 C 10.4834 10.0700 0.0 0 CFG=1
M  V30 26 C 7.0029 8.1294 0.0 0
M  V30 27 C 6.6827 6.6230 0.0 0
M  V30 28 C 5.8585 9.1598 0.0 0
M  V30 29 C 5.2182 6.1471 0.0 0
M  V30 30 C 4.3938 8.6840 0.0 0
M  V30 31 C 4.0736 7.1777 0.0 0
M  V30 32 C 9.7134 4.6200 0.0 0
M  V30 33 C 11.0471 3.8500 0.0 0
M  V30 34 C 8.3798 3.8500 0.0 0
M  V30 35 C 11.0471 2.3100 0.0 0
M  V30 36 C 8.3798 2.3100 0.0 0
M  V30 37 C 9.7134 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 32
M  V30 5 1 4 5
M  V30 6 1 23 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 24 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 25 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 18
M  V30 19 1 17 31
M  V30 20 1 18 19
M  V30 21 1 20 37
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 22 26 CFG=1
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 22 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-51-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091766
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME281 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 N 5.3900 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 13.0900 4.0009 0.0 0
M  V30 7 F 3.0800 0.0000 0.0 0
M  V30 8 C 8.4700 4.0009 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 9.2400 2.6673 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 10.7800 2.6673 0.0 0
M  V30 13 C 11.5500 4.0009 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 C 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0009 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(2-Fluorophenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-(...
C27H34FNO4S2
951636-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 9.0731 0.0 0 VAL=6
M  V30 2 O 9.2154 10.6131 0.0 0
M  V30 3 O 9.2154 7.5331 0.0 0
M  V30 4 C 7.2460 6.3625 0.0 0
M  V30 5 C 6.2156 5.2181 0.0 0
M  V30 6 C 6.6915 3.7534 0.0 0
M  V30 7 C 5.6610 2.6091 0.0 0
M  V30 8 C 6.1369 1.1444 0.0 0
M  V30 9 C 5.1065 0.0000 0.0 0
M  V30 10 C 4.0596 10.7483 0.0 0
M  V30 11 O 2.6528 10.1220 0.0 0
M  V30 12 O 4.2207 12.2798 0.0 0
M  V30 13 S 4.0596 7.3979 0.0 0
M  V30 14 C 2.6528 8.0243 0.0 0
M  V30 15 C 1.4069 7.1191 0.0 0
M  V30 16 C 0.0000 7.7454 0.0 0
M  V30 17 F 4.7092 12.6078 0.0 0
M  V30 18 C 15.3754 9.0731 0.0 0
M  V30 19 N 7.6754 9.0731 0.0 0
M  V30 20 C 6.7701 10.3189 0.0 0 CFG=1
M  V30 21 C 6.7701 7.8272 0.0 0 CFG=2
M  V30 22 C 5.3055 9.8431 0.0 0 CFG=2
M  V30 23 C 5.3055 8.3031 0.0 0 CFG=1
M  V30 24 C 7.2460 11.7836 0.0 0
M  V30 25 C 6.2156 12.9280 0.0 0
M  V30 26 C 8.7524 12.1038 0.0 0
M  V30 27 C 6.6915 14.3927 0.0 0
M  V30 28 C 9.2283 13.5685 0.0 0
M  V30 29 C 8.1977 14.7129 0.0 0
M  V30 30 C 10.7554 9.0731 0.0 0
M  V30 31 C 11.5254 10.4067 0.0 0
M  V30 32 C 11.5254 7.7394 0.0 0
M  V30 33 C 13.0654 10.4067 0.0 0
M  V30 34 C 13.0654 7.7394 0.0 0
M  V30 35 C 13.8354 9.0731 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 25
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-62-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME282 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 C 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]...
C27H33Cl2NO4S2
951636-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 5.4291 11.3158 0.0 0
M  V30 5 O 6.0556 12.7226 0.0 0
M  V30 6 O 3.8976 11.1547 0.0 0
M  V30 7 C 9.8149 8.1294 0.0 0
M  V30 8 C 10.9593 9.1598 0.0 0
M  V30 9 C 12.4240 8.6840 0.0 0
M  V30 10 C 13.5684 9.7144 0.0 0
M  V30 11 C 15.0331 9.2385 0.0 0
M  V30 12 C 16.1775 10.2689 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Cl 0.6403 9.7144 0.0 0
M  V30 18 Cl 0.0000 6.7017 0.0 0
M  V30 19 C 7.1044 0.0000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 N 7.1044 7.7000 0.0 0
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 24 C 7.8744 10.0700 0.0 0 CFG=2
M  V30 25 C 4.3938 8.1294 0.0 0
M  V30 26 C 3.2494 9.1598 0.0 0
M  V30 27 C 4.0736 6.6230 0.0 0
M  V30 28 C 1.7847 8.6840 0.0 0
M  V30 29 C 2.6091 6.1471 0.0 0
M  V30 30 C 1.4645 7.1777 0.0 0
M  V30 31 C 7.1044 4.6200 0.0 0
M  V30 32 C 5.7707 3.8500 0.0 0
M  V30 33 C 8.4380 3.8500 0.0 0
M  V30 34 C 5.7707 2.3100 0.0 0
M  V30 35 C 8.4380 2.3100 0.0 0
M  V30 36 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 30
M  V30 20 1 19 36
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-63-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-59-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME283 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(2-thienylmethylene)benzenesulfonamide
C12H11NO2S2
951762-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.2198 2.5795 0.0 0 VAL=6
M  V30 2 N 4.6798 2.5795 0.0 0
M  V30 3 O 6.2198 1.0395 0.0 0
M  V30 4 O 6.2198 4.1195 0.0 0
M  V30 5 C 3.9098 1.2459 0.0 0
M  V30 6 C 12.3798 2.5795 0.0 0
M  V30 7 C 7.7598 2.5795 0.0 0
M  V30 8 C 8.5298 1.2459 0.0 0
M  V30 9 C 8.5298 3.9132 0.0 0
M  V30 10 C 10.0698 1.2459 0.0 0
M  V30 11 C 10.0698 3.9132 0.0 0
M  V30 12 C 10.8398 2.5795 0.0 0
M  V30 13 C 2.3698 1.2459 0.0 0
M  V30 14 C 1.4645 2.4917 0.0 0
M  V30 15 S 1.4645 0.0000 0.0 0
M  V30 16 C 0.0000 2.0159 0.0 0
M  V30 17 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1-ylthio)-...
C25H33NO4S3
951636-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 9.0732 0.0 0 VAL=6
M  V30 2 O 9.2154 7.5332 0.0 0
M  V30 3 O 9.2154 10.6132 0.0 0
M  V30 4 C 7.2460 6.3627 0.0 0
M  V30 5 C 6.2156 5.2181 0.0 0
M  V30 6 C 6.6915 3.7536 0.0 0
M  V30 7 C 5.6610 2.6091 0.0 0
M  V30 8 C 6.1369 1.1445 0.0 0
M  V30 9 C 5.1065 0.0000 0.0 0
M  V30 10 C 4.0596 10.7483 0.0 0
M  V30 11 O 4.2207 12.2800 0.0 0
M  V30 12 O 2.6528 10.1220 0.0 0
M  V30 13 S 4.0596 7.3980 0.0 0
M  V30 14 C 2.6528 8.0243 0.0 0
M  V30 15 C 1.4069 7.1191 0.0 0
M  V30 16 C 0.0000 7.7456 0.0 0
M  V30 17 C 15.3754 9.0732 0.0 0
M  V30 18 N 7.6754 9.0732 0.0 0
M  V30 19 C 6.7701 10.3191 0.0 0 CFG=1
M  V30 20 C 6.7701 7.8272 0.0 0 CFG=2
M  V30 21 C 5.3055 9.8432 0.0 0 CFG=2
M  V30 22 C 5.3055 8.3032 0.0 0 CFG=1
M  V30 23 C 7.2460 11.7836 0.0 0
M  V30 24 C 6.3408 13.0295 0.0 0
M  V30 25 S 8.7107 12.2595 0.0 0
M  V30 26 C 7.2460 14.2755 0.0 0
M  V30 27 C 8.7107 13.7995 0.0 0
M  V30 28 C 10.7554 9.0732 0.0 0
M  V30 29 C 11.5254 10.4069 0.0 0
M  V30 30 C 11.5254 7.7394 0.0 0
M  V30 31 C 13.0654 10.4069 0.0 0
M  V30 32 C 13.0654 7.7394 0.0 0
M  V30 33 C 13.8354 9.0732 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 21 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 22 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 33
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-64-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-67-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29552691
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME284 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[[4-(1-methylethyl)phenyl]methylene]benzenesulfonamide
C17H19NO2S
951762-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 9.2400 0.0000 0.0 0
M  V30 4 O 9.2400 3.0800 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 15.4000 1.5400 0.0 0
M  V30 7 C 0.7700 2.8736 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 0.0000 4.2073 0.0 0
M  V30 10 C 10.7800 1.5400 0.0 0
M  V30 11 C 11.5500 2.8736 0.0 0
M  V30 12 C 11.5500 0.2062 0.0 0
M  V30 13 C 13.0900 2.8736 0.0 0
M  V30 14 C 13.0900 0.2062 0.0 0
M  V30 15 C 13.8600 1.5400 0.0 0
M  V30 16 C 5.3900 2.8736 0.0 0
M  V30 17 C 4.6200 4.2073 0.0 0
M  V30 18 C 4.6200 1.5400 0.0 0
M  V30 19 C 3.0800 4.2073 0.0 0
M  V30 20 C 3.0800 1.5400 0.0 0
M  V30 21 C 2.3100 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-2-[4-(1-methylethyl)phenyl]-1-[(4-methylphenyl)sulf...
C30H41NO4S2
951636-70-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.2489 6.1600 0.0 0 VAL=6
M  V30 2 O 9.7889 6.1600 0.0 0
M  V30 3 O 6.7089 6.1600 0.0 0
M  V30 4 C 10.9594 8.1294 0.0 0
M  V30 5 C 12.1038 9.1598 0.0 0
M  V30 6 C 13.5685 8.6839 0.0 0
M  V30 7 C 14.7129 9.7143 0.0 0
M  V30 8 C 16.1775 9.2385 0.0 0
M  V30 9 C 17.3219 10.2689 0.0 0
M  V30 10 C 6.5736 11.3158 0.0 0
M  V30 11 O 5.0421 11.1547 0.0 0
M  V30 12 O 7.2000 12.7226 0.0 0
M  V30 13 S 9.9241 11.3158 0.0 0
M  V30 14 C 9.2976 12.7226 0.0 0
M  V30 15 C 10.2028 13.9684 0.0 0
M  V30 16 C 9.5765 15.3754 0.0 0
M  V30 17 C 1.1444 6.7016 0.0 0
M  V30 18 C 0.0000 7.7322 0.0 0
M  V30 19 C 0.8242 5.1953 0.0 0
M  V30 20 C 8.2489 0.0000 0.0 0
M  V30 21 N 8.2489 7.7000 0.0 0
M  V30 22 C 7.0030 8.6052 0.0 0 CFG=1
M  V30 23 C 9.4947 8.6052 0.0 0 CFG=2
M  V30 24 C 7.4789 10.0699 0.0 0 CFG=2
M  V30 25 C 9.0189 10.0699 0.0 0 CFG=1
M  V30 26 C 5.5383 8.1294 0.0 0
M  V30 27 C 4.3939 9.1598 0.0 0
M  V30 28 C 5.2181 6.6229 0.0 0
M  V30 29 C 2.9292 8.6839 0.0 0
M  V30 30 C 3.7534 6.1471 0.0 0
M  V30 31 C 2.6091 7.1776 0.0 0
M  V30 32 C 8.2489 4.6200 0.0 0
M  V30 33 C 9.5825 3.8500 0.0 0
M  V30 34 C 6.9152 3.8500 0.0 0
M  V30 35 C 9.5825 2.3100 0.0 0
M  V30 36 C 6.9152 2.3100 0.0 0
M  V30 37 C 8.2489 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 32
M  V30 5 1 4 5
M  V30 6 1 23 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 24 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 25 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 31
M  V30 21 1 20 37
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 22 26 CFG=1
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 22 23 24 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-66-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-70-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME285 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Fluorophenyl)-5-hexyl-1-[(4-methylphenyl)sulfonyl]-4-(...
C27H34FNO4S2
951636-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 F 0.0000 9.7144 0.0 0
M  V30 18 C 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-68-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16059121
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME286 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951762-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(4-chlorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31Cl2NO4S2
951636-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Cl 0.0000 6.7017 0.0 0
M  V30 18 Cl 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-69-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-74-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090196
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME287 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-5-hexyl-2-(4-methylphenyl)-4-(...
C27H34ClNO4S2
951636-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 C 0.0000 6.7017 0.0 0
M  V30 18 Cl 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-72-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-78-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082268
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME288 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-2-(4-methylphenyl)-1-[(2-methylphenyl)sulfonyl]-4-(...
C28H37NO4S2
951636-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 C 9.7718 10.7554 0.0 0
M  V30 18 C 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-79-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088276
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME289 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-5-hexyl-1-[(2-methylphenyl)sulfonyl]...
C27H33Cl2NO4S2
951688-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 5.5644 9.2154 0.0 0
M  V30 3 O 8.6444 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 3.8976 4.2207 0.0 0
M  V30 6 O 6.0556 2.6528 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 0.6403 5.6611 0.0 0
M  V30 18 C 9.7718 10.7554 0.0 0
M  V30 19 Cl 0.0000 8.6738 0.0 0
M  V30 20 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 21 N 7.1044 7.6754 0.0 0
M  V30 22 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 23 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 24 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 25 C 4.3938 7.2460 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 4.0736 8.7525 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 2.6091 9.2283 0.0 0
M  V30 30 C 1.4645 8.1978 0.0 0
M  V30 31 C 7.1044 10.7554 0.0 0
M  V30 32 C 8.4380 11.5254 0.0 0
M  V30 33 C 5.7707 11.5254 0.0 0
M  V30 34 C 8.4380 13.0654 0.0 0
M  V30 35 C 5.7707 13.0654 0.0 0
M  V30 36 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 32
M  V30 20 1 19 30
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-84-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089780
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME290 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-2-fluorobenzenesulfonamide
C13H8Cl2FNO2S
951762-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 F 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-1-[(2-fluorophenyl)sulfonyl]-5-hexyl...
C26H30Cl2FNO4S2
951688-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 0.6403 5.6611 0.0 0
M  V30 18 F 9.7718 10.7554 0.0 0
M  V30 19 Cl 0.0000 8.6738 0.0 0
M  V30 20 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 21 N 7.1044 7.6754 0.0 0
M  V30 22 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 23 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 24 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 25 C 4.3938 7.2460 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 4.0736 8.7525 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 2.6091 9.2283 0.0 0
M  V30 30 C 1.4645 8.1978 0.0 0
M  V30 31 C 7.1044 10.7554 0.0 0
M  V30 32 C 8.4380 11.5254 0.0 0
M  V30 33 C 5.7707 11.5254 0.0 0
M  V30 34 C 8.4380 13.0654 0.0 0
M  V30 35 C 5.7707 13.0654 0.0 0
M  V30 36 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 32
M  V30 20 1 19 30
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-85-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-24-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME291 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8Cl3NO2S
951762-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 Cl 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-5-hexyl...
C26H30Cl3NO4S2
951688-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 5.5644 9.2154 0.0 0
M  V30 3 O 8.6444 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 3.8976 4.2207 0.0 0
M  V30 6 O 6.0556 2.6528 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 0.6403 5.6611 0.0 0
M  V30 18 Cl 9.7718 10.7554 0.0 0
M  V30 19 Cl 0.0000 8.6738 0.0 0
M  V30 20 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 21 N 7.1044 7.6754 0.0 0
M  V30 22 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 23 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 24 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 25 C 4.3938 7.2460 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 4.0736 8.7525 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 2.6091 9.2283 0.0 0
M  V30 30 C 1.4645 8.1978 0.0 0
M  V30 31 C 7.1044 10.7554 0.0 0
M  V30 32 C 8.4380 11.5254 0.0 0
M  V30 33 C 5.7707 11.5254 0.0 0
M  V30 34 C 8.4380 13.0654 0.0 0
M  V30 35 C 5.7707 13.0654 0.0 0
M  V30 36 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 32
M  V30 20 1 19 30
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-86-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092774
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME292 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8BrCl2NO2S
951762-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 Br 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-5-hexyl-...
C26H30BrCl2NO4S2
951688-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 5.5644 9.2154 0.0 0
M  V30 3 O 8.6444 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 3.8976 4.2207 0.0 0
M  V30 6 O 6.0556 2.6528 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 0.6403 5.6611 0.0 0
M  V30 18 Br 9.7718 10.7554 0.0 0
M  V30 19 Cl 0.0000 8.6738 0.0 0
M  V30 20 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 21 N 7.1044 7.6754 0.0 0
M  V30 22 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 23 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 24 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 25 C 4.3938 7.2460 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 4.0736 8.7525 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 2.6091 9.2283 0.0 0
M  V30 30 C 1.4645 8.1978 0.0 0
M  V30 31 C 7.1044 10.7554 0.0 0
M  V30 32 C 8.4380 11.5254 0.0 0
M  V30 33 C 5.7707 11.5254 0.0 0
M  V30 34 C 8.4380 13.0654 0.0 0
M  V30 35 C 5.7707 13.0654 0.0 0
M  V30 36 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 32
M  V30 20 1 19 30
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-87-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-26-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083316
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME293 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Hexyl-2-(3-methylphenyl)-1-[(2-methylphenyl)sulfonyl]-4-(...
C28H37NO4S2
951688-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 5.4153 2.6528 0.0 0
M  V30 12 O 3.2573 4.2207 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 C 9.1315 10.7554 0.0 0
M  V30 18 C 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-88-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16070773
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME294 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Fluorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12FNO2S
951762-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Fluorophenyl)-5-hexyl-1-[(2-methylphenyl)sulfonyl]-4-(...
C27H34FNO4S2
951688-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 C 9.1315 10.7554 0.0 0
M  V30 18 F 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-90-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16057601
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME295 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
951762-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-5-hexyl-1-[(2-methylphenyl)sulfonyl]-4-(...
C27H34ClNO4S2
951688-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 C 9.1315 10.7554 0.0 0
M  V30 18 Cl 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-91-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-29-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087837
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME296 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-2-methylbenzenesulfonamide
C14H12BrNO2S
951762-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-5-hexyl-1-[(2-methylphenyl)sulfonyl]-4-(2...
C27H34BrNO4S2
951688-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 C 9.1315 10.7554 0.0 0
M  V30 18 Br 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-92-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-30-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089351
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME297 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951762-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Fluorophenyl)sulfonyl]-5-hexyl-2-(3-methylphenyl)-4-(...
C27H34FNO4S2
951688-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 F 9.1315 10.7554 0.0 0
M  V30 18 C 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-93-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090855
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME298 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951762-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Fluorophenyl)-1-[(2-fluorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31F2NO4S2
951688-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 F 9.1315 10.7554 0.0 0
M  V30 18 F 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-94-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-32-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME299 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9ClFNO2S
951762-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(2-fluorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31ClFNO4S2
951688-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 F 9.1315 10.7554 0.0 0
M  V30 18 Cl 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-95-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-33-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088037
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME300 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9BrFNO2S
951762-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(2-fluorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrFNO4S2
951688-34-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 5.4153 2.6528 0.0 0
M  V30 12 O 3.2573 4.2207 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 F 9.1315 10.7554 0.0 0
M  V30 18 Br 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-96-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-34-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME301 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-5-hexyl-2-(3-methylphenyl)-4-(...
C27H34ClNO4S2
951688-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Cl 9.1315 10.7554 0.0 0
M  V30 18 C 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-97-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091063
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME302 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951762-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-2-(3-fluorophenyl)-5-hexyl-4-(...
C26H31ClFNO4S2
951688-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Cl 9.1315 10.7554 0.0 0
M  V30 18 F 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-98-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092531
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME303 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951762-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 3.2311 4.4137 0.0 0
M  V30 4 O 4.7712 1.7464 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(2-chlorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31Cl2NO4S2
951688-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 4.9240 9.2154 0.0 0
M  V30 3 O 8.0040 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Cl 9.1315 10.7554 0.0 0
M  V30 18 Cl 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-99-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-37-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083074
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME304 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-2-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(2-chlorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrClNO4S2
951688-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Cl 9.1315 10.7554 0.0 0
M  V30 18 Br 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-00-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-38-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16064986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME305 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
951763-01-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-5-hexyl-2-(3-methylphenyl)-4-(2...
C27H34BrNO4S2
951688-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Br 9.1315 10.7554 0.0 0
M  V30 18 C 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-01-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME306 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951763-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(3-fluorophenyl)-5-hexyl-4-(2...
C26H31BrFNO4S2
951688-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Br 9.1315 10.7554 0.0 0
M  V30 18 F 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-02-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16059026
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME307 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(3-chlorophenyl)-5-hexyl-4-(2...
C26H31BrClNO4S2
951688-41-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Br 9.1315 10.7554 0.0 0
M  V30 18 Cl 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-03-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-41-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME308 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(2-bromophenyl)sulfonyl]-5-hexyl-4-(2-...
C26H31Br2NO4S2
951688-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 8.0040 9.2154 0.0 0
M  V30 3 O 4.9240 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Br 9.1315 10.7554 0.0 0
M  V30 18 Br 0.0000 5.6611 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 27
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-04-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-42-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME309 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Fluorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12FNO2S
951763-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Fluorophenyl)-5-hexyl-1-[(2-methylphenyl)sulfonyl]-4-(...
C27H34FNO4S2
951688-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 C 9.7718 10.7554 0.0 0
M  V30 18 F 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-05-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071316
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME310 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-2-methylbenzenesulfonamide
C14H12BrNO2S
951763-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-hexyl-1-[(2-methylphenyl)sulfonyl]-4-(2...
C27H34BrNO4S2
951688-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 C 9.7718 10.7554 0.0 0
M  V30 18 Br 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-06-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME311 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951763-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Fluorophenyl)sulfonyl]-5-hexyl-2-(4-methylphenyl)-4-(...
C27H34FNO4S2
951688-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 F 9.7718 10.7554 0.0 0
M  V30 18 C 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-07-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-45-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16075936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME312 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951763-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Fluorophenyl)-1-[(2-fluorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31F2NO4S2
951688-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 5.5644 9.2154 0.0 0
M  V30 3 O 8.6444 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 3.8976 4.2207 0.0 0
M  V30 6 O 6.0556 2.6528 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 F 9.7718 10.7554 0.0 0
M  V30 18 F 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 3.2494 6.2156 0.0 0
M  V30 26 C 4.0736 8.7525 0.0 0
M  V30 27 C 1.7847 6.6915 0.0 0
M  V30 28 C 2.6091 9.2283 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-08-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME313 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9ClFNO2S
951763-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(2-fluorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31ClFNO4S2
951688-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 3.8976 4.2207 0.0 0
M  V30 6 O 6.0556 2.6528 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 F 9.7718 10.7554 0.0 0
M  V30 18 Cl 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 3.2494 6.2156 0.0 0
M  V30 26 C 4.0736 8.7525 0.0 0
M  V30 27 C 1.7847 6.6915 0.0 0
M  V30 28 C 2.6091 9.2283 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-09-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-47-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092295
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME314 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9BrFNO2S
951763-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(2-fluorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrFNO4S2
951688-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 5.5644 9.2154 0.0 0
M  V30 3 O 8.6444 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 3.8976 4.2207 0.0 0
M  V30 6 O 6.0556 2.6528 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 F 9.7718 10.7554 0.0 0
M  V30 18 Br 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 3.2494 6.2156 0.0 0
M  V30 26 C 4.0736 8.7525 0.0 0
M  V30 27 C 1.7847 6.6915 0.0 0
M  V30 28 C 2.6091 9.2283 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-10-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082834
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME315 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-5-hexyl-2-(4-methylphenyl)-4-(...
C27H34ClNO4S2
951688-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 9.7718 10.7554 0.0 0
M  V30 18 C 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-11-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-49-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071288
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME316 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Chlorophenyl)sulfonyl]-2-(4-fluorophenyl)-5-hexyl-4-(...
C26H31ClFNO4S2
951688-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 9.7718 10.7554 0.0 0
M  V30 18 F 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-12-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16065150
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME317 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(2-chlorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31Cl2NO4S2
951688-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 9.7718 10.7554 0.0 0
M  V30 18 Cl 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-13-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME318 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-2-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(2-chlorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrClNO4S2
951688-52-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 9.7718 10.7554 0.0 0
M  V30 18 Br 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-14-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-52-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088875
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME319 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
951763-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-5-hexyl-2-(4-methylphenyl)-4-(2...
C27H34BrNO4S2
951688-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Br 9.7718 10.7554 0.0 0
M  V30 18 C 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-15-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-53-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084530
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME320 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951763-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(4-fluorophenyl)-5-hexyl-4-(2...
C26H31BrFNO4S2
951688-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 5.5644 9.2154 0.0 0
M  V30 3 O 8.6444 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Br 9.7718 10.7554 0.0 0
M  V30 18 F 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-16-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-54-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086041
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME321 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-2-(4-chlorophenyl)-5-hexyl-4-(2...
C26H31BrClNO4S2
951688-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Br 9.7718 10.7554 0.0 0
M  V30 18 Cl 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-55-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087570
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME322 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(2-bromophenyl)sulfonyl]-5-hexyl-4-(2-...
C26H31Br2NO4S2
951688-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Br 9.7718 10.7554 0.0 0
M  V30 18 Br 0.0000 8.6738 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-18-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-56-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089094
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME323 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-fluorobenzenesulfonamide
C13H8Cl2FNO2S
951763-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 F 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3,4-Dichlorophenyl)-1-[(4-fluorophenyl)sulfonyl]-5-hexyl...
C26H30Cl2FNO4S2
951689-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 5.4291 11.3158 0.0 0
M  V30 5 O 6.0556 12.7226 0.0 0
M  V30 6 O 3.8976 11.1547 0.0 0
M  V30 7 C 9.8149 8.1294 0.0 0
M  V30 8 C 10.9593 9.1598 0.0 0
M  V30 9 C 12.4240 8.6840 0.0 0
M  V30 10 C 13.5684 9.7144 0.0 0
M  V30 11 C 15.0331 9.2385 0.0 0
M  V30 12 C 16.1775 10.2689 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Cl 0.6403 9.7144 0.0 0
M  V30 18 Cl 0.0000 6.7017 0.0 0
M  V30 19 F 7.1044 0.0000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 N 7.1044 7.7000 0.0 0
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 24 C 7.8744 10.0700 0.0 0 CFG=2
M  V30 25 C 4.3938 8.1294 0.0 0
M  V30 26 C 3.2494 9.1598 0.0 0
M  V30 27 C 4.0736 6.6230 0.0 0
M  V30 28 C 1.7847 8.6840 0.0 0
M  V30 29 C 2.6091 6.1471 0.0 0
M  V30 30 C 1.4645 7.1777 0.0 0
M  V30 31 C 7.1044 4.6200 0.0 0
M  V30 32 C 5.7707 3.8500 0.0 0
M  V30 33 C 8.4380 3.8500 0.0 0
M  V30 34 C 5.7707 2.3100 0.0 0
M  V30 35 C 8.4380 2.3100 0.0 0
M  V30 36 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 30
M  V30 20 1 19 36
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-19-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-61-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16064690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME324 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8Cl3NO2S
951763-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 Cl 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-5-hexyl...
C26H30Cl3NO4S2
951689-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 5.4291 11.3158 0.0 0
M  V30 5 O 3.8976 11.1547 0.0 0
M  V30 6 O 6.0556 12.7226 0.0 0
M  V30 7 C 9.8149 8.1294 0.0 0
M  V30 8 C 10.9593 9.1598 0.0 0
M  V30 9 C 12.4240 8.6840 0.0 0
M  V30 10 C 13.5684 9.7144 0.0 0
M  V30 11 C 15.0331 9.2385 0.0 0
M  V30 12 C 16.1775 10.2689 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Cl 0.6403 9.7144 0.0 0
M  V30 18 Cl 0.0000 6.7017 0.0 0
M  V30 19 Cl 7.1044 0.0000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 N 7.1044 7.7000 0.0 0
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 24 C 7.8744 10.0700 0.0 0 CFG=2
M  V30 25 C 4.3938 8.1294 0.0 0
M  V30 26 C 3.2494 9.1598 0.0 0
M  V30 27 C 4.0736 6.6230 0.0 0
M  V30 28 C 1.7847 8.6840 0.0 0
M  V30 29 C 2.6091 6.1471 0.0 0
M  V30 30 C 1.4645 7.1777 0.0 0
M  V30 31 C 7.1044 4.6200 0.0 0
M  V30 32 C 5.7707 3.8500 0.0 0
M  V30 33 C 8.4380 3.8500 0.0 0
M  V30 34 C 5.7707 2.3100 0.0 0
M  V30 35 C 8.4380 2.3100 0.0 0
M  V30 36 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 30
M  V30 20 1 19 36
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-21-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-62-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME325 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8BrCl2NO2S
951763-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 Br 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-5-hexyl-...
C26H30BrCl2NO4S2
951689-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 5.4291 11.3158 0.0 0
M  V30 5 O 6.0556 12.7226 0.0 0
M  V30 6 O 3.8976 11.1547 0.0 0
M  V30 7 C 9.8149 8.1294 0.0 0
M  V30 8 C 10.9593 9.1598 0.0 0
M  V30 9 C 12.4240 8.6840 0.0 0
M  V30 10 C 13.5684 9.7144 0.0 0
M  V30 11 C 15.0331 9.2385 0.0 0
M  V30 12 C 16.1775 10.2689 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Cl 0.6403 9.7144 0.0 0
M  V30 18 Cl 0.0000 6.7017 0.0 0
M  V30 19 Br 7.1044 0.0000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 N 7.1044 7.7000 0.0 0
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 24 C 7.8744 10.0700 0.0 0 CFG=2
M  V30 25 C 4.3938 8.1294 0.0 0
M  V30 26 C 3.2494 9.1598 0.0 0
M  V30 27 C 4.0736 6.6230 0.0 0
M  V30 28 C 1.7847 8.6840 0.0 0
M  V30 29 C 2.6091 6.1471 0.0 0
M  V30 30 C 1.4645 7.1777 0.0 0
M  V30 31 C 7.1044 4.6200 0.0 0
M  V30 32 C 5.7707 3.8500 0.0 0
M  V30 33 C 8.4380 3.8500 0.0 0
M  V30 34 C 5.7707 2.3100 0.0 0
M  V30 35 C 8.4380 2.3100 0.0 0
M  V30 36 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 30
M  V30 20 1 19 36
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-23-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083719
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME326 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951763-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Fluorophenyl)sulfonyl]-5-hexyl-2-(3-methylphenyl)-4-(...
C27H34FNO4S2
951689-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 C 0.0000 9.7144 0.0 0
M  V30 18 F 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-24-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-64-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085216
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME327 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951763-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Fluorophenyl)-1-[(4-fluorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31F2NO4S2
951689-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 F 0.0000 9.7144 0.0 0
M  V30 18 F 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-25-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091900
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME328 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9ClFNO2S
951763-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(4-fluorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31ClFNO4S2
951689-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 Cl 0.0000 9.7144 0.0 0
M  V30 18 F 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-26-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME329 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9BrFNO2S
951763-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(4-fluorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrFNO4S2
951689-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 Br 0.0000 9.7144 0.0 0
M  V30 18 F 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-27-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-67-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083909
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME330 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-5-hexyl-2-(3-methylphenyl)-4-(...
C27H34ClNO4S2
951689-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 C 0.0000 9.7144 0.0 0
M  V30 18 Cl 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-28-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-68-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071017
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME331 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-2-(3-fluorophenyl)-5-hexyl-4-(...
C26H31ClFNO4S2
951689-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 F 0.0000 9.7144 0.0 0
M  V30 18 Cl 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-29-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-69-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME332 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(4-chlorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31Cl2NO4S2
951689-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 Cl 0.0000 9.7144 0.0 0
M  V30 18 Cl 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-30-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME333 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(4-chlorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrClNO4S2
951689-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 Br 0.0000 9.7144 0.0 0
M  V30 18 Cl 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-31-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME334 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
951763-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 4.0010 5.3901 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 2.6673 6.1601 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-5-hexyl-2-(3-methylphenyl)-4-(2...
C27H34BrNO4S2
951689-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 C 0.0000 9.7144 0.0 0
M  V30 18 Br 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-32-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-72-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME335 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(3-chlorophenyl)-5-hexyl-4-(2...
C26H31BrClNO4S2
951689-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 Cl 0.0000 9.7144 0.0 0
M  V30 18 Br 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-33-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-74-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16056834
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME336 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(4-bromophenyl)sulfonyl]-5-hexyl-4-(2-...
C26H31Br2NO4S2
951689-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 8.0040 6.1600 0.0 0
M  V30 3 O 4.9240 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 3.2573 11.1547 0.0 0
M  V30 6 O 5.4153 12.7226 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 Br 0.0000 9.7144 0.0 0
M  V30 18 Br 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-34-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071380
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME337 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951763-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Fluorophenyl)sulfonyl]-5-hexyl-2-(4-methylphenyl)-4-(...
C27H34FNO4S2
951689-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 C 0.0000 6.7017 0.0 0
M  V30 18 F 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-35-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-76-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME338 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951763-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Fluorophenyl)-1-[(4-fluorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31F2NO4S2
951689-77-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 F 0.0000 6.7017 0.0 0
M  V30 18 F 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-36-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-77-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16056780
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME339 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9ClFNO2S
951763-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(4-fluorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31ClFNO4S2
951689-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Cl 0.0000 6.7017 0.0 0
M  V30 18 F 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-37-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME340 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9BrFNO2S
951763-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(4-fluorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrFNO4S2
951689-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Br 0.0000 6.7017 0.0 0
M  V30 18 F 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-38-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085189
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME341 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 0.0000 0.0 0
M  V30 16 C 10.7800 2.6673 0.0 0
M  V30 17 C 12.3200 0.0000 0.0 0
M  V30 18 C 12.3200 2.6673 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Chlorophenyl)sulfonyl]-2-(4-fluorophenyl)-5-hexyl-4-(...
C26H31ClFNO4S2
951689-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 F 0.0000 6.7017 0.0 0
M  V30 18 Cl 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 8.4380 3.8500 0.0 0
M  V30 32 C 5.7707 3.8500 0.0 0
M  V30 33 C 8.4380 2.3100 0.0 0
M  V30 34 C 5.7707 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-39-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-80-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086706
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME342 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(4-chlorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrClNO4S2
951689-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Br 0.0000 6.7017 0.0 0
M  V30 18 Cl 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 5.7707 3.8500 0.0 0
M  V30 32 C 8.4380 3.8500 0.0 0
M  V30 33 C 5.7707 2.3100 0.0 0
M  V30 34 C 8.4380 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-40-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-81-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088225
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME343 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951763-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(4-fluorophenyl)-5-hexyl-4-(2...
C26H31BrFNO4S2
951689-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 8.6444 6.1600 0.0 0
M  V30 3 O 5.5644 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 3.8976 11.1547 0.0 0
M  V30 12 O 6.0556 12.7226 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 F 0.0000 6.7017 0.0 0
M  V30 18 Br 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 8.4380 3.8500 0.0 0
M  V30 32 C 5.7707 3.8500 0.0 0
M  V30 33 C 8.4380 2.3100 0.0 0
M  V30 34 C 5.7707 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-41-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091253
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME344 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(4-chlorophenyl)-5-hexyl-4-(2...
C26H31BrClNO4S2
951689-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 3.8976 11.1547 0.0 0
M  V30 12 O 6.0556 12.7226 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Cl 0.0000 6.7017 0.0 0
M  V30 18 Br 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 4.0736 6.6230 0.0 0
M  V30 26 C 3.2494 9.1598 0.0 0
M  V30 27 C 2.6091 6.1471 0.0 0
M  V30 28 C 1.7847 8.6840 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 8.4380 3.8500 0.0 0
M  V30 32 C 5.7707 3.8500 0.0 0
M  V30 33 C 8.4380 2.3100 0.0 0
M  V30 34 C 5.7707 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-42-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-84-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092730
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME345 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(4-bromophenyl)sulfonyl]-5-hexyl-4-(2-...
C26H31Br2NO4S2
951689-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 6.1600 0.0 0 VAL=6
M  V30 2 O 5.5644 6.1600 0.0 0
M  V30 3 O 8.6444 6.1600 0.0 0
M  V30 4 C 9.8149 8.1294 0.0 0
M  V30 5 C 10.9593 9.1598 0.0 0
M  V30 6 C 12.4240 8.6840 0.0 0
M  V30 7 C 13.5684 9.7144 0.0 0
M  V30 8 C 15.0331 9.2385 0.0 0
M  V30 9 C 16.1775 10.2689 0.0 0
M  V30 10 C 5.4291 11.3158 0.0 0
M  V30 11 O 6.0556 12.7226 0.0 0
M  V30 12 O 3.8976 11.1547 0.0 0
M  V30 13 S 8.7796 11.3158 0.0 0
M  V30 14 C 8.1533 12.7226 0.0 0
M  V30 15 C 9.0583 13.9685 0.0 0
M  V30 16 C 8.4320 15.3754 0.0 0
M  V30 17 Br 0.0000 6.7017 0.0 0
M  V30 18 Br 7.1044 0.0000 0.0 0
M  V30 19 N 7.1044 7.7000 0.0 0
M  V30 20 C 5.8585 8.6053 0.0 0 CFG=1
M  V30 21 C 8.3502 8.6053 0.0 0 CFG=2
M  V30 22 C 6.3344 10.0700 0.0 0 CFG=2
M  V30 23 C 7.8744 10.0700 0.0 0 CFG=1
M  V30 24 C 4.3938 8.1294 0.0 0
M  V30 25 C 3.2494 9.1598 0.0 0
M  V30 26 C 4.0736 6.6230 0.0 0
M  V30 27 C 1.7847 8.6840 0.0 0
M  V30 28 C 2.6091 6.1471 0.0 0
M  V30 29 C 1.4645 7.1777 0.0 0
M  V30 30 C 7.1044 4.6200 0.0 0
M  V30 31 C 8.4380 3.8500 0.0 0
M  V30 32 C 5.7707 3.8500 0.0 0
M  V30 33 C 8.4380 2.3100 0.0 0
M  V30 34 C 5.7707 2.3100 0.0 0
M  V30 35 C 7.1044 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=3
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-43-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-85-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME346 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8Cl3NO2S
951763-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0022 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 7.2322 1.7464 0.0 0
M  V30 4 O 8.7722 4.4137 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 Cl 13.3370 3.0801 0.0 0
M  V30 7 Cl 0.0000 3.0801 0.0 0
M  V30 8 Cl 0.0000 6.1601 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 C 12.0033 2.3101 0.0 0
M  V30 13 C 10.6697 0.0000 0.0 0
M  V30 14 C 12.0033 0.7700 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 4.0010 5.3901 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 2.6673 6.1601 0.0 0
M  V30 20 C 1.3337 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 12
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-2-(3,4-dichlorophenyl)-5-hexyl...
C26H30Cl3NO4S2
951689-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 5.5644 9.2154 0.0 0
M  V30 3 O 8.6444 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 3.8976 4.2207 0.0 0
M  V30 6 O 6.0556 2.6528 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 0.6403 5.6611 0.0 0
M  V30 18 Cl 0.0000 8.6738 0.0 0
M  V30 19 Cl 9.7718 13.8354 0.0 0
M  V30 20 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 21 N 7.1044 7.6754 0.0 0
M  V30 22 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 23 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 24 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 25 C 4.3938 7.2460 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 4.0736 8.7525 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 2.6091 9.2283 0.0 0
M  V30 30 C 1.4645 8.1978 0.0 0
M  V30 31 C 7.1044 10.7554 0.0 0
M  V30 32 C 8.4380 11.5254 0.0 0
M  V30 33 C 5.7707 11.5254 0.0 0
M  V30 34 C 8.4380 13.0654 0.0 0
M  V30 35 C 5.7707 13.0654 0.0 0
M  V30 36 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 22 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 23 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 24 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 28
M  V30 19 1 18 30
M  V30 20 1 19 34
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 20 25 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-44-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-86-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089922
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME347 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-5-hexyl-2-(3-methylphenyl)-4-(...
C27H34ClNO4S2
951689-87-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 4.9240 9.2154 0.0 0
M  V30 3 O 8.0040 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 C 0.0000 5.6611 0.0 0
M  V30 18 Cl 9.1315 13.8354 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 33
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-45-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-87-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME348 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-2-(3-fluorophenyl)-5-hexyl-4-(...
C26H31ClFNO4S2
951689-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 4.9240 9.2154 0.0 0
M  V30 3 O 8.0040 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 F 0.0000 5.6611 0.0 0
M  V30 18 Cl 9.1315 13.8354 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 33
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-46-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-88-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076555
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME349 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31Cl2NO4S2
951689-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 4.9240 9.2154 0.0 0
M  V30 3 O 8.0040 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Cl 0.0000 5.6611 0.0 0
M  V30 18 Cl 9.1315 13.8354 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 33
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-47-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-89-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME350 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-3-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(3-chlorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrClNO4S2
951689-90-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 4.9240 9.2154 0.0 0
M  V30 3 O 8.0040 9.2154 0.0 0
M  V30 4 C 9.1746 7.2460 0.0 0
M  V30 5 C 10.3190 6.2156 0.0 0
M  V30 6 C 11.7837 6.6915 0.0 0
M  V30 7 C 12.9281 5.6611 0.0 0
M  V30 8 C 14.3928 6.1369 0.0 0
M  V30 9 C 15.5371 5.1065 0.0 0
M  V30 10 C 4.7888 4.0596 0.0 0
M  V30 11 O 3.2573 4.2207 0.0 0
M  V30 12 O 5.4153 2.6528 0.0 0
M  V30 13 S 8.1392 4.0596 0.0 0
M  V30 14 C 7.5128 2.6528 0.0 0
M  V30 15 C 8.4180 1.4070 0.0 0
M  V30 16 C 7.7917 0.0000 0.0 0
M  V30 17 Br 0.0000 5.6611 0.0 0
M  V30 18 Cl 9.1315 13.8354 0.0 0
M  V30 19 N 6.4640 7.6754 0.0 0
M  V30 20 C 5.2182 6.7702 0.0 0 CFG=1
M  V30 21 C 7.7099 6.7702 0.0 0 CFG=2
M  V30 22 C 5.6940 5.3055 0.0 0 CFG=2
M  V30 23 C 7.2340 5.3055 0.0 0 CFG=1
M  V30 24 C 3.7535 7.2460 0.0 0
M  V30 25 C 2.6091 6.2156 0.0 0
M  V30 26 C 3.4333 8.7525 0.0 0
M  V30 27 C 1.1444 6.6915 0.0 0
M  V30 28 C 1.9687 9.2283 0.0 0
M  V30 29 C 0.8242 8.1978 0.0 0
M  V30 30 C 6.4640 10.7554 0.0 0
M  V30 31 C 7.7977 11.5254 0.0 0
M  V30 32 C 5.1304 11.5254 0.0 0
M  V30 33 C 7.7977 13.0654 0.0 0
M  V30 34 C 5.1304 13.0654 0.0 0
M  V30 35 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 22 10 CFG=1
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 33
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-48-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-90-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME351 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 C 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-5-hexyl-2-(4-methylphenyl)-4-(...
C27H34ClNO4S2
951689-91-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 C 0.0000 8.6738 0.0 0
M  V30 18 Cl 9.7718 13.8354 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 33
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-49-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-91-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME352 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 F 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(3-Chlorophenyl)sulfonyl]-2-(4-fluorophenyl)-5-hexyl-4-(...
C26H31ClFNO4S2
951689-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 F 0.0000 8.6738 0.0 0
M  V30 18 Cl 9.7718 13.8354 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 33
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-50-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-92-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087995
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME353 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Cl 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]-5-hexyl-4-(...
C26H31Cl2NO4S2
951689-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Cl 0.0000 8.6738 0.0 0
M  V30 18 Cl 9.7718 13.8354 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 33
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-51-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-93-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089505
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME354 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-3-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Br 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(3-chlorophenyl)sulfonyl]-5-hexyl-4-(2...
C26H31BrClNO4S2
951689-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 8.6444 9.2154 0.0 0
M  V30 3 O 5.5644 9.2154 0.0 0
M  V30 4 C 5.4291 4.0596 0.0 0
M  V30 5 O 6.0556 2.6528 0.0 0
M  V30 6 O 3.8976 4.2207 0.0 0
M  V30 7 C 9.8149 7.2460 0.0 0
M  V30 8 C 10.9593 6.2156 0.0 0
M  V30 9 C 12.4240 6.6915 0.0 0
M  V30 10 C 13.5684 5.6611 0.0 0
M  V30 11 C 15.0331 6.1369 0.0 0
M  V30 12 C 16.1775 5.1065 0.0 0
M  V30 13 S 8.7796 4.0596 0.0 0
M  V30 14 C 8.1533 2.6528 0.0 0
M  V30 15 C 9.0583 1.4070 0.0 0
M  V30 16 C 8.4320 0.0000 0.0 0
M  V30 17 Br 0.0000 8.6738 0.0 0
M  V30 18 Cl 9.7718 13.8354 0.0 0
M  V30 19 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 20 N 7.1044 7.6754 0.0 0
M  V30 21 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 22 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 23 C 7.8744 5.3055 0.0 0 CFG=2
M  V30 24 C 4.3938 7.2460 0.0 0
M  V30 25 C 4.0736 8.7525 0.0 0
M  V30 26 C 3.2494 6.2156 0.0 0
M  V30 27 C 2.6091 9.2283 0.0 0
M  V30 28 C 1.7847 6.6915 0.0 0
M  V30 29 C 1.4645 8.1978 0.0 0
M  V30 30 C 7.1044 10.7554 0.0 0
M  V30 31 C 8.4380 11.5254 0.0 0
M  V30 32 C 5.7707 11.5254 0.0 0
M  V30 33 C 8.4380 13.0654 0.0 0
M  V30 34 C 5.7707 13.0654 0.0 0
M  V30 35 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=1
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 29
M  V30 19 1 18 33
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-52-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-94-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091028
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME355 STEP1
$RXN



  3  1
$MOL
2,3-Decadienoic acid
C10H16O2
27007-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0010 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 12 C 13.3370 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951764-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-2-(3-fluorophenyl)-5-hexyl-4-(2...
C26H31BrFNO4S2
951689-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 4.9240 6.1600 0.0 0
M  V30 3 O 8.0040 6.1600 0.0 0
M  V30 4 C 4.7888 11.3158 0.0 0
M  V30 5 O 5.4153 12.7226 0.0 0
M  V30 6 O 3.2573 11.1547 0.0 0
M  V30 7 C 9.1746 8.1294 0.0 0
M  V30 8 C 10.3190 9.1598 0.0 0
M  V30 9 C 11.7837 8.6839 0.0 0
M  V30 10 C 12.9281 9.7144 0.0 0
M  V30 11 C 14.3928 9.2385 0.0 0
M  V30 12 C 15.5371 10.2689 0.0 0
M  V30 13 S 8.1392 11.3158 0.0 0
M  V30 14 C 7.5128 12.7226 0.0 0
M  V30 15 C 8.4180 13.9685 0.0 0
M  V30 16 C 7.7917 15.3754 0.0 0
M  V30 17 F 0.0000 9.7144 0.0 0
M  V30 18 Br 6.4640 0.0000 0.0 0
M  V30 19 C 5.2182 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 22 C 7.7099 8.6053 0.0 0 CFG=2
M  V30 23 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 24 C 3.7535 8.1294 0.0 0
M  V30 25 C 2.6091 9.1598 0.0 0
M  V30 26 C 3.4333 6.6230 0.0 0
M  V30 27 C 1.1444 8.6839 0.0 0
M  V30 28 C 1.9687 6.1471 0.0 0
M  V30 29 C 0.8242 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 23 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 17 27
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27007-77-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951764-30-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-73-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16075866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl α-diazo-4-(1-methylethyl)benzeneacetate
C17H16N2O2
2773372-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 C 5.3348 3.8500 0.0 0
M  V30 3 N 6.6684 1.5400 0.0 0 CHG=1 VAL=4
M  V30 4 O 4.0010 3.0800 0.0 0
M  V30 5 O 5.3348 5.3901 0.0 0
M  V30 6 N 6.6684 0.0000 0.0 0 CHG=-1
M  V30 7 C 12.0032 6.1601 0.0 0
M  V30 8 C 12.0032 7.7001 0.0 0
M  V30 9 C 13.3369 5.3901 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 9.3359 3.0800 0.0 0
M  V30 12 C 8.0021 5.3901 0.0 0
M  V30 13 C 10.6695 3.8500 0.0 0
M  V30 14 C 9.3359 6.1601 0.0 0
M  V30 15 C 10.6695 5.3901 0.0 0
M  V30 16 C 2.6673 3.8500 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 C 2.6673 5.3901 0.0 0
M  V30 19 C 0.0000 3.8500 0.0 0
M  V30 20 C 1.3337 6.1601 0.0 0
M  V30 21 C 0.0000 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 3 6
M  V30 7 1 4 16
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl (αS)-α-[(1,1-dimethylethyl)thio]-4-(1-methylethyl)benzeneacetate
C21H26O2S
2773372-65-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.6437 0.0 0 CFG=2
M  V30 2 C 8.0022 4.4137 0.0 0
M  V30 3 S 6.6685 2.1037 0.0 0
M  V30 4 O 9.3360 3.6437 0.0 0
M  V30 5 O 8.0022 5.9538 0.0 0
M  V30 6 C 5.3348 1.3337 0.0 0
M  V30 7 C 6.1048 0.0000 0.0 0
M  V30 8 C 4.0010 0.5637 0.0 0
M  V30 9 C 4.5648 2.6673 0.0 0
M  V30 10 C 1.3337 6.7238 0.0 0
M  V30 11 C 0.0000 5.9538 0.0 0
M  V30 12 C 1.3337 8.2638 0.0 0
M  V30 13 C 5.3348 4.4137 0.0 0
M  V30 14 C 4.0010 3.6437 0.0 0
M  V30 15 C 5.3348 5.9538 0.0 0
M  V30 16 C 2.6673 4.4137 0.0 0
M  V30 17 C 4.0010 6.7238 0.0 0
M  V30 18 C 2.6673 5.9538 0.0 0
M  V30 19 C 10.6697 4.4137 0.0 0
M  V30 20 C 10.6697 5.9538 0.0 0
M  V30 21 C 12.0033 3.6437 0.0 0
M  V30 22 C 12.0033 6.7238 0.0 0
M  V30 23 C 13.3370 4.4137 0.0 0
M  V30 24 C 13.3370 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 19
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 18
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2773372-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2773372-65-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32169870
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1854050-80-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ee 77%, alternate reaction in presence of additive gave
lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhodium(I)-catalyzed C-S bond formation via enantioselective carbenoid
S-H insertion: catalytic asymmetric synthesis of α-thioesters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Yu-Tuo; Rao, Xiaofeng; Xu, Weici; Xu, Ming-Hua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2022), 9(13), 3467-3472

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-L-Mannopyranose, 6-deoxy-, 1,2,3,4-tetraacetate
C14H20O9
27821-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 1.3338 0.0 0
M  V30 2 C 8.4700 1.3338 0.0 0
M  V30 3 C 9.2400 2.6674 0.0 0
M  V30 4 O 9.2400 0.0000 0.0 0
M  V30 5 O 3.8500 1.3338 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 1.5400 2.6674 0.0 0
M  V30 8 O 1.5400 0.0000 0.0 0
M  V30 9 O 8.4700 4.0011 0.0 0
M  V30 10 C 9.2400 5.3347 0.0 0
M  V30 11 C 8.4700 6.6685 0.0 0
M  V30 12 O 10.7800 5.3347 0.0 0
M  V30 13 O 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 5.3347 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 16 O 2.3100 6.6685 0.0 0
M  V30 17 C 3.8500 6.6685 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0 CFG=1
M  V30 19 C 4.6200 2.6674 0.0 0 CFG=2
M  V30 20 C 6.9300 4.0011 0.0 0 CFG=2
M  V30 21 C 3.8500 4.0011 0.0 0 CFG=1
M  V30 22 O 6.1600 5.3347 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 19 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 20 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 21 13 CFG=1
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 23 17 CFG=3
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 18 19 20 21 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
α-L-Mannopyranoside, 1-methylethyl 6-deoxy-1-thio-, 2,3,4-triacetate
C15H24O7S
946499-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 1.3338 0.0 0
M  V30 2 C 8.4700 1.3338 0.0 0
M  V30 3 C 9.2400 2.6674 0.0 0
M  V30 4 O 9.2400 0.0000 0.0 0
M  V30 5 O 3.8500 1.3338 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 1.5400 2.6674 0.0 0
M  V30 8 O 1.5400 0.0000 0.0 0
M  V30 9 S 8.4700 4.0011 0.0 0
M  V30 10 C 9.2400 5.3347 0.0 0
M  V30 11 C 8.4700 6.6685 0.0 0
M  V30 12 C 10.7800 5.3347 0.0 0
M  V30 13 O 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 5.3347 0.0 0
M  V30 15 C 0.0000 5.3347 0.0 0
M  V30 16 O 2.3100 6.6685 0.0 0
M  V30 17 C 3.8500 6.6685 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0 CFG=1
M  V30 19 C 4.6200 2.6674 0.0 0 CFG=2
M  V30 20 C 6.9300 4.0011 0.0 0 CFG=2
M  V30 21 C 3.8500 4.0011 0.0 0 CFG=1
M  V30 22 O 6.1600 5.3347 0.0 0
M  V30 23 C 4.6200 5.3347 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 19 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 20 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 21 13 CFG=1
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 23 17 CFG=3
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 18 19 20 21 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27821-11-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 946499-63-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-6821
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-63-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, Helferich conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile synthesis of cleistetroside-2, a partially acetylated
oligorhamnoside from Cleistopholis glauca and patens
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Lijian; Chen, Qi; Du, Yuguo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Carbohydrate Research (2007), 342(11), 1496-1501

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
2-Propyne-1-thiol
C3H4S
27846-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 S 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Bis(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl) 2-butenedi...
C24H10F34O4
49676-48-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  62 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 8.2085 0.0 0
M  V30 2 C 6.1600 8.2085 0.0 0
M  V30 3 C 9.2400 8.2085 0.0 0
M  V30 4 F 7.7000 6.6685 0.0 0
M  V30 5 F 7.7000 9.7485 0.0 0
M  V30 6 C 4.6200 8.2085 0.0 0
M  V30 7 F 6.1600 6.6685 0.0 0
M  V30 8 F 6.1600 9.7485 0.0 0
M  V30 9 C 10.7800 8.2085 0.0 0
M  V30 10 F 9.2400 6.6685 0.0 0
M  V30 11 F 9.2400 9.7485 0.0 0
M  V30 12 C 3.0800 8.2085 0.0 0
M  V30 13 F 4.6200 6.6685 0.0 0
M  V30 14 F 4.6200 9.7485 0.0 0
M  V30 15 C 12.3200 8.2085 0.0 0
M  V30 16 F 10.7800 6.6685 0.0 0
M  V30 17 F 10.7800 9.7485 0.0 0
M  V30 18 C 1.5400 8.2085 0.0 0
M  V30 19 F 3.0800 6.6685 0.0 0
M  V30 20 F 3.0800 9.7485 0.0 0
M  V30 21 C 13.8600 8.2085 0.0 0
M  V30 22 F 12.3200 6.6685 0.0 0
M  V30 23 F 12.3200 9.7485 0.0 0
M  V30 24 F 0.0000 8.2085 0.0 0
M  V30 25 F 1.5400 6.6685 0.0 0
M  V30 26 F 1.5400 9.7485 0.0 0
M  V30 27 C 14.6300 6.8747 0.0 0
M  V30 28 O 16.1700 6.8747 0.0 0
M  V30 29 C 16.9400 5.5411 0.0 0
M  V30 30 C 18.4800 5.5411 0.0 0
M  V30 31 O 16.1700 4.2074 0.0 0
M  V30 32 C 19.2500 4.2074 0.0 0
M  V30 33 C 20.7900 4.2074 0.0 0
M  V30 34 O 21.5600 2.8738 0.0 0
M  V30 35 O 21.5600 5.5411 0.0 0
M  V30 36 C 23.1000 2.8738 0.0 0
M  V30 37 C 23.8700 1.5400 0.0 0
M  V30 38 C 25.4100 1.5400 0.0 0
M  V30 39 C 26.9500 1.5400 0.0 0
M  V30 40 F 25.4100 0.0000 0.0 0
M  V30 41 F 25.4100 3.0800 0.0 0
M  V30 42 C 28.4900 1.5400 0.0 0
M  V30 43 F 26.9500 0.0000 0.0 0
M  V30 44 F 26.9500 3.0800 0.0 0
M  V30 45 C 30.0300 1.5400 0.0 0
M  V30 46 F 28.4900 0.0000 0.0 0
M  V30 47 F 28.4900 3.0800 0.0 0
M  V30 48 C 31.5700 1.5400 0.0 0
M  V30 49 F 30.0300 0.0000 0.0 0
M  V30 50 F 30.0300 3.0800 0.0 0
M  V30 51 C 33.1100 1.5400 0.0 0
M  V30 52 F 31.5700 0.0000 0.0 0
M  V30 53 F 31.5700 3.0800 0.0 0
M  V30 54 C 34.6500 1.5400 0.0 0
M  V30 55 F 33.1100 0.0000 0.0 0
M  V30 56 F 33.1100 3.0800 0.0 0
M  V30 57 C 36.1900 1.5400 0.0 0
M  V30 58 F 34.6500 0.0000 0.0 0
M  V30 59 F 34.6500 3.0800 0.0 0
M  V30 60 F 37.7300 1.5400 0.0 0
M  V30 61 F 36.1900 0.0000 0.0 0
M  V30 62 F 36.1900 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 1 12 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 15 23
M  V30 23 1 18 24
M  V30 24 1 18 25
M  V30 25 1 18 26
M  V30 26 1 21 27
M  V30 27 1 27 28
M  V30 28 1 28 29
M  V30 29 1 29 30
M  V30 30 2 29 31
M  V30 31 2 30 32 CFG=2
M  V30 32 1 32 33
M  V30 33 1 33 34
M  V30 34 2 33 35
M  V30 35 1 34 36
M  V30 36 1 36 37
M  V30 37 1 37 38
M  V30 38 1 38 39
M  V30 39 1 38 40
M  V30 40 1 38 41
M  V30 41 1 39 42
M  V30 42 1 39 43
M  V30 43 1 39 44
M  V30 44 1 42 45
M  V30 45 1 42 46
M  V30 46 1 42 47
M  V30 47 1 45 48
M  V30 48 1 45 49
M  V30 49 1 45 50
M  V30 50 1 48 51
M  V30 51 1 48 52
M  V30 52 1 48 53
M  V30 53 1 51 54
M  V30 54 1 51 55
M  V30 55 1 51 56
M  V30 56 1 54 57
M  V30 57 1 54 58
M  V30 58 1 54 59
M  V30 59 1 57 60
M  V30 60 1 57 61
M  V30 61 1 57 62
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Bis(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl) 2-(2-propy...
C27H14F34O4S
1838200-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  66 65 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 30.0300 8.0021 0.0 0
M  V30 2 C 31.5700 8.0021 0.0 0
M  V30 3 C 28.4900 8.0021 0.0 0
M  V30 4 F 30.0300 6.4621 0.0 0
M  V30 5 F 30.0300 9.5421 0.0 0
M  V30 6 C 33.1100 8.0021 0.0 0
M  V30 7 F 31.5700 6.4621 0.0 0
M  V30 8 F 31.5700 9.5421 0.0 0
M  V30 9 C 26.9500 8.0021 0.0 0
M  V30 10 F 28.4900 6.4621 0.0 0
M  V30 11 F 28.4900 9.5421 0.0 0
M  V30 12 C 34.6500 8.0021 0.0 0
M  V30 13 F 33.1100 6.4621 0.0 0
M  V30 14 F 33.1100 9.5421 0.0 0
M  V30 15 C 25.4100 8.0021 0.0 0
M  V30 16 F 26.9500 6.4621 0.0 0
M  V30 17 F 26.9500 9.5421 0.0 0
M  V30 18 C 36.1900 8.0021 0.0 0
M  V30 19 F 34.6500 6.4621 0.0 0
M  V30 20 F 34.6500 9.5421 0.0 0
M  V30 21 C 23.8700 8.0021 0.0 0
M  V30 22 F 25.4100 6.4621 0.0 0
M  V30 23 F 25.4100 9.5421 0.0 0
M  V30 24 F 37.7300 8.0021 0.0 0
M  V30 25 F 36.1900 6.4621 0.0 0
M  V30 26 F 36.1900 9.5421 0.0 0
M  V30 27 C 23.1000 6.6684 0.0 0
M  V30 28 O 21.5600 6.6684 0.0 0
M  V30 29 C 20.7900 5.3347 0.0 0
M  V30 30 C 19.2500 5.3347 0.0 0
M  V30 31 O 21.5600 4.0011 0.0 0
M  V30 32 C 18.4800 6.6684 0.0 0
M  V30 33 S 18.4800 4.0011 0.0 0
M  V30 34 C 16.9400 6.6684 0.0 0
M  V30 35 C 19.2500 2.6674 0.0 0
M  V30 36 O 16.1700 8.0021 0.0 0
M  V30 37 O 16.1700 5.3347 0.0 0
M  V30 38 C 18.4800 1.3336 0.0 0
M  V30 39 C 14.6300 8.0021 0.0 0
M  V30 40 C 17.7100 0.0000 0.0 0
M  V30 41 C 13.8600 9.3358 0.0 0
M  V30 42 C 12.3200 9.3358 0.0 0
M  V30 43 C 10.7800 9.3358 0.0 0
M  V30 44 F 12.3200 10.8758 0.0 0
M  V30 45 F 12.3200 7.7958 0.0 0
M  V30 46 C 9.2400 9.3358 0.0 0
M  V30 47 F 10.7800 10.8758 0.0 0
M  V30 48 F 10.7800 7.7958 0.0 0
M  V30 49 C 7.7000 9.3358 0.0 0
M  V30 50 F 9.2400 10.8758 0.0 0
M  V30 51 F 9.2400 7.7958 0.0 0
M  V30 52 C 6.1600 9.3358 0.0 0
M  V30 53 F 7.7000 10.8758 0.0 0
M  V30 54 F 7.7000 7.7958 0.0 0
M  V30 55 C 4.6200 9.3358 0.0 0
M  V30 56 F 6.1600 10.8758 0.0 0
M  V30 57 F 6.1600 7.7958 0.0 0
M  V30 58 C 3.0800 9.3358 0.0 0
M  V30 59 F 4.6200 10.8758 0.0 0
M  V30 60 F 4.6200 7.7958 0.0 0
M  V30 61 C 1.5400 9.3358 0.0 0
M  V30 62 F 3.0800 10.8758 0.0 0
M  V30 63 F 3.0800 7.7958 0.0 0
M  V30 64 F 0.0000 9.3358 0.0 0
M  V30 65 F 1.5400 10.8758 0.0 0
M  V30 66 F 1.5400 7.7958 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 1 12 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 15 23
M  V30 23 1 18 24
M  V30 24 1 18 25
M  V30 25 1 18 26
M  V30 26 1 21 27
M  V30 27 1 27 28
M  V30 28 1 28 29
M  V30 29 1 29 30
M  V30 30 2 29 31
M  V30 31 1 30 32
M  V30 32 1 30 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 36 2 34 37
M  V30 37 1 35 38
M  V30 38 1 36 39
M  V30 39 3 38 40
M  V30 40 1 39 41
M  V30 41 1 41 42
M  V30 42 1 42 43
M  V30 43 1 42 44
M  V30 44 1 42 45
M  V30 45 1 43 46
M  V30 46 1 43 47
M  V30 47 1 43 48
M  V30 48 1 46 49
M  V30 49 1 46 50
M  V30 50 1 46 51
M  V30 51 1 49 52
M  V30 52 1 49 53
M  V30 53 1 49 54
M  V30 54 1 52 55
M  V30 55 1 52 56
M  V30 56 1 52 57
M  V30 57 1 55 58
M  V30 58 1 55 59
M  V30 59 1 55 60
M  V30 60 1 58 61
M  V30 61 1 58 62
M  V30 62 1 58 63
M  V30 63 1 61 64
M  V30 64 1 61 65
M  V30 65 1 61 66
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 27846-30-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 49676-48-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1838200-26-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-11084552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Novel Silanes Functionalized with Mono- and
Bis-Fluoroalkylated [1,2,3]-Triazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cai, Lu; Yuan, Yanhua; Li, Zhanxiong; Wang, Wanjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2015), 190(11),
1755-1763

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-β-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-α-methylenebenzenep...
C17H25ClO3Si
281195-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 O 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 Si 3.0800 6.6685 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 1.5400 6.6685 0.0 0
M  V30 8 C 3.0800 5.1285 0.0 0
M  V30 9 C 3.0800 8.2085 0.0 0
M  V30 10 O 4.6200 1.3338 0.0 0
M  V30 11 O 6.9300 2.6674 0.0 0
M  V30 12 C 1.5400 8.2085 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 1.5400 5.1285 0.0 0
M  V30 15 C 5.3900 0.0000 0.0 0
M  V30 16 Cl 11.5500 5.3347 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 7.7000 6.6685 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 5 10
M  V30 11 2 5 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 7 14
M  V30 15 1 10 15
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (αR,βR)-4-chloro-β-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-α-[(eth...
C19H31ClO3SSi
491580-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0 CFG=1
M  V30 2 C 6.6685 6.9302 0.0 0 CFG=1
M  V30 3 O 4.0012 6.9302 0.0 0
M  V30 4 C 8.0022 6.1601 0.0 0
M  V30 5 C 6.6685 8.4702 0.0 0
M  V30 6 Si 2.6673 6.1601 0.0 0
M  V30 7 S 9.3360 6.9302 0.0 0
M  V30 8 O 8.0022 9.2402 0.0 0
M  V30 9 O 5.3348 9.2402 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 C 1.8973 7.4938 0.0 0
M  V30 12 C 3.4374 4.8265 0.0 0
M  V30 13 C 10.6697 6.1601 0.0 0
M  V30 14 C 8.0022 10.7802 0.0 0
M  V30 15 C 2.1037 4.0564 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 0.5637 6.7238 0.0 0
M  V30 18 C 12.0033 6.9302 0.0 0
M  V30 19 Cl 5.3348 0.0000 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 6.6685 3.8501 0.0 0
M  V30 22 C 4.0012 3.8501 0.0 0
M  V30 23 C 6.6685 2.3101 0.0 0
M  V30 24 C 4.0012 2.3101 0.0 0
M  V30 25 C 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 20
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 6 12
M  V30 13 1 7 13
M  V30 14 1 8 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 10 17
M  V30 18 1 13 18
M  V30 19 1 19 25
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 281195-10-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 491580-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9757872
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Michael addn., product contains 1 % of anti-isomer;
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient stereoselective synthesis of β-lactams from
β-hydroxy-α-thioalkylesters prepared from Michael/aldol tandem reaction
or stereoselective addition of thiols to the Baylis-Hillman adducts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kamimura, Akio; Morita, Rie; Matsuura, Kenji; Mitsudera, Hiromasa;
Shirai, Masashi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2003), 59(50), 9931-9938

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloro-β-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-α-methylenebenzenep...
C17H25ClO3Si
281195-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 O 4.6200 6.6685 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 Si 3.0800 6.6685 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 1.5400 6.6685 0.0 0
M  V30 8 C 3.0800 5.1285 0.0 0
M  V30 9 C 3.0800 8.2085 0.0 0
M  V30 10 O 4.6200 1.3338 0.0 0
M  V30 11 O 6.9300 2.6674 0.0 0
M  V30 12 C 1.5400 8.2085 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 C 1.5400 5.1285 0.0 0
M  V30 15 C 5.3900 0.0000 0.0 0
M  V30 16 Cl 11.5500 5.3347 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 7.7000 6.6685 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 5 10
M  V30 11 2 5 11
M  V30 12 1 7 12
M  V30 13 1 7 13
M  V30 14 1 7 14
M  V30 15 1 10 15
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (αR,βR)-4-chloro-β-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-α-[(eth...
C19H31ClO3SSi
491580-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0 CFG=1
M  V30 2 C 6.6685 6.9302 0.0 0 CFG=1
M  V30 3 O 4.0012 6.9302 0.0 0
M  V30 4 C 8.0022 6.1601 0.0 0
M  V30 5 C 6.6685 8.4702 0.0 0
M  V30 6 Si 2.6673 6.1601 0.0 0
M  V30 7 S 9.3360 6.9302 0.0 0
M  V30 8 O 8.0022 9.2402 0.0 0
M  V30 9 O 5.3348 9.2402 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 C 1.8973 7.4938 0.0 0
M  V30 12 C 3.4374 4.8265 0.0 0
M  V30 13 C 10.6697 6.1601 0.0 0
M  V30 14 C 8.0022 10.7802 0.0 0
M  V30 15 C 2.1037 4.0564 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 0.5637 6.7238 0.0 0
M  V30 18 C 12.0033 6.9302 0.0 0
M  V30 19 Cl 5.3348 0.0000 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 6.6685 3.8501 0.0 0
M  V30 22 C 4.0012 3.8501 0.0 0
M  V30 23 C 6.6685 2.3101 0.0 0
M  V30 24 C 4.0012 2.3101 0.0 0
M  V30 25 C 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 20
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 6 12
M  V30 13 1 7 13
M  V30 14 1 8 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 10 17
M  V30 18 1 13 18
M  V30 19 1 19 25
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 281195-10-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 491580-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-6263168
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Michael addn. to Baylis-Hillman adduct, syn:anti 99:1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Simple preparation of β-hydroxy-α-thiomethyl carbonyl compounds via
stereoselective conjugate addition of thiol to Baylis-Hillman adducts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kamimura, Akio; Morita, Rie; Matsuura, Kenji; Omata, Yoji; Shirai,
Masashi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(35), 6189-6191

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(Diphenylmethyl)sulfinyl]methyl]-1,4,2-dioxazol-5-one
C16H13NO4S
2864796-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.6201 0.0 0
M  V30 2 S 5.3348 5.3901 0.0 0 VAL=4
M  V30 3 C 6.6687 4.6201 0.0 0
M  V30 4 O 5.3348 6.9302 0.0 0
M  V30 5 O 11.9713 5.7473 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 1.3338 4.6201 0.0 0
M  V30 14 C 2.6675 6.9302 0.0 0
M  V30 15 C 0.0000 5.3901 0.0 0
M  V30 16 C 1.3338 7.7002 0.0 0
M  V30 17 C 0.0000 6.9302 0.0 0
M  V30 18 C 8.0023 5.3901 0.0 0
M  V30 19 N 8.1633 6.9217 0.0 0
M  V30 20 O 9.4091 4.7638 0.0 0
M  V30 21 O 9.6697 7.2419 0.0 0
M  V30 22 C 10.4397 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 18
M  V30 7 2 5 22
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Diphenylmethyl)sulfinyl]-N-[(1-methylethyl)thio]acetamide
C18H21NO2S2
2864796-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.6201 0.0 0
M  V30 2 S 5.3348 5.3901 0.0 0 VAL=4
M  V30 3 C 6.6684 4.6201 0.0 0
M  V30 4 O 5.3348 6.9301 0.0 0
M  V30 5 C 8.0021 5.3901 0.0 0
M  V30 6 N 9.3359 4.6201 0.0 0
M  V30 7 O 8.0021 6.9301 0.0 0
M  V30 8 S 10.6695 5.3901 0.0 0
M  V30 9 C 12.0032 4.6201 0.0 0
M  V30 10 C 12.0032 3.0800 0.0 0
M  V30 11 C 13.3369 5.3901 0.0 0
M  V30 12 C 2.6673 5.3901 0.0 0
M  V30 13 C 2.6673 6.9301 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 7.7001 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 C 0.0000 6.9301 0.0 0
M  V30 18 C 4.0010 3.0800 0.0 0
M  V30 19 C 5.3348 2.3100 0.0 0
M  V30 20 C 2.6673 2.3100 0.0 0
M  V30 21 C 5.3348 0.7700 0.0 0
M  V30 22 C 2.6673 0.7700 0.0 0
M  V30 23 C 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2864796-74-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2864796-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34708443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 534-16-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 578743-87-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 920-66-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-acyl sulfenamides via copper catalysis and their use as
S-sulfenylating reagents of thiols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bai, Ziqian; Zhu, Shiyang; Hu, Yiyao; Yang, Peng; Chu, Xin; He, Gang;
Wang, Hao; Chen, Gong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2022), 13(1), 6445

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
N-Phenylmaleimide
C10H7NO2
941-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9406 5.4211 0.0 0
M  V30 2 O 1.9406 0.0000 0.0 0
M  V30 3 N 2.3698 2.7106 0.0 0
M  V30 4 C 1.4645 3.9564 0.0 0
M  V30 5 C 1.4645 1.4647 0.0 0
M  V30 6 C 0.0000 3.4806 0.0 0
M  V30 7 C 0.0000 1.9406 0.0 0
M  V30 8 C 3.9098 2.7106 0.0 0
M  V30 9 C 4.6798 4.0442 0.0 0
M  V30 10 C 4.6798 1.3769 0.0 0
M  V30 11 C 6.2198 4.0442 0.0 0
M  V30 12 C 6.2198 1.3769 0.0 0
M  V30 13 C 6.9898 2.7106 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Hexadecanethiol
C16H34S
2917-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 0.7700 0.0 0
M  V30 2 C 12.0033 0.0000 0.0 0
M  V30 3 C 9.3360 0.0000 0.0 0
M  V30 4 C 13.3370 0.7700 0.0 0
M  V30 5 C 8.0022 0.7700 0.0 0
M  V30 6 C 14.6708 0.0000 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 16.0045 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 17.3382 0.0000 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 18.6720 0.7700 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 20.0057 0.0000 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 21.3393 0.7700 0.0 0
M  V30 17 S 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Hexadecylthio)-1-phenyl-2,5-pyrrolidinedione
C26H41NO2S
1335134-12-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3050 5.3913 0.0 0
M  V30 2 O 4.7384 0.0000 0.0 0
M  V30 3 S 8.3658 4.0286 0.0 0
M  V30 4 C 9.6996 3.2586 0.0 0
M  V30 5 C 11.0333 4.0286 0.0 0
M  V30 6 C 12.3669 3.2586 0.0 0
M  V30 7 C 13.7006 4.0286 0.0 0
M  V30 8 C 15.0344 3.2586 0.0 0
M  V30 9 C 16.3681 4.0286 0.0 0
M  V30 10 C 17.7018 3.2586 0.0 0
M  V30 11 C 19.0354 4.0286 0.0 0
M  V30 12 C 20.3693 3.2586 0.0 0
M  V30 13 C 21.7029 4.0286 0.0 0
M  V30 14 C 23.0366 3.2586 0.0 0
M  V30 15 C 24.3703 4.0286 0.0 0
M  V30 16 C 25.7041 3.2586 0.0 0
M  V30 17 C 27.0378 4.0286 0.0 0
M  V30 18 C 28.3714 3.2586 0.0 0
M  V30 19 C 29.7051 4.0286 0.0 0
M  V30 20 N 4.5947 2.7405 0.0 0
M  V30 21 C 5.6253 3.8850 0.0 0
M  V30 22 C 5.3647 1.4068 0.0 0
M  V30 23 C 7.0321 3.2586 0.0 0
M  V30 24 C 6.8712 1.7270 0.0 0
M  V30 25 C 3.0631 2.9016 0.0 0
M  V30 26 C 2.4368 4.3084 0.0 0
M  V30 27 C 2.1579 1.6557 0.0 0
M  V30 28 C 0.9051 4.4693 0.0 0
M  V30 29 C 0.6263 1.8166 0.0 0
M  V30 30 C 0.0000 3.2234 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 21
M  V30 2 2 2 22
M  V30 3 1 3 4
M  V30 4 1 3 23
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 25
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 941-69-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2917-26-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1335134-12-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-818418
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 140-72-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Experimental Procedure for the
Preparation of Thia-Michael Adducts. To a 100-mL round-bottom flask
containing (40 mL) of distilled water, were added CTAB or CPB (10 mmol%)
and stirred at room temperature. To this mixture 1-dodecanethiol (0.35 g,
1.56 mmol) was added in one portion, followed by N-phenylmaleimide (1)
(0.3 g, 1.56 mmol) added portionwise. Stirring was continued for an
additional 1 h at room temperature. As the reaction completed (monitored
by thin-layer chromatography, TLC) the precipitated product was collected
by vacuum filtration and dried at room temperature. Thereafter it was
crystallized from ethanol / ethyl acetate as a white crystalline solid.
3-(Hexadecylthio)-1-phenylpyrrolidine-2,5-dione (2d, C26H41NO2S). White
solid. Thiol (n): 14, Yield: 95%. m.p.: 78-79 °C (Ref., 65-67 °C); 1H NMR
(400 MHz, CDCl3): δ = 7.50-7.46 (m, 2H, Ar), 7.42-7.39 (m, 1H, Ar),
7.31-7.29 (m, 2H, Ar), 3.87 (dd, J1 = 9.2 Hz, J2 = 3.6 Hz, 1H, SCH), 3.31
(dd, J1 = 18.4 Hz, J2 = 9.2 Hz, 1H, SCHCH2), 2.99-2.92 (m, 1H, SCH2),
2.84-2.77 (m, 1H, SCH2), 2.68 (dd, J1 = 18.8 Hz, J2 = 3.6 Hz, 1H,
SCHCH2), 1.71-1.59 (m, 2H, SCH2CH2), 1.41 (quin, J = 6.8 Hz, 2H,
SCH2CH2CH2CH2), 1.32-1.26 (m, 24H, (CH2)12), 0.88 (t, J = 7.2 Hz, 3H,
CH3); 13C NMR (100 MHz, CDCl3): δ = 175.57, 173.86, 131.63, 129.22,
128.78, 126.42, 39.07, 36.18, 31.93, 31.89, 29.71, 29.68, 29.59, 29.51,
29.38, 29.17, 28.99, 28.82, 22.71, 14.15; elemental analysis calcd (%)
for C26H41NO2S: C 72.34, H 9.57, N 3.24, S 7.43; found: C 72.31, H 9.51,
N 3.21, S 7.41.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry-solvent, alternative catalyst gave lower
yield (Cetyl trimethylammonium bromide), thia-Michael reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Surfactant-Catalyzed Addition of Higher Thiols to N-Aryl Substituted
Maleimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yildirim, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2014), 44(8), 1137-1141

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(2-Cyanoethyl)thio]butanedioic acid
C7H9NO4S
297732-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8500 0.0 0
M  V30 2 S 4.0011 4.6201 0.0 0
M  V30 3 C 2.6675 2.3100 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8500 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 6.1601 0.0 0
M  V30 8 O 0.0000 3.8500 0.0 0
M  V30 9 C 6.6684 4.6201 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 O 0.0000 2.3100 0.0 0
M  V30 12 C 8.0022 3.8500 0.0 0
M  V30 13 N 9.3359 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 9 12
M  V30 12 3 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[3-(Ethylthio)-3-thioxopropyl]thio]butanedioic acid
C9H14O4S3
297732-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.8501 0.0 0
M  V30 2 S 4.0012 4.6201 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 6.1601 0.0 0
M  V30 8 O 0.0000 3.8501 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 O 0.0000 2.3101 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 S 9.3360 4.6201 0.0 0
M  V30 14 S 8.0022 2.3101 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 297732-10-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 297732-14-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29591729
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7783-06-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 9003-47-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: ω-Dithioester Carboxylic Acids 7a-d. According
to the procedure described above, the reaction was carried out in a 250
mL round-bottom flask, with ω-cyanocarboxylic acids 6a-d (0.1 mol)
dissolved in CH2Cl2 or for 7d in CH2Cl2/DMF (2/1) 150 mL, ethanethiol
(0.1 mol) 1 equiv, and 6 equiv of polyvinylpyridine (70 g). After
hydrogen sulfide was passed over the reaction for 2 h at 0 °C, the
saturated solution was allowed to react overnight. The resulting mixture
was filtered, the solvent was removed under Vacuum and poured in 10%
dilute HCl and then extracted with chloroform, dried over MgSO4, and
concentrated under reduced pressure. ω-Carboxydithioesters 7a-c were
purified by chromatography on silica gel using dichloromethane as the
eluent. 2-[2-(Ethylthiothiocarbonyl)ethylthio]butanedioic Acid (7d),
HOOCCH2CH(COOH)S(CH2)2CSSEt. Yield: = 95%, yellow powder. Mp: = 150 °C.
7d was purified by precipitation in 10% dilute hydrochloric acid and
drying under Vacuum. 1H NMR (CD3OD): 0,90 (3H, t, J = 6 Hz, CH3),
2.10-3.30 (9H, m, CH2, CH), 10.25 (2H, s, COOH). 13C NMR (D2O): 12,49
(CH3), 31.48, 32.84, 37.51 (CH2), 43.17 (CH), 52.22 (CH2CS2), 173.96,
175.06 (C=O), 237.08 (C=S). UV-vis (D2O): 307 (log ε = 4.02). IR (KBr
pellets): 1690, 1710 (C=O), 3100 (OH). Anal. Calcd for: C9H14O4S3
(282.37) C, 38.28; H, 5.01; S, 34.06. Found: C, 38.18; H, 5.09; S, 34.00.
Mass: 282 (M+· 0.3); 264 (2); 235 (2); 204 (2); 165 (7); 132 (20); 104
(32); 71 (100); 60 (34); 59 (36); 45 (95).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protein Thioacylation. 1. Reagents Design and Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Levesque, Guy; Arsene, Philippe; Fanneau-Bellenger, Valerie; Pham,
Thi-Nhan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biomacromolecules (2000), 1(3), 387-399

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenediazonium, 4-cyano-, salt with 1,3,2-benzodithiazole 1,1,3,3-tetraoxid...
C7H4N3.C6H4NO4S2
301151-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.6833 7.6990 0.0 0
M  V30 2 O 6.3042 9.2305 0.0 0
M  V30 3 O 3.6513 4.6357 0.0 0
M  V30 4 O 5.6674 4.2073 0.0 0
M  V30 5 C 4.6368 8.0192 0.0 0
M  V30 6 C 3.8668 6.6855 0.0 0
M  V30 7 S 6.1432 7.6990 0.0 0 VAL=6
M  V30 8 C 3.8668 9.3528 0.0 0
M  V30 9 S 4.8974 5.5409 0.0 0 VAL=6
M  V30 10 C 2.3267 6.6855 0.0 0
M  V30 11 N 6.3042 6.1674 0.0 0 CHG=-1
M  V30 12 C 2.3267 9.3528 0.0 0
M  V30 13 C 1.5567 8.0192 0.0 0
M  V30 14 C 1.5400 1.3336 0.0 0
M  V30 15 N 0.0000 1.3336 0.0 0
M  V30 16 N 7.7000 1.3336 0.0 0 CHG=1 VAL=4
M  V30 17 N 9.2400 1.3336 0.0 0
M  V30 18 C 3.0800 1.3336 0.0 0
M  V30 19 C 3.8500 0.0000 0.0 0
M  V30 20 C 3.8500 2.6673 0.0 0
M  V30 21 C 5.3900 0.0000 0.0 0
M  V30 22 C 5.3900 2.6673 0.0 0
M  V30 23 C 6.1600 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 7
M  V30 3 2 3 9
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 15 3 14 15
M  V30 16 1 14 18
M  V30 17 3 16 17
M  V30 18 1 16 23
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzonitrile, 4-[(1Z)-[(1,1-dimethylethyl)thio]azo]-
C11H13N3S
29577-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 4.4137 0.0 0
M  V30 2 N 2.6673 3.6437 0.0 0
M  V30 3 S 2.6673 2.1037 0.0 0
M  V30 4 C 1.3337 1.3337 0.0 0
M  V30 5 C 2.1037 0.0000 0.0 0
M  V30 6 C 0.0000 0.5637 0.0 0
M  V30 7 C 0.5637 2.6673 0.0 0
M  V30 8 C 9.3360 1.3337 0.0 0
M  V30 9 N 10.6697 0.5637 0.0 0
M  V30 10 C 5.3348 3.6437 0.0 0
M  V30 11 C 5.3348 2.1037 0.0 0
M  V30 12 C 6.6685 4.4137 0.0 0
M  V30 13 C 6.6685 1.3337 0.0 0
M  V30 14 C 8.0023 3.6437 0.0 0
M  V30 15 C 8.0023 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 3 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 301151-80-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29577-88-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25650842
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (Z)-(tert-Butylsulfanyl)(aryl)diazenes[or
(Z)-tert-Butyl Aryl Diazosulfides] 3a-r
(Z)-(tert-Butylsulfanyl)(2-fluorophenyl)diazene (3f); Representative
Procedure According to the procedure previously reported 1 for the
preparation of (Z)-(tert-butylsulfanyl)(phenyl)diazene (3a),
2-fluorobenzenediazonium o-benzenedisulfonimide (1, Ar = 2-FC6H4) (3.41
g, 10 mmol) was added in one portion with vigorous stirring, to a soln of
sodium 2-methylpropan-2-thiolate, prepared from 2-methylpropan-2-thiol
(2) (0.99 g, 11 mmol) and sodium methoxide (30% soln in MeOH; 2.00 g, 11
mmol) in anhyd MeOH (20 mL), at r.t. (20-25 °C). The salt dissolved at
once and a yellow-orange soln was obtained. No evolution of nitrogen was
observed. Stirring was maintained until a test of azocoupling with
2-naphthol was negative (10 min). The reaction mixture was poured into
Et2O-sat. aq NaCl (200 mL, 1:1). The aq soln was separated and extracted
with Et2O (100 mL). The combined organic extracts were washed with sat.
aq NaCl (2 × 100 mL), dried (Na2SO4), and evaporated under reduced
pressure. Compound 3k, Yield: 95%. mp: 70-71°C, Lit: 69-70°C.
$DTYPE RXN:VAR(1):NOTES
$DATUM safety (- reactant is a potentially explosive diazonium salt),
stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A general procedure to selectively prepare N-alkylanilines by an
unexpected reaction of (Z)-(tert-butylsulfanyl)(aryl)diazenes with
alkyllithium reagents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barbero, Margherita; Degani, Iacopo; Dughera, Stefano; Fochi, Rita
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2003), (5), 742-750

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Bis(chloromethyl)pyridine
C7H7Cl2N
3099-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 3.0801 0.0 0
M  V30 4 Cl 8.0023 2.3101 0.0 0
M  V30 5 N 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Bis[[(1,1-dimethylethyl)thio]methyl]pyridine
C15H25NS2
343304-42-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 S 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 3.0801 0.0 0
M  V30 4 C 0.5637 1.7464 0.0 0
M  V30 5 C 0.0000 3.8501 0.0 0
M  V30 6 C 2.1037 4.4137 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 S 10.6697 2.3101 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 C 11.2333 4.4137 0.0 0
M  V30 11 C 13.3370 3.8501 0.0 0
M  V30 12 C 12.7733 1.7464 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 N 6.6685 3.0801 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 8.0022 2.3101 0.0 0
M  V30 17 C 6.6685 0.0000 0.0 0
M  V30 18 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3099-28-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 343304-42-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-1720484
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Microwave-Assisted C-C and C-S Couplings Catalysed by Organometallic
Pd-SCS or Coordination Ni-SNS Pincer Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Basauri-Molina, Manuel; Hernandez-Ortega, Simon; Morales-Morales, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Inorganic Chemistry (2014), 2014(27), 4619-4625

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[(1E)-2-Chloro-1,2-diphenylethenyl]sulfonyl]-4-methylbenzene
C21H17ClO2S
31598-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3347 0.0 0
M  V30 2 S 4.6200 5.3347 0.0 0 VAL=6
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 O 4.6200 6.8747 0.0 0
M  V30 5 O 4.6200 3.7947 0.0 0
M  V30 6 Cl 0.7700 4.0011 0.0 0
M  V30 7 C 10.7800 5.3347 0.0 0
M  V30 8 C 2.3100 6.6684 0.0 0
M  V30 9 C 3.0800 8.0021 0.0 0
M  V30 10 C 0.7700 6.6684 0.0 0
M  V30 11 C 2.3100 9.3358 0.0 0
M  V30 12 C 0.0000 8.0021 0.0 0
M  V30 13 C 0.7700 9.3358 0.0 0
M  V30 14 C 6.1600 5.3347 0.0 0
M  V30 15 C 6.9300 6.6684 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 8.4700 6.6684 0.0 0
M  V30 18 C 8.4700 4.0011 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 3.0800 2.6674 0.0 0
M  V30 21 C 4.6200 2.6674 0.0 0
M  V30 22 C 2.3100 1.3336 0.0 0
M  V30 23 C 5.3900 1.3336 0.0 0
M  V30 24 C 3.0800 0.0000 0.0 0
M  V30 25 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 14
M  V30 7 1 3 6
M  V30 8 1 3 20
M  V30 9 1 7 19
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[(1E)-2-[(1,1-Dimethylethyl)thio]-1,2-diphenylethenyl]sulfonyl]-4-methylbe...
C25H26O2S2
1011802-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.4136 4.0011 0.0 0
M  V30 2 C 3.6436 5.3347 0.0 0
M  V30 3 S 5.9536 4.0011 0.0 0 VAL=6
M  V30 4 S 2.1036 5.3347 0.0 0
M  V30 5 O 5.9536 5.5411 0.0 0
M  V30 6 O 5.9536 2.4611 0.0 0
M  V30 7 C 1.3336 6.6684 0.0 0
M  V30 8 C 2.6673 7.4384 0.0 0
M  V30 9 C 0.5636 8.0021 0.0 0
M  V30 10 C 0.0000 5.8984 0.0 0
M  V30 11 C 12.1136 4.0011 0.0 0
M  V30 12 C 3.6436 2.6674 0.0 0
M  V30 13 C 4.4136 1.3336 0.0 0
M  V30 14 C 2.1036 2.6674 0.0 0
M  V30 15 C 3.6436 0.0000 0.0 0
M  V30 16 C 1.3336 1.3336 0.0 0
M  V30 17 C 2.1036 0.0000 0.0 0
M  V30 18 C 4.4136 6.6684 0.0 0
M  V30 19 C 5.9536 6.6684 0.0 0
M  V30 20 C 3.6436 8.0021 0.0 0
M  V30 21 C 6.7236 8.0021 0.0 0
M  V30 22 C 4.4136 9.3358 0.0 0
M  V30 23 C 5.9536 9.3358 0.0 0
M  V30 24 C 7.4936 4.0011 0.0 0
M  V30 25 C 8.2636 2.6674 0.0 0
M  V30 26 C 8.2636 5.3347 0.0 0
M  V30 27 C 9.8036 2.6674 0.0 0
M  V30 28 C 9.8036 5.3347 0.0 0
M  V30 29 C 10.5736 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 18
M  V30 6 2 3 5
M  V30 7 2 3 6
M  V30 8 1 3 24
M  V30 9 1 4 7
M  V30 10 1 7 8
M  V30 11 1 7 9
M  V30 12 1 7 10
M  V30 13 1 11 29
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 31598-99-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1011802-97-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-7324807
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (E)-1-Alkylthio-2-p-tolylsulphonylstilbenes
(3a-i)-General Procedure A solution of sodium alkanethiolate prepared by
adding an appropriate alkanethiol (6 mmoI) to a solution of sodium (6 mg
atom) in abs. ethanol (25 ml) was added to a solution of 1 (6 m mol)
dissolved in abs. ethanol (75 mI). The reaction mixture was heated under
reflux. Refluxion time varied from 5 to 7 h in different cases. In many
cases, the solution upon cooling deposited the sulphide-suIphones, (3)
which were recrystallized from an appropriate solvent.
(E)-1-t-butylthio-2-p-tolylsulphonylstilbene (3g) It was recrystallized
from isopropanol as colorless crystals, yield 95.1% m.p. 161-62°C,
(Found: C, 71.28; H, 6.12; S, 15.04. C25H26O2S2 requires C, 71.06; H,
6.20; S, 15.14%). EIMS: m/z (rel.int.%) 422(26), 333(8), 301(4), 269(29),
268(8), 267(30), 212(18), 211(96), 210(30), 180(70), 179(28), 178(100),
165(15), 155(14), 139(11), 123(8), 121(6), 105(18), 91(40), 69(16),
57(49), 55(14), and 43(19).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Mass Spectral Studies of Some (E)- and (Z)-1-Alkylthio- and
1-Alkylsulphonyl-2-p-Tolylsulphonylstilbenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shafi, Mahammed; Hussain, Manzoor; Peeran, S. Ghouse
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2007), 182(9),
2087-2103

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-[(1,1-dimethylethyl)thio]-1-nitrobenzene
C10H12BrNO2S
1628181-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 5.3349 0.0 0 VAL=5
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 O 2.3100 6.6685 0.0 0
M  V30 4 S 4.6200 5.3349 0.0 0
M  V30 5 C 6.1600 5.3349 0.0 0
M  V30 6 C 6.1600 6.8749 0.0 0
M  V30 7 C 7.7000 5.3349 0.0 0
M  V30 8 C 6.1600 3.7949 0.0 0
M  V30 9 Br 4.6200 0.0000 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 15 C 3.8500 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628181-89-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-11668010
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationship studies of novel [6,6,5]
tricyclic oxazolidinone derivatives as potential antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xue, Tao; Ding, Shi; Guo, Bin; Chu, Wenjing; Wang, Hui; Yang, Yushe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2015), 25(10), 2203-2210

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1,1-Dimethylethyl)thio]-6-nitroquinoline
C13H14N2O2S
321732-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 2.1037 0.0 0
M  V30 2 C 2.6675 1.3337 0.0 0
M  V30 3 C 3.4375 0.0000 0.0 0
M  V30 4 C 1.3337 0.5637 0.0 0
M  V30 5 C 1.8975 2.6673 0.0 0
M  V30 6 N 6.6687 3.6437 0.0 0 VAL=5
M  V30 7 O 8.0023 4.4137 0.0 0
M  V30 8 O 6.6687 2.1037 0.0 0
M  V30 9 C 2.6675 4.4137 0.0 0
M  V30 10 C 4.0012 3.6437 0.0 0
M  V30 11 C 2.6675 5.9538 0.0 0
M  V30 12 C 1.3337 3.6437 0.0 0
M  V30 13 C 5.3348 4.4137 0.0 0
M  V30 14 C 4.0012 6.7238 0.0 0
M  V30 15 N 1.3337 6.7238 0.0 0
M  V30 16 C 0.0000 4.4137 0.0 0
M  V30 17 C 5.3348 5.9538 0.0 0
M  V30 18 C 0.0000 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Ethylthio)-6-nitroquinoline
C11H10N2O2S
321732-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 2.3100 0.0 0
M  V30 2 C 2.6674 1.5400 0.0 0
M  V30 3 C 2.6674 0.0000 0.0 0
M  V30 4 N 6.6685 3.8500 0.0 0 VAL=5
M  V30 5 O 6.6685 2.3100 0.0 0
M  V30 6 O 8.0021 4.6200 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 5.3347 4.6200 0.0 0
M  V30 10 C 2.6674 6.1600 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 5.3347 6.1600 0.0 0
M  V30 13 C 4.0011 6.9300 0.0 0
M  V30 14 N 1.3336 6.9300 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 13
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321732-62-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 321732-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30167088
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative prepn. gave lower yields
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct thioalkylation of nitroquinolines with alkanethiolate anions via
nucleophilic displacement of a ring hydrogen atom
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kawakami, Takehiko; Suzuki, Hitomi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Perkin 1 (2000), (21), 3640-3644

$RFMT $RIREG SCHEME368 STEP1
$RXN



  3  1
$MOL
Potassium thiocyanate
CHNS.K
333-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 0.0000 1.5400 0.0 0
M  V30 3 S 3.0800 1.5400 0.0 0
M  V30 4 K 1.5400 0.0000 0.0 0 VAL=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Furancarbonyl chloride
C5H3ClO2
527-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 Cl 5.1048 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 2.4374 2.3100 0.0 0
M  V30 5 C 1.0306 1.6835 0.0 0
M  V30 6 O 2.2764 3.8416 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-(2-furanylcarbonyl)carbamodithioate
C8H9NO2S2
1407995-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 N 5.1048 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6218 0.0 0
M  V30 5 S 7.7722 1.8517 0.0 0
M  V30 6 S 6.4384 4.1618 0.0 0
M  V30 7 C 9.1059 2.6218 0.0 0
M  V30 8 C 10.4396 1.8517 0.0 0
M  V30 9 C 2.4374 1.8517 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 O 2.2763 0.3202 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 333-20-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 527-69-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1407995-99-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2195389
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Three practical approaches for the synthesis of novel
4,7-dihetarylpyrazolo[1,5-a][1,3,5]triazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Insuasty, Henry; Insuasty, Braulio; Castro, Edison; Quiroga, Jairo;
Abonia, Rodrigo; Nogueras, Manuel; Cobo, Justo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(46), 9384-9390

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Diphenyl-1,3-oxathiolane
C15H14OS
33735-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 2.4781 0.0 0
M  V30 2 O 1.6732 1.8517 0.0 0
M  V30 3 S 4.1105 1.3337 0.0 0
M  V30 4 C 1.8342 0.3202 0.0 0
M  V30 5 C 3.3405 0.0000 0.0 0
M  V30 6 C 2.3101 3.8119 0.0 0
M  V30 7 C 3.0801 5.1456 0.0 0
M  V30 8 C 0.7700 3.8119 0.0 0
M  V30 9 C 2.3101 6.4792 0.0 0
M  V30 10 C 0.0000 5.1456 0.0 0
M  V30 11 C 0.7700 6.4792 0.0 0
M  V30 12 C 4.3260 3.3833 0.0 0
M  V30 13 C 5.7329 2.7570 0.0 0
M  V30 14 C 4.1650 4.9150 0.0 0
M  V30 15 C 6.9788 3.6622 0.0 0
M  V30 16 C 5.4109 5.8201 0.0 0
M  V30 17 C 6.8179 5.1938 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 1 12
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 4 5
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-[Bis(ethylthio)methylene]bis[benzene]
C17H20S2
7282-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.8501 0.0 0
M  V30 2 S 2.6673 3.0801 0.0 0
M  V30 3 S 4.0010 2.3101 0.0 0
M  V30 4 C 1.3337 3.8501 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 0.0000 3.0801 0.0 0
M  V30 7 C 2.6673 0.0000 0.0 0
M  V30 8 C 5.5410 3.8501 0.0 0
M  V30 9 C 6.3111 2.5163 0.0 0
M  V30 10 C 6.3111 5.1838 0.0 0
M  V30 11 C 7.8511 2.5163 0.0 0
M  V30 12 C 7.8511 5.1838 0.0 0
M  V30 13 C 8.6211 3.8501 0.0 0
M  V30 14 C 3.2310 5.1838 0.0 0
M  V30 15 C 1.6910 5.1838 0.0 0
M  V30 16 C 4.0010 6.5174 0.0 0
M  V30 17 C 0.9209 6.5174 0.0 0
M  V30 18 C 3.2310 7.8511 0.0 0
M  V30 19 C 1.6910 7.8511 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 1 14
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33735-40-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7282-09-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-013-CAS-11202284
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 108-77-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure: A mixture of 1 mmol
O,O-acetal or 1 mmol O,S-acetal and 2.1 mmol thiol or 1.1 mmol dithiol in
the presence of a catalytic amount of cyanuric chloride (0.03 mmol) in 5
cm3 DMF was stirred at room temperature for the specified time (Table 1).
After completion of the reaction (TLC), the product was extracted with 35
cm3 diethyl ether. The organic layer was washed with H2O, dried (Na2SO4),
and evaporated under vacuum to furnish the crude product, which was
further purified by column chromatography (petroleum ether:ethyl
acetate=9:1). Entry 17, yield 95%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2,4,6-trichloro-1,3,5-triazine-catalyzed chemoselective
transthioacetalization of aldehyde acetals and oxathioacetals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bandgar, Babasaheb P.; Joshi, Neeta S.; Bettigeri, Sampada V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Monatshefte fuer Chemie (2007), 138(1), 67-71

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzyl bromide
C7H6Br2
3433-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 Br 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-[(ethylthio)methyl]benzene
C9H11BrS
99180-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 S 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 Br 1.3336 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3433-80-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 99180-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-2439396
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic Chemical Amide Synthesis at Room Temperature: One More Step
Toward Peptide Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Erb, William; Berhault, Yohann; Rouden, Jacques;
Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(9), 4532-4544

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzyl bromide
C7H6Br2
3433-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 Br 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-[[(1-methylethyl)thio]methyl]benzene
C10H13BrS
1251123-28-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 S 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 C 8.0021 2.3100 0.0 0
M  V30 5 C 6.6685 4.6200 0.0 0
M  V30 6 Br 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 0.7700 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3433-80-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1251123-28-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-11850972
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic Chemical Amide Synthesis at Room Temperature: One More Step
Toward Peptide Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohy El Dine, Tharwat; Erb, William; Berhault, Yohann; Rouden, Jacques;
Blanchet, Jerome
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(9), 4532-4544

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-fluorobenzene
C6H4ClF
352-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 F 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethyl)thio]-4-fluorobenzene
C10H13FS
52323-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.1037 2.6673 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 0.0000 2.1037 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 2.6673 0.5637 0.0 0
M  V30 6 F 8.2638 2.6673 0.0 0
M  V30 7 C 3.6437 2.6673 0.0 0
M  V30 8 C 4.4137 1.3337 0.0 0
M  V30 9 C 4.4137 4.0010 0.0 0
M  V30 10 C 5.9538 1.3337 0.0 0
M  V30 11 C 5.9538 4.0010 0.0 0
M  V30 12 C 6.7238 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 352-33-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52323-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-56742
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1023743-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for catalytic C-S coupling
reactions. 1 (121 μL of 0.04 M stock solution in toluene, 0.0049 mmol)
was combined with aryl halide (0.18 mmol) and NaOtBu (31 mg, 0.36 mmol)
in a screw cap vial with a stir bar and dissolved in toluene (1.0 mL).
The thiol reagent (0.16 mmol) was added to the sample along with the
internal standard. For reactions with Fsubstituted aryl halides,
benzotrifluoride (CF3C6H5) was used as the internal standard. For
reactions with CF3-substituted aryl halides, fluorobenzene was used as
the internal standard. Mesitylene was used as the internal standard for
reactions containing no fluorine substituents. The reaction vial was
sealed and heated in a 110°C oil bath. Reactions were monitored by 19F
NMR or 1H NMR spectroscopy. Preparative scale reactions were performed by
combining 1 (15 mg, 0.032 mmol), aryl halide (1.1 mmol), and NaOt Bu (192
mg, 2 mmol) in a screw cap vial with a teflon stir bar and dissolved in
toluene. The thiol reagent (1.0 mmol) was then added. For product
isolation, the sample was passed through a pad of Celite/silica gel and
the volatiles were removed by vacuum. Products were identified by 1H NMR
spectroscopy and the spectra for the known compounds were compared to
those reported in the literature. 6 (CMe3)S(p-C6H4F) (s). 1H NMR (C6D6):
δ 7.28 (t, J = 6.0 Hz, 2H), 6.65 (t, J = 10 Hz, 2H), 1.12 (s, 9 H); 19F
NMR (C6D6): δ -113.6 (m). 13C{1H} NMR (C6D6): δ 163.7 (d, J FC = 249 Hz),
139.7 (d, J FC = 8 Hz), 128.8 (d, J FC = 3.4 Hz), 115.7 (d, J FC = 22
Hz), 45.5 (s), 30.9 (s).
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown, scalable, screw-cap vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Well-Defined (POCOP)Rh Catalyst for the Coupling of Aryl Halides with
Thiols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Timpa, Samuel D.; Pell, Christopher J.; Ozerov, Oleg V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2014), 136(42), 14772-14779

$RFMT $RIREG SCHEME373 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-chlorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C25H30ClNO4S2
951636-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 8.6738 13.5684 0.0 0
M  V30 16 C 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-05-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16065052
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME374 STEP1
$RXN



  3  1
$MOL
2,3-Nonadienoic acid
C9H14O2
80472-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-4-[(1-methylethyl)thio]-1-[(4-methylphen...
C26H34ClNO4S2
951303-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.2801 6.1600 0.0 0 VAL=6
M  V30 2 O 7.8201 6.1600 0.0 0
M  V30 3 O 4.7401 6.1600 0.0 0
M  V30 4 C 3.5696 8.1294 0.0 0
M  V30 5 C 3.2494 6.6229 0.0 0
M  V30 6 C 1.7847 6.1471 0.0 0
M  V30 7 C 1.4645 4.6408 0.0 0
M  V30 8 C 0.0000 4.1648 0.0 0
M  V30 9 C 7.9554 11.3158 0.0 0
M  V30 10 O 9.4869 11.1547 0.0 0
M  V30 11 O 7.3289 12.7226 0.0 0
M  V30 12 S 4.6049 11.3158 0.0 0
M  V30 13 C 3.0734 11.1547 0.0 0
M  V30 14 C 2.4469 9.7479 0.0 0
M  V30 15 C 2.1682 12.4006 0.0 0
M  V30 16 Cl 13.3845 6.7016 0.0 0
M  V30 17 C 6.2801 0.0000 0.0 0
M  V30 18 N 6.2801 7.7000 0.0 0
M  V30 19 C 7.5260 8.6052 0.0 0 CFG=1
M  V30 20 C 5.0343 8.6052 0.0 0 CFG=2
M  V30 21 C 7.0501 10.0698 0.0 0 CFG=2
M  V30 22 C 5.5101 10.0698 0.0 0 CFG=1
M  V30 23 C 8.9907 8.1294 0.0 0
M  V30 24 C 10.1351 9.1598 0.0 0
M  V30 25 C 9.3109 6.6229 0.0 0
M  V30 26 C 11.5998 8.6839 0.0 0
M  V30 27 C 10.7754 6.1471 0.0 0
M  V30 28 C 11.9199 7.1775 0.0 0
M  V30 29 C 6.2801 4.6200 0.0 0
M  V30 30 C 4.9465 3.8500 0.0 0
M  V30 31 C 7.6138 3.8500 0.0 0
M  V30 32 C 4.9465 2.3100 0.0 0
M  V30 33 C 7.6138 2.3100 0.0 0
M  V30 34 C 6.2801 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 21 9 CFG=1
M  V30 13 1 12 13
M  V30 14 1 22 12 CFG=1
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 16 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 80472-30-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951303-60-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME375 STEP1
$RXN



  3  1
$MOL
2,3-Nonadienoic acid
C9H14O2
80472-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 C 4.0012 1.5400 0.0 0
M  V30 4 C 8.0022 0.7700 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 10.6697 0.7700 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 3 5 CFG=2
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-1-[(4-methylphenyl)sulfonyl]-5-pentyl-4-...
C26H32ClNO4S2
951636-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.9287 0.0 0 VAL=6
M  V30 2 O 9.2154 9.4687 0.0 0
M  V30 3 O 9.2154 6.3887 0.0 0
M  V30 4 C 7.2460 5.2181 0.0 0
M  V30 5 C 6.2156 4.0738 0.0 0
M  V30 6 C 6.6915 2.6091 0.0 0
M  V30 7 C 5.6610 1.4647 0.0 0
M  V30 8 C 6.1369 0.0000 0.0 0
M  V30 9 C 4.0596 9.6039 0.0 0
M  V30 10 O 2.6528 8.9776 0.0 0
M  V30 11 O 4.2207 11.1354 0.0 0
M  V30 12 S 4.0596 6.2535 0.0 0
M  V30 13 C 2.6528 6.8799 0.0 0
M  V30 14 C 1.4069 5.9747 0.0 0
M  V30 15 C 0.0000 6.6011 0.0 0
M  V30 16 Cl 8.6737 15.0332 0.0 0
M  V30 17 C 15.3754 7.9287 0.0 0
M  V30 18 N 7.6754 7.9287 0.0 0
M  V30 19 C 6.7701 9.1745 0.0 0 CFG=1
M  V30 20 C 6.7701 6.6828 0.0 0 CFG=2
M  V30 21 C 5.3055 8.6987 0.0 0 CFG=2
M  V30 22 C 5.3055 7.1587 0.0 0 CFG=1
M  V30 23 C 7.2460 10.6392 0.0 0
M  V30 24 C 6.2156 11.7836 0.0 0
M  V30 25 C 8.7524 10.9594 0.0 0
M  V30 26 C 6.6915 13.2483 0.0 0
M  V30 27 C 9.2283 12.4241 0.0 0
M  V30 28 C 8.1977 13.5685 0.0 0
M  V30 29 C 10.7554 7.9287 0.0 0
M  V30 30 C 11.5254 9.2623 0.0 0
M  V30 31 C 11.5254 6.5950 0.0 0
M  V30 32 C 13.0654 9.2623 0.0 0
M  V30 33 C 13.0654 6.5950 0.0 0
M  V30 34 C 13.8354 7.9287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 21 9 CFG=1
M  V30 13 1 12 13
M  V30 14 1 22 12 CFG=1
M  V30 15 1 13 14
M  V30 16 2 14 15
M  V30 17 1 16 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 80472-30-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082729
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME376 STEP1
$RXN



  3  1
$MOL
5-Cyclopentyl-2,3-pentadienoic acid
C10H14O2
942283-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4384 2.6218 0.0 0
M  V30 4 C 7.7722 3.3918 0.0 0
M  V30 5 C 9.1059 2.6218 0.0 0
M  V30 6 O 10.4396 3.3918 0.0 0
M  V30 7 O 9.1059 1.0817 0.0 0
M  V30 8 C 2.4374 1.8517 0.0 0
M  V30 9 C 2.2763 0.3202 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3 CFG=2
M  V30 4 2 3 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
357417-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Chlorophenyl)-5-(cyclopentylmethyl)-1-[(4-methylphenyl...
C27H32ClNO4S2
951636-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 7.1043 0.0 0 VAL=6
M  V30 2 O 9.2154 5.5643 0.0 0
M  V30 3 O 9.2154 8.6443 0.0 0
M  V30 4 C 4.0596 5.4293 0.0 0
M  V30 5 O 4.2207 3.8976 0.0 0
M  V30 6 O 2.6528 6.0556 0.0 0
M  V30 7 C 7.2460 9.8149 0.0 0
M  V30 8 S 4.0596 8.7795 0.0 0
M  V30 9 C 2.6528 8.1532 0.0 0
M  V30 10 C 1.4069 9.0584 0.0 0
M  V30 11 C 0.0000 8.4320 0.0 0
M  V30 12 Cl 8.6737 0.0000 0.0 0
M  V30 13 C 15.3754 7.1043 0.0 0
M  V30 14 C 6.7701 5.8585 0.0 0 CFG=1
M  V30 15 N 7.6754 7.1043 0.0 0
M  V30 16 C 5.3055 6.3343 0.0 0 CFG=2
M  V30 17 C 6.7701 8.3503 0.0 0 CFG=2
M  V30 18 C 5.3055 7.8743 0.0 0 CFG=2
M  V30 19 C 7.2460 4.3939 0.0 0
M  V30 20 C 6.2156 3.2494 0.0 0
M  V30 21 C 8.7524 4.0738 0.0 0
M  V30 22 C 6.6915 1.7849 0.0 0
M  V30 23 C 9.2283 2.6091 0.0 0
M  V30 24 C 8.1977 1.4647 0.0 0
M  V30 25 C 10.7554 7.1043 0.0 0
M  V30 26 C 11.5254 5.7707 0.0 0
M  V30 27 C 11.5254 8.4381 0.0 0
M  V30 28 C 13.0654 5.7707 0.0 0
M  V30 29 C 13.0654 8.4381 0.0 0
M  V30 30 C 13.8354 7.1043 0.0 0
M  V30 31 C 6.2156 10.9594 0.0 0
M  V30 32 C 4.6841 10.7983 0.0 0
M  V30 33 C 6.5358 12.4657 0.0 0
M  V30 34 C 4.0576 12.2053 0.0 0
M  V30 35 C 5.2021 13.2357 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 25
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 16 4 CFG=3
M  V30 8 1 17 7 CFG=1
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 1 18 8 CFG=3
M  V30 12 1 9 10
M  V30 13 2 10 11
M  V30 14 1 12 24
M  V30 15 1 13 30
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 19 CFG=1
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 14 16 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 942283-78-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 357417-22-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-91-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME377 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 C 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3,4-dichlorophenyl)-1-[(4-methylphenyl)sulfonyl]...
C26H33Cl2NO4S2
951337-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 4.9240 0.0 0
M  V30 3 O 9.2154 8.0040 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 1.5679 2.9784 0.0 0
M  V30 15 C 0.0000 5.1364 0.0 0
M  V30 16 Cl 5.6611 12.9281 0.0 0
M  V30 17 Cl 8.6738 13.5684 0.0 0
M  V30 18 C 15.3754 6.4640 0.0 0
M  V30 19 N 7.6754 6.4640 0.0 0
M  V30 20 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 21 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 22 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 23 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 24 C 7.2460 9.1746 0.0 0
M  V30 25 C 6.2156 10.3190 0.0 0
M  V30 26 C 8.7525 9.4948 0.0 0
M  V30 27 C 6.6915 11.7837 0.0 0
M  V30 28 C 9.2283 10.9593 0.0 0
M  V30 29 C 8.1978 12.1038 0.0 0
M  V30 30 C 10.7554 6.4640 0.0 0
M  V30 31 C 11.5254 7.7977 0.0 0
M  V30 32 C 11.5254 5.1304 0.0 0
M  V30 33 C 13.0654 7.7977 0.0 0
M  V30 34 C 13.0654 5.1304 0.0 0
M  V30 35 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 22 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 23 11 CFG=1
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 16 27
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=3
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-63-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951337-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16070493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME378 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butanethiol
C4H10S
513-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 S 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-ethoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-4-[...
C28H39NO5S2
951335-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.9273 5.3348 0.0 0 VAL=6
M  V30 2 O 9.2611 6.1048 0.0 0
M  V30 3 O 6.5936 4.5648 0.0 0
M  V30 4 C 4.5953 5.6852 0.0 0
M  V30 5 C 5.0712 4.2204 0.0 0
M  V30 6 C 4.0407 3.0761 0.0 0
M  V30 7 C 4.5166 1.6113 0.0 0
M  V30 8 C 6.8003 10.6376 0.0 0
M  V30 9 O 8.2071 11.2639 0.0 0
M  V30 10 O 5.5543 11.5428 0.0 0
M  V30 11 S 3.8987 8.9624 0.0 0
M  V30 12 C 2.6527 8.0571 0.0 0 CFG=3
M  V30 13 C 1.2459 8.6835 0.0 0
M  V30 14 C 2.8138 6.5256 0.0 0
M  V30 15 C 0.0000 7.7784 0.0 0
M  V30 16 O 13.8093 9.3563 0.0 0
M  V30 17 C 14.2852 10.8209 0.0 0
M  V30 18 C 15.7915 11.1410 0.0 0
M  V30 19 C 11.0074 0.0000 0.0 0
M  V30 20 N 7.1573 6.6686 0.0 0
M  V30 21 C 7.7838 8.0755 0.0 0 CFG=1
M  V30 22 C 5.6257 6.8296 0.0 0 CFG=2
M  V30 23 C 6.6392 9.1059 0.0 0 CFG=2
M  V30 24 C 5.3056 8.3359 0.0 0 CFG=1
M  V30 25 C 9.2901 8.3956 0.0 0
M  V30 26 C 10.3205 7.2512 0.0 0
M  V30 27 C 9.7659 9.8603 0.0 0
M  V30 28 C 11.8270 7.5714 0.0 0
M  V30 29 C 11.2724 10.1805 0.0 0
M  V30 30 C 12.3028 9.0361 0.0 0
M  V30 31 C 8.6973 4.0011 0.0 0
M  V30 32 C 7.9273 2.6675 0.0 0
M  V30 33 C 10.2373 4.0011 0.0 0
M  V30 34 C 8.6973 1.3338 0.0 0
M  V30 35 C 11.0074 2.6675 0.0 0
M  V30 36 C 10.2373 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 1 22 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 23 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 24 11 CFG=1
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 30
M  V30 19 1 17 18
M  V30 20 1 19 36
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 21 25 CFG=3
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 513-53-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951335-66-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16057384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME379 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(phenylmethylene)benzenesulfonamide
C14H13NO2S
51608-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 N 5.3900 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 13.0900 2.6673 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 10.7800 1.3336 0.0 0
M  V30 11 C 10.7800 4.0011 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 C 3.0800 1.3336 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 16 C 0.7700 2.6673 0.0 0
M  V30 17 C 0.7700 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-methylphenyl)sulfonyl]-2-phenyl-4-(2-propen-1...
C25H31NO4S2
951635-97-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7534 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6610 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5129 0.0 0
M  V30 10 O 4.2207 9.6707 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4069 4.5100 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 C 15.3754 6.4640 0.0 0
M  V30 16 N 7.6754 6.4640 0.0 0
M  V30 17 C 6.7701 7.7099 0.0 0 CFG=1
M  V30 18 C 6.7701 5.2181 0.0 0 CFG=2
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 21 C 7.2460 9.1746 0.0 0
M  V30 22 C 6.2156 10.3189 0.0 0
M  V30 23 C 8.7524 9.4947 0.0 0
M  V30 24 C 6.6915 11.7836 0.0 0
M  V30 25 C 9.2283 10.9594 0.0 0
M  V30 26 C 8.1977 12.1038 0.0 0
M  V30 27 C 10.7554 6.4640 0.0 0
M  V30 28 C 11.5254 5.1304 0.0 0
M  V30 29 C 11.5254 7.7976 0.0 0
M  V30 30 C 13.0654 5.1304 0.0 0
M  V30 31 C 13.0654 7.7976 0.0 0
M  V30 32 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 19 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 20 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51608-60-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-97-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME380 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-1-butanethiol
C5H12S
541-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 S 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-4-[(3-methylbutyl)thio]-2-(4-methylphenyl)-1-[(2-me...
C28H39NO4S2
951341-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 7.1044 0.0 0 VAL=6
M  V30 2 O 4.6200 5.5644 0.0 0
M  V30 3 O 4.6200 8.6444 0.0 0
M  V30 4 C 9.7758 5.4291 0.0 0
M  V30 5 O 11.1826 6.0556 0.0 0
M  V30 6 O 9.6147 3.8976 0.0 0
M  V30 7 C 6.5894 9.8149 0.0 0
M  V30 8 C 7.6198 10.9593 0.0 0
M  V30 9 C 7.1439 12.4240 0.0 0
M  V30 10 C 8.1744 13.5684 0.0 0
M  V30 11 S 9.7758 8.7796 0.0 0
M  V30 12 C 11.1826 8.1533 0.0 0
M  V30 13 C 12.4285 9.0583 0.0 0
M  V30 14 C 13.8354 8.4320 0.0 0
M  V30 15 C 15.0813 9.3372 0.0 0
M  V30 16 C 13.9964 6.9005 0.0 0
M  V30 17 C 3.0800 9.7718 0.0 0
M  V30 18 C 5.1616 0.0000 0.0 0
M  V30 19 C 7.0652 5.8585 0.0 0 CFG=1
M  V30 20 N 6.1600 7.1044 0.0 0
M  V30 21 C 8.5299 6.3344 0.0 0 CFG=2
M  V30 22 C 7.0652 8.3502 0.0 0 CFG=2
M  V30 23 C 8.5298 7.8744 0.0 0 CFG=2
M  V30 24 C 6.5894 4.3938 0.0 0
M  V30 25 C 5.0829 4.0736 0.0 0
M  V30 26 C 7.6198 3.2494 0.0 0
M  V30 27 C 4.6071 2.6091 0.0 0
M  V30 28 C 7.1439 1.7847 0.0 0
M  V30 29 C 5.6375 1.4645 0.0 0
M  V30 30 C 3.0800 7.1044 0.0 0
M  V30 31 C 2.3100 8.4380 0.0 0
M  V30 32 C 2.3100 5.7707 0.0 0
M  V30 33 C 0.7700 8.4380 0.0 0
M  V30 34 C 0.7700 5.7707 0.0 0
M  V30 35 C 0.0000 7.1044 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 23 11 CFG=1
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 17 31
M  V30 19 1 18 29
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-79-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 541-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951341-07-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME381 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Methoxyphenyl)methylene]benzenesulfonamide
C14H13NO3S
664985-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 O 13.0900 2.8736 0.0 0
M  V30 7 C 13.8600 4.2073 0.0 0
M  V30 8 C 3.0800 1.5400 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 2.3100 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.7700 2.8736 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 9.2400 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 10.7800 1.5400 0.0 0
M  V30 19 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-methoxyphenyl)-1-(phenylsulfonyl)-4-(2-propen-...
C25H31NO5S2
951636-19-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 9.2154 0.0 0 VAL=6
M  V30 2 O 4.9240 9.2154 0.0 0
M  V30 3 O 8.0040 9.2154 0.0 0
M  V30 4 C 3.7534 7.2460 0.0 0
M  V30 5 C 2.6091 6.2156 0.0 0
M  V30 6 C 1.1444 6.6915 0.0 0
M  V30 7 C 0.0000 5.6610 0.0 0
M  V30 8 C 8.1392 4.0596 0.0 0
M  V30 9 O 9.6707 4.2207 0.0 0
M  V30 10 O 7.5129 2.6528 0.0 0
M  V30 11 S 4.7888 4.0596 0.0 0
M  V30 12 C 5.4153 2.6528 0.0 0
M  V30 13 C 4.5100 1.4069 0.0 0
M  V30 14 C 5.1364 0.0000 0.0 0
M  V30 15 O 13.5685 8.6737 0.0 0
M  V30 16 C 14.7129 7.6432 0.0 0
M  V30 17 N 6.4640 7.6754 0.0 0
M  V30 18 C 7.7099 6.7701 0.0 0 CFG=1
M  V30 19 C 5.2181 6.7701 0.0 0 CFG=2
M  V30 20 C 7.2340 5.3055 0.0 0 CFG=2
M  V30 21 C 5.6940 5.3055 0.0 0 CFG=1
M  V30 22 C 9.1746 7.2460 0.0 0
M  V30 23 C 10.3189 6.2156 0.0 0
M  V30 24 C 9.4947 8.7524 0.0 0
M  V30 25 C 11.7836 6.6915 0.0 0
M  V30 26 C 10.9594 9.2283 0.0 0
M  V30 27 C 12.1038 8.1977 0.0 0
M  V30 28 C 6.4640 10.7554 0.0 0
M  V30 29 C 7.7976 11.5254 0.0 0
M  V30 30 C 5.1304 11.5254 0.0 0
M  V30 31 C 7.7976 13.0654 0.0 0
M  V30 32 C 5.1304 13.0654 0.0 0
M  V30 33 C 6.4640 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 1 15 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664985-99-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-19-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME382 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]benzenesulfonamide
C13H10ClNO2S
664986-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 N 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 Cl 13.0900 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 2.3100 2.8736 0.0 0
M  V30 9 C 2.3100 0.2062 0.0 0
M  V30 10 C 0.7700 2.8736 0.0 0
M  V30 11 C 0.7700 0.2062 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 14 C 9.2400 1.5400 0.0 0
M  V30 15 C 9.2400 4.2073 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 11.5500 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-chlorophenyl)-1-(phenylsulfonyl)-4-(2-propen-1...
C24H28ClNO4S2
951636-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 5.1616 13.5684 0.0 0
M  V30 16 N 6.1600 6.4640 0.0 0
M  V30 17 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 18 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 19 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 20 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 21 C 6.5894 9.1746 0.0 0
M  V30 22 C 7.6198 10.3190 0.0 0
M  V30 23 C 5.0829 9.4948 0.0 0
M  V30 24 C 7.1439 11.7837 0.0 0
M  V30 25 C 4.6071 10.9593 0.0 0
M  V30 26 C 5.6377 12.1038 0.0 0
M  V30 27 C 3.0800 6.4640 0.0 0
M  V30 28 C 2.3100 5.1304 0.0 0
M  V30 29 C 2.3100 7.7977 0.0 0
M  V30 30 C 0.7700 5.1304 0.0 0
M  V30 31 C 0.7700 7.7977 0.0 0
M  V30 32 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 19 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 20 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 664986-03-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME383 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
738626-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-4-(ethylthio)-2-(3-methylphenyl)-1-[(4-methylphenyl...
C25H33NO4S2
951300-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.8084 6.4640 0.0 0 VAL=6
M  V30 2 O 7.8084 8.0040 0.0 0
M  V30 3 O 7.8084 4.9240 0.0 0
M  V30 4 C 5.8391 3.7535 0.0 0
M  V30 5 C 4.8087 2.6091 0.0 0
M  V30 6 C 5.2845 1.1444 0.0 0
M  V30 7 C 4.2541 0.0000 0.0 0
M  V30 8 C 2.6528 8.1392 0.0 0
M  V30 9 O 2.8137 9.6708 0.0 0
M  V30 10 O 1.2459 7.5128 0.0 0
M  V30 11 S 2.6528 4.7888 0.0 0
M  V30 12 C 1.2459 5.4153 0.0 0
M  V30 13 C 0.0000 4.5101 0.0 0
M  V30 14 C 4.2541 12.9280 0.0 0
M  V30 15 C 13.9685 6.4640 0.0 0
M  V30 16 N 6.2684 6.4640 0.0 0
M  V30 17 C 5.3632 7.7099 0.0 0 CFG=1
M  V30 18 C 5.3632 5.2181 0.0 0 CFG=2
M  V30 19 C 3.8987 7.2340 0.0 0 CFG=2
M  V30 20 C 3.8987 5.6940 0.0 0 CFG=1
M  V30 21 C 5.8391 9.1746 0.0 0
M  V30 22 C 4.8087 10.3190 0.0 0
M  V30 23 C 7.3455 9.4947 0.0 0
M  V30 24 C 5.2845 11.7836 0.0 0
M  V30 25 C 7.8214 10.9593 0.0 0
M  V30 26 C 6.7910 12.1038 0.0 0
M  V30 27 C 9.3484 6.4640 0.0 0
M  V30 28 C 10.1184 5.1304 0.0 0
M  V30 29 C 10.1184 7.7977 0.0 0
M  V30 30 C 11.6584 5.1304 0.0 0
M  V30 31 C 11.6584 7.7977 0.0 0
M  V30 32 C 12.4284 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 27
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 19 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 20 11 CFG=1
M  V30 14 1 12 13
M  V30 15 1 14 24
M  V30 16 1 15 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951300-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090521
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME384 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
738626-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-methylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C26H33NO4S2
951636-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 C 5.6611 12.9281 0.0 0
M  V30 16 C 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-18-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME385 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(1-naphthalenylmethylene)benzenesulfonamide
C18H15NO2S
738626-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 S 8.0022 3.0801 0.0 0 VAL=6
M  V30 4 O 8.7722 1.7464 0.0 0
M  V30 5 O 7.2322 4.4137 0.0 0
M  V30 6 C 13.3370 6.1601 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 C 4.0010 0.7700 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 18 C 9.3360 5.3901 0.0 0
M  V30 19 C 10.6697 3.0801 0.0 0
M  V30 20 C 10.6697 6.1601 0.0 0
M  V30 21 C 12.0033 3.8501 0.0 0
M  V30 22 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 2 12 15
M  V30 17 2 13 16
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-methylphenyl)sulfonyl]-2-(1-naphthalenyl)-4-(...
C29H33NO4S2
951636-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2899 5.5837 0.0 0 VAL=6
M  V30 2 O 9.6101 7.0902 0.0 0
M  V30 3 O 8.9697 4.0775 0.0 0
M  V30 4 C 4.5952 8.2943 0.0 0
M  V30 5 O 3.0888 7.9741 0.0 0
M  V30 6 O 5.0711 9.7590 0.0 0
M  V30 7 C 6.8002 3.3420 0.0 0
M  V30 8 C 5.5542 2.4367 0.0 0
M  V30 9 C 5.7152 0.9052 0.0 0
M  V30 10 C 4.4694 0.0000 0.0 0
M  V30 11 S 3.8987 5.0172 0.0 0
M  V30 12 C 2.6526 5.9224 0.0 0
M  V30 13 C 1.2459 5.2959 0.0 0
M  V30 14 C 0.0000 6.2011 0.0 0
M  V30 15 C 15.3153 4.3031 0.0 0
M  V30 16 C 7.1572 7.3108 0.0 0 CFG=1
M  V30 17 N 7.7836 5.9039 0.0 0
M  V30 18 C 5.6256 7.1499 0.0 0 CFG=2
M  V30 19 C 6.6391 4.8735 0.0 0 CFG=2
M  V30 20 C 5.3055 5.6435 0.0 0 CFG=2
M  V30 21 C 7.9272 8.6445 0.0 0
M  V30 22 C 7.1572 9.9781 0.0 0
M  V30 23 C 9.4672 8.6445 0.0 0
M  V30 24 C 7.9272 11.3119 0.0 0
M  V30 25 C 5.6171 9.9781 0.0 0
M  V30 26 C 10.2372 9.9781 0.0 0
M  V30 27 C 9.4672 11.3119 0.0 0
M  V30 28 C 7.1572 12.6456 0.0 0
M  V30 29 C 4.8471 11.3119 0.0 0
M  V30 30 C 5.6171 12.6456 0.0 0
M  V30 31 C 10.7963 5.2636 0.0 0
M  V30 32 C 11.2722 3.7990 0.0 0
M  V30 33 C 11.8267 6.4081 0.0 0
M  V30 34 C 12.7785 3.4789 0.0 0
M  V30 35 C 13.3332 6.0879 0.0 0
M  V30 36 C 13.8090 4.6232 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 18 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 19 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 20 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 36
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21 CFG=3
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 22 25
M  V30 27 1 23 26
M  V30 28 1 24 27
M  V30 29 1 24 28
M  V30 30 2 25 29
M  V30 31 2 26 27
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 738626-22-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-09-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME386 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Cyanophenyl)methylene]-4-methylbenzenesulfonamide
C15H12N2O2S
848005-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 N 16.1700 2.8736 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 3 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanethiol
C3H8S
75-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-cyanophenyl)-4-[(1-methylethyl)thio]-1-[(4-met...
C26H32N2O4S2
951303-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6814 5.3348 0.0 0 VAL=6
M  V30 2 O 8.0152 6.1048 0.0 0
M  V30 3 O 5.3477 4.5648 0.0 0
M  V30 4 C 3.3494 5.6852 0.0 0
M  V30 5 C 3.8253 4.2204 0.0 0
M  V30 6 C 2.7948 3.0760 0.0 0
M  V30 7 C 3.2707 1.6113 0.0 0
M  V30 8 C 5.5544 10.6376 0.0 0
M  V30 9 O 6.9612 11.2639 0.0 0
M  V30 10 O 4.3084 11.5428 0.0 0
M  V30 11 S 2.6528 8.9623 0.0 0
M  V30 12 C 1.4068 8.0571 0.0 0
M  V30 13 C 1.5679 6.5255 0.0 0
M  V30 14 C 0.0000 8.6834 0.0 0
M  V30 15 C 12.5634 9.3563 0.0 0
M  V30 16 N 14.0697 9.6764 0.0 0
M  V30 17 C 9.7614 0.0000 0.0 0
M  V30 18 N 5.9114 6.6686 0.0 0
M  V30 19 C 6.5379 8.0754 0.0 0 CFG=1
M  V30 20 C 4.3798 6.8295 0.0 0 CFG=2
M  V30 21 C 5.3933 9.1059 0.0 0 CFG=2
M  V30 22 C 4.0597 8.3358 0.0 0 CFG=1
M  V30 23 C 8.0442 8.3956 0.0 0
M  V30 24 C 8.5200 9.8603 0.0 0
M  V30 25 C 9.0746 7.2512 0.0 0
M  V30 26 C 10.0265 10.1805 0.0 0
M  V30 27 C 10.5810 7.5714 0.0 0
M  V30 28 C 11.0569 9.0361 0.0 0
M  V30 29 C 7.4514 4.0011 0.0 0
M  V30 30 C 6.6814 2.6675 0.0 0
M  V30 31 C 8.9914 4.0011 0.0 0
M  V30 32 C 7.4514 1.3338 0.0 0
M  V30 33 C 9.7614 2.6675 0.0 0
M  V30 34 C 8.9914 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 21 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=1
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 3 15 16
M  V30 17 1 15 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848005-24-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951303-33-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090331
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME387 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 C 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3,4-dichlorophenyl)-4-[(1,1-dimethylethyl)thio]-...
C26H33Cl2NO4S2
951334-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.5626 7.1043 0.0 0 VAL=6
M  V30 2 O 6.5626 8.6443 0.0 0
M  V30 3 O 6.5626 5.5643 0.0 0
M  V30 4 C 4.5932 9.8149 0.0 0
M  V30 5 C 6.0996 10.1350 0.0 0
M  V30 6 C 6.5755 11.5997 0.0 0
M  V30 7 C 8.0818 11.9199 0.0 0
M  V30 8 C 1.4068 5.4293 0.0 0
M  V30 9 O 0.0000 6.0556 0.0 0
M  V30 10 O 1.5679 3.8976 0.0 0
M  V30 11 S 1.4068 8.7795 0.0 0
M  V30 12 C 1.5679 10.3112 0.0 0
M  V30 13 C 3.0994 10.1501 0.0 0
M  V30 14 C 1.7288 11.8428 0.0 0
M  V30 15 C 0.0362 10.4722 0.0 0
M  V30 16 Cl 3.0082 0.6403 0.0 0
M  V30 17 Cl 6.0209 0.0000 0.0 0
M  V30 18 C 12.7226 7.1043 0.0 0
M  V30 19 N 5.0226 7.1043 0.0 0
M  V30 20 C 4.1173 5.8585 0.0 0 CFG=1
M  V30 21 C 4.1173 8.3503 0.0 0 CFG=2
M  V30 22 C 2.6528 6.3343 0.0 0 CFG=2
M  V30 23 C 2.6528 7.8743 0.0 0 CFG=1
M  V30 24 C 4.5932 4.3939 0.0 0
M  V30 25 C 3.5628 3.2494 0.0 0
M  V30 26 C 6.0996 4.0738 0.0 0
M  V30 27 C 4.0386 1.7849 0.0 0
M  V30 28 C 6.5755 2.6091 0.0 0
M  V30 29 C 5.5451 1.4647 0.0 0
M  V30 30 C 8.1026 7.1043 0.0 0
M  V30 31 C 8.8726 5.7707 0.0 0
M  V30 32 C 8.8726 8.4381 0.0 0
M  V30 33 C 10.4126 5.7707 0.0 0
M  V30 34 C 10.4126 8.4381 0.0 0
M  V30 35 C 11.1826 7.1043 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 22 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 23 11 CFG=3
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 16 27
M  V30 18 1 17 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-63-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951334-02-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME388 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Cyanophenyl)methylene]-4-methylbenzenesulfonamide
C15H12N2O2S
848005-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 N 16.1700 2.8736 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 3 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-cyanophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2...
C26H30N2O4S2
951636-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 8.5690 0.0 0 VAL=6
M  V30 2 O 9.2154 10.1090 0.0 0
M  V30 3 O 9.2154 7.0290 0.0 0
M  V30 4 C 7.2460 11.2796 0.0 0
M  V30 5 C 6.2156 12.4241 0.0 0
M  V30 6 C 6.6915 13.8886 0.0 0
M  V30 7 C 5.6610 15.0332 0.0 0
M  V30 8 C 4.0596 6.8940 0.0 0
M  V30 9 O 2.6528 7.5203 0.0 0
M  V30 10 O 4.2207 5.3623 0.0 0
M  V30 11 S 4.0596 10.2442 0.0 0
M  V30 12 C 2.6528 9.6179 0.0 0
M  V30 13 C 1.4069 10.5231 0.0 0
M  V30 14 C 0.0000 9.8967 0.0 0
M  V30 15 C 8.6737 1.4647 0.0 0
M  V30 16 N 9.1496 0.0000 0.0 0
M  V30 17 C 15.3754 8.5690 0.0 0
M  V30 18 N 7.6754 8.5690 0.0 0
M  V30 19 C 6.7701 7.3232 0.0 0 CFG=1
M  V30 20 C 6.7701 9.8150 0.0 0 CFG=2
M  V30 21 C 5.3055 7.7990 0.0 0 CFG=2
M  V30 22 C 5.3055 9.3390 0.0 0 CFG=1
M  V30 23 C 7.2460 5.8586 0.0 0
M  V30 24 C 6.2156 4.7141 0.0 0
M  V30 25 C 8.7524 5.5385 0.0 0
M  V30 26 C 6.6915 3.2496 0.0 0
M  V30 27 C 9.2283 4.0738 0.0 0
M  V30 28 C 8.1977 2.9294 0.0 0
M  V30 29 C 10.7554 8.5690 0.0 0
M  V30 30 C 11.5254 9.9028 0.0 0
M  V30 31 C 11.5254 7.2354 0.0 0
M  V30 32 C 13.0654 9.9028 0.0 0
M  V30 33 C 13.0654 7.2354 0.0 0
M  V30 34 C 13.8354 8.5690 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 21 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 3 15 16
M  V30 17 1 15 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848005-24-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-03-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086642
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME389 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
861145-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-5-butyl-2-(4-methylphenyl)-4-(2...
C25H30BrNO4S2
951689-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 C 8.6738 13.5684 0.0 0
M  V30 16 Br 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 861145-18-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-48-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088929
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME390 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12ClNO2S
863401-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-chlorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C25H30ClNO4S2
951636-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 5.6611 12.9281 0.0 0
M  V30 16 C 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 863401-19-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-06-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16064915
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME391 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
865060-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-chlorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(...
C25H30ClNO4S2
951636-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 C 3.0800 3.7966 0.0 0
M  V30 16 Cl 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 865060-34-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-20-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME392 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethylphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO2S
951762-59-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 0.0000 0.0 0
M  V30 4 O 6.1600 3.0800 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 4.6200 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 2.3100 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 1.5400 1.5400 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.7800 1.5400 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 18 C 12.3200 1.5400 0.0 0
M  V30 19 C 12.3200 4.2073 0.0 0
M  V30 20 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-ethylphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(2...
C27H35NO4S2
951635-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 8.2489 0.0 0 VAL=6
M  V30 2 O 9.2154 6.7089 0.0 0
M  V30 3 O 9.2154 9.7889 0.0 0
M  V30 4 C 7.2460 10.9594 0.0 0
M  V30 5 C 6.2156 12.1038 0.0 0
M  V30 6 C 6.6915 13.5685 0.0 0
M  V30 7 C 5.6610 14.7129 0.0 0
M  V30 8 C 4.0596 6.5736 0.0 0
M  V30 9 O 4.2207 5.0421 0.0 0
M  V30 10 O 2.6528 7.2000 0.0 0
M  V30 11 S 4.0596 9.9241 0.0 0
M  V30 12 C 2.6528 9.2976 0.0 0
M  V30 13 C 1.4069 10.2028 0.0 0
M  V30 14 C 0.0000 9.5765 0.0 0
M  V30 15 C 8.6737 1.1444 0.0 0
M  V30 16 C 7.6432 0.0000 0.0 0
M  V30 17 C 15.3754 8.2489 0.0 0
M  V30 18 N 7.6754 8.2489 0.0 0
M  V30 19 C 6.7701 7.0030 0.0 0 CFG=1
M  V30 20 C 6.7701 9.4947 0.0 0 CFG=2
M  V30 21 C 5.3055 7.4789 0.0 0 CFG=2
M  V30 22 C 5.3055 9.0189 0.0 0 CFG=1
M  V30 23 C 7.2460 5.5383 0.0 0
M  V30 24 C 6.2156 4.3939 0.0 0
M  V30 25 C 8.7524 5.2181 0.0 0
M  V30 26 C 6.6915 2.9292 0.0 0
M  V30 27 C 9.2283 3.7534 0.0 0
M  V30 28 C 8.1977 2.6091 0.0 0
M  V30 29 C 10.7554 8.2489 0.0 0
M  V30 30 C 11.5254 6.9152 0.0 0
M  V30 31 C 11.5254 9.5825 0.0 0
M  V30 32 C 13.0654 6.9152 0.0 0
M  V30 33 C 13.0654 9.5825 0.0 0
M  V30 34 C 13.8354 8.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 21 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 1 15 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 23 CFG=1
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-59-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951635-99-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME393 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Ethoxyphenyl)methylene]-4-methylbenzenesulfonamide
C16H17NO3S
951762-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 6.1600 3.0800 0.0 0
M  V30 4 O 6.1600 0.0000 0.0 0
M  V30 5 C 8.4700 2.8736 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 O 14.6300 2.8736 0.0 0
M  V30 8 C 15.4000 4.2073 0.0 0
M  V30 9 C 16.9400 4.2073 0.0 0
M  V30 10 C 4.6200 1.5400 0.0 0
M  V30 11 C 3.8500 0.2062 0.0 0
M  V30 12 C 3.8500 2.8736 0.0 0
M  V30 13 C 2.3100 0.2062 0.0 0
M  V30 14 C 2.3100 2.8736 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 C 10.0100 2.8736 0.0 0
M  V30 17 C 10.7800 1.5400 0.0 0
M  V30 18 C 10.7800 4.2073 0.0 0
M  V30 19 C 12.3200 1.5400 0.0 0
M  V30 20 C 12.3200 4.2073 0.0 0
M  V30 21 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-ethoxyphenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C27H35NO5S2
951636-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4640 6.1600 0.0 0 VAL=6
M  V30 2 O 8.0040 6.1600 0.0 0
M  V30 3 O 4.9240 6.1600 0.0 0
M  V30 4 C 8.1392 11.3158 0.0 0
M  V30 5 O 7.5128 12.7226 0.0 0
M  V30 6 O 9.6708 11.1547 0.0 0
M  V30 7 C 3.7535 8.1294 0.0 0
M  V30 8 C 2.6091 9.1598 0.0 0
M  V30 9 C 1.1444 8.6839 0.0 0
M  V30 10 C 0.0000 9.7144 0.0 0
M  V30 11 S 4.7888 11.3158 0.0 0
M  V30 12 C 5.4151 12.7226 0.0 0
M  V30 13 C 4.5101 13.9685 0.0 0
M  V30 14 C 5.1364 15.3754 0.0 0
M  V30 15 O 13.5684 6.7017 0.0 0
M  V30 16 C 14.7129 7.7322 0.0 0
M  V30 17 C 16.1775 7.2562 0.0 0
M  V30 18 C 6.4640 0.0000 0.0 0
M  V30 19 C 7.7099 8.6053 0.0 0 CFG=1
M  V30 20 N 6.4640 7.7000 0.0 0
M  V30 21 C 7.2340 10.0700 0.0 0 CFG=2
M  V30 22 C 5.2182 8.6053 0.0 0 CFG=2
M  V30 23 C 5.6940 10.0700 0.0 0 CFG=2
M  V30 24 C 9.1746 8.1294 0.0 0
M  V30 25 C 10.3190 9.1598 0.0 0
M  V30 26 C 9.4948 6.6230 0.0 0
M  V30 27 C 11.7837 8.6839 0.0 0
M  V30 28 C 10.9593 6.1471 0.0 0
M  V30 29 C 12.1038 7.1777 0.0 0
M  V30 30 C 6.4640 4.6200 0.0 0
M  V30 31 C 5.1304 3.8500 0.0 0
M  V30 32 C 7.7977 3.8500 0.0 0
M  V30 33 C 5.1304 2.3100 0.0 0
M  V30 34 C 7.7977 2.3100 0.0 0
M  V30 35 C 6.4640 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 21 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 22 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 23 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 1 15 29
M  V30 18 1 16 17
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 19 24 CFG=3
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-60-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089481
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME394 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(2-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 N 5.3900 4.0009 0.0 0
M  V30 3 O 6.9300 5.5409 0.0 0
M  V30 4 O 6.9300 2.4609 0.0 0
M  V30 5 C 4.6200 2.6673 0.0 0
M  V30 6 C 13.0900 4.0009 0.0 0
M  V30 7 F 3.0800 0.0000 0.0 0
M  V30 8 C 8.4700 4.0009 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 9.2400 2.6673 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 10.7800 2.6673 0.0 0
M  V30 13 C 11.5500 4.0009 0.0 0
M  V30 14 C 3.0800 2.6673 0.0 0
M  V30 15 C 2.3100 1.3336 0.0 0
M  V30 16 C 2.3100 4.0009 0.0 0
M  V30 17 C 0.7700 1.3336 0.0 0
M  V30 18 C 0.7700 4.0009 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(2-fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C25H30FNO4S2
951636-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7534 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6610 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5129 0.0 0
M  V30 10 O 4.2207 9.6707 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4069 4.5100 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 F 4.7092 9.9988 0.0 0
M  V30 16 C 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7701 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7701 5.2181 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1745 0.0 0
M  V30 23 C 6.2156 10.3189 0.0 0
M  V30 24 C 8.7524 9.4947 0.0 0
M  V30 25 C 6.6915 11.7836 0.0 0
M  V30 26 C 9.2283 10.9594 0.0 0
M  V30 27 C 8.1977 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7976 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7976 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 23
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-62-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-04-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088157
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME395 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 C 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3,4-dichlorophenyl)-1-[(4-methylphenyl)sulfonyl]...
C25H29Cl2NO4S2
951636-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 5.6611 12.9281 0.0 0
M  V30 16 Cl 8.6738 13.5684 0.0 0
M  V30 17 C 15.3754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 N 7.6754 6.4640 0.0 0
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 22 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 23 C 7.2460 9.1746 0.0 0
M  V30 24 C 6.2156 10.3190 0.0 0
M  V30 25 C 8.7525 9.4948 0.0 0
M  V30 26 C 6.6915 11.7837 0.0 0
M  V30 27 C 9.2283 10.9593 0.0 0
M  V30 28 C 8.1978 12.1038 0.0 0
M  V30 29 C 10.7554 6.4640 0.0 0
M  V30 30 C 11.5254 5.1304 0.0 0
M  V30 31 C 11.5254 7.7977 0.0 0
M  V30 32 C 13.0654 5.1304 0.0 0
M  V30 33 C 13.0654 7.7977 0.0 0
M  V30 34 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-63-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-07-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092657
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME396 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-(2-thienylmethylene)benzenesulfonamide
C12H11NO2S2
951762-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.2198 2.5795 0.0 0 VAL=6
M  V30 2 N 4.6798 2.5795 0.0 0
M  V30 3 O 6.2198 1.0395 0.0 0
M  V30 4 O 6.2198 4.1195 0.0 0
M  V30 5 C 3.9098 1.2459 0.0 0
M  V30 6 C 12.3798 2.5795 0.0 0
M  V30 7 C 7.7598 2.5795 0.0 0
M  V30 8 C 8.5298 1.2459 0.0 0
M  V30 9 C 8.5298 3.9132 0.0 0
M  V30 10 C 10.0698 1.2459 0.0 0
M  V30 11 C 10.0698 3.9132 0.0 0
M  V30 12 C 10.8398 2.5795 0.0 0
M  V30 13 C 2.3698 1.2459 0.0 0
M  V30 14 C 1.4645 2.4917 0.0 0
M  V30 15 S 1.4645 0.0000 0.0 0
M  V30 16 C 0.0000 2.0159 0.0 0
M  V30 17 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-methylphenyl)sulfonyl]-4-(2-propen-1-ylthio)-...
C23H29NO4S3
951636-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4642 0.0 0 VAL=6
M  V30 2 O 9.2154 4.9242 0.0 0
M  V30 3 O 9.2154 8.0042 0.0 0
M  V30 4 C 7.2460 3.7536 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1445 0.0 0
M  V30 7 C 5.6610 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5129 0.0 0
M  V30 10 O 4.2207 9.6709 0.0 0
M  V30 11 S 4.0596 4.7889 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4069 4.5100 0.0 0
M  V30 14 C 0.0000 5.1365 0.0 0
M  V30 15 C 15.3754 6.4642 0.0 0
M  V30 16 N 7.6754 6.4642 0.0 0
M  V30 17 C 6.7701 7.7100 0.0 0 CFG=1
M  V30 18 C 6.7701 5.2181 0.0 0 CFG=2
M  V30 19 C 5.3055 7.2342 0.0 0 CFG=2
M  V30 20 C 5.3055 5.6942 0.0 0 CFG=1
M  V30 21 C 7.2460 9.1745 0.0 0
M  V30 22 C 8.7107 9.6504 0.0 0
M  V30 23 S 6.3408 10.4204 0.0 0
M  V30 24 C 8.7107 11.1904 0.0 0
M  V30 25 C 7.2460 11.6664 0.0 0
M  V30 26 C 10.7554 6.4642 0.0 0
M  V30 27 C 11.5254 5.1304 0.0 0
M  V30 28 C 11.5254 7.7978 0.0 0
M  V30 29 C 13.0654 5.1304 0.0 0
M  V30 30 C 13.0654 7.7978 0.0 0
M  V30 31 C 13.8354 6.4642 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 18 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 19 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 20 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 31
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 21 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-64-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28335084
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME397 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Methyl-N-[[4-(1-methylethyl)phenyl]methylene]benzenesulfonamide
C17H19NO2S
951762-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 1.5400 0.0 0 VAL=6
M  V30 2 N 7.7000 1.5400 0.0 0
M  V30 3 O 9.2400 0.0000 0.0 0
M  V30 4 O 9.2400 3.0800 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 15.4000 1.5400 0.0 0
M  V30 7 C 0.7700 2.8736 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 0.0000 4.2073 0.0 0
M  V30 10 C 10.7800 1.5400 0.0 0
M  V30 11 C 11.5500 2.8736 0.0 0
M  V30 12 C 11.5500 0.2062 0.0 0
M  V30 13 C 13.0900 2.8736 0.0 0
M  V30 14 C 13.0900 0.2062 0.0 0
M  V30 15 C 13.8600 1.5400 0.0 0
M  V30 16 C 5.3900 2.8736 0.0 0
M  V30 17 C 4.6200 4.2073 0.0 0
M  V30 18 C 4.6200 1.5400 0.0 0
M  V30 19 C 3.0800 4.2073 0.0 0
M  V30 20 C 3.0800 1.5400 0.0 0
M  V30 21 C 2.3100 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 2 5
M  V30 6 1 5 16
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-[4-(1-methylethyl)phenyl]-1-[(4-methylphenyl)sulf...
C28H37NO4S2
951636-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 8.2489 0.0 0 VAL=6
M  V30 2 O 9.2154 6.7089 0.0 0
M  V30 3 O 9.2154 9.7889 0.0 0
M  V30 4 C 7.2460 10.9594 0.0 0
M  V30 5 C 6.2156 12.1038 0.0 0
M  V30 6 C 6.6915 13.5685 0.0 0
M  V30 7 C 5.6610 14.7129 0.0 0
M  V30 8 C 4.0596 6.5736 0.0 0
M  V30 9 O 2.6528 7.2000 0.0 0
M  V30 10 O 4.2207 5.0421 0.0 0
M  V30 11 S 4.0596 9.9241 0.0 0
M  V30 12 C 2.6528 9.2976 0.0 0
M  V30 13 C 1.4069 10.2028 0.0 0
M  V30 14 C 0.0000 9.5765 0.0 0
M  V30 15 C 8.6737 1.1444 0.0 0
M  V30 16 C 10.1800 0.8242 0.0 0
M  V30 17 C 7.6432 0.0000 0.0 0
M  V30 18 C 15.3754 8.2489 0.0 0
M  V30 19 N 7.6754 8.2489 0.0 0
M  V30 20 C 6.7701 7.0030 0.0 0 CFG=1
M  V30 21 C 6.7701 9.4947 0.0 0 CFG=2
M  V30 22 C 5.3055 7.4789 0.0 0 CFG=2
M  V30 23 C 5.3055 9.0189 0.0 0 CFG=1
M  V30 24 C 7.2460 5.5383 0.0 0
M  V30 25 C 8.7524 5.2181 0.0 0
M  V30 26 C 6.2156 4.3939 0.0 0
M  V30 27 C 9.2283 3.7534 0.0 0
M  V30 28 C 6.6915 2.9292 0.0 0
M  V30 29 C 8.1977 2.6091 0.0 0
M  V30 30 C 10.7554 8.2489 0.0 0
M  V30 31 C 11.5254 9.5825 0.0 0
M  V30 32 C 11.5254 6.9152 0.0 0
M  V30 33 C 13.0654 9.5825 0.0 0
M  V30 34 C 13.0654 6.9152 0.0 0
M  V30 35 C 13.8354 8.2489 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 30
M  V30 5 1 4 5
M  V30 6 1 21 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 22 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 23 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 29
M  V30 19 1 18 35
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 20 24 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 20 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-66-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-13-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16070742
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME398 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Fluorophenyl)methylene]-4-methylbenzenesulfonamide
C14H12FNO2S
951762-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-fluorophenyl)-1-[(4-methylphenyl)sulfonyl]-4-(...
C25H30FNO4S2
951636-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 F 5.6611 12.9281 0.0 0
M  V30 16 C 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-68-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME399 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951762-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-chlorophenyl)-1-[(4-chlorophenyl)sulfonyl]-4-(...
C24H27Cl2NO4S2
951636-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 8.6738 13.5684 0.0 0
M  V30 16 Cl 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-69-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME400 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-chlorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(...
C25H30ClNO4S2
951636-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 C 8.6738 13.5684 0.0 0
M  V30 16 Cl 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-72-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-17-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090951
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME401 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(4-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-methylphenyl)-1-[(2-methylphenyl)sulfonyl]-4-(...
C26H33NO4S2
951636-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 C 3.0800 3.7966 0.0 0
M  V30 16 C 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-79-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951636-21-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085967
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME402 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H11Cl2NO2S
951762-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3,4-dichlorophenyl)-1-[(2-methylphenyl)sulfonyl]...
C25H29Cl2NO4S2
951687-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 9.7758 8.1392 0.0 0
M  V30 5 O 11.1826 7.5128 0.0 0
M  V30 6 O 9.6147 9.6708 0.0 0
M  V30 7 C 6.5894 3.7535 0.0 0
M  V30 8 C 7.6198 2.6091 0.0 0
M  V30 9 C 7.1439 1.1444 0.0 0
M  V30 10 C 8.1744 0.0000 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 8.1744 12.9281 0.0 0
M  V30 16 C 3.0800 3.7966 0.0 0
M  V30 17 Cl 5.1616 13.5684 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 N 6.1600 6.4640 0.0 0
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 22 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 23 C 6.5894 9.1746 0.0 0
M  V30 24 C 7.6198 10.3190 0.0 0
M  V30 25 C 5.0829 9.4948 0.0 0
M  V30 26 C 7.1439 11.7837 0.0 0
M  V30 27 C 4.6071 10.9593 0.0 0
M  V30 28 C 5.6377 12.1038 0.0 0
M  V30 29 C 3.0800 6.4640 0.0 0
M  V30 30 C 2.3100 5.1304 0.0 0
M  V30 31 C 2.3100 7.7977 0.0 0
M  V30 32 C 0.7700 5.1304 0.0 0
M  V30 33 C 0.7700 7.7977 0.0 0
M  V30 34 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 30
M  V30 18 1 17 28
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-84-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084910
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME403 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-2-fluorobenzenesulfonamide
C13H8Cl2FNO2S
951762-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 F 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3,4-dichlorophenyl)-1-[(2-fluorophenyl)sulfonyl]...
C24H26Cl2FNO4S2
951687-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 9.7758 8.1392 0.0 0
M  V30 5 O 11.1826 7.5128 0.0 0
M  V30 6 O 9.6147 9.6708 0.0 0
M  V30 7 C 6.5894 3.7535 0.0 0
M  V30 8 C 7.6198 2.6091 0.0 0
M  V30 9 C 7.1439 1.1444 0.0 0
M  V30 10 C 8.1744 0.0000 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 8.1744 12.9281 0.0 0
M  V30 16 F 3.0800 3.7966 0.0 0
M  V30 17 Cl 5.1616 13.5684 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 N 6.1600 6.4640 0.0 0
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 22 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 23 C 6.5894 9.1746 0.0 0
M  V30 24 C 7.6198 10.3190 0.0 0
M  V30 25 C 5.0829 9.4948 0.0 0
M  V30 26 C 7.1439 11.7837 0.0 0
M  V30 27 C 4.6071 10.9593 0.0 0
M  V30 28 C 5.6377 12.1038 0.0 0
M  V30 29 C 3.0800 6.4640 0.0 0
M  V30 30 C 2.3100 5.1304 0.0 0
M  V30 31 C 2.3100 7.7977 0.0 0
M  V30 32 C 0.7700 5.1304 0.0 0
M  V30 33 C 0.7700 7.7977 0.0 0
M  V30 34 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 30
M  V30 18 1 17 28
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-85-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME404 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8Cl3NO2S
951762-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 Cl 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(2-chlorophenyl)sulfonyl]-2-(3,4-dichlorophenyl)...
C24H26Cl3NO4S2
951687-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 9.7758 8.1392 0.0 0
M  V30 5 O 9.6147 9.6708 0.0 0
M  V30 6 O 11.1826 7.5128 0.0 0
M  V30 7 C 6.5894 3.7535 0.0 0
M  V30 8 C 7.6198 2.6091 0.0 0
M  V30 9 C 7.1439 1.1444 0.0 0
M  V30 10 C 8.1744 0.0000 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 8.1744 12.9281 0.0 0
M  V30 16 Cl 3.0800 3.7966 0.0 0
M  V30 17 Cl 5.1616 13.5684 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 N 6.1600 6.4640 0.0 0
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 22 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 23 C 6.5894 9.1746 0.0 0
M  V30 24 C 7.6198 10.3190 0.0 0
M  V30 25 C 5.0829 9.4948 0.0 0
M  V30 26 C 7.1439 11.7837 0.0 0
M  V30 27 C 4.6071 10.9593 0.0 0
M  V30 28 C 5.6377 12.1038 0.0 0
M  V30 29 C 3.0800 6.4640 0.0 0
M  V30 30 C 2.3100 5.1304 0.0 0
M  V30 31 C 2.3100 7.7977 0.0 0
M  V30 32 C 0.7700 5.1304 0.0 0
M  V30 33 C 0.7700 7.7977 0.0 0
M  V30 34 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 30
M  V30 18 1 17 28
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-86-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-89-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087953
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME405 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8BrCl2NO2S
951762-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 4.6200 2.4611 0.0 0
M  V30 4 O 4.6200 5.5411 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 Br 3.0800 6.6685 0.0 0
M  V30 7 Cl 11.5500 0.0000 0.0 0
M  V30 8 Cl 13.0900 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 1.3338 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.7800 1.3338 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 10
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-5-butyl-2-(3,4-dichlorophenyl)-...
C24H26BrCl2NO4S2
951687-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 9.7758 8.1392 0.0 0
M  V30 5 O 11.1826 7.5128 0.0 0
M  V30 6 O 9.6147 9.6708 0.0 0
M  V30 7 C 6.5894 3.7535 0.0 0
M  V30 8 C 7.6198 2.6091 0.0 0
M  V30 9 C 7.1439 1.1444 0.0 0
M  V30 10 C 8.1744 0.0000 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 8.1744 12.9281 0.0 0
M  V30 16 Br 3.0800 3.7966 0.0 0
M  V30 17 Cl 5.1616 13.5684 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 N 6.1600 6.4640 0.0 0
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 22 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 23 C 6.5894 9.1746 0.0 0
M  V30 24 C 7.6198 10.3190 0.0 0
M  V30 25 C 5.0829 9.4948 0.0 0
M  V30 26 C 7.1439 11.7837 0.0 0
M  V30 27 C 4.6071 10.9593 0.0 0
M  V30 28 C 5.6377 12.1038 0.0 0
M  V30 29 C 3.0800 6.4640 0.0 0
M  V30 30 C 2.3100 5.1304 0.0 0
M  V30 31 C 2.3100 7.7977 0.0 0
M  V30 32 C 0.7700 5.1304 0.0 0
M  V30 33 C 0.7700 7.7977 0.0 0
M  V30 34 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 30
M  V30 18 1 17 28
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-87-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-90-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089452
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME406 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Methyl-N-[(3-methylphenyl)methylene]benzenesulfonamide
C15H15NO2S
951762-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-methylphenyl)-1-[(2-methylphenyl)sulfonyl]-4-(...
C26H33NO4S2
951687-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 C 3.0800 3.7966 0.0 0
M  V30 16 C 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-88-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083997
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME407 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Fluorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12FNO2S
951762-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-fluorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(...
C25H30FNO4S2
951687-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 C 3.0800 3.7966 0.0 0
M  V30 16 F 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-90-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-93-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085493
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME408 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12ClNO2S
951762-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-chlorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(...
C25H30ClNO4S2
951687-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 C 3.0800 3.7966 0.0 0
M  V30 16 Cl 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-91-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-95-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME409 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-2-methylbenzenesulfonamide
C14H12BrNO2S
951762-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-5-butyl-1-[(2-methylphenyl)sulfonyl]-4-(2...
C25H30BrNO4S2
951687-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 C 3.0800 3.7966 0.0 0
M  V30 16 Br 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-92-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-96-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088540
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME410 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951762-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(2-fluorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(...
C25H30FNO4S2
951687-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 F 3.0800 3.7966 0.0 0
M  V30 16 C 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-93-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090033
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME411 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951762-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-fluorophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(...
C24H27F2NO4S2
951687-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 F 3.0800 3.7966 0.0 0
M  V30 16 F 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-94-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-98-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091561
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME412 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9ClFNO2S
951762-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-chlorophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(...
C24H27ClFNO4S2
951687-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 F 3.0800 3.7966 0.0 0
M  V30 16 Cl 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-95-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951687-99-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16081647
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME413 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9BrFNO2S
951762-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 F 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-5-butyl-1-[(2-fluorophenyl)sulfonyl]-4-(2...
C24H27BrFNO4S2
951688-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 F 3.0800 3.7966 0.0 0
M  V30 16 Br 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-96-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-00-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME414 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951762-97-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(2-chlorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(...
C25H30ClNO4S2
951688-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 3.0800 3.7966 0.0 0
M  V30 16 C 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-97-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME415 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951762-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(2-chlorophenyl)sulfonyl]-2-(3-fluorophenyl)-4-(...
C24H27ClFNO4S2
951688-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 3.0800 3.7966 0.0 0
M  V30 16 F 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-98-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME416 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951762-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 3.2311 4.4137 0.0 0
M  V30 4 O 4.7712 1.7464 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-chlorophenyl)-1-[(2-chlorophenyl)sulfonyl]-4-(...
C24H27Cl2NO4S2
951688-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 3.0800 3.7966 0.0 0
M  V30 16 Cl 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951762-99-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-03-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME417 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-2-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Cl 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-5-butyl-1-[(2-chlorophenyl)sulfonyl]-4-(2...
C24H27BrClNO4S2
951688-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 3.0800 3.7966 0.0 0
M  V30 16 Br 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-00-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-04-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083764
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME418 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
951763-01-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 C 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-5-butyl-2-(3-methylphenyl)-4-(2...
C25H30BrNO4S2
951688-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Br 3.0800 3.7966 0.0 0
M  V30 16 C 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-01-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-05-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085263
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME419 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951763-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 F 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-5-butyl-2-(3-fluorophenyl)-4-(2...
C24H27BrFNO4S2
951688-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Br 3.0800 3.7966 0.0 0
M  V30 16 F 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-02-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-06-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086773
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME420 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 Cl 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-5-butyl-2-(3-chlorophenyl)-4-(2...
C24H27BrClNO4S2
951688-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Br 3.0800 3.7966 0.0 0
M  V30 16 Cl 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-03-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088307
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME421 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(3-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 3.0801 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 O 4.7712 1.7464 0.0 0
M  V30 4 O 3.2311 4.4137 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 Br 1.3337 4.6201 0.0 0
M  V30 7 Br 12.0033 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 9.3360 6.1601 0.0 0
M  V30 19 C 10.6697 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(2-bromophenyl)sulfonyl]-5-butyl-4-(2-...
C24H27Br2NO4S2
951688-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Br 3.0800 3.7966 0.0 0
M  V30 16 Br 8.1744 12.9281 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-04-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-08-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089807
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME422 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Fluorophenyl)methylene]-2-methylbenzenesulfonamide
C14H12FNO2S
951763-05-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-fluorophenyl)-1-[(2-methylphenyl)sulfonyl]-4-(...
C25H30FNO4S2
951688-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 C 3.0800 3.7966 0.0 0
M  V30 16 F 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-05-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-09-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME423 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-2-methylbenzenesulfonamide
C14H12BrNO2S
951763-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-butyl-1-[(2-methylphenyl)sulfonyl]-4-(2...
C25H30BrNO4S2
951688-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 C 3.0800 3.7966 0.0 0
M  V30 16 Br 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-06-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-10-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076468
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME424 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951763-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(2-fluorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(...
C25H30FNO4S2
951688-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 F 3.0800 3.7966 0.0 0
M  V30 16 C 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-07-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-11-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076423
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME425 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Fluoro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951763-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-fluorophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(...
C24H27F2NO4S2
951688-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 F 3.0800 3.7966 0.0 0
M  V30 16 F 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-08-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-12-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084842
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME426 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9ClFNO2S
951763-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-chlorophenyl)-1-[(2-fluorophenyl)sulfonyl]-4-(...
C24H27ClFNO4S2
951688-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 F 3.0800 3.7966 0.0 0
M  V30 16 Cl 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-09-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-13-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME427 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-2-fluorobenzenesulfonamide
C13H9BrFNO2S
951763-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 F 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-butyl-1-[(2-fluorophenyl)sulfonyl]-4-(2...
C24H27BrFNO4S2
951688-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 F 3.0800 3.7966 0.0 0
M  V30 16 Br 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-10-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076636
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME428 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(2-chlorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(...
C25H30ClNO4S2
951688-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 3.0800 3.7966 0.0 0
M  V30 16 C 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-11-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-15-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME429 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(2-chlorophenyl)sulfonyl]-2-(4-fluorophenyl)-4-(...
C24H27ClFNO4S2
951688-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 3.0800 3.7966 0.0 0
M  V30 16 F 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-12-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-16-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085032
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME430 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-chlorophenyl)-1-[(2-chlorophenyl)sulfonyl]-4-(...
C24H27Cl2NO4S2
951688-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 3.0800 3.7966 0.0 0
M  V30 16 Cl 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-13-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-17-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086550
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME431 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-2-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-butyl-1-[(2-chlorophenyl)sulfonyl]-4-(2...
C24H27BrClNO4S2
951688-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 3.0800 3.7966 0.0 0
M  V30 16 Br 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-14-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088082
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME432 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
951763-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-5-butyl-2-(4-methylphenyl)-4-(2...
C25H30BrNO4S2
951688-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Br 3.0800 3.7966 0.0 0
M  V30 16 C 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-15-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16089585
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME433 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951763-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 F 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-5-butyl-2-(4-fluorophenyl)-4-(2...
C24H27BrFNO4S2
951688-20-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Br 3.0800 3.7966 0.0 0
M  V30 16 F 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-16-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-20-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME434 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 Cl 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(2-Bromophenyl)sulfonyl]-5-butyl-2-(4-chlorophenyl)-4-(2...
C24H27BrClNO4S2
951688-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Br 3.0800 3.7966 0.0 0
M  V30 16 Cl 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-17-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-21-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092565
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME435 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-2-Bromo-N-[(4-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6674 0.0 0
M  V30 3 O 4.6200 1.1274 0.0 0
M  V30 4 O 4.6200 4.2074 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Br 3.0800 0.0000 0.0 0
M  V30 7 Br 13.0900 4.0011 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.7700 4.0011 0.0 0
M  V30 13 C 0.0000 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.7800 2.6674 0.0 0
M  V30 18 C 10.7800 5.3349 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 9
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(2-bromophenyl)sulfonyl]-5-butyl-4-(2-...
C24H27Br2NO4S2
951688-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.1044 9.2154 0.0 0 VAL=6
M  V30 2 O 5.5644 9.2154 0.0 0
M  V30 3 O 8.6444 9.2154 0.0 0
M  V30 4 C 9.8149 7.2460 0.0 0
M  V30 5 C 10.9593 6.2156 0.0 0
M  V30 6 C 12.4240 6.6915 0.0 0
M  V30 7 C 13.5684 5.6611 0.0 0
M  V30 8 C 5.4291 4.0596 0.0 0
M  V30 9 O 6.0556 2.6528 0.0 0
M  V30 10 O 3.8976 4.2207 0.0 0
M  V30 11 S 8.7796 4.0596 0.0 0
M  V30 12 C 8.1533 2.6528 0.0 0
M  V30 13 C 9.0583 1.4070 0.0 0
M  V30 14 C 8.4320 0.0000 0.0 0
M  V30 15 Br 9.7718 10.7554 0.0 0
M  V30 16 Br 0.0000 8.6738 0.0 0
M  V30 17 N 7.1044 7.6754 0.0 0
M  V30 18 C 5.8585 6.7702 0.0 0 CFG=1
M  V30 19 C 8.3502 6.7702 0.0 0 CFG=2
M  V30 20 C 6.3344 5.3055 0.0 0 CFG=2
M  V30 21 C 7.8744 5.3055 0.0 0 CFG=1
M  V30 22 C 4.3938 7.2460 0.0 0
M  V30 23 C 3.2494 6.2156 0.0 0
M  V30 24 C 4.0736 8.7525 0.0 0
M  V30 25 C 1.7847 6.6915 0.0 0
M  V30 26 C 2.6091 9.2283 0.0 0
M  V30 27 C 1.4645 8.1978 0.0 0
M  V30 28 C 7.1044 10.7554 0.0 0
M  V30 29 C 8.4380 11.5254 0.0 0
M  V30 30 C 5.7707 11.5254 0.0 0
M  V30 31 C 8.4380 13.0654 0.0 0
M  V30 32 C 5.7707 13.0654 0.0 0
M  V30 33 C 7.1044 13.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 29
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-18-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951688-22-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083104
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME436 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3,4-Dichlorophenyl)methylene]-4-fluorobenzenesulfonamide
C13H8Cl2FNO2S
951763-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 F 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3,4-dichlorophenyl)-1-[(4-fluorophenyl)sulfonyl]...
C24H26Cl2FNO4S2
951689-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 5.6611 12.9281 0.0 0
M  V30 16 Cl 8.6738 13.5684 0.0 0
M  V30 17 F 15.3754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 N 7.6754 6.4640 0.0 0
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 22 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 23 C 7.2460 9.1746 0.0 0
M  V30 24 C 6.2156 10.3190 0.0 0
M  V30 25 C 8.7525 9.4948 0.0 0
M  V30 26 C 6.6915 11.7837 0.0 0
M  V30 27 C 9.2283 10.9593 0.0 0
M  V30 28 C 8.1978 12.1038 0.0 0
M  V30 29 C 10.7554 6.4640 0.0 0
M  V30 30 C 11.5254 5.1304 0.0 0
M  V30 31 C 11.5254 7.7977 0.0 0
M  V30 32 C 13.0654 5.1304 0.0 0
M  V30 33 C 13.0654 7.7977 0.0 0
M  V30 34 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-19-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME437 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8Cl3NO2S
951763-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 Cl 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-chlorophenyl)sulfonyl]-2-(3,4-dichlorophenyl)...
C24H26Cl3NO4S2
951689-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 5.6611 12.9281 0.0 0
M  V30 16 Cl 8.6738 13.5684 0.0 0
M  V30 17 Cl 15.3754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 N 7.6754 6.4640 0.0 0
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 22 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 23 C 7.2460 9.1746 0.0 0
M  V30 24 C 6.2156 10.3190 0.0 0
M  V30 25 C 8.7525 9.4948 0.0 0
M  V30 26 C 6.6915 11.7837 0.0 0
M  V30 27 C 9.2283 10.9593 0.0 0
M  V30 28 C 8.1978 12.1038 0.0 0
M  V30 29 C 10.7554 6.4640 0.0 0
M  V30 30 C 11.5254 5.1304 0.0 0
M  V30 31 C 11.5254 7.7977 0.0 0
M  V30 32 C 13.0654 5.1304 0.0 0
M  V30 33 C 13.0654 7.7977 0.0 0
M  V30 34 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-21-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-28-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME438 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8BrCl2NO2S
951763-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 2 N 6.9300 4.0009 0.0 0
M  V30 3 O 8.4700 2.4609 0.0 0
M  V30 4 O 8.4700 5.5409 0.0 0
M  V30 5 C 6.1600 2.6673 0.0 0
M  V30 6 Br 14.6300 4.0009 0.0 0
M  V30 7 Cl 1.5400 0.0000 0.0 0
M  V30 8 Cl 0.0000 2.6673 0.0 0
M  V30 9 C 10.0100 4.0009 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 13.0900 4.0009 0.0 0
M  V30 15 C 4.6200 2.6673 0.0 0
M  V30 16 C 3.8500 1.3336 0.0 0
M  V30 17 C 3.8500 4.0009 0.0 0
M  V30 18 C 2.3100 1.3336 0.0 0
M  V30 19 C 2.3100 4.0009 0.0 0
M  V30 20 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 14
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-5-butyl-2-(3,4-dichlorophenyl)-...
C24H26BrCl2NO4S2
951689-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 5.6611 12.9281 0.0 0
M  V30 16 Cl 8.6738 13.5684 0.0 0
M  V30 17 Br 15.3754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 N 7.6754 6.4640 0.0 0
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 22 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 23 C 7.2460 9.1746 0.0 0
M  V30 24 C 6.2156 10.3190 0.0 0
M  V30 25 C 8.7525 9.4948 0.0 0
M  V30 26 C 6.6915 11.7837 0.0 0
M  V30 27 C 9.2283 10.9593 0.0 0
M  V30 28 C 8.1978 12.1038 0.0 0
M  V30 29 C 10.7554 6.4640 0.0 0
M  V30 30 C 11.5254 5.1304 0.0 0
M  V30 31 C 11.5254 7.7977 0.0 0
M  V30 32 C 13.0654 5.1304 0.0 0
M  V30 33 C 13.0654 7.7977 0.0 0
M  V30 34 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 28
M  V30 18 1 17 34
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-23-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082917
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME439 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951763-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-fluorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(...
C25H30FNO4S2
951689-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 C 5.6611 12.9281 0.0 0
M  V30 16 F 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-24-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-30-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME440 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951763-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-fluorophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(...
C24H27F2NO4S2
951689-31-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 F 5.6611 12.9281 0.0 0
M  V30 16 F 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-25-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-31-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME441 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Chlorophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9ClFNO2S
951763-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-chlorophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(...
C24H27ClFNO4S2
951689-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 4.9240 0.0 0
M  V30 3 O 9.2154 8.0040 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 5.6611 12.9281 0.0 0
M  V30 16 F 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-26-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-32-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087436
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME442 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9BrFNO2S
951763-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-5-butyl-1-[(4-fluorophenyl)sulfonyl]-4-(2...
C24H27BrFNO4S2
951689-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Br 5.6611 12.9281 0.0 0
M  V30 16 F 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-27-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088957
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME443 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-chlorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(...
C25H30ClNO4S2
951689-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 C 5.6611 12.9281 0.0 0
M  V30 16 Cl 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-28-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-34-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME444 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-chlorophenyl)sulfonyl]-2-(3-fluorophenyl)-4-(...
C24H27ClFNO4S2
951689-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 F 5.6611 12.9281 0.0 0
M  V30 16 Cl 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-29-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086129
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME445 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-chlorophenyl)-1-[(4-chlorophenyl)sulfonyl]-4-(...
C24H27Cl2NO4S2
951689-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 5.6611 12.9281 0.0 0
M  V30 16 Cl 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-30-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-36-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076136
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME446 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-4-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-5-butyl-1-[(4-chlorophenyl)sulfonyl]-4-(2...
C24H27BrClNO4S2
951689-37-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Br 5.6611 12.9281 0.0 0
M  V30 16 Cl 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-31-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-37-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16071090
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME447 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12BrNO2S
951763-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 4.0010 5.3901 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 2.6673 6.1601 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-5-butyl-2-(3-methylphenyl)-4-(2...
C25H30BrNO4S2
951689-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 C 5.6611 12.9281 0.0 0
M  V30 16 Br 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-32-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-38-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090654
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME448 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-5-butyl-2-(3-chlorophenyl)-4-(2...
C24H27BrClNO4S2
951689-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 5.6611 12.9281 0.0 0
M  V30 16 Br 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-33-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-40-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16082683
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME449 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-34-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-1-[(4-bromophenyl)sulfonyl]-5-butyl-4-(2-...
C24H27Br2NO4S2
951689-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Br 5.6611 12.9281 0.0 0
M  V30 16 Br 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-34-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084176
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME450 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12FNO2S
951763-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 C 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-fluorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(...
C25H30FNO4S2
951689-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 C 8.6738 13.5684 0.0 0
M  V30 16 F 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-35-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-42-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085682
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME451 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Fluoro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9F2NO2S
951763-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-fluorophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(...
C24H27F2NO4S2
951689-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 F 8.6738 13.5684 0.0 0
M  V30 16 F 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-36-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-43-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087229
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME452 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Chlorophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9ClFNO2S
951763-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-chlorophenyl)-1-[(4-fluorophenyl)sulfonyl]-4-(...
C24H27ClFNO4S2
951689-44-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 8.6738 13.5684 0.0 0
M  V30 16 F 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-37-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-44-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088727
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME453 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-fluorobenzenesulfonamide
C13H9BrFNO2S
951763-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 F 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3336 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-butyl-1-[(4-fluorophenyl)sulfonyl]-4-(2...
C24H27BrFNO4S2
951689-45-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Br 8.6738 13.5684 0.0 0
M  V30 16 F 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-38-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-45-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084359
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME454 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Chloro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 4.2073 0.0 0
M  V30 4 O 6.1600 1.1273 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 0.0000 0.0 0
M  V30 16 C 10.7800 2.6673 0.0 0
M  V30 17 C 12.3200 0.0000 0.0 0
M  V30 18 C 12.3200 2.6673 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(4-chlorophenyl)sulfonyl]-2-(4-fluorophenyl)-4-(...
C24H27ClFNO4S2
951689-46-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 F 8.6738 13.5684 0.0 0
M  V30 16 Cl 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-39-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-46-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085873
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME455 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-4-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Cl 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-butyl-1-[(4-chlorophenyl)sulfonyl]-4-(2...
C24H27BrClNO4S2
951689-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Br 8.6738 13.5684 0.0 0
M  V30 16 Cl 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-40-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087406
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME456 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951763-41-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 F 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-5-butyl-2-(4-fluorophenyl)-4-(2...
C24H27BrFNO4S2
951689-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 F 8.6738 13.5684 0.0 0
M  V30 16 Br 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-41-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090416
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME457 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9BrClNO2S
951763-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 Cl 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-5-butyl-2-(4-chlorophenyl)-4-(2...
C24H27BrClNO4S2
951689-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Cl 8.6738 13.5684 0.0 0
M  V30 16 Br 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-42-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-50-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16091940
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME458 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(4-bromophenyl)methylene]benzenesulfonamide
C13H9Br2NO2S
951763-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.1600 2.6673 0.0 0 VAL=6
M  V30 2 N 7.7000 2.6673 0.0 0
M  V30 3 O 6.1600 1.1273 0.0 0
M  V30 4 O 6.1600 4.2073 0.0 0
M  V30 5 C 8.4700 1.3336 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 Br 14.6300 1.3336 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3336 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6673 0.0 0
M  V30 14 C 10.0100 1.3336 0.0 0
M  V30 15 C 10.7800 2.6673 0.0 0
M  V30 16 C 10.7800 0.0000 0.0 0
M  V30 17 C 12.3200 2.6673 0.0 0
M  V30 18 C 12.3200 0.0000 0.0 0
M  V30 19 C 13.0900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-1-[(4-bromophenyl)sulfonyl]-5-butyl-4-(2-...
C24H27Br2NO4S2
951689-51-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 7.2460 3.7535 0.0 0
M  V30 5 C 6.2156 2.6091 0.0 0
M  V30 6 C 6.6915 1.1444 0.0 0
M  V30 7 C 5.6611 0.0000 0.0 0
M  V30 8 C 4.0596 8.1392 0.0 0
M  V30 9 O 2.6528 7.5128 0.0 0
M  V30 10 O 4.2207 9.6708 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4151 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 Br 8.6738 13.5684 0.0 0
M  V30 16 Br 15.3754 6.4640 0.0 0
M  V30 17 N 7.6754 6.4640 0.0 0
M  V30 18 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 19 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 20 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=1
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=1
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 27
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=3
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-43-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-51-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16064934
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME459 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3,4-dichlorophenyl)methylene]benzenesulfonamide
C13H8Cl3NO2S
951763-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0022 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 7.2322 1.7464 0.0 0
M  V30 4 O 8.7722 4.4137 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 Cl 13.3370 3.0801 0.0 0
M  V30 7 Cl 0.0000 3.0801 0.0 0
M  V30 8 Cl 0.0000 6.1601 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 C 12.0033 2.3101 0.0 0
M  V30 13 C 10.6697 0.0000 0.0 0
M  V30 14 C 12.0033 0.7700 0.0 0
M  V30 15 C 4.0010 3.8501 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 4.0010 5.3901 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 2.6673 6.1601 0.0 0
M  V30 20 C 1.3337 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 2 2 5
M  V30 6 1 5 15
M  V30 7 1 6 12
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(3-chlorophenyl)sulfonyl]-2-(3,4-dichlorophenyl)...
C24H26Cl3NO4S2
951689-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 9.7758 8.1392 0.0 0
M  V30 5 O 11.1826 7.5128 0.0 0
M  V30 6 O 9.6147 9.6708 0.0 0
M  V30 7 C 6.5894 3.7535 0.0 0
M  V30 8 C 7.6198 2.6091 0.0 0
M  V30 9 C 7.1439 1.1444 0.0 0
M  V30 10 C 8.1744 0.0000 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 8.1744 12.9281 0.0 0
M  V30 16 Cl 5.1616 13.5684 0.0 0
M  V30 17 Cl 0.0000 3.7966 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 N 6.1600 6.4640 0.0 0
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 22 C 8.5299 5.6940 0.0 0 CFG=2
M  V30 23 C 6.5894 9.1746 0.0 0
M  V30 24 C 7.6198 10.3190 0.0 0
M  V30 25 C 5.0829 9.4948 0.0 0
M  V30 26 C 7.1439 11.7837 0.0 0
M  V30 27 C 4.6071 10.9593 0.0 0
M  V30 28 C 5.6377 12.1038 0.0 0
M  V30 29 C 3.0800 6.4640 0.0 0
M  V30 30 C 2.3100 5.1304 0.0 0
M  V30 31 C 2.3100 7.7977 0.0 0
M  V30 32 C 0.7700 5.1304 0.0 0
M  V30 33 C 0.7700 7.7977 0.0 0
M  V30 34 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 29
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 20 4 CFG=3
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=1
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 22 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 26
M  V30 17 1 16 28
M  V30 18 1 17 32
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 23 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-44-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16083947
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME460 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(3-chlorophenyl)sulfonyl]-2-(3-methylphenyl)-4-(...
C25H30ClNO4S2
951689-53-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 C 8.1744 12.9281 0.0 0
M  V30 16 Cl 0.0000 3.7966 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 31
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-45-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-53-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME461 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(3-chlorophenyl)sulfonyl]-2-(3-fluorophenyl)-4-(...
C24H27ClFNO4S2
951689-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 F 8.1744 12.9281 0.0 0
M  V30 16 Cl 0.0000 3.7966 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 31
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-46-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-54-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16086977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME462 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(3-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Cl 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(3-chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]-4-(...
C24H27Cl2NO4S2
951689-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 8.1744 12.9281 0.0 0
M  V30 16 Cl 0.0000 3.7966 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 31
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-47-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-55-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16076126
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME463 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(3-Bromophenyl)methylene]-3-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 6.1048 1.7464 0.0 0
M  V30 4 O 4.5648 4.4137 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Br 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 3.8501 0.0 0
M  V30 18 C 10.6697 6.1601 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(3-Bromophenyl)-5-butyl-1-[(3-chlorophenyl)sulfonyl]-4-(2...
C24H27BrClNO4S2
951689-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4153 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Br 8.1744 12.9281 0.0 0
M  V30 16 Cl 0.0000 3.7966 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 31
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-48-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16084139
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME464 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(4-methylphenyl)methylene]benzenesulfonamide
C14H12ClNO2S
951763-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 C 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(3-chlorophenyl)sulfonyl]-2-(4-methylphenyl)-4-(...
C25H30ClNO4S2
951689-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 0.0000 3.7966 0.0 0
M  V30 16 C 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 31
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-49-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-57-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16085637
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME465 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(4-fluorophenyl)methylene]benzenesulfonamide
C13H9ClFNO2S
951763-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 F 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-1-[(3-chlorophenyl)sulfonyl]-2-(4-fluorophenyl)-4-(...
C24H27ClFNO4S2
951689-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 4.9240 0.0 0
M  V30 3 O 4.6200 8.0040 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 0.0000 3.7966 0.0 0
M  V30 16 F 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 31
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-50-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-58-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16087185
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME466 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-3-Chloro-N-[(4-chlorophenyl)methylene]benzenesulfonamide
C13H9Cl2NO2S
951763-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Cl 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-5-Butyl-2-(4-chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]-4-(...
C24H27Cl2NO4S2
951689-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 0.0000 3.7966 0.0 0
M  V30 16 Cl 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 31
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-51-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-59-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16088697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME467 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[(4-Bromophenyl)methylene]-3-chlorobenzenesulfonamide
C13H9BrClNO2S
951763-52-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 Br 13.3370 6.1601 0.0 0
M  V30 8 C 4.0010 2.3101 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 0.7700 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 10.6697 6.1601 0.0 0
M  V30 18 C 12.0033 3.8501 0.0 0
M  V30 19 C 12.0033 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 11
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-2-(4-Bromophenyl)-5-butyl-1-[(3-chlorophenyl)sulfonyl]-4-(2...
C24H27BrClNO4S2
951689-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 6.4640 0.0 0 VAL=6
M  V30 2 O 4.6200 8.0040 0.0 0
M  V30 3 O 4.6200 4.9240 0.0 0
M  V30 4 C 6.5894 3.7535 0.0 0
M  V30 5 C 7.6198 2.6091 0.0 0
M  V30 6 C 7.1439 1.1444 0.0 0
M  V30 7 C 8.1744 0.0000 0.0 0
M  V30 8 C 9.7758 8.1392 0.0 0
M  V30 9 O 11.1826 7.5128 0.0 0
M  V30 10 O 9.6147 9.6708 0.0 0
M  V30 11 S 9.7758 4.7888 0.0 0
M  V30 12 C 11.1826 5.4151 0.0 0
M  V30 13 C 12.4285 4.5101 0.0 0
M  V30 14 C 13.8354 5.1364 0.0 0
M  V30 15 Cl 0.0000 3.7966 0.0 0
M  V30 16 Br 5.1616 13.5684 0.0 0
M  V30 17 N 6.1600 6.4640 0.0 0
M  V30 18 C 7.0652 7.7099 0.0 0 CFG=1
M  V30 19 C 7.0652 5.2182 0.0 0 CFG=2
M  V30 20 C 8.5299 7.2340 0.0 0 CFG=2
M  V30 21 C 8.5299 5.6940 0.0 0 CFG=1
M  V30 22 C 6.5894 9.1746 0.0 0
M  V30 23 C 7.6198 10.3190 0.0 0
M  V30 24 C 5.0829 9.4948 0.0 0
M  V30 25 C 7.1439 11.7837 0.0 0
M  V30 26 C 4.6071 10.9593 0.0 0
M  V30 27 C 5.6377 12.1038 0.0 0
M  V30 28 C 3.0800 6.4640 0.0 0
M  V30 29 C 2.3100 5.1304 0.0 0
M  V30 30 C 2.3100 7.7977 0.0 0
M  V30 31 C 0.7700 5.1304 0.0 0
M  V30 32 C 0.7700 7.7977 0.0 0
M  V30 33 C 0.0000 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 1 19 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 20 8 CFG=3
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 31
M  V30 17 1 16 27
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 18 22 CFG=1
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 18 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951763-52-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16090187
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME468 STEP1
$RXN



  3  1
$MOL
2,3-Octadienoic acid
C8H12O2
36253-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[N(E)]-4-Bromo-N-[(3-fluorophenyl)methylene]benzenesulfonamide
C13H9BrFNO2S
951764-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 2.3101 0.0 0
M  V30 3 O 6.1048 4.4137 0.0 0
M  V30 4 O 4.5648 1.7464 0.0 0
M  V30 5 C 8.0022 3.0801 0.0 0
M  V30 6 Br 0.0000 6.1601 0.0 0
M  V30 7 F 13.3370 3.0801 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 2.6673 3.0801 0.0 0
M  V30 10 C 4.0010 5.3901 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 0.0000 0.0 0
M  V30 19 C 12.0033 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 1 5 14
M  V30 7 1 6 13
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allyl mercaptan
C3H6S
870-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 0.0000 0.7700 0.0 0
M  V30 4 S 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R,4S,5R)-1-[(4-Bromophenyl)sulfonyl]-5-butyl-2-(3-fluorophenyl)-4-(2...
C24H27BrFNO4S2
951689-39-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2154 6.4640 0.0 0 VAL=6
M  V30 2 O 9.2154 8.0040 0.0 0
M  V30 3 O 9.2154 4.9240 0.0 0
M  V30 4 C 4.0596 8.1392 0.0 0
M  V30 5 O 2.6528 7.5128 0.0 0
M  V30 6 O 4.2207 9.6708 0.0 0
M  V30 7 C 7.2460 3.7535 0.0 0
M  V30 8 C 6.2156 2.6091 0.0 0
M  V30 9 C 6.6915 1.1444 0.0 0
M  V30 10 C 5.6611 0.0000 0.0 0
M  V30 11 S 4.0596 4.7888 0.0 0
M  V30 12 C 2.6528 5.4153 0.0 0
M  V30 13 C 1.4070 4.5101 0.0 0
M  V30 14 C 0.0000 5.1364 0.0 0
M  V30 15 F 5.6611 12.9281 0.0 0
M  V30 16 Br 15.3754 6.4640 0.0 0
M  V30 17 C 6.7702 7.7099 0.0 0 CFG=1
M  V30 18 N 7.6754 6.4640 0.0 0
M  V30 19 C 5.3055 7.2340 0.0 0 CFG=2
M  V30 20 C 6.7702 5.2182 0.0 0 CFG=2
M  V30 21 C 5.3055 5.6940 0.0 0 CFG=2
M  V30 22 C 7.2460 9.1746 0.0 0
M  V30 23 C 6.2156 10.3190 0.0 0
M  V30 24 C 8.7525 9.4948 0.0 0
M  V30 25 C 6.6915 11.7837 0.0 0
M  V30 26 C 9.2283 10.9593 0.0 0
M  V30 27 C 8.1978 12.1038 0.0 0
M  V30 28 C 10.7554 6.4640 0.0 0
M  V30 29 C 11.5254 5.1304 0.0 0
M  V30 30 C 11.5254 7.7977 0.0 0
M  V30 31 C 13.0654 5.1304 0.0 0
M  V30 32 C 13.0654 7.7977 0.0 0
M  V30 33 C 13.8354 6.4640 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 1 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 19 4 CFG=1
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=3
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 21 11 CFG=1
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 15 25
M  V30 17 1 16 33
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 22 CFG=3
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 36253-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 951764-30-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 870-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951689-39-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16092159
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 14338-32-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The allenoic acids 4 were coupled to the
benzyl alcohol units of the SynPhase-PS lanterns grafted with Wang resin
3 using Mukaiyama's reagent and Hunig's base for 4a/b or Et3N for 4c/d.
The direct use of an unmodified Wang resin minimizes the number of
synthetic operations run on solid support. In addition, our strategy
enabled simple trifluoroacetic acid (TFA)-mediated cleavage to release
the carboxylic acid group, a key functional group in our GGTIs. The
phosphine-catalyzed annulation between solid-bound polymer-supported
allenoates 5 and N-tosylimines proceeded smoothly. The allenoates 5a and
5b were treated with N-tosyltolualdimine and 50 mol% of PPh3 (for 5a) or
PBu3 (for 5b) in benzene at 60 °C to provide the polymer-bound
dihydropyrroles 6. Tetrahydropyridines 7 were formed from the reactions
of 5c and 5d with N-tosyltolualdimine in the presence of 50 mol% of PBu3
at room temperature for 2 and 4 days, respectively. The α ,β -unsaturated
enoate functionalities in 6 and 7 were utilized to further increase the
modularity and number of analogs. For example, the Michael additions of
thiols to 6 and 7 using n-butyllithium as base provided 10 and 11,
respectively, which upon TFA mediated cleavage yielded 12 and 13,
respectively, in 77-95% yield (Scheme 2). These two-step sequences
occurred with high diastereoselectivities, providing the pentasubstituted
pyrrolidine 12 and the tetrasubstituted piperidine 13 as single
diastereoisomeric products. Yield 95%.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, solid-supported reaction, stereoselective (in stages 2 and
3), Michael addition in stage 3, Et3N can also be used as alternate base
in stage 1, attachment to Wang linker in stage 1, alternate reaction
conditions also shown in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of protein prenyltransferases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kwon, Ohyun; Tamanoi, Fuyuhiko; Fiji, Hannah; Watanabe, Masaru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010014054 A1 2010-02-04

$RFMT $RIREG SCHEME469 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butoxycarbonyl-D-proline
C10H17NO4
37784-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=1
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[(ethylthio)carbonyl]-1-pyrrolidinecarboxylate
C12H21NO3S
852324-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6438 3.7710 0.0 0
M  V30 2 O 2.1038 3.7710 0.0 0
M  V30 3 O 4.4138 5.1048 0.0 0
M  V30 4 C 1.3338 5.1048 0.0 0
M  V30 5 C 0.0000 4.3348 0.0 0
M  V30 6 C 0.5638 6.4384 0.0 0
M  V30 7 C 2.6674 5.8748 0.0 0
M  V30 8 C 6.9757 3.4208 0.0 0
M  V30 9 S 8.4822 3.1006 0.0 0
M  V30 10 O 6.4999 4.8855 0.0 0
M  V30 11 C 9.5126 4.2450 0.0 0
M  V30 12 C 11.0190 3.9248 0.0 0
M  V30 13 N 4.4138 2.4374 0.0 0
M  V30 14 C 5.9453 2.2764 0.0 0 CFG=1
M  V30 15 C 3.7873 1.0306 0.0 0
M  V30 16 C 6.2655 0.7700 0.0 0
M  V30 17 C 4.9319 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37784-17-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 852324-75-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-6068996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: (2R)-N-Boc-Prolinethioester To a solution of DCC (2.55 g, 12.4
mmol), DMAP (100 mg), and EtSH (0.71 g, 11.1 mmol) DCM (30 mL) was added
a solution of (2R)-N-Boc-proline (3.00 g, 9.52 mmol) in DCM (30 mL).
After the reaction mixture was stirred at rt for 30 min., the precipitate
was filtered off through Celite. The filtrate was dried over MgSO4 and
concentrated in vacuo, and the residue was purified by column
chromatography (eluent: EtOAc/Hex = 1/4) to give the title compound (2.34
g, 95.2%). (2R)-N-Boc-Prolinethioester, Yield (2.34 g, 95.2%). MS [M+H] =
260 (M+1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino acid piperidinamides as melanocortin receptor
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Koo; Park, Heui-Sul; Ahn, In-Ae; Yoo, Hyun-Ju; Choi, Sung-Pil; Choi,
Deog-Young; Yim, Hyeon-Joo; Kwon, O-Hwan; Kondoh, Yutaka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005047253 A1 2005-05-26

$RFMT $RIREG SCHEME469 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butoxycarbonyl-D-proline
C10H17NO4
37784-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=1
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=3
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R)-2-[(ethylthio)carbonyl]-1-pyrrolidinecarboxylate
C12H21NO3S
852324-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6438 3.7710 0.0 0
M  V30 2 O 2.1038 3.7710 0.0 0
M  V30 3 O 4.4138 5.1048 0.0 0
M  V30 4 C 1.3338 5.1048 0.0 0
M  V30 5 C 0.0000 4.3348 0.0 0
M  V30 6 C 0.5638 6.4384 0.0 0
M  V30 7 C 2.6674 5.8748 0.0 0
M  V30 8 C 6.9757 3.4208 0.0 0
M  V30 9 S 8.4822 3.1006 0.0 0
M  V30 10 O 6.4999 4.8855 0.0 0
M  V30 11 C 9.5126 4.2450 0.0 0
M  V30 12 C 11.0190 3.9248 0.0 0
M  V30 13 N 4.4138 2.4374 0.0 0
M  V30 14 C 5.9453 2.2764 0.0 0 CFG=1
M  V30 15 C 3.7873 1.0306 0.0 0
M  V30 16 C 6.2655 0.7700 0.0 0
M  V30 17 C 4.9319 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37784-17-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 852324-75-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-5913467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: (2R)-N-BOC-proline ethylthioester: To a solution of DCC (2.55 g,
12.4 mmol), DMAP (100 mg), and EtSH (0.71 g, 11.1 mmol) in DCM was added
dropwise a solution of (2R)-N-BOC-proline (3.00 g, 9.52 mmol) in DCM (30
mL). The reaction mixture was stirred at rt for 30 min, and filtered
though Celite. The filtrate was dried over MgSO4 and concentrated in
vacuo, and the residue was purified by column chomatography (EtOAc/Hex =
1/4) to give the title compound, yield 2.34 g, 95%. MS [M+H] = 260 (M+1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino acid aminoheterocyclyl amides as melanocortin
receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Koo; Park, Heui-Sul; Ahn, In-Ae; Yoo, Hyun-Ju; Kim, Jong-Yup; Choi,
Deog-Young; Yim, Hyeon-Joo; Chung, Kyung-Ha; Shim, Dong-Sup; Lee,
Sang-Kyun; Kondoh, Yutaka; Hirabayashi, Ryoji; Honda, Shugo; Kaku,
Hidetaka; Shishikura, Jun-ichi; Ito, Hiroyuki; Kurama, Takeshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005047251 A1 2005-05-26

$RFMT $RIREG SCHEME470 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R)-2-[(2-Methoxy-4-nitrophenoxy)methyl]oxirane
C10H11NO5
394248-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 O 4.0012 6.1601 0.0 0
M  V30 4 C 2.6675 6.9302 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0 CFG=2
M  V30 15 C 10.1060 5.9538 0.0 0
M  V30 16 O 10.8760 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 14 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-1-(Ethylthio)-3-(2-methoxy-4-nitrophenoxy)-2-propanol
C12H17NO5S
1221420-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3358 4.6201 0.0 0 CFG=2
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 O 9.3358 6.1601 0.0 0
M  V30 6 S 12.0033 4.6201 0.0 0
M  V30 7 C 13.3370 3.8501 0.0 0
M  V30 8 C 14.6707 4.6201 0.0 0
M  V30 9 O 4.0010 6.1601 0.0 0
M  V30 10 C 2.6673 6.9302 0.0 0
M  V30 11 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 O 0.0000 2.3101 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 4.0010 1.5400 0.0 0
M  V30 19 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 15
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394248-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1221420-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-014-CAS-11028633
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmad, Saleem; Zhao, Guohua; Washburn, William N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014039411 A1 2014-03-13

$RFMT $RIREG SCHEME471 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Galactose pentaacetate
C16H22O11
4163-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 3.8500 0.0 0
M  V30 2 C 1.3336 4.6200 0.0 0
M  V30 3 C 0.0000 3.8500 0.0 0
M  V30 4 O 1.3336 6.1600 0.0 0
M  V30 5 O 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6673 2.3100 0.0 0
M  V30 8 O 4.0011 0.0000 0.0 0
M  V30 9 O 2.6673 6.9300 0.0 0
M  V30 10 C 2.6673 8.4700 0.0 0
M  V30 11 C 4.0011 9.2400 0.0 0
M  V30 12 O 1.3336 9.2400 0.0 0
M  V30 13 C 8.0020 3.8500 0.0 0
M  V30 14 O 9.3358 4.6200 0.0 0
M  V30 15 C 10.6694 3.8500 0.0 0
M  V30 16 C 10.6694 2.3100 0.0 0
M  V30 17 O 12.0031 4.6200 0.0 0
M  V30 18 O 5.3347 8.4700 0.0 0
M  V30 19 C 6.6684 9.2400 0.0 0
M  V30 20 C 6.6684 10.7800 0.0 0
M  V30 21 O 8.0020 8.4700 0.0 0
M  V30 22 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 23 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 24 C 4.0011 6.1600 0.0 0 CFG=1
M  V30 25 C 6.6684 4.6200 0.0 0 CFG=1
M  V30 26 C 5.3347 6.9300 0.0 0 CFG=2
M  V30 27 O 6.6684 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 23 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 24 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 25 13 CFG=3
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 26 18 CFG=3
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 22 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
α-D-Galactopyranoside, 1,1-dimethylethyl 1-thio-, tetraacetate
C18H28O9S
263839-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 3.8501 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 C 0.0000 3.8501 0.0 0
M  V30 4 O 1.3337 6.1601 0.0 0
M  V30 5 O 2.6673 6.9302 0.0 0
M  V30 6 C 2.6673 8.4702 0.0 0
M  V30 7 C 4.0012 9.2402 0.0 0
M  V30 8 O 1.3337 9.2402 0.0 0
M  V30 9 O 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 O 2.6673 2.3101 0.0 0
M  V30 13 S 5.3348 8.4702 0.0 0
M  V30 14 C 6.6685 9.2402 0.0 0
M  V30 15 C 5.8985 10.5739 0.0 0
M  V30 16 C 8.0022 10.0102 0.0 0
M  V30 17 C 7.4385 7.9065 0.0 0
M  V30 18 C 8.0022 3.8501 0.0 0
M  V30 19 O 9.3360 4.6201 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 21 C 10.6697 2.3101 0.0 0
M  V30 22 O 12.0033 4.6201 0.0 0
M  V30 23 C 4.0012 4.6201 0.0 0 CFG=1
M  V30 24 C 4.0012 6.1601 0.0 0 CFG=1
M  V30 25 C 5.3348 3.8501 0.0 0 CFG=1
M  V30 26 C 5.3348 6.9302 0.0 0 CFG=1
M  V30 27 C 6.6685 4.6201 0.0 0 CFG=1
M  V30 28 O 6.6685 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 24 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 25 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 26 13 CFG=1
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 18 19
M  V30 19 1 27 18 CFG=3
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 23 24 25 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4163-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 263839-84-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-9974630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-63-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, product depends on temperature
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphinite thioglycosides derived from natural D-sugars as useful P/S
ligands for the synthesis of both enantiomers in palladium-catalyzed
asymmetric substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khiar, Noureddine; Suarez, Belen; Valdivia, Victoria; Fernandez,
Inmaculada
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2005), (19), 2963-2967

$RFMT $RIREG SCHEME472 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Galactose pentaacetate
C16H22O11
4163-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 3.8500 0.0 0
M  V30 2 C 1.3336 4.6200 0.0 0
M  V30 3 C 0.0000 3.8500 0.0 0
M  V30 4 O 1.3336 6.1600 0.0 0
M  V30 5 O 5.3347 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6673 2.3100 0.0 0
M  V30 8 O 4.0011 0.0000 0.0 0
M  V30 9 O 2.6673 6.9300 0.0 0
M  V30 10 C 2.6673 8.4700 0.0 0
M  V30 11 C 4.0011 9.2400 0.0 0
M  V30 12 O 1.3336 9.2400 0.0 0
M  V30 13 C 8.0020 3.8500 0.0 0
M  V30 14 O 9.3358 4.6200 0.0 0
M  V30 15 C 10.6694 3.8500 0.0 0
M  V30 16 C 10.6694 2.3100 0.0 0
M  V30 17 O 12.0031 4.6200 0.0 0
M  V30 18 O 5.3347 8.4700 0.0 0
M  V30 19 C 6.6684 9.2400 0.0 0
M  V30 20 C 6.6684 10.7800 0.0 0
M  V30 21 O 8.0020 8.4700 0.0 0
M  V30 22 C 4.0011 4.6200 0.0 0 CFG=2
M  V30 23 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 24 C 4.0011 6.1600 0.0 0 CFG=1
M  V30 25 C 6.6684 4.6200 0.0 0 CFG=1
M  V30 26 C 5.3347 6.9300 0.0 0 CFG=2
M  V30 27 O 6.6684 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 23 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 24 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 25 13 CFG=3
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 18 19
M  V30 19 1 26 18 CFG=3
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 22 23 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
β-D-Galactopyranoside, 1,1-dimethylethyl 1-thio-, tetraacetate
C18H28O9S
79763-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 3.8501 0.0 0
M  V30 2 C 1.3337 4.6201 0.0 0
M  V30 3 C 0.0000 3.8501 0.0 0
M  V30 4 O 1.3337 6.1601 0.0 0
M  V30 5 O 2.6673 6.9302 0.0 0
M  V30 6 C 2.6673 8.4702 0.0 0
M  V30 7 C 4.0012 9.2402 0.0 0
M  V30 8 O 1.3337 9.2402 0.0 0
M  V30 9 O 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 O 2.6673 2.3101 0.0 0
M  V30 13 S 5.3348 8.4702 0.0 0
M  V30 14 C 6.6685 9.2402 0.0 0
M  V30 15 C 5.8985 10.5739 0.0 0
M  V30 16 C 8.0022 10.0102 0.0 0
M  V30 17 C 7.4385 7.9065 0.0 0
M  V30 18 C 8.0022 3.8501 0.0 0
M  V30 19 O 9.3360 4.6201 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 21 C 10.6697 2.3101 0.0 0
M  V30 22 O 12.0033 4.6201 0.0 0
M  V30 23 C 4.0012 4.6201 0.0 0 CFG=1
M  V30 24 C 4.0012 6.1601 0.0 0 CFG=1
M  V30 25 C 5.3348 3.8501 0.0 0 CFG=1
M  V30 26 C 5.3348 6.9302 0.0 0 CFG=2
M  V30 27 C 6.6685 4.6201 0.0 0 CFG=1
M  V30 28 O 6.6685 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 24 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 25 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 26 13 CFG=3
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 18 19
M  V30 19 1 27 18 CFG=3
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 23 24 25 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4163-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79763-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-12102604
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-63-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, product depends on temperature
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphinite thioglycosides derived from natural D-sugars as useful P/S
ligands for the synthesis of both enantiomers in palladium-catalyzed
asymmetric substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khiar, Noureddine; Suarez, Belen; Valdivia, Victoria; Fernandez,
Inmaculada
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2005), (19), 2963-2967

$RFMT $RIREG SCHEME473 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,4S)-2-[(2S,3R,4E)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-6-methyl-1-ox...
C30H47NO4Si
442913-26-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9935 8.0021 0.0 0
M  V30 2 C 6.7635 6.6685 0.0 0 CFG=1
M  V30 3 O 6.7635 9.3359 0.0 0
M  V30 4 C 8.3035 6.6685 0.0 0 CFG=1
M  V30 5 O 5.9935 5.3348 0.0 0
M  V30 6 O 9.0735 5.3348 0.0 0
M  V30 7 C 9.0735 8.0021 0.0 0
M  V30 8 C 6.7635 4.0011 0.0 0
M  V30 9 Si 10.6136 5.3348 0.0 0
M  V30 10 C 8.3035 9.3359 0.0 0
M  V30 11 C 12.1536 5.3348 0.0 0
M  V30 12 C 10.6136 6.8748 0.0 0
M  V30 13 C 10.6136 3.7948 0.0 0
M  V30 14 C 9.0735 10.6696 0.0 0
M  V30 15 C 12.1536 6.8748 0.0 0
M  V30 16 C 13.6936 5.3348 0.0 0
M  V30 17 C 12.1536 3.7948 0.0 0
M  V30 18 C 8.3035 12.0033 0.0 0
M  V30 19 C 10.6136 10.6696 0.0 0
M  V30 20 O 3.3332 6.0854 0.0 0
M  V30 21 C 0.3748 8.0526 0.0 0
M  V30 22 C 0.0000 8.8787 0.0 0
M  V30 23 C 0.9633 10.7960 0.0 0
M  V30 24 C 3.0351 8.4403 0.0 0 CFG=1
M  V30 25 N 4.4534 8.0021 0.0 0
M  V30 26 C 1.1288 6.6309 0.0 0
M  V30 27 C 2.5738 9.7622 0.0 0
M  V30 28 C 3.2205 7.6213 0.0 0
M  V30 29 C 1.8979 7.8253 0.0 0 CFG=2
M  V30 30 C 1.4689 9.3415 0.0 0
M  V30 31 C 5.9935 2.6673 0.0 0
M  V30 32 C 6.7635 1.3337 0.0 0
M  V30 33 C 4.4534 2.6673 0.0 0
M  V30 34 C 5.9935 0.0000 0.0 0
M  V30 35 C 3.6834 1.3337 0.0 0
M  V30 36 C 4.4534 0.0000 0.0 0
M  V30 37 H 4.1043 9.5488 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 25
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6 CFG=1
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 8 31
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 11 17
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 2 20 28
M  V30 22 1 29 21 CFG=3
M  V30 23 1 22 30
M  V30 24 1 23 30
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 24 27
M  V30 28 1 24 37 CFG=1
M  V30 29 1 25 28
M  V30 30 1 26 29
M  V30 31 1 27 30
M  V30 32 1 28 29
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 4 24 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
S-Ethyl (2S,3R,4E)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-methyl-2-(phen...
C23H38O3SSi
442913-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3901 0.0 0 CFG=1
M  V30 2 C 6.6685 4.6201 0.0 0 CFG=2
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 5.3348 6.9302 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 O 8.0022 5.3901 0.0 0
M  V30 7 Si 2.6673 5.3901 0.0 0
M  V30 8 C 6.6685 7.7002 0.0 0
M  V30 9 S 8.0022 2.3101 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 9.3360 4.6201 0.0 0
M  V30 12 C 1.3337 6.1601 0.0 0
M  V30 13 C 3.4374 6.7238 0.0 0
M  V30 14 C 1.8973 4.0564 0.0 0
M  V30 15 C 6.6685 9.2402 0.0 0
M  V30 16 C 8.0022 0.7700 0.0 0
M  V30 17 C 0.5637 4.8265 0.0 0
M  V30 18 C 0.0000 6.9302 0.0 0
M  V30 19 C 2.1037 7.4938 0.0 0
M  V30 20 C 8.0022 10.0102 0.0 0
M  V30 21 C 5.3348 10.0102 0.0 0
M  V30 22 C 9.3360 0.0000 0.0 0
M  V30 23 C 10.6697 5.3901 0.0 0
M  V30 24 C 12.0033 4.6201 0.0 0
M  V30 25 C 10.6697 6.9302 0.0 0
M  V30 26 C 13.3370 5.3901 0.0 0
M  V30 27 C 12.0033 7.7002 0.0 0
M  V30 28 C 13.3370 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 8 15
M  V30 15 1 9 16
M  V30 16 1 11 23
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 12 19
M  V30 20 1 15 20
M  V30 21 1 15 21
M  V30 22 1 16 22
M  V30 23 2 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 27
M  V30 27 2 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 442913-26-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 442913-41-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-362-CAS-21042431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The development of a convergent and efficient enantioselective synthesis
of the bengamides via a common polyol intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boeckman, Robert K. Jr.; Clark, Tammy J.; Shook, Brian C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2002), 85(12), 4532-4560

$RFMT $RIREG SCHEME474 STEP1
$RXN



  2  1
$MOL
4-(Trifluoromethyl)benzoic acid
C8H5F3O2
455-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.5400 0.0 0
M  V30 2 F 6.9300 3.0800 0.0 0
M  V30 3 F 8.4700 1.5400 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
S-Ethyl 4-(trifluoromethyl)benzenecarbothioate
C10H9F3OS
160911-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6673 0.0 0
M  V30 2 S 8.4700 1.3336 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 C 10.0100 1.3336 0.0 0
M  V30 5 C 10.7800 0.0000 0.0 0
M  V30 6 C 1.5400 2.6673 0.0 0
M  V30 7 F 1.5400 1.1273 0.0 0
M  V30 8 F 0.0000 2.6673 0.0 0
M  V30 9 F 1.5400 4.2073 0.0 0
M  V30 10 C 6.1600 2.6673 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 3.8500 4.0011 0.0 0
M  V30 14 C 3.8500 1.3336 0.0 0
M  V30 15 C 3.0800 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 455-24-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 160911-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-356-CAS-6863968
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From carboxylic acids to the trifluoromethyl group using BrF3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cohen, Or; Mishani, Eyal; Rozen, Shlomo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2010), 66(20), 3579-3582

$RFMT $RIREG SCHEME475 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iron(1+), [(2,3,4,5,6-η)-rel-(1R,7S)-bicyclo[5.1.0]octa-3,5-dien-2-yl]dicarbo...
C28H24FeO2P.BF4
459167-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 9.2865 9.1111 0.0 0 VAL=4
M  V30 2 C 4.3857 9.1111 0.0 0
M  V30 3 O 2.9693 9.1111 0.0 0 VAL=3
M  V30 4 C 6.8361 7.6947 0.0 0
M  V30 5 O 5.4197 7.6947 0.0 0 VAL=3
M  V30 6 Fe 6.8361 10.5236 0.0 0 CHG=2 VAL=8
M  V30 7 C 0.0000 20.5202 0.0 0 VAL=5
M  V30 8 C 0.0000 25.4288 0.0 0 VAL=5
M  V30 9 C 4.2062 18.0620 0.0 0 VAL=5
M  V30 10 C 9.1148 18.0620 0.0 0 CHG=-1 VAL=4
M  V30 11 C 6.6644 29.2838 0.0 0 VAL=5
M  V30 12 C 13.3210 20.5202 0.0 0
M  V30 13 C 13.3210 25.4288 0.0 0
M  V30 14 C 17.5273 22.9745 0.0 0
M  V30 15 C 10.5117 9.8173 0.0 0
M  V30 16 C 10.5117 11.3547 0.0 0
M  V30 17 C 11.8461 9.0486 0.0 0
M  V30 18 C 11.8461 12.1194 0.0 0
M  V30 19 C 13.1728 9.8173 0.0 0
M  V30 20 C 13.1728 11.3547 0.0 0
M  V30 21 C 9.2865 7.6947 0.0 0
M  V30 22 C 7.9520 6.9260 0.0 0
M  V30 23 C 10.6131 6.9260 0.0 0
M  V30 24 C 7.9520 5.3887 0.0 0
M  V30 25 C 10.6131 5.3887 0.0 0
M  V30 26 C 9.2865 4.6200 0.0 0
M  V30 27 C 11.2491 7.9951 0.0 0
M  V30 28 C 11.2491 6.4578 0.0 0
M  V30 29 C 12.5836 8.7638 0.0 0
M  V30 30 C 12.5836 5.6891 0.0 0
M  V30 31 C 13.9102 7.9951 0.0 0
M  V30 32 C 13.9102 6.4578 0.0 0
M  V30 33 B 8.7636 1.5400 0.0 0 CHG=3 VAL=4
M  V30 34 F 7.2236 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 35 F 10.3036 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 36 F 8.7636 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 37 F 8.7636 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 15
M  V30 3 1 1 21
M  V30 4 1 1 27
M  V30 5 3 2 3
M  V30 6 1 2 6
M  V30 7 3 4 5
M  V30 8 1 4 6
M  V30 9 1 6 7
M  V30 10 1 6 8
M  V30 11 1 6 9
M  V30 12 1 6 10
M  V30 13 1 6 11
M  V30 14 1 7 8
M  V30 15 2 7 9
M  V30 16 2 8 11
M  V30 17 1 9 10
M  V30 18 1 10 12
M  V30 19 1 11 13
M  V30 20 1 12 13
M  V30 21 1 12 14
M  V30 22 1 13 14
M  V30 23 2 15 16
M  V30 24 1 15 17
M  V30 25 1 16 18
M  V30 26 2 17 19
M  V30 27 2 18 20
M  V30 28 1 19 20
M  V30 29 2 21 22
M  V30 30 1 21 23
M  V30 31 1 22 24
M  V30 32 2 23 25
M  V30 33 2 24 26
M  V30 34 1 25 26
M  V30 35 2 27 28
M  V30 36 1 27 29
M  V30 37 1 28 30
M  V30 38 2 29 31
M  V30 39 2 30 32
M  V30 40 1 31 32
M  V30 41 1 33 34
M  V30 42 1 33 35
M  V30 43 1 33 36
M  V30 44 1 33 37
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iron, dicarbonyl[(2,3,4,5-η)-6-(ethylthio)bicyclo[5.1.0]octa-2,4-diene](triph...
C30H29FeO2PS
692732-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 15.3964 4.4939 0.0 0 VAL=4
M  V30 2 C 10.4883 7.3270 0.0 0
M  V30 3 O 9.0698 7.3270 0.0 0 VAL=3
M  V30 4 C 12.9424 3.0754 0.0 0
M  V30 5 O 14.3609 3.0754 0.0 0 VAL=3
M  V30 6 S 9.8631 13.3253 0.0 0
M  V30 7 C 8.6361 12.6180 0.0 0
M  V30 8 C 7.4090 13.3253 0.0 0
M  V30 9 Fe 12.9424 5.9124 0.0 0 VAL=7
M  V30 10 C 20.5429 23.3682 0.0 0 VAL=5
M  V30 11 C 20.5429 17.6199 0.0 0 VAL=5
M  V30 12 C 12.7353 27.8894 0.0 0 VAL=5
M  V30 13 C 15.6114 14.7438 0.0 0 VAL=5
M  V30 14 C 4.9355 23.3682 0.0 0
M  V30 15 C 9.8631 14.7438 0.0 0
M  V30 16 C 4.9355 17.6199 0.0 0
M  V30 17 C 0.0000 20.4960 0.0 0
M  V30 18 C 16.6235 5.2012 0.0 0
M  V30 19 C 16.6235 6.7408 0.0 0
M  V30 20 C 17.9599 4.4353 0.0 0
M  V30 21 C 17.9599 7.5106 0.0 0
M  V30 22 C 19.2885 5.2012 0.0 0
M  V30 23 C 19.2885 6.7408 0.0 0
M  V30 24 C 15.3964 3.0754 0.0 0
M  V30 25 C 14.0639 2.3056 0.0 0
M  V30 26 C 16.7290 2.3056 0.0 0
M  V30 27 C 14.0639 0.7698 0.0 0
M  V30 28 C 16.7290 0.7698 0.0 0
M  V30 29 C 15.3964 0.0000 0.0 0
M  V30 30 C 17.3620 3.3763 0.0 0
M  V30 31 C 17.3620 1.8405 0.0 0
M  V30 32 C 18.6985 4.1461 0.0 0
M  V30 33 C 18.6985 1.0707 0.0 0
M  V30 34 C 20.0271 3.3763 0.0 0
M  V30 35 C 20.0271 1.8405 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 18
M  V30 3 1 1 24
M  V30 4 1 1 30
M  V30 5 3 2 3
M  V30 6 1 2 9
M  V30 7 3 4 5
M  V30 8 1 4 9
M  V30 9 1 6 7
M  V30 10 1 6 15
M  V30 11 1 7 8
M  V30 12 1 9 10
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 15 1 9 13
M  V30 16 1 10 11
M  V30 17 2 10 12
M  V30 18 2 11 13
M  V30 19 1 12 14
M  V30 20 1 13 15
M  V30 21 1 14 16
M  V30 22 1 14 17
M  V30 23 1 15 16
M  V30 24 1 16 17
M  V30 25 2 18 19
M  V30 26 1 18 20
M  V30 27 1 19 21
M  V30 28 2 20 22
M  V30 29 2 21 23
M  V30 30 1 22 23
M  V30 31 2 24 25
M  V30 32 1 24 26
M  V30 33 1 25 27
M  V30 34 2 26 28
M  V30 35 2 27 29
M  V30 36 1 28 29
M  V30 37 2 30 31
M  V30 38 1 30 32
M  V30 39 1 31 33
M  V30 40 2 32 34
M  V30 41 2 33 35
M  V30 42 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 459167-47-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 692732-43-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30682920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-09-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Dicarbonyl(6-ethanesulfanylbicyclo[5.1.0]octa-2,4-diene)(triphenylphosphine)iron
(13e). The reaction of 8 (0.4247 g, 0.7502 mmol) with ethanethiol and
NaOAc was carried out in a fashion similar to the reaction of 5. After
being stirred for 4.5 h, the green solution was concentrated using a
stream of N2. The viscous material was dissolved in fresh ether and
washed with water followed by brine. The organic solution was dried,
filtered through a short bed of alumina, and concentrated to give 13e as
a yellow foam (0.3855 g, 95%), which was unstable toward extended
exposure to common chromatographic adsorbents. mp &gt;34 °C dec; IR (KBr)
3057, 2969, 1968, 1909, 1480, 1434, 1090, 696 cm-1; 1H NMR (C6D6) δ
0.12-0.20 (m, 1H), 0.59-0.69 (m, 1H), 1.10-1.23 (m, 1H), 1.14 (t, J = 7.3
Hz, 3H), 1.43-1.55 (m, 1H), 2.39 (q, J = 7.3 Hz, 2H), 2.91-3.01 (m, 1H),
3.13-3.23 (m, 1H), 4.01 (dd, J= 4.6, 7.5 Hz, 1H), 4.34-4.43 (m, 1H),
4.51-4.60 (m, 1H), 6.93-7.04 (m, 9H), 7.47-7.56 (m, 6H); 13C NMR (C6D6) δ
16.8, 18.7, 20.4, 22.3, 26.8, 45.2, 61.9, 64.1, 87.7, 88.2, 128.9 (d, JCP
= 9.2 Hz), 130.2 (d, JCP = 2.3 Hz), 133.7 (d, JCP = 10.4 Hz), 136.4 (d,
JCP = 36.9 Hz). Anal. Calcd for C30H29FeO2PS: C, 66.67; H, 5.41. Found:
C, 66.33; H, 5.49.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactivity of (Bicyclo[5.1.0]octadienyl)iron(1+) Cations: Application to
the Synthesis of cis-2-(2'-Carboxycyclopropyl)glycines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wallock, Nathaniel J.; Donaldson, William A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2004), 69(9), 2997-3007

$RFMT $RIREG SCHEME476 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzaldehyde
C7H5FO
459-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 F 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[Bis(ethylthio)methyl]-4-fluorobenzene
C11H15FS2
346592-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8500 0.0 0
M  V30 2 S 6.6684 4.6201 0.0 0
M  V30 3 S 5.3348 2.3100 0.0 0
M  V30 4 C 8.0022 3.8500 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 C 6.6684 0.0000 0.0 0
M  V30 8 F 0.0000 6.9301 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 4.0011 6.1601 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 2.6675 6.9301 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 459-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 346592-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-2107565
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7758-98-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: The Thioacetalization of Aldehydes and
Transthioacetalization of Acetals in a Solvent General Procedure The
dithiol (3 mmol) or thiol (5-6 mmol)was added to a stirring solution of
aldehydes or acetals (2.5 mmol) in CH2Cl2 (15 mL). Then, anhydrous copper
sulfate (3.5 mmol) was added, and the resulting mixture was stirred at
r.t. for an appropriate time as required for completion of the reaction,
which was monitored by TLC (petroleum ether:ethyl acetate, 4:1). After
separation of the catalyst by filtration, the solvent was removed under
reduced pressure. In all these cases, crude products were sufficiently
pure (TLC and 1H-NMR), and the further pure products were obtained by
crystallization from petroleum ether (b.p. 100-140°C) or PTLC. TABLE 1,
Entry 7, yield 95%
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Mild and Chemoselective Dithioacetalization of Aldehydes in the
Presence of Anhydrous Copper(II) Sulfate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, Firouz; Bardajee, Ghasem; Oskui, Afsane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2006), 181(6),
1445-1450

$RFMT $RIREG SCHEME476 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzaldehyde
C7H5FO
459-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 F 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[Bis(ethylthio)methyl]-4-fluorobenzene
C11H15FS2
346592-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8500 0.0 0
M  V30 2 S 6.6684 4.6201 0.0 0
M  V30 3 S 5.3348 2.3100 0.0 0
M  V30 4 C 8.0022 3.8500 0.0 0
M  V30 5 C 6.6684 1.5400 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 C 6.6684 0.0000 0.0 0
M  V30 8 F 0.0000 6.9301 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 4.0011 6.1601 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 2.6675 6.9301 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 459-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 346592-31-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-12691295
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 144026-79-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 174501-64-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective thioacetalization and transthioacetalization of carbonyl
compounds catalyzed by immobilized scandium(III) triflate in ionic
liquids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kamal, Ahmed; Chouhan, Gagan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2003), 44(16), 3337-3340

$RFMT $RIREG SCHEME477 STEP1
$RXN



  2  1
$MOL
Methyl thiosalicylate
C8H8O2S
4892-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 S 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[(1,1-dimethylethyl)dithio]benzoate
C12H16O2S2
927270-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 4.0012 0.0 0
M  V30 2 O 8.2638 4.0012 0.0 0
M  V30 3 O 5.9538 5.3348 0.0 0
M  V30 4 C 9.0338 5.3348 0.0 0
M  V30 5 S 3.6437 4.0012 0.0 0
M  V30 6 S 2.1037 4.0012 0.0 0
M  V30 7 C 1.3337 5.3348 0.0 0
M  V30 8 C 0.0000 4.5648 0.0 0
M  V30 9 C 0.5637 6.6687 0.0 0
M  V30 10 C 2.6673 6.1048 0.0 0
M  V30 11 C 5.9538 2.6675 0.0 0
M  V30 12 C 4.4137 2.6675 0.0 0
M  V30 13 C 6.7238 1.3338 0.0 0
M  V30 14 C 3.6437 1.3338 0.0 0
M  V30 15 C 5.9538 0.0000 0.0 0
M  V30 16 C 4.4137 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4892-02-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 927270-06-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-511-CAS-7419650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 95-14-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 21050-95-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, one-pot reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiolsulfinate allicin from garlic. Inspiration for a new antimicrobial
agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hunter, Roger; Caira, Mino; Stellenboom, Nashia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Annals of the New York Academy of Sciences (2005), 1056234-241

$RFMT $RIREG SCHEME478 STEP1
$RXN



  2  1
$MOL
Ethanethiol
C2H6S
75-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.0000 0.0 0
M  V30 2 C 0.0000 0.7700 0.0 0
M  V30 3 S 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hexenal
C6H10O
505-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Bis(ethylthio)-2-hexene
C10H20S2
440361-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0
M  V30 2 C 4.0011 4.6200 0.0 0
M  V30 3 S 1.3336 4.6200 0.0 0
M  V30 4 S 2.6674 2.3100 0.0 0
M  V30 5 C 5.3347 3.8500 0.0 0
M  V30 6 C 1.3336 6.1600 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 C 0.0000 6.9300 0.0 0
M  V30 10 C 1.3336 0.0000 0.0 0
M  V30 11 C 8.0021 3.8500 0.0 0
M  V30 12 C 9.3358 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5 CFG=2
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-08-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 505-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 440361-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-307-CAS-8804233
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-38-1
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM silica-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Thioacetalization and Transthioacetalization;
General Procedure To a stirred mixture of a carbonyl compound (1 mmol) or
an acetal (1 mmol) and alkyl thiol (2.2 mmol) or ethane dithiol (1.2
mmol) in CH2Cl2 (10 mL), activated NaHSO4·SiO2 (200 mg) was added at r.t.
The progress of the reaction was monitored by TLC. After completion of
the reaction, the mixture was filtered and the filtrate was concentrated.
The residue was subjected to column chromatography over silica gel and
the column was eluted with EtOAc-hexane (1:4) to afford pure thioacetal.
The spectral and analytical data of the unknown compound are given below.
Compound 2p, yield 95%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Studies on novel synthetic methodologies. Part 39. Simple, mild and
efficient thioacetalization and transthioacetalization of carbonyl
compounds and deprotection of thioacetals: unique role of thiols in the
selectivity of thioacetalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Biswanath; Ramu, Ravirala; Reddy, Majjigapu Ravinder; Mahender,
Gurram
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2005), (2), 250-254

$RFMT $RIREG SCHEME479 STEP1
$RXN



  2  1
$MOL
tert-Butyl mercaptan
C4H10S
75-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 3.0800 1.5400 0.0 0
M  V30 5 S 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1-(2,4-difluorophenyl)ethanone
C8H5ClF2O
51336-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 C 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 Cl 0.0000 4.0010 0.0 0
M  V30 5 F 3.8501 0.0000 0.0 0
M  V30 6 F 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2,4-Difluorophenyl)-2-[(1,1-dimethylethyl)thio]ethanone
C12H14F2OS
294841-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 S 8.0023 1.5400 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 10.1060 0.9764 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 C 8.5660 3.6437 0.0 0
M  V30 9 F 2.6673 0.0000 0.0 0
M  V30 10 F 0.0000 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 12
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-66-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51336-94-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 294841-85-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-026-CAS-1409216
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-t-Butylsulfanyl-1-(2,4-difluoro-phenyl)-ethanone (179): Potassium
carbonate (0.84 g, 6.11 mmol) was added to a solution of
2-chloro-2',4'-difluoro acetophenone (0.970 g, 5.09 mmol) and t-butyl
thiol (0.63 cm**3, 5.6 mmol) in methanol (10 cm**3) at 0 degC. The
mixture was stirred at room temperature for two hours. After filtration,
most of the solvent was removed in vacuo. The residue was poured into
distilled water (10 cm**3) and extracted with chloroform (3 x 10 cm**3).
The combined organic layers were dried over MgSO4 and evaporated in vacuo
to afford the title compound 179 as a yellow oil (1.19 g, 95 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Application of the Stereoselective Cycloaddition of Sulfenic Acids with
Alkenes in Target Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tisselli, Patrizia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2004), (20140701), No pp.

$RFMT $RIREG SCHEME480 STEP1
$RXN



  2  1
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Securinine
C13H15NO2
5610-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.3288 5.4237 0.0 0
M  V30 2 C 4.7196 3.7343 0.0 0 CFG=2
M  V30 3 C 3.8736 2.6673 0.0 0 CFG=1
M  V30 4 C 4.3484 5.2289 0.0 0
M  V30 5 C 3.0545 4.2624 0.0 0
M  V30 6 O 6.2558 3.6252 0.0 0
M  V30 7 N 2.3336 2.6673 0.0 0
M  V30 8 C 4.6437 1.3337 0.0 0
M  V30 9 C 3.0995 5.7862 0.0 0
M  V30 10 C 5.6553 6.0437 0.0 0
M  V30 11 C 1.4948 3.7270 0.0 0 CFG=1
M  V30 12 C 6.8341 5.0527 0.0 0
M  V30 13 C 1.5636 1.3337 0.0 0
M  V30 14 C 3.8736 0.0000 0.0 0
M  V30 15 C 1.7436 5.0687 0.0 0
M  V30 16 C 2.3336 0.0000 0.0 0
M  V30 17 H 5.4095 2.5545 0.0 0
M  V30 18 H 0.0000 3.3563 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 17 CFG=3
M  V30 9 1 4 9
M  V30 10 2 4 10
M  V30 11 1 11 5 CFG=1
M  V30 12 1 6 12
M  V30 13 1 7 11
M  V30 14 1 7 13
M  V30 15 1 8 14
M  V30 16 2 9 15
M  V30 17 1 10 12
M  V30 18 1 11 15
M  V30 19 1 11 18
M  V30 20 1 13 16
M  V30 21 1 14 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 3 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6S,11aR,11bS)-5,6,9,10,11,11a-Hexahydro-5-[(2-methylpropyl)thio]-8H-6,11b-me...
C17H25NO2S
1693754-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.4694 0.0000 0.0 0
M  V30 2 S 6.8649 6.4993 0.0 0
M  V30 3 C 8.1060 5.5872 0.0 0
M  V30 4 C 9.5162 6.2060 0.0 0
M  V30 5 C 9.6854 7.7367 0.0 0
M  V30 6 C 10.7571 5.2942 0.0 0
M  V30 7 C 2.8110 3.9704 0.0 0 CFG=2
M  V30 8 C 2.3101 5.2363 0.0 0 CFG=1
M  V30 9 C 4.2910 3.5444 0.0 0
M  V30 10 C 4.1008 5.1483 0.0 0
M  V30 11 O 1.9486 2.6944 0.0 0
M  V30 12 N 3.0801 6.5701 0.0 0
M  V30 13 C 0.7700 5.2363 0.0 0
M  V30 14 C 5.3981 4.3475 0.0 0
M  V30 15 C 4.3432 2.0053 0.0 0
M  V30 16 C 4.4171 6.7668 0.0 0 CFG=1
M  V30 17 C 2.8954 1.4800 0.0 0
M  V30 18 C 2.3101 7.9038 0.0 0
M  V30 19 C 0.0000 6.5701 0.0 0
M  V30 20 C 5.4546 5.8805 0.0 0 CFG=3
M  V30 21 C 0.7700 7.9038 0.0 0
M  V30 22 H 1.4442 3.9627 0.0 0
M  V30 23 H 4.8434 8.2466 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10 CFG=1
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 8 22 CFG=3
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 16 10 CFG=1
M  V30 17 1 11 17
M  V30 18 1 12 16
M  V30 19 1 12 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 1 15 17
M  V30 23 1 16 20
M  V30 24 1 16 23
M  V30 25 1 18 21
M  V30 26 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 8 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5610-40-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693754-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-238-CAS-1515578
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Small molecule securinine and norsecurinine analogs and their use in
cancers inflammatory diseases and infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gundluru, Mahesh K.; Agarwal, Mukesh; Xia, Zhiqing; Karan, Goutam; Wald,
David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015051284 A2 2015-04-09

$RFMT $RIREG SCHEME480 STEP1
$RXN



  2  1
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Securinine
C13H15NO2
5610-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.3288 5.4237 0.0 0
M  V30 2 C 4.7196 3.7343 0.0 0 CFG=2
M  V30 3 C 3.8736 2.6673 0.0 0 CFG=1
M  V30 4 C 4.3484 5.2289 0.0 0
M  V30 5 C 3.0545 4.2624 0.0 0
M  V30 6 O 6.2558 3.6252 0.0 0
M  V30 7 N 2.3336 2.6673 0.0 0
M  V30 8 C 4.6437 1.3337 0.0 0
M  V30 9 C 3.0995 5.7862 0.0 0
M  V30 10 C 5.6553 6.0437 0.0 0
M  V30 11 C 1.4948 3.7270 0.0 0 CFG=1
M  V30 12 C 6.8341 5.0527 0.0 0
M  V30 13 C 1.5636 1.3337 0.0 0
M  V30 14 C 3.8736 0.0000 0.0 0
M  V30 15 C 1.7436 5.0687 0.0 0
M  V30 16 C 2.3336 0.0000 0.0 0
M  V30 17 H 5.4095 2.5545 0.0 0
M  V30 18 H 0.0000 3.3563 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 17 CFG=3
M  V30 9 1 4 9
M  V30 10 2 4 10
M  V30 11 1 11 5 CFG=1
M  V30 12 1 6 12
M  V30 13 1 7 11
M  V30 14 1 7 13
M  V30 15 1 8 14
M  V30 16 2 9 15
M  V30 17 1 10 12
M  V30 18 1 11 15
M  V30 19 1 11 18
M  V30 20 1 13 16
M  V30 21 1 14 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 3 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6S,11aR,11bS)-5,6,9,10,11,11a-Hexahydro-5-[(2-methylpropyl)thio]-8H-6,11b-me...
C17H25NO2S
1693754-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.4694 0.0000 0.0 0
M  V30 2 S 6.8649 6.4993 0.0 0
M  V30 3 C 8.1060 5.5872 0.0 0
M  V30 4 C 9.5162 6.2060 0.0 0
M  V30 5 C 9.6854 7.7367 0.0 0
M  V30 6 C 10.7571 5.2942 0.0 0
M  V30 7 C 2.8110 3.9704 0.0 0 CFG=2
M  V30 8 C 2.3101 5.2363 0.0 0 CFG=1
M  V30 9 C 4.2910 3.5444 0.0 0
M  V30 10 C 4.1008 5.1483 0.0 0
M  V30 11 O 1.9486 2.6944 0.0 0
M  V30 12 N 3.0801 6.5701 0.0 0
M  V30 13 C 0.7700 5.2363 0.0 0
M  V30 14 C 5.3981 4.3475 0.0 0
M  V30 15 C 4.3432 2.0053 0.0 0
M  V30 16 C 4.4171 6.7668 0.0 0 CFG=1
M  V30 17 C 2.8954 1.4800 0.0 0
M  V30 18 C 2.3101 7.9038 0.0 0
M  V30 19 C 0.0000 6.5701 0.0 0
M  V30 20 C 5.4546 5.8805 0.0 0 CFG=3
M  V30 21 C 0.7700 7.9038 0.0 0
M  V30 22 H 1.4442 3.9627 0.0 0
M  V30 23 H 4.8434 8.2466 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10 CFG=1
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 8 22 CFG=3
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 16 10 CFG=1
M  V30 17 1 11 17
M  V30 18 1 12 16
M  V30 19 1 12 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 1 15 17
M  V30 23 1 16 20
M  V30 24 1 16 23
M  V30 25 1 18 21
M  V30 26 1 19 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 8 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5610-40-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1693754-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-238-CAS-370878
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Small molecule securinine and norsecurinine analogs and their use in
inhibiting myeloperoxidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gundluru, Mahesh K.; Agarwal, Mukesh; Xia, Zhiqing; Karan, Goutam; Wald,
David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015051276 A1 2015-04-09

$RFMT $RIREG SCHEME481 STEP1
$RXN



  2  1
$MOL
2-Methyl-1-propanethiol
C4H10S
513-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 1.3337 0.0000 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 S 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-3,4-dinitro-1H-pyrazole
C4H4N4O4
66296-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.8385 0.0 0 VAL=5
M  V30 2 O 1.3337 6.3785 0.0 0
M  V30 3 O 0.0000 4.0685 0.0 0
M  V30 4 N 1.6839 1.5063 0.0 0 VAL=5
M  V30 5 O 0.2193 1.9823 0.0 0
M  V30 6 O 2.0040 0.0000 0.0 0
M  V30 7 C 6.6363 3.7113 0.0 0
M  V30 8 C 2.6673 4.0685 0.0 0
M  V30 9 C 2.8284 2.5369 0.0 0
M  V30 10 C 4.0743 4.6948 0.0 0
M  V30 11 N 4.3347 2.2167 0.0 0
M  V30 12 N 5.1048 3.5504 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-4-[(2-methylpropyl)thio]-3-nitro-1H-pyrazole
C8H13N3O2S
1890144-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5063 4.9524 0.0 0 VAL=5
M  V30 2 O 0.0000 4.6323 0.0 0
M  V30 3 O 1.9823 6.4170 0.0 0
M  V30 4 S 4.8385 5.3026 0.0 0
M  V30 5 C 6.3785 5.3026 0.0 0
M  V30 6 C 7.1485 6.6363 0.0 0
M  V30 7 C 6.3785 7.9700 0.0 0
M  V30 8 C 8.6886 6.6363 0.0 0
M  V30 9 C 3.7113 0.0000 0.0 0
M  V30 10 C 2.5369 3.8079 0.0 0
M  V30 11 C 4.0685 3.9690 0.0 0
M  V30 12 N 2.2167 2.3016 0.0 0
M  V30 13 C 4.6948 2.5620 0.0 0
M  V30 14 N 3.5504 1.5316 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 513-44-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 66296-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1890144-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-171-CAS-21170234
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as
potent anaplastic lymphoma kinase (ALK) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Peilong; Dong, Jiaqiang; Zhong, Boyu; Zhang, Deyi; Yuan, Hongbin;
Jin, Can; Xu, Xiangyuan; Li, Hailong; Zhou, Yong; Liang, Zhi; Ji,
Minghua; Xu, Tao; Song, Guowei; Zhang, Ling; Chen, Gang; Meng, Xuejing;
Sun, Desheng; Shih, Joe; Zhang, Ruihao; Hou, Guojun; Wang, Chengcheng;
Jin, Ying; Yang, Qiong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(8), 1910-1918

